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“Chemical synthesis always has some element of planning in it. But, the planning should never 
be too rigid. Because, in fact, the specific objective which the synthetic chemist uses as an excuse 
for his activity is often not of special importance in the general sense; rather, the important 
things are those that he finds out in the course of attempting to reach his objective.” 
R. B. Woodward. Proc. Robert A. Welch Foundation Conf. Chem. Res. 1969, 12, 3. 
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Abstract 
 
This thesis describes synthetic studies directed towards the total synthesis of the nakafuran and 
florlide marine natural products. Chapter One provides an overview of the importance of 
natural products to current medicinal chemistry and describes how the “supply issue” associated 
with these biologically derived compounds can be resolved through the process of total 
synthesis. Two families of marine natural products, the nakafurans and the florlides, are 
introduced as synthetic targets and strategies utilising a type II intramolecular Diels-Alder 
(IMDA) reaction to achieve their total synthesis are delineated. 
 
The efficient preparation of regio- and stereodefined vinyl coupling fragments via 
hydrostannylation and hydrohalogenation methodology is described in Chapter Two. The 
palladium-catalysed cross-coupling of these fragments, via Stille or Negishi coupling 
methodology, yielded dienes which were successfully advanced to IMDA triene precursors. 
 
Chapter Three describes investigation of the type II IMDA reaction to give 
bicyclo[4.3.1]decene carbocyclic skeletons. A facile acid-catalysed Δ6,7 ? Δ7,8 olefinic 
isomerisation, via a proposed oxonium intermediate, and the inability to appropriately 
functionalise the desired adducts impeded progress along the synthetic route. Molecular 
modelling was conducted to investigate the causes of this unexpected reactivity. 
 
Investigations in Chapter Four describe the successful synthesis and cyclisation of homomethyl 
triene analogues prepared via application of enyne metathesis chemistry. The use of an exo-
cyclopropylcarbinyl fragmentation was found to be unsuccessful as a means of installing the 
desired 6-methyl-bicyclo[4.3.1]decan-2-one core with a competing endo-ring expansion giving 
rise to a bicyclo[4.4.1]undecane ring system. 
 
Chapter 5 summarises the above results and gives a brief discussion of the future potential of 
this research to provide for a total synthesis of the nakafuran and florlide natural products. 
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This dissertation uses standard abbreviations and acronyms as recommended by the American 
Chemical Society.* Additional terms are listed below. 
 
BHT 2,6-di-tert-butyl-4-methylphenol 
cat. catalytic 
CIGAR  constant time inverse-detected gradient accordion rescaled 
COSY correlation spectroscopy 
2D NMR two dimensional nuclear magnetic resonance spectroscopy 
dba dibenzylideneacetone 
DHP dihydropyran 
DMPU 1,3-dimethyl-3,4,5,6-tetrahydro-2(1H)-pyridimidinone 
DNB 1,3-dinitrobenzoyl 
EDCI 1-[3-(dimethylamino)propyl]-3-ethylcarbodiimide hydrochloride 
HMBC heteronuclear multiple bond coherence 
HSQC heteronuclear single quantum coherence 
HMDS hexamethyldisilazane 
Hünig’s base N,N-diisopropylethylamine 
Imid imidazole 
MPLC medium-pressure liquid chromatography 
MS mass spectrometry 
NMO N-methylmorpholine-N-oxide 
NMP 1-methyl-2-pyrrolidinone 
NOESY nuclear Overhauser effect spectroscopy 
PMB para-methoxybenzyl 
PDC pyridinium dichromate 
sat. saturated 
TBAF tetra-n-butylammonium fluoride 
TBS tert-butyldimethylsilyl 
TES triethylsilyl 
TFP tri(2-furyl)phosphine 
TMP 2,2,6,6-tetramethylpiperidine 
TMSI iodotrimethylsilane 
TOCSY total correlation spectroscopy 
TPAP tetra-n-propylammonium perruthenate
                                                 
* ACS Guidelines for Authors, J. Org. Chem, 2006, 71, 1, 1A-11A. 
Chapter One – Introduction to Natural Product Synthesis  1
Chapter One 
Introduction to Natural Product Synthesis 
1.1 The Origins of Natural Products 
 
The processes of nature result in the synthesis of a remarkable array of primary and secondary 
metabolites. The primary metabolic system, which refers to the normal anabolic and catabolic 
biochemical processes common to all cellular organisms, generates and utilises ubiquitous 
compounds such as proteins, nucleic acids, carbohydrates and lipids. By contrast, secondary 
metabolism consists of a large number of diverse biochemical processes that are characteristic or 
unique to certain cell types or species. Plants, fungi and bacteria produce a profusion of 
structurally diverse secondary metabolites, also known as natural products, which encompass 
such elements as the alkaloids, glycosides, terpenes, phenols and rare amino acid products. 
 
Secondary metabolites are often described as having no explicit role within the internal economy 
of the producing organism.1 It is postulated that the expression of natural products has evolved to 
provide a selective survival advantage to the producing organism, by either attracting or 
repelling other organisms.2 Whilst many natural products deter predation or infection through the 
cellular expression of noxious, bactericidal or antimitotic compounds, secondary metabolites 
have also been observed to serve integral functions in such diverse roles as differentiation 
effectors, metal transporting agents, sex hormones and in symbiotic communication. 
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1.2 Therapeutic Applications of Natural Products 
 
Historically, it has been the pharmacological properties and physiological effects of natural 
products that have elicited the most interest. From aspirin and caffeine, to morphine and quinine; 
human society has pursued the ingestion of biologically derived compounds to elicit a desired 
physiological effect.3 In the present day, natural products continue to provide most of the world’s 
population with their pharmacopoeia, and represent the source, or inspiration, for a significant 
proportion of the Western world’s pharmaceuticals.  
 
Secondary metabolites contained within terrestrial plant extracts have, for thousands of years, 
played an essential role in traditional medicine systems. Historical pharmacopoeias such as the 
Eber’s Papyrus, compiled by Egyptian priest-physicians in 1550 BC and the writings of Galen 
(129-199 AD) illustrate the extensive use of plant-derived materials in a medicinal context. 
Knowledge of the bioactive constituents was limited and the discovery process was largely 
empirical or observationally derived. Principal examples included the use of the bark of the 
willow tree (order Salicaceae) as an analgesic, extracts of Papaver somniferum poppy to treat 
pain, and extracts from the bark of the Peruvian Cinchona tree for the treatment of malaria.  
 
These bioactive compounds, identified by present day nomenclature as salicin (1.1), morphine 
(1.2) and quinine (1.3) respectively, occupy not only a role as traditional medicinal agents but 
also as prominent chemical milestones that illustrate the isolation, elucidation and synthesis of 
natural products (Figure 1.1).4,5 
O
O
HO
HO
HO
OH
OH
O
HO
HO
NMe
H
N
N
MeO
HO
H
1.1 1.2 1.3  
Figure 1.1 Historically significant natural products. 
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Natural products have played, and continue to play, an important role in drug discovery and the 
advancement of organic chemistry.5-7 The clinical success of the sulfonamides and penicillins in 
the period 1938-1945 transformed the treatment of bacterial infection. It led to the acceptance of 
the idea that many human diseases would be amenable to treatment with selectively toxic 
chemicals of a synthetic or biological origin.8,9 
 
In this context, the enormous biodiversity inherent in nature represents a tremendous resource for 
scientific researchers. Over the past two centuries, a strikingly diverse array of secondary 
metabolites have been isolated from plant, fungal, animal, and recently, microbial sources.10 
These isolated natural products display a diverse range of physiological and pharmacological 
properties which are intimately related to the often novel and structurally complex molecular 
architecture. Some of these molecules have served as biochemical tools to assist in the 
elucidation of metabolic pathways and intracellular interactions and many have been developed 
into medicinal agents for the treatment of disease.9 It has been estimated that 39% of the new 
drugs approved in the period 1983-1994 and 60-80% of the antibacterial, anticancer and anti-
HIV drugs were derived from natural products.5 
 
 
1.3 Marine Natural Products 
1.3.1 Biochemical and Structural Diversity Arising from Biological 
Diversity 
 
Whilst initial endeavours to discover substances of therapeutic potential focused primarily on 
terrestrial plants, fungi and micro-organisms, pioneering work by academic chemists in the 
1970s stimulated interest in the field of marine natural products.11,12 The extension of 
bioprospecting to the oceans is a natural progression, when the biodiversity inherent in the 
marine environment is considered.13 It is estimated that the majority of all species live in the 
oceans, which cover 70% of the planet’s surface. Of the 38 phyla in the animal kingdom, 26 are 
exclusively aquatic and only one is exclusively terrestrial.2 Furthermore, the marine environment 
encompasses a tremendous variety of habitats, differing markedly in temperature, pressure, light, 
                                                 
2 Velvet worms from the phyla Onchyophora, are the only known exclusively terrestrial phyla. Fossils discovered in 
the Burgess Shale, from the Cambrian period, indicate that this phylum evolved in the oceans. 
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pH, salinity and anaerobic conditions. The marine environment is yet to be extensively 
investigated; discoveries are being continually made of new sea life and unique ecosystems in 
the pelagic region. 
 
Advancement of modern scientific methods, especially bioassay-guided screening in conjunction 
with advanced spectroscopic techniques (2D-NMR, HPLC, LC/MS), have made it possible to 
detect, fractionate and elucidate the structure of natural products of low abundance and high 
structural complexity. These advances have resulted in the rapid and steady growth of marine 
natural product literature over the last thirty years. For example, in the period 2000 to 2003, 2450 
new natural products of marine origin were reported. This compares to around 100 in the period 
1965 to 1970.14  
 
Compounds isolated from the marine environment are extraordinary for their complexity and 
connectivity, with substantial incorporation of heteroatom and halogen functionality. Faulkner 
suggested that marine organisms possess a greater prevalence of bioactive metabolites than do 
terrestrial organisms.15 Indeed, secondary metabolites isolated from marine environments have 
been a rich source of antibiotic and antimitotic agents.14 Published reviews clearly indicate the 
tremendous potential of taxonomically diverse marine micro- and macro-organisms as a source 
of pharmaceuticals, possessing a wide range of pharmacological activities including antitumour, 
antibacterial, anti-inflammatory, antifungal and antiviral activities (Figure 1.2).7,13,16 
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Figure 1.2 A selection of marine secondary metabolites, illustrative of the structural and 
pharmacological diversity, which have been successfully synthesised. 
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Marine compounds commonly display remarkably high levels of bioactivity. The high potency is 
believed to be an evolutionary adaptation to counteract the effect of high dilution in an aqueous 
environment. An example of this phenomenon is ciguatera, which is an important form of human 
poisoning. Ciguatera is caused by the consumption of affected shellfish and seafood following 
algal blooms or “red tides”. More than 20 000 people are affected annually, making it the most 
common form of non-bacterial food poisoning. Epiphytic dinoflagellates, such as Gambierdiscus 
toxicus, are the causative organism. They produce a number of highly-toxic polycyclic ether 
macrolides such as ciguatoxin (1.4) (Figure 1.3),17 maitotoxin,18 brevetoxin,19,20 gambierol,21-23 
gymnocin A24 and palytoxin.25 These molecules are remarkable not only for their extraordinary 
toxicity (inducing neurological, gastrointestinal, and cardiovascular disorders at concentrations 
as low as 0.25 μg to 100 μg/kg) but also due to their stereochemically complex linear 
macrocyclic arrays.26 
O
O
O
O
O
O
O
O
O
O
O O
OH
HO H HHO H H H H
H
H H H H
H
OH
H H H H H
HO H
H H
H
O
H
OH
1.4
Ciguatoxin (CTX) 
Na+ channel voltage gate-blocker  
Figure 1.3 Ciguatoxin, elucidated in 1989 by Yasumoto et al.27 was recently synthesised by 
Hirama et al.28 
 
1.3.2 Marine Natural Product Pharmaceuticals 
 
There is little doubt that marine biodiversity is a source of chemical and structural diversity. 
However, of the over 14 000 compounds described,29 many of which display potent biological 
activity and have been utilised as bio-medical leads, few have proceeded to become approved 
pharmaceutical drugs.7,3 
 
                                                 
3 Drugs currently on the market of a marine “origin”, whether an isolate or derived from a lead compound, are the 
antiviral drug Acyclovir, anticancer agent Cytarabine, the antibiotic Cephalosporin, (which is also expressed by 
many terrestrial microorganisms) and Ziconotide (Conus toxin) for the treatment of severe chronic pain. Yondelis 
(ecteinascidin 743) is currently in Phase III trials in Europe. 
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The reasons for this are manifold. Most significant is simply the later emergence of marine 
natural product chemistry compared with the established chemistry of terrestrial natural 
products. However, specific difficulties associated with the isolation and study of marine natural 
products have also delayed the progress of them or their analogues through clinical trials. 
Promising bioactive compounds are often expressed in low natural abundance (~10-6 % net 
weight) within the source organism. Consequently, it has proven notoriously difficult to obtain 
adequate, reliable and, most importantly, renewable supplies of these compounds from the 
marine environment. Compounding this problem is the inherent structural complexity of many 
marine natural products, which eliminates the possibility of commercial synthesis. 
 
An example of this is the isolation of Spongistatin 1 from the marine sponge Spongia. An initial 
extraction from 400 kg of Spongia yielded 13.8 mg of Spongistatin 1, a potent antitumour agent 
(Figure 1.2).30 Attempted recollection of 20 tonnes failed to yield significantly larger amounts.31 
Many researchers believe that the Spongistatin compounds are actually produced by symbiotic 
micro-organisms, yet bacteria or fungi that provide these metabolites have not been isolated from 
the parent organism. The successful total syntheses of the Spongistatins are yet to yield 
pharmaceutically viable quantities.32 Without an adequate and reproducible resource of supply, it 
is impossible to advance a compound forward into therapeutic use. 
 
Considerable effort has been expended attempting to find a solution to the issues of supply. 
Aquaculture of marine organisms, genomic expression in bacterial hosts, tissue culture and total 
synthesis have all been advanced as potential solutions.33 
 
1.3.3 Total Synthesis as a Solution to the Supply Problem 
 
The total synthesis of an isolated natural product was originally pursued to unequivocally 
confirm the postulated structural assignment through a sequence of well-defined chemical 
transformations. With the advent of sophisticated spectroscopic, mass spectral and X-ray 
analysis techniques, structural elucidation has increasingly been completed before the 
commencement of a synthetic endeavour. However, while modern techniques such as NMR 
spectroscopy have been very successful in allowing the structures of even very complex natural 
products to be determined, the unambiguous structure determination of stereochemical issues are 
often difficult or impossible to elucidate by spectroscopic methodology alone. The synthesis of 
one or more of the possible stereoisomers is required to establish the correct structure. A recent 
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review illustrated that it is not uncommon for a total synthesis to be achieved, only to find that 
the natural product structural assignment was incorrect.34 These incorrect natural product 
assignments can have implications in the development of biosynthetic proposals for entire 
classes of compounds. 
 
As well as maintaining its importance in structural elucidation, total synthesis is often pursued 
for the purpose of providing sufficient material and structural analogues to assist in biological 
testing, structure-activity relationships (SAR) or for pharmaceutical purposes. 
 
A topical example that illustrates the use of chemical synthesis to establish supply is the 
industrial synthesis of discodermolide (1.5). In 1990, Gunasekera and co-workers reported the 
isolation and structural elucidation of (+)-discodermolide, derived from the deep sea marine 
sponge Discodermia dissolute (Figure 1.4).35 
O OOH
OH
HO
OH
O
H
O
NH2
1.5
(+)-Discodermolide 
antitumour, microtubule stabilizer  
Figure 1.4 (+)-Discodermolide, isolated from Discodermia dissolute (0.002% w/w from the 
frozen sponge). 
 
Subsequently, the groups of ter Haar36 and Schreiber37 independently revealed that (+)-
discodermolide possesses potent antimitotic activity, akin to the clinically proven anticancer 
agent TaxolTM (paclitaxel), with a similar mechanism of action that entails binding to and 
stabilising of microtubule structures. Importantly, (+)-discodermolide displayed significant 
tumour cell growth inhibitory activity against a wide range of known cancer cell lines, including 
Taxol-resistant cells.38,39 
 
The limited availability of discodermolide from natural sources compromised access to practical 
quantities required to investigate the promising biological activity. Considerable interest in this 
natural product led to a total synthesis by Schreiber and co-workers,40 followed by the groups of 
Smith,41 Myles,42 Marshall43 and Paterson39,44 and a number of advanced fragment syntheses.41 
Novartis Pharmaceuticals, utilising a hybrid synthetic scheme incorporating elements of the 
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Paterson, Smith and Marshall routes, were able to prepare 60 grams of (+)-discodermolide in 26 
linear steps and 1% overall yield (Scheme 1.1).45 
O OOH
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HO
OH
O
H
O
NH2
*
* * *
** *
* *
O
N
OTBSO
MeO
Me
PMBO
OTBS
I
***
PMBO N
OH O
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O
I
TBSO
O
Pd-catalysed 
Suzuki coupling
Boron Aldol
* *
** *
*
*
* *
OOH
OH
O
O
NH2
* * *
** *
H
1.5
1.6
 
Scheme 1.1 Novartis’s retrosynthetic scheme to (+)-discodermolide. 
 
The successful synthesis benefited from the identification of a common stereotriad which is 
repeated three times in the linear polypropionate chain, allowing the synthesis to proceed from a 
common precursor (1.6), readily available from (+)-S-Roche's ester. Successive improvements 
by the groups of Smith41 and Paterson,46 aimed at facilitating large scale production, have 
reduced the number of steps to 17 and 23 respectively whilst increasing the total overall yield to 
9%. These studies have also resulted in the preparation of numerous simplified structural 
analogues that have assisted in determining the biological profile.47 The synthetic preparation of 
significant quantities has allowed (+)-discodermolide to progress to Phase I clinical trials.7 
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As described, chemical synthesis presents an attractive solution to the supply problem. This can 
either be by de-novo synthesis, as in the case of (+)-discodermolide, or via semi-synthesis from a 
naturally available starting material, such as that utilised in the preparation of TaxolTM 
(paclitaxel) (1.7)48,49 and ecteinascidin 743 (1.8)50-52 (Figure 1.5). 
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Figure 1.5 Semi-synthetic preparation of pharmaceutical drugs from abundant natural 
compounds. 
 
Natural products can also be seen as playing a major role in driving forward the science and 
theory of organic synthesis. The structural diversity presented by natural products encourages the 
investigation of novel transformations and the discovery and implementation of new synthetic 
methodology to achieve the total synthesis of these increasingly complex, densely functionalised 
chemical targets. The structurally complex marine natural products illustrated in Figure 1.2, by 
necessity, have required the development of unique and inventive synthetic transformations in 
their successful total syntheses.53 
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The continued discovery of new and unique natural products from the marine environment, and 
the synthetic endeavours conducted towards their total synthesis, represents a strong motivation 
for the continued development and application of organic synthetic methodology. The 
advancement of the field of contemporary organic synthesis can be gauged by the ease and the 
specificity with which selected synthetic transformations can be achieved within such complex 
systems. 
 
 
1.4 Marine Natural Product Target Structures 
 
Marine sponges (Phylum Porifera) are considered to be primitive organisms with relatively 
simple internal organisation. Sponges, particularly those without spicules, frequently produce 
large quantities of secondary metabolites that are thought to deter potential predators and to 
inhibit the growth of fouling organisms. As many sponges contain symbiotic micro-organisms, 
there is always some uncertainty concerning the true origin of isolated sponge metabolites. An 
unusually diverse array of bioactive metabolites have been isolated from various specimens of 
Dysidea herbacea54 including polybrominated biphenyl ethers (1.9), chlorinated nitrogenous 
metabolites (1.10), sesquiterpenoids (1.11) and sterols (1.12) (Figure 1.6).55-58 It is believed that 
the majority of terpenoid metabolites are produced by the sponges, possibly in specialised 
spherulous cells,59,60 whereas the halogenated metabolites show strong resemblances to 
metabolites of epiphytic blue-green algae known to co-exist with D. herbacea. 
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Figure 1.6 Structurally diverse bioactive metabolites isolated from various specimens of 
Dysidea herbacea. 
 
Nudibranchs are marine molluscs of the order Gastropod, subclass Opisthobranchia which are 
soft-bodied, unprotected, and highly colourful members of the coral reef ecosystem. Despite 
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having a sedentary lifestyle and no physical defence mechanisms, they have few predators. In 
order to deter predation, many nudibranch concentrate selected metabolites from their sponge 
diet in non-mucous skin-glands located in the dorsum and employ these ichthyodeterrent 
allomones in defensive secretions. In most cases, the nudibranch can be found in the immediate 
vicinity of the dietary source of its metabolites, although a few nudibranchs are capable of de-
novo synthesis of defensive chemicals.61,62 Most nudibranchs appear capable of modifying 
dietary chemicals to provide more effective allomones.63-66 
 
The discussion of marine metabolites in this thesis will be restricted to those containing the 
bicyclo[4.3.1]decane core (1.13) as a common structural motif (Figure 1.7). 
1.13  
Figure 1.7 Bicyclo[4.3.1]decane core structure common to targeted marine natural products. 
 
 
1.4.1 Nakafuran Metabolites 
 
Investigation of the marine sponge Dysidea fragilis, and the secretions of three distinct 
nudibranchs (Phyllidia varicose, Hypselodoris godeffroyana and Chromodoris maridadilus) 
observed to be grazing on the sponge, resulted in the isolation of the furanosesquiterpenes, 
nakafuran-8 (1.14) and nakafuran-9 (1.15) (Figure 1.8).67 These metabolites have antimicrobial 
activity against a range of bacteria, inhibitory activity against P388 (murine leukaemia) cells in 
cytotoxicity assays and the capacity to repel reef fish in laboratory assays. It is postulated that the 
nakafuran metabolites are selectively retained from dietary sources by the molluscs for their 
defence against predators.54 A single large nudibranch, (H. godeffroyana, 1.5 grams) was 
extracted with methanol and the purification of the extract led to the isolation of 32 mg of 
nakafuran-8 and 5 mg of nakafuran-9. This is a remarkable ratio of 2.5% mass to body weight.67 
In feeding experiments, two species of reef fish, Chaetodons sp., were repelled by the nakafurans 
1.14 and 1.15, whilst another Dysidea sesquiterpene, upial (1.16), which was not present in the 
nudibranch, had no repellent properties, indicating a selective retention of ingested metabolites.67 
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Figure 1.8 Members of the nakafuran family of marine isolates. 
 
In 1999, Sera and colleagues reported the bio-assay guided fractionation of 39 mg of a new 
furanosesquiterpene (1.17), isolated as a pure white solid, from 1.6 kg of D. herbacea collected 
from the Milky Way marine lake in Palau.68 The structural assignment, based on NMR 
spectroscopy, was determined to be 2-hydroxy-9,11-dimethyl-10-methylene-3-oxatricyclo-
[7.3.1.02,6]tridec-5-en-4-one. 4 
 
This bioactive metabolite was observed to exhibit antifouling activity against blue foot mussels 
(Mytilus edulis galloprovincialis) at 100 ppm. The unnamed sesquiterpene possesses structural 
homology with the nakafuran-9 carbocycle, with the γ-hydroxy-α,β-unsaturated-γ-lactone 
presumably derived from oxidation of the furan moiety. 
 
Both furan and butenolide sesquiterpene metabolites are common in marine invertebrates.69 
Furan to lactone oxidation via a hydroperoxide intermediate is observed with the related 
metabolite furodysinin (1.18), isolated from Chromodoris funerea, a nudibranch found on 
sponges of the Dysidea genus.70 This transformation could be duplicated experimentally by 
reacting a methanolic solution of 1.18 at -78oC with singlet oxygen, generated photolytically 
using Rose Bengal as a catalyst, to yield the hydroperoxide 1.19. Oxidation with manganese 
dioxide yielded the O-methoxyfurodysinin lactone 1.20 (Scheme 1.2). 
 
O O
OOH
OMe
O
O
OMe
1O2, -78oC
MeOH
MnO2
1.18 1.19 1.20  
Scheme 1.2 Synthetic oxidation of furodysinin. 
 
 
                                                 
4 Flowers et al. used a numbering system for the nakafuran-9 series (1.15) which commences from the furan CH, 
while Sera et al. and Fusetani et al. number from the bridgehead atom adjacent to the furan. 
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1.4.1.1 Biological Origins 
 
The biogenetic origin of the nakafuran skeleton is postulated to be an extension of established 
biogenetic transformations.67 Farnesylpyrophosphate (1.21) serves as a starting material for a 
large number of naturally occurring sesquiterpenes.62 As indicated in Figure 1.9, sequences 
involving transannular carbocation cyclisations, cationic rearrangement and oxidations give rise 
to the drimane, pallascensin, microcionin and nakafuran families of natural products observed in 
Dysidea sp.62,71 
OPP
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Figure 1.9 Postulated biological origin of a number of marine secondary metabolite families. 
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Nakafuran-8 (1.14) can participate in further rearrangement via a Wagner-Meerwein-like 
carbocation intermediate. Elimination of a β-hydrogen gives rise to three isomeric nakafuran-9 
species 1.22, 1.23 and 1.15, differing only in the position of the double bond. As discussed for 
furodysinin, sequential oxidation of the furan moiety to a hydroperoxide and then butenolide 
gives rise to the known isolated nakafuran natural products 1.17 and 1.24-1.26 (Figure 1.10).71-74 
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Figure 1.10 Extension of the postulated biogenetic pathway to provide for the synthesis of the 
known members of the nakafuran family of marine natural products.  
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1.4.1.2 Prior Syntheses  
 
Tanis and Herrinton disclosed a route to the nakafuran family of metabolites exploiting a 
cationic π-cyclisation in the construction of the bridged ring system.75 The cyclisation precursor 
was prepared via a sequence commencing with the conjugate addition of a methylfuryl cuprate to 
vinyl epoxide 1.27. Subsequent manipulations yielded the enone 1.28 required for the 
electrophilic addition. Cyclisation was effected with a biphasic mixture of anhydrous formic acid 
and cyclohexane, affording the bicyclo[4.3.l]decanone 1.29 as a 60:40 mixture at C7. The methyl 
group and double bond were introduced via a Wittig reaction with subsequent double bond 
migration under acidic conditions yielding a 95:5 mixture of nakafuran-9 (1.15) and Δ8,9-
isonakafuran-9 (1.30) (Scheme 1.3). 
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Scheme 1.3 Cationic π-cyclisation formation of the bicyclo[4.3.1]decane system. 
 
Uyehara et al. reported the synthesis of nakafuran-8, in which they constructed the 
bicyclo[4.2.2]decadiene skeleton via sequential Shioiri ring enlargement76,77 of a 
bicyclo[2.2.2]oct-5-en-2-one ring system (1.31).78 The ring expansions also generated significant 
amounts of the isomeric bridged bicyclic ketones (~30% of isolated crude product), resulting 
from insertion of the carbene at the bridgehead carbon. Alkylation with excess ethyl iodoacetate 
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to generate the keto ester 1.32, was followed by hydrolysis, lactonisation and reduction to furnish 
nakafuran-8 (1.14) (Scheme 1.4). 
 
O O O
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H
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1.321.14
(i) TMSCHN2,
49%
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44%
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(iii) LDA, HMPA,
ethyl iodoacetate
(iv) K2CO3,
      MeOH(vi) DIBAL-H
(v) p-TsOH37%
(4 steps).
 
Scheme 1.4 Ring expansion route of a bicyclo[2.2.2]octane skeleton to nakafuran-8. 
 
White et al. reported the free radical annulation of an olefinic β-keto ester 1.33, mediated by 
Mn(OAc)3, to form the bicyclo[4.3.l]decane core 1.34 in a synthesis of 2,3-dihydropallescensin 
D (1.35) (Scheme 1.5).79  
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Scheme 1.5 Manganese(III) mediated cyclisation to derive the bicyclo[4.3.1] core. 
 
Also pertinent to the synthetic preparation of the nakafuran compounds was the initial report 
detailing the isolation of Δ7,14-nakafuran by Flowers et al. which indicated that it was possible to 
isomerise the Δ7,14- (1.22) and Δ8,13-nakafuran (1.23) to the Δ7,8-nakafuran-9 (1.15) using mild 
acid catalysis, (p-TsOH, benzene, reflux, 20 min).73 
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1.4.2 Xenicane Metabolites 
 
Xenicanes are a class of diterpenes and norditerpenes isolated from soft corals of the genus 
Xenia, (order Alcyonacea, family Xeniidae), but are also frequently found in the brown algae 
genus Dictyolaceae. Isolated metabolites have been found to possess substituted 
bicyclo[7.4.0]tridecane, bicyclo[7.2.0]undecane or bicyclo[4.3.1]decane ring structures, 
presumably derived from a common xeniaphyllenol precursor. Xenicanes (1.36) are diterpenoid 
analogues of the caryophyllene (1.37) class of natural products, which are common herbaceous 
secondary metabolites (Figure 1.11).80-83 
 
The structure of xenicin (1.38), a metabolite of Xenia elongate, was established by single crystal 
X-ray diffraction in 1977 by Schmitz et al.84 Numerous examples have subsequently been 
isolated from the xenicane family and can be classified into five main groups; xenicins 
(possessing a 11-oxabicyclo[7.4.0]tridecane ring system), xeniolides (the lactone derivatives of 
the xenicins), xeniaphyllanes (having a bicyclo[7.2.0]undecane ring system), xeniaethers 
(bearing a oxabicyclo[7.3.0]undecane ring system), and more recently, the azamilides and 
dictyotadial groups (with an opened A-ring and the nine-membered monocarbocyclic skeleton 
acylated with a series of C16-C20 saturated fatty acids) (Figure 1.11).69,85 The xenicanes display 
biological activity, including ichthyotoxicity, cytotoxicity, anti-inflammatory and antifungal 
activities. 
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Figure 1.11 Structures of the five main groups of the xenicane family, bearing the xenicane 
skeleton 1.36. 
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The proposed biosynthesis of the xenicane skeleton 1.36 is based on the initial transannular 
carbocation cyclisation of geranylgeraniol pyrophosphate (1.39) to the xeniaphyllane core 1.40. 
Subsequent modification through a series of oxidation, reduction and cyclisation pathways forms 
a profusion of natural products, members of which are illustrated in Figure 1.12.86 Members of 
the xenicane sub-families contain variable carbon oxidation states, including hydroxylation or 
epoxidation of the double bonds, variable oxidation levels of alcohol and carbonyl functionality, 
extensive double bond migration, and halogenation. 
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Figure 1.12 Postulated biosynthetic pathways to members of the xenicane family from 
geranylgeraniol pyrophosphate. 
 
Chapter One – Introduction to Natural Product Synthesis  21
1.4.3 Florlide Metabolites 
 
The second class of natural products that are of synthetic interest to this dissertation are the 
related florlide and florether families which contain the bicyclo[4.3.1]decane core 1.13 (Figure 
1.13). 
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Figure 1.13 Florlide, florether and floridicin natural products. 
 
Iwagawa proposed that the Florlide C (1.48) and D (1.49) epoxy-nonane skeletons are the 
biosynthetic precursors of the Florlide A (1.41) and B (1.42) bicyclo[4.3.1]decane core via a 
hydrolytic 6-endo-Tet transannular epoxide cleavage (Figure 1.14).87,88 A similar rearrangement 
can be assumed for the formation of the floridicin core from the xeniafaraunol skeleton. The 
recently reported Xenibellol A (1.56),89 which contains a tetrahydrofuran ring, presumably arises 
via an alternative 4-exo-Tet transannular cyclisation.90,91 
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Figure 1.14 Proposed biogenesis of Florlide A and Xenibellol A. 
 
The predisposition for this rearrangement was observed in the pursuit of the total synthesis of 
coraxeniolide A (1.57) by Leumann et al.92 An attempt to oxidise the acetal 1.58 to lactone 1.59, 
using a two step protocol involving acidic hydrolysis of the methyl acetal followed by treatment 
with Fetizon’s reagent (Ag2CO3 on Celite), resulted in the isolation of a 1:1 mixture of 
bicyclo[4.3.1]decane core isomers 1.60 in 61% yield. Despite variation in the nature and 
concentration of the acid (H2SO4, HCl, AcOH) 1.60a and 1.60b were always isolated as the main 
products (Scheme 1.6). Similar carbocation-induced transannular cyclisations are well-known in 
the caryophyllene series.93 
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Scheme 1.6 Leumann et al.’s synthesis of coraxeniolide A. 
 
A solution to this problem was found by employing the TBS-silyl acetal 1.61 which 
simultaneously increased the yield of the exo-methylene formation and allowed deprotection 
under basic conditions. Oxidation to the desired lactone 1.59 occurred without any observed 
transannular cyclisation products. 
In this context it can be seen that the florlide skeleton is closely related to the xeniolide core 
structure. 
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1.5 Retrosynthetic Approach 
 
The nakafuran and florlide natural products targeted in this thesis all contain the common motif 
of a 6-methyl-bicyclo[4.3.1]decane core 1.62 (Figure 1.15). 
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Figure 1.15 Targeted natural products that contain the core structure 1.62. 
 
In addition to the common carbon skeleton (1.62), the nakafurans and florlides possess a similar 
disposition of functional groups upon the ring system. The synthesis of a common intermediate 
7-alkoxy-bicyclo[4.3.1]dec-6-en-2-one (1.63) could be envisaged to allow selective elaboration 
to both target systems. As such, the preparation and functionalisation of this molecule is central 
to both retrosynthetic schemes as depicted in Scheme 1.7. 
 
Nakafuran
 R = Me
Florlides
R = H
PO
R
O
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R
O1.641.63
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Scheme 1.7 The central retrosynthetic concept showing the pivotal transformation of an 
acyclic triene 1.64 to the bridged bicyclic system 1.63. 
 
The proposed retrosynthetic routes to 1.63 feature a type II intramolecular Diels-Alder reaction 
(IMDA) as the key transformation to secure the desired bicyclo[4.3.1]decane core (Schemes 1.8 
and 1.9). The IMDA reaction has been demonstrated to achieve facile access to bicyclo[4.3.1] 
and bicyclo[5.3.1] ring systems in a single step from acyclic precursors. The utility of this 
reaction can be seen in the recent application of type II IMDA reactions in the total synthesis of a 
number of complex natural products (Chapter Three). 
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It is necessary to ensure that sufficient functionality is present in the acyclic precursor 1.64 to 
allow subsequent modification of the Diels-Alder adduct 1.63 to readily conclude the synthesis. 
In this respect the C2 ketone is integral to installation of the furan moiety, in the case of the 
nakafurans, and the conjugated olefinic system at C3 of the florlide metabolites. The Δ6,7-olefinic 
bond and the C7 ether will assist in establishing the C6 quaternary bridgehead methyl group and 
the C7 oxidation state. Introduction of the appropriate functionality is advantageous prior to 
cyclisation in terms of end game analysis, but the functionality should not hinder the IMDA 
reaction from occurring. 
 
1.5.1 Nakafuran Retrosynthetic Analysis 
 
The proposed route for the synthesis of a number of nakafuran natural products is depicted in 
Scheme 1.8. The formation of Δ7,14-nakafuran-9 (1.22) constitutes one of the primary objectives 
of this synthetic scheme, as it will serve as an intermediate which can be used to access a number 
of closely related nakafuran products. Isomerisation of the Δ7,14-olefinic bond to the Δ7,8 position 
under acidic conditions will generate nakafuran-9 (1.15), whereas photochemical oxidation of 
the furan functionality with singlet oxygen, and subsequent reduction will generate the 
butenolide functionality of the recently isolated natural product target (1.17). 
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Scheme 1.8 Retrosynthetic scheme for the synthesis of the nakafuran compounds 1.15, 1.17 
and 1.22. 
 
It is anticipated that deprotection and oxidation of the C3 side-chain of 1.66 to an aldehyde 
should establish the requisite functionality to effect the one-step furan annulation with a 
concomitant C7 methyl-ether hydrolysis-cyclopropane cleavage reaction to generate 1.65. To 
deliver the desired quaternary C6 methyl group, it is crucial that the external C7-C13 
cyclopropane bond is regioselectively cleaved in preference to the internal C6-C7 bond. 
Application of the Tebbe reaction conditions to the newly revealed C7 ketone of 1.65 should 
allow installation of the exocyclic methylene group to form Δ7,14-nakafuran-9 (1.22). 
The formation of 1.66 can be envisaged via the sequential regioselective alkylation at C3 on the 
cycloheptane ring of 1.68 adjacent to the C2 ketone functionality and cyclopropanation of the 
Δ6,7-bridgehead alkene. 
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The IMDA adduct 1.68, derived from the cyclisation of the triene precursor 1.69, represents the 
key intermediate in this retrosynthetic sequence. The Diels-Alder reaction will simultaneously 
form the carbocyclic core structure, establish the desired stereochemistry of the C15 methyl 
group relative to the bridgehead and position the olefinic bond at the C6-C7 bridgehead position 
to allow subsequent cyclopropanation.  
 
The palladium-catalysed cross-coupling of two appropriately functionalised fragments 1.71 and 
1.72 would result in the stereoselective formation of the Weinreb amide 1.70. Exposure of this 
adduct to vinylmagnesium bromide should result in the generation of the triene system 1.69 
required for the Diels-Alder cyclisation. The two coupling fragments 1.71 and 1.72 will be 
stereoselectively prepared from 5-hexyn-1-ol and 1-methoxypropyne respectively. 
 
1.5.2 Florlide Retrosynthetic Analysis 
 
Retrosynthetically, a similar sequence can be envisaged to achieve a synthesis of the florlide and 
florether natural products (Scheme 1.9). From the common intermediate 1.73, esterification 
leads to the florlide products 1.41. Reduction and subsequent nucleophilic addition to the 
extended Michael acceptor of 1.74 delivers the desired florether core structure 1.43. It is 
anticipated that 1.73 would be accessible via the conjugate addition of the mixed cuprate species 
1.75 to 1.76. Consideration of the molecular conformation of 1.76 indicates that cuprate addition 
should occur predominantly from the less hindered convex face of the bicyclo[4.3.1]decene core. 
This would deliver the thermodynamically more stable trans-stereochemical relationship 
between the unsaturated chain and the ester group present in 1.73. Installation of the C6 
quaternary methyl and C7 hydroxyl groups can be achieved via cyclopropane cleavage and 
reduction of the resultant ketone as described in the nakafuran retrosynthetic scheme (Scheme 
1.8). Formation of the C2,C3 α,β-unsaturated ester is envisaged to occur via the palladium-
catalysed carbonylation of an enol triflate derived from the C2 ketone of 1.78. 
Insertion of the C1 bridgehead hydroxyl group observed in the florlide and florether targets will 
be achieved via the regioselective hydroxylation of the C1 bridgehead carbon, under conditions 
of kinetic deprotonation developed by Shea et al. for a closely related bicyclo[5.3.1]decane 
system.94 
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The synthetic methodology required to deliver the cyclopropanated intermediate 1.78 and 
precursors to this species (1.79, 1.80, 1.81 and 1.82) closely resemble those required in the 
synthesis of the nakafuran IMDA product 1.68. The palladium-catalysed coupling, however, 
utilises the enol ether 1.82 to generate the conjugated diene 1.81, instead of the three carbon 
propene equivalent used in the nakafuran synthesis. 
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Scheme 1.9 Retrosynthetic scheme for the synthesis of the florlide compounds 1.41 and 1.43. 
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1.6 Work Described in this Thesis 
 
The research described in this thesis deals with the synthetic studies conducted to form the 
bicyclo[4.3.1]dec-6-en-2-one core common to the nakafuran and florlide marine natural 
products. Elaboration of these intermediates towards the total synthesis of these products is 
detailed. 
 
The initial aims of this research were as follows: 
 
• To design a method for the synthesis of type II IMDA precursors of variable functionality 
and investigate their reactivity with respect to forming the desired bicyclo[4.3.1]dec-6-
en-2-one carbocycles. 
• To elaborate the bicyclic intermediates so as to obtain routes to the nakafuran-9 natural 
product and related metabolites. 
• To design and implement a synthesis of the florlide natural product sidechain and 
stereoselectively introduce it into the elaborated carbocycle to provide access to the 
florlide and florether natural products. 
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Chapter Two 
Preparation of IMDA Precursors 
 
2.1 Analysis of the Retrosynthetic Scheme 
 
The central transformation of the proposed syntheses is a type II intramolecular Diels-Alder 
(IMDA) reaction, which should allow a rapid and stereoselective formation of the bridged 
bicyclic core 1.68, as depicted in Scheme 2.1. The stereochemical outcomes of IMDA processes 
are increasingly predictable on the basis of well-established concepts such as diene-dienophile 
conformational geometry, non-bonding interactions in the transition-state and extensive 
empirical observation.1-4 Based upon such considerations, a cis-diene structure 1.69 is required to 
deliver the desired anti-relationship between the methyl group and the bridgehead carbon, 
observed in the natural product target 1.17. 
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Scheme 2.1 Retrosynthesis of 1.68 derives coupling fragments 1.71 and 1.72. 
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The stereoselective synthesis of triene 1.69 is envisaged to be secured through a palladium-
catalysed cross-coupling reaction of two fragments, 1.71 and 1.72, to yield the diene system 
1.70. The nature of the X and Y groups in the coupling fragments are variable and transposable, 
such that palladium-catalysed couplings can be conducted utilising a number of different 
methodologies such as Stille (Sn, Halogen), Negishi (Zn, Halogen) and Suzuki (B, Halogen). 
The flexibility incorporated into these two complementary coupling fragments should allow 
access to a number of synthetic analogues and coupling protocols. 
 
 
2.2 Transition Metal-Catalysed Cross-Coupling Reactions 
 
At the most basic level, organic synthesis focuses on the controlled chemo-, regio- and 
stereoselective formation of carbon-carbon bonds. The discovery of nickel- and palladium-
mediated cross-coupling reactions between organometallic Grignard reagents and sp2 alkenyl-
halides can be viewed as the seminal discovery that has revolutionised the practice of organic 
synthesis in the past few decades.5 The original protocols have been substantially improved and 
expanded to include the coupling reactions of a wide range of organometallic compounds.6-12 
Applications of these protocols allow the transformations of organic molecules in manners not 
achievable by traditional synthetic methods. As such, transition metal-catalysed cross-coupling 
reactions have become a simple yet indispensable method to achieve often complex 
transformations of organic molecules. 
 
The general reaction for the cross-coupling of an organometallic reagent (R-M) with an organic 
electrophile (R1-X) mediated by the presence of a Group 8-10 metal-catalyst [M] is depicted in 
Figure 2.1. These reactions are accessible for a range of organometallic reagents and 
electrophiles, and are characterised to a large extent by the simplicity of synthesis of the 
reagents, the ease of isolation of products and the compatibility of coupling conditions with a 
wide range of functional groups. 
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Figure 2.1 Transition metal-catalysed cross-couplings. 
 
The reaction of lithium and magnesium Grignard reagents with electrophiles, in the presence of 
catalytic amounts of a transition metal, were first discovered by Kochi and Tamao13 and by 
Kumada.14 However these highly electropositive metal reagents displayed appreciable 
nucleophilicity and basicity, which restricted the functionality that could be incorporated in the 
coupling species. Successive extensions of this methodology saw the use of less reactive 
organometallic reagents (Li, Mg ? Al, Zn, Zr, Cu ? Sn, B, Si) which allowed greater functional 
group compatibility in the cross-coupling. Investigations revealed that the use of coordinating 
phosphine-ligand metal complexes diminished the extensive homocoupling, previously observed 
with unsupported transition metal salts, and that palladium-catalysed processes proceeded in 
greater yield and with superior retention of stereochemistry than the analogous nickel-catalysed 
reactions. The utilisation of highly covalently bonded carbon-metal organometallic reagents such 
as organostannanes, organoboranes and organosilanes, allowed the isolation and purification of 
these intermediates, ensuring highly homogenous stereochemical yields in subsequent cross-
coupling reactions. 
 
The advantages conferred by transition metal-mediated cross-couplings have seen their extensive 
application in the synthesis of natural products and fine chemicals. Coupling reactions have been 
used as key steps in numerous natural product syntheses, allowing synthetic disconnections to be 
contemplated that are inaccessible via traditional carbon-carbon bond forming reactions.11,12,15 
The facile synthesis of many natural products can be seen as showcases of the synthetic coupling 
methodology, as demonstrated by the rapid iterative synthesis of β-carotene (2.1) reported by the 
laboratory of Negishi (Figure 2.2).16 
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Figure 2.2 Iterative coupling methodology for polyene synthesis.  
 
2.2.1 Palladium-Catalysed Cross-Coupling Cycle 
 
The palladium-catalysed cross-coupling reaction has been extensively investigated synthetically 
and mechanistically, but remains to be conclusively defined due to intrinsic variations that occur 
as a function of substrate, palladium catalyst, ligand, temperature, solvent and additive effects. It 
is generally agreed that the first step in the catalytic cycle is the oxidative addition of R1-X to the 
coordinatively unsaturated, active catalyst, [LnPd(0)], to give a cis-[R1-Pd(X)Ln] species (i), 
which rapidly isomerises to the trans-[R1-Pd(X)Ln] species (ii) (Figure 2.3). Transmetallation by 
the organometallic species R-M to generate the bis-substituted complex [R1,R-PdLn] has been 
identified as the rate limiting step in the catalytic cycle (iii). Ligand displacement, to allow co-
ordination of the organometallic species to the active catalyst, has been postulated to occur via 
either a dissociative, associative or cyclic associative mechanism and is still an active area of 
research.8 Reductive elimination releases the cross-coupled product R1-R and regenerates the 
active catalyst [LnPd(0)] (iv). 
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Figure 2.3 Proposed catalytic cycle of palladium-catalysed cross-coupling reactions. 
 
Based on the proposed catalytic cycle displayed in Figure 2.3, a number of important palladium-
catalysed couplings have been developed, including alkene, terminal alkyne, carbon-heteroatom 
(N, O, P), carbonylation and cycloisomerisations.8-10 With the exception of reactions that 
proceed via free radical intermediates, all the above mentioned carbon-carbon and carbon-
heteroatom bond-forming reactions generally proceed with retention of the double bond 
geometry of the starting organometallic species providing highly chemioselective, regioselective 
and stereoselective reactions. 
 
 
2.3 Transition-Metal Catalysed Couplings of Organometallics with 
Electrophiles 
 
2.3.1 Synthetic Preparation of Dienes via Organostannane Coupling 
 
The transition metal-catalysed coupling of organostannane species with organo-halides or 
triflates is known as the Migita-Kosugi-Stille coupling, or more commonly the Stille coupling, 
after the influential mechanistic and synthetic studies of J. K. Stille (Figure 2.4).17 
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Figure 2.4 The Migita-Kosugi-Stille coupling. 
 
The ability to achieve stereoselective carbon-carbon bond formation, under mild and neutral 
conditions, with a tolerance of virtually all functional groups has contributed to the extensive use 
of the Stille reaction in the synthesis of natural products and complex molecules via intra- or 
inter-molecular couplings.8,18 
 
Particularly instructive examples have emerged from the laboratories of Pattenden19 
(amphidinolide A,20 pateamine,21 rhizoxin D22); Nicolaou (apoptolidin,23 epothilone E,24 
rapamycin,25 sanglifehrin A26); Smith (macrolactin A,27 rapamycin28) and numerous others,29 
which illustrate the power of the Stille reaction to form macrocycles, sensitive polyene systems 
and unprotected natural products as a final synthetic step. 
Pattenden et al. accessed the presumed amphidinolide A structure 2.4 through the novel use of 
sequential selective Stille reactions.20 An intermolecular sp2-sp2 Stille reaction of the alkenyl 
stannane and vinyl iodide functionality was followed by an intramolecular sp2-sp3 Stille reaction 
achieving a macrocyclisation with the union of the alkenyl stannane and the allylic acetate 
moieties (Figure 2.5). 
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(iii) Pd2(dba)3, Ph3As, LiCl, cyclohexane, 3h, 42%.
 
Figure 2.5 Final steps in the Pattenden synthesis of amphidinolide A.  
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The synthesis of potent antiviral agent (-)-macrolactin A (2.5) by Smith et al. utilised multiple 
Stille reactions to achieve a convergent union of the macrolide core.27 Key to achieving these 
couplings in high yield was the ability to transpose terminal coupling functionality (Figure 2.6). 
 
O
OH
O
HO
HO
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TESO
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I
SnBu3
SnMe3 OH
I
Bu3SnI
OTBS
2.5  
Figure 2.6 Key bond formations in the Smith synthesis of (-)-macrolactin A. 
 
The extensive application that the Stille reaction has received in the field of total synthesis and in 
the preparation of complex molecules has led to a sustained effort to define the catalytic cycle 
through which the palladium-catalysed union of the organostannane and the organoelectrophile 
occurs.17,30 The generally accepted mechanistic cycle is depicted in Figure 2.3, in which the 
catalytic cycle proceeds via a rapid oxidative addition step, followed by a relatively slow rate 
determining transmetallation reaction. Reductive elimination of this intermediate generates the 
cross-coupled product and a halostannane by-product. However, mechanistic and synthetic 
studies18,31 have demonstrated that the nuances of this reaction are heavily dependent on such 
factors as the nature and concentration of the metal-coordinating ligands,32,33 the solvent polarity 
and coordinating ability, the nature of the R and R1 coupling partners, internal heteroatom 
coordination,34 the inclusion of copper salts,33,35,36 halide salts37 or additives,38 and the 
temperature regime under which the reaction is conducted. The number of influencing factors 
implicated in the Stille reaction allows considerable scope for the optimisation of reaction 
conditions. 
 
2.3.2 Synthetic Preparation of Dienes via Organozinc Coupling 
 
The palladium-catalysed coupling of an organozinc reagent with an organic electrophile is 
commonly referred to as the Negishi reaction.39 Organozinc species exhibit reduced basicity and 
nucleophilicity relative to more cationic organometallics (Li, Na, K, Mg) and can be generated in 
the presence of sensitive functional groups.40-42 The organozinc species also demonstrate higher 
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reactivity than the analogous organostannanes, with the Negishi couplings being successfully 
applied to the synthesis of a number of complex natural products,43 especially in instances in 
which the Stille reaction was observed to proceed in moderate to low yield.44,45 Figure 2.2 
depicts the application of the Negishi coupling to the concise synthesis of the polyene β-carotene 
2.1 in high yield with excellent retention of stereochemistry. 
 
The application of the Stille and Negishi coupling methodologies to the preparation of dienes 
1.70 and 1.81 is described in Section 2.8. 
 
 
2.4 Organometallic Coupling Fragments 
 
The selective synthesis of vinyl organometallic compounds is of importance in contemporary 
organic synthesis due to their extensive use as intermediates in natural product synthesis and in 
materials sciences.10-12 The need to access vinyl organometallic species with different 
substitution patterns, geometry and functionalities requires a diverse and complementary set of 
methodologies. 
 
Vinyl-metal moieties may exist as non-isolable species formed in-situ (Li, Mg, Cu, Zn, Al, Zr) or 
as isolable species (Sn, B, Si) amenable to purification procedures. However, the primary 
requirement remains that the formation of these species proceeds regioselectively with the 
retention of stereochemistry and that the process of generation of the organometallic species 
displays tolerance to other functionality present in the coupling partners. 
 
It was decided to investigate the use of organotin species as stable vinyl-metalloid equivalents. 
This decision was based on the demonstrated synthetic utility of organostannane 
intermediates.46,47 The routes of preparation and versatility of organostannanes are depicted in 
Figure 2.7. Preparation of organostannanes can be achieved via a number of complementary 
synthetic methods that achieve regioselective and stereoselective control through the influence of 
steric interactions, electronic differentiation and neighbouring heteroatom coordination. The 
derived organostannanes [R-Sn(R1)3] display significant stability to moisture and oxygen, thus 
being amenable to isolation and purification48,49 to obtain stereochemically and regiochemically 
homogenous materials. 
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Figure 2.7 Synthetic transformation of organostannanes. 
 
The organostannane material [R-Sn(R1)3] can be advanced through a number of protocols 
including halogenation, transition metal-catalysed cross-coupling and transmetallation with 
lithium to yield nucleophilic species that can undergo alkylative procedures, or be modified 
through additional transmetallation.9,50 
 
An important aspect of the organostannane coupling methodology, which lends to its synthetic 
versatility, is the capacity to reverse the functionality of the organostannane and electrophile 
components to optimise the coupling conditions or to enable the facile synthesis of coupling 
components.27 Application of this principle can be observed in the planned synthesis of diene 
1.70 depicted in Scheme 2.2.  
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Scheme 2.2 Transposition of coupling functionality to generate homologous products. 
Reagents: (i) I2, cyclohexane; (ii) BuLi, -78oC; Bu3SnCl; (iii) (Bu3Sn)2, (PPh3)2PdCl2; (iv) cat. Pd(0). 
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Access to the stereo-defined diene system 1.70 can be achieved via the Stille coupling of E-1-
methoxy-1-iodopropene 2.6 and α-vinyl stannane 2.7, or alternatively via the coupling of the 
reciprocal E-1-methoxy-1-stannylpropene 2.8 and α-vinyl iodide 2.9. 
 
The vinyl coupling partners 2.6/2.8 and 2.7/2.9 can be readily interconverted via facile high 
yielding halogenation or metallation reactions, such that a stereoselective route to either coupling 
partner can be utilised to form both the halogen and stannane coupling variants. 
 
 
2.5 Synthetic Preparation of Coupling Fragments 2.6 and 2.8  
 
Three distinct routes can be envisaged to generate the desired α-functionalised α-
alkoxypropenes 2.6 and 2.8 as depicted in Figure 2.8. 
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Figure 2.8 Retrosynthetic analysis of routes to 1-alkoxy-1-functionalised propenes. 
 
These routes are specifically the:  
(a) stereoselective enolisation of a carbonyl functionality (2.10), with in-situ capture of 
the oxygen anion to generate a protected enol ether, (Route A); 
(b) the regiospecific α-metallation adjacent to an alkoxy-group (2.11), (Route B); 
(c) the regioselective hydro-functionalisation of an alkyne (2.12), where the addition 
would proceed stereospecifically to yield a E-alkene, (Route C). 
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2.5.1 Route A: Enolisation Strategy 
 
Ireland et al. systematically investigated methods for the stereoselective deprotonation and 
silylation of esters as intermediates in the stereocontrolled ester-enolate Claisen rearrangement.51 
 
The observed silyl ketene acetal geometry of 2.13E and 2.13Z is controlled by the 
stereoselective formation of the respective 2.14Z and 2.14E ester enolates. Changing the solvent, 
additives and base resulted in a change in selectivity between the kinetic (E) and the 
thermodynamic (Z) silyl ketene acetals (Figure 2.9). 
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Figure 2.9  Silyl ketene acetals observed as a function of enolate geometry. 
 
A cyclic transition state model is proposed for the enolisation of carbonyl esters with amide 
bases.52 In THF solutions, the metal cation is closely coordinated to and interacts with the 
carbonyl oxygen and the base. The severe 1,3-diaxial interactions between the isopropyl group 
and the R substituent in TS II favour deprotonation via TS I to form the Z-enolate. In a dipolar 
solvent, caused by the inclusion of additives such as HMPA, DMPU or TMEDA, a greater 
degree of solvation of the metal cation weakens the metal-carbonyl interaction and expands the 
transition state. The 1,3-diaxial strain (TS II) is diminished in comparison to the A1,3-strain (TS 
I) favouring the formation of the E-enolate via TS II. The inclusion of bulky substituents on the 
carbonyl carbon also favours the formation of the E-enolate due to increased A1,3-strain. 
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The enolisation of acyl stannane 2.1053 with LDA in a dipolar solvent was anticipated to lead to 
an exclusive E-enolate 2.15E, due to the bulky stannane substituent. In-situ anion capture would 
yield the desired E-silyl ketene stannane 2.16E (Scheme 2.3).54-56 
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Scheme 2.3 Attempted stereoselective generation of vinyl stannane 2.16E via acyl stannane 
2.10. 
Reagents and yields: (i) Mg, Bu3SnCl, ether, reflux; then purification via distillation, 54%; (ii) LDA, Bu3SnH, THF; 
then S-ethyl thiopropionate (0.5 equiv), -78oC ? -23oC; (iii) LDA (1.1 equiv), THF/45% DMPU; then TMSCl. 
 
Rapid access to the acyl stannane material (2.10) and control over the ketene stereochemistry 
were anticipated to compensate for the potential synthetic difficulty in dealing with such a 
reactive species. In practice however, the acyl stannane 2.10 proved to be difficult to manipulate, 
readily decomposing during attempts to purify it, due to a noted reactivity to molecular oxygen 
and light as has been previously observed.53,57-59 Efforts to achieve acceptable synthetic yields 
via either Cannizzaro reaction of a stannyl Grignard57 or nucleophilic attack of tributylstannyl 
lithium on S-ethyl thiopropionate53,57 were hindered by the difficulty in purification of the crude 
mixtures. Analysis of the acyl stannane material, obtained following purification via either 
chromatography under an inert atmosphere or aqueous workup, indicated the formation of 
significant quantities of tributylstannylpropionate. A mass ion at m/z 307 observed via LRMS 
was attributed to the loss of a butyl group from EtC(O)OSnBu3, the product arising from the 
oxidation of the acyl stannane carbonyl-tin bond. 
 
Additionally, preliminary investigations of the enolisation-silyl protection step indicated that this 
methodology was not sufficient to deliver the desired isomer 2.16E with an acceptable level of 
stereocontrol. Following the procedure of Verlhac,56 reaction of purified acyl stannane 2.10 with 
LDA in THF at -78oC, with in-situ quenching of the resultant enolate with TMSCl, gave after 
careful distillation (b.p ~90-100oC / 0.05 mm Hg ), a 78:12 mixture of 2.16Z:2.16E silyl ketenes. 
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The use of a dipolar aprotic solvent, through the inclusion of 45% DMPU/THF, was observed to 
generate the desired 2.16E silyl ketene almost exclusively (10:90) as anticipated. However, low 
yields and extensive decomposition upon distillation (b.p. ~115oC / 0.05 mm Hg) hindered 
preparation of significant quantities. A number of bases (LDA, LiHMDS, NaHMDS) and solvent 
systems (THF; 45% DMPU / THF; 20% HMPA / THF) were attempted but the Z-isomer 
predominated upon attempted purification. Attempts to quench with TBSCl resulted in further 
reduced yields. 
 
Exploratory attempts at palladium-mediated cross couplings of the acyl stannane 2.10 or the 
stannyl-silylketene acetal mixture (2.16E/Z) with 2.9 were also unsuccessful under a number of 
standard conditions yielding no evidence of the anticipated coupling adducts (Scheme 2.4).18 
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Scheme 2.4 Attempted Stille coupling of acyl stannanes equivalents with vinyl iodide 2.9. 
 
The acyl stannane intermediate 2.10 was shown to be a competent coupling partner with the 
preparation of two α,β-diketo structures 2.17 and 2.18 under palladium-mediated coupling 
conditions (Scheme 2.5).57,60,61  
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Scheme 2.5 α,β-Diketone formation via Stille coupling. 
Reagents and yields: (i) Pd(PPh3)2Cl2, toluene, 100oC; 2.17 51%; 2.18 66%. 
 
The synthetic difficulty of manipulating the sensitive acyl stannane 2.10, the poor E/Z-
stereocontrol observed for the formation of the silyl ketenes and silyl acetals and the absence of 
discernable coupling product with the vinyl iodide 2.9 encouraged investigation of an alternative 
strategy to provide access to the diene system 1.70. 
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2.5.2 Route B: Alkene α-Metallation 
 
The difficulties in implementing an enolisation strategy for the preparation of the desired vinyl 
stannane species 2.8 were the result of the need to prepare and manipulate the sensitive acyl 
stannane material 2.10 and 2.16E at the commencement of the synthesis. A deprotonation or 
hydrometallation strategy would offer the advantage of allowing the preparation of reactive 
reagents in-situ without isolation, or preparation of compounds more amenable to standard 
synthetic manipulation. The lack of extensive research utilising acyl stannanes in synthesis 
perhaps reflects the difficulties inherent in using these unstable intermediates. 
 
α-Ethoxyethenyllithium (2.19) and its methoxy-analogue, by contrast, have received extensive 
use as nucleophilic acylating agents, reacting with alkyl halides and carbonyl compounds.62 The 
lithiated species are usually prepared by metallation of commercially available alkoxyalkenes 
using t-BuLi and TMEDA in pentane at -30oC or n-BuLi/t-BuOK,63-65 but the most convenient 
procedure devised by Baldwin et al. simply uses t-BuLi in pentane/THF (-65°C ? 0°C).62 The 
observed α-metallation can be understood as pre-coordination of the lithiating reagent by the 
vinyl oxygen, directing deprotonation to occur at the adjacent kinetically more acidic α-vinyl 
position, where the anion is stabilised through inductive effects.66 Transmetallation of this 
species to cerium, copper, zinc or alkyltin enables an expanded manifold of reactions including 
additions to hindered carbonyls,67 conjugate addition to enones68 and Negishi (Zn)69 and Stille 
(Sn)70 cross-coupling reactions (Figure 2.10). 
 
OEt
CeCl2 CeCl3 Zn
Cl 2
OEt
Li
OEt
Cu(L)Li
OEt
SnBu3
Bu 3
SnC
l CuX
OEt
ZnCl
Negishi
coupling
conjugate 
additions
Carbonyl 
addition
Stille 
coupling
2.19
 
Figure 2.10  Synthetic variants via transmetallation of α-ethoxyethenyllithium. 
 
However, despite the varied chemistry of α-alkoxyethenyl metal derivatives, longer chain 
homologues have not been extensively reported in the literature.71 This may be due to the failure 
of β-alkyl-substituted acyclic enol ethers to undergo clean lithiation under generally applicable 
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conditions72 and, additionally, the difficulty associated with establishing the desired E/Z ratio in 
the enol-ether substrate. 
 
Gould et al. reported that 1,3-dibutoxypropene (2.20) undergoes regioselective vinylic α-
metallation in preference to the allylic deprotonation.73 Alkylation with primary alkyl bromides 
and iodides proceeded with retention of stereochemistry as determined by deuterium quenching 
studies (Figure 2.11). However, the synthetic route used to prepare the vinyl enol-ether 
generated an isomeric mixture of alkenes that could only be adequately separated via HPLC. 
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Figure 2.11 Retention of stereochemistry demonstrated in α-alkoxy,α-lithio derivatives. 
 
Very few synthetic routes to the required Z-enol ether (2.11) have been reported. Those utilising 
an E1cB mechanism of a suitable leaving group often result in the generation of E/Z isomeric 
mixtures as observed by Gould. The formation of the E-isomer is usually favoured due to 
minimisation of steric interactions in the transition state, however internal coordination can result 
in preferential Z-isomer formation.74  
 
The controlled syn-hydrogenation of alkyne 2.12 over a heterogeneous catalyst75 or the 
isomerisation of a terminal allylic ether (2.22) to an internal propenyl ether under basic or 
transition metal catalysed conditions76 also present plausible stereoselective routes to the 
preparation of Z-enol ether 2.11 (Figure 2.12) 
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Figure 2.12 Preparation of (Z)-1-methoxypropene (2.11) via reduction or isomerisation. 
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However, competitive reactions such as the isomerisations of 1-alkoxyalkynes to terminal allylic 
alcohols under heterogeneous catalysis and the formation of π-allyl complexes (2.24) and 
stabilised α,β-enol-γ-metallocycle intermediates (2.25) may complicate such a synthetic 
preparation.9,77 It is pertinent to note that literature examples of alkyl-lithium mediated 
deprotonation of long chain homologues of alkoxy-ethenes to form α-metallated vinyl ethers are 
of a carbocyclic or allenic nature in which the π-allyl metallocyclic structure 2.25 would be 
unable to form due to steric and torsional constraints.78 As such, it is uncertain whether α-
metallation of (Z)-propenyl-ethers of non-carbocyclic nature is feasible. Furthermore, the 
separation of product from starting materials and of the potential for E/Z-isomers rendered such 
approaches to 2.23 synthetically problematic. 
 
 
2.5.3 Route C: Alkyne Hydrofunctionalisation 
 
Difficulties in preparing stereodefined alkenyl-metal or alkenyl halide species via selective 
deprotonation of alkenes have led to investigation into synthetically equivalent regio- and 
stereoselective hydrometallation-transmetallation sequences. Hydrometallation, involving the 
syn- or anti-addition of a metal hydride species across an alkyne bond results in a vinyl-metalloid 
species (2.26) (Figure 2.13). 
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Figure 2.13 Vinyl metalloid generation via hydrometallation. 
 
The vinyl organometallic species 2.26 can be broadly divided into three classes: 
Class A (Sn, B, Si): Primary methods and species for alkyne functionalisation that have been 
utilised extensively in organic synthesis and natural product synthesis. These functionalised 
vinyl-metalloid intermediates are often amenable to isolation and purification and have been 
extensively reviewed.58,79-81 
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Class B (Zr, Al, Mg): Non-isolable intermediates that are coupled or converted in-situ via 
transmetallation. Excellent regio- and stereo-selectivity can be achieved with the utilisation of 
heteroatom coordination or steric effects.82,83 
Class C (Hg, Ge, Te): Less frequently prepared vinyl organometallic species, due to replication 
of Class A and B properties, or toxicity issues, although some exhibit novel capabilities that have 
been used synthetically.84-86 
 
Vinyl organostannanes have been extensively utilised due to their ease of synthesis, purification, 
functional group tolerance and for the ability to access additional reactivity manifolds via 
transmetallation, as discussed in Section 2.4.  
 
However, in contrast to terminal alkynes, where the regioselectivity, stereochemistry and 
mechanisms of hydrostannylation are often well investigated, internal alkynes have received far 
less attention. The issues of stereochemistry and the product distribution of internal alkynes are 
poorly documented despite the importance of tri-substituted olefin structures to synthetic 
chemistry. 
 
Vinyl organostannanes can be prepared via three synthetic protocols, which result in distinct 
regio- and stereochemical product distributions. The nature of the product distributions reflects 
the dominant reaction mechanism through which hydrometallation occurs. 
 
2.5.3.1 Radical Hydrostannylation 
 
The most prominent method for the addition of an alkyltin hydride to an alkyne is the radical-
induced process. The hydrostannylation of alkynes, alkenes and allenes under free-radical 
conditions has been widely studied and gives, in general, a mixture of stereoisomers with 
regiochemistry controlled by the relative stability of the two possible intermediate β-stannyl 
radicals (Figure 2.14).87-89 Excluding known systems such as enynes, enynols and propargyl 
alcohols, a strong regiochemical preference is observed for the formation of the β-stannyl adduct 
2.27β-E due to the stability of the E-vinyl radical.90,91 Stereoselectivity is often a significant 
problem however, since the initially formed kinetic product is equilibrated by further addition - 
elimination processes under the reaction conditions. 
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Figure 2.14 Product distributions under radical conditions. 
 
Radical hydrostannylation of internal alkynes suffer from poor selectivities, with complex 
systems often giving statistical mixtures based on substituent steric effects, electronic effects and 
intramolecular heteroatom coordination. 
 
2.5.3.2 Transition Metal-Catalysed Hydrostannylation 
 
The transition metal-catalysed hydrostannylation of alkynes is a field of continuing 
development.92 Although a definitive mechanism has not been elucidated, a general catalytic 
cycle based upon an oxidative addition/hydrometallation/reductive elimination sequence has 
been proposed that endeavours to rationalise the existing literature data for the hydrostannylation 
of sterically differentiated alkynes (Figure 2.15).93 
 
R2R1
MLn
H M SnR3
Ln
δ δ
R3SnH
oxidative 
addition
R3Sn M
H
Ln
R1 R2
M H
Ln
R3Sn
hydrometallation
reductive
 elimination
R2R1
HR3Sn
XR2R1
H M
SnR3
Ln
XR2R1
MH
Ln
SnR3
hydrometallation
reductive
 elimination
R1 XR2
H SnR3
MLn
steric effects
R2 > R1
heteroatom
pre-coordination
2.282.30
2.29
2.31
2.32
2.33
2.34
 
Figure 2.15 Proposed transition metal-catalysed hydrostannylation of alkynes utilising steric 
or coordination effects. 
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Oxidative addition of R3SnH to the transition metal centre (MLn) generates the metal-hydrido 
complex 2.28. Coordination to the π-system of the alkyne (2.29), and subsequent 
hydrometallation affords the vinyl metallated species 2.30, which furnishes the organostannane 
product 2.31 via a reductive elimination. The proposed mechanism correctly predicts the 
observed syn-addition to generate E-vinyl stannanes, and the relative influence of R1 and R2 due 
to steric effects (Table 2.1 - entry 1 vs 5). 
Electronic effects such as heteroatom coordination by neighbouring groups (propargyl alcohols 
and amines), conjugation and polarizing functional groups can dominate the regiochemistry of 
hydrostannylation.94,95 Pre-coordination of the transition metal centre 2.28 by the heteroatom 
(XR2) in a putative metallacycle (2.32) favours the generation of adducts with the stannane 
proximal to the coordinating functionality (2.34) (entry 6 v 7).  
 
Table 2.1 Observed regioselectivity of the transition metal-catalysed hydrostannylation of 
terminal alkynes due to steric and coordination effects. 
R H
R
Bu3Sn
R
SnBu3
α β  
Entry R α:βa Yield (%)b Reference 
1 (CH2)2CH3 1 : 2.2 - 95 
2 CH2OH 1.3 : 1 95 95 
3 (CH2)3CH2OH 1 : 3 95 95 
4 (CH2)2CH2Cl 1 : 1.4 84 96 
5 t-Bu 1 : 99 59 96 
6 Ph 1 : 1.2 82 97 
7 CH2OPh 10 : 1 85 98 
8 CO2Me 100 : 0 94 98 
9c CH2OH 8.1 : 1 94 99 
Notes: (a) Product ratio determined by 1H NMR; (b) Reaction conducted with Pd(PPh3)2Cl2 (5 
mol %), Bu3SnH (1.1 equiv), values refer to isolated yields; (c) Mo(CO)3(t-BuNC)3 catalyst, 
with Bu3SnH (3 equiv). 
 
Palladium and molybdenum catalysts, such as Pd(PPh3)4, Pd(PPh3)2Cl2 and 
Mo(allyl)(CO)2(MeCN)2Br, display good syn-stereoselectivity but poor regioselectivity for 
addition to terminal and internal alkynes.100 Significant use has been made of steric or electronic 
control elements such as propargyl alcohol (entry 1 vs 2),98  fluorination, conjugation101 or 
aromatic groups (entry 4 vs 7)102 to achieve high regiocontrol. Recently, Mo(t-BuNC)3CO3 has 
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or 
Kugelrohr 
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2.36α2.35
been developed as a catalyst that delivers good regioselectivity (>90:10) for α-vinyl stannanes 
adjacent to propargyl alcohol functionality (entry 9).99 
 
The regiochemical preferences displayed for the palladium-catalysed hydrostannylation of 
terminal alkynes (α:β ~ 1:2)95 is in contrast to the strong intrinsic preference for β-
regiochemistry observed for hydroboration,103 hydrozirconation104 and free radical 
hydrostannylation. Two exceptions to these observations are the use of Lewis-acidic ZrCl4, 
which gives exclusive Z-β-stannanes,105 and the preparation of E-β-stannanes from 
bromoalkynes utilising a hydrostannylation - debromination pathway in the presence of excess 
tin hydride.98 
 
Pertinent to the preparation of α-methoxy-stannylpropene 2.8 is the work of Kocieński et al. who 
demonstrated that syn-addition is maintained during palladium-catalysed hydrostannylation of 
internal alkoxy-alkynes (2.35) and that the regiochemistry is strongly influenced by steric effects 
of the R1 and R2 substituents (Figure 2.16).106 Increasing the steric size of R2 increased the 
proportion of 2.36α; while conversely increasing the steric demand of R1 lead to an increase in 
the amount of the regioisomer 2.36β generated. 
 
 
 
 
 
 
R1 R2 2.36α 2.36βa %b 
OBn n-Bu 1.8 1 46 
OBn s-Bu 5.2 1 57 
OBn t-Bu 100 1 71 
1-menthyl Me 1 3 23 
(a) destroyed via Al2O3 chromatography or Kugelrohr distillation;  
(b) yield of isolated pure 2.36α. 
Figure 2.16 Hydrostannylation of internal 1-alkoxyalkynes. 
 
Subsequent transmetallation of the α-alkoxyalkenylstannane 2.36α proceeded regio- and 
stereoselectively in quantitative yield to give α-alkoxyalkenyllithium 2.38. This 
hydrostannylation - transmetallation protocol overcomes the problems associated with the 
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lithium-based deprotonation of non-cyclic long-chain homologues of enol ethers as discussed 
previously.107 
 
2.5.3.3 Metallostannylation 
 
Free-radical or transition metal-catalysed (Pd, Mo) hydrostannylation results predominantly in 
regio- and stereo-defined β-vinyl stannanes from alkyl alkynes. The development of alkyne 
metallometallations, such as stannylcupration (Sn-Cu),108-110 silastannylation (Sn-Si),111 and 
others (-Zn, -Al, -Sn, -Mn, -B, -Mg, -Ge)109,112 have allowed access to the less readily available 
α-vinyl stannanes in a stereospecific and regioselective manner. 
Stannylcupration and silastannylation have been the most extensively investigated, with a 
number of natural product syntheses using α-stannyl species generated via stannylcupration.113 
Silastannylation shows potential to allow differential coupling protocols to occur based on 
sequential Stille – Hiyama coupling. 
 
 
2.5.3.4 Preparation of 1-Methoxypropyne 
 
From the above discussion, the most favourable route to the regio- and stereo-defined 1-alkoxy-
1-functionalised-propenes 2.6 and 2.8 required the controlled hydrometallation or 
metallometalation of an appropriately substituted 1-alkoxypropyne. 
 
1-Methoxypropyne (2.12) was chosen as a suitable alkyne source due to consideration of factors 
such as steric constraints, ease of hydrolysis and spectroscopic identification. Synthetic routes to 
the preparation of 1-alkoxyalkynes have been described, commonly employing base induced 
eliminations from haloalkenyl ethers, dihaloethers and haloacetals to generate the alkyne 
functional group (Figure 2.17).114,115 
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Figure 2.17 Elimination routes to 1-alkoxyalkynes. 
 
These protocols (Figure 2.17) are most suited to the preparation of higher R and R1 homologues 
of 2.12 where the desired alkyne product can be efficiently distilled from the reaction solvent 
and excess alkyl halide (R1-I). The separation of 2.12 (b.p. 65.7-66.3°C / 760 mmHg)116 from the 
reaction solvent and excess iodomethane was anticipated to be problematic. 
 
The reaction sequence detailed by Nooi et al. provides a solution to this issue (Scheme 2.6). The 
final step to generate 2.12 involves the controlled distillation of the volatile alkyne from a 
heterogeneous mixture comprised of bromo-alkene 2.39Z and solid potassium hydroxide.116 
Using this method, pure 1-methoxypropyne (2.12) was generated in four steps from 
propionaldehyde in 51% yield on a 1.5 mole scale. A noted side product was the formation of 
methoxy-allene 2.40 arising from the anti-periplanar elimination of hydrogen bromide from 
rotationally restricted 2-bromo-1-methoxypropene 2.39E. 
 
OMe
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H
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Scheme 2.6 Preparation of 1-Methoxypropyne (2.12). 
Reagents and yields: (i) 1 equiv MeOH, excess anhyd. HCl, -10oC; (ii) 1 equiv Br2, rt; (iii) N,N-diethylaniline, 
reflux; distillation to separate 2.39Z and 2.39E; (iv) 5 equiv KOH, 51% (four steps). 
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2.5.4 Hydrostannylation Studies 
 
Attempts to prepare 1-methoxy-1-stannylpropene (2.8) in a stereo and regiocontrolled fashion 
from 1-methoxypropyne (2.12) led to the investigation of a number of hydrostannylation 
reactions (Table 2.2). 
 
Table 2.2 Hydrostannylation of 2.12. 
OMe
Me
Me
MeO SnBu3
Me
Bu3Sn OMe
Me
MeO
SnBu3 Bu3Sn
MeO
Me
2.422.8 2.432.41
1H NMR [δHa]
Coupling
4.63
multiplet
5.26
triplet of quartets
JH-H = 6.5 Hz
5.62
triplet
J = 1.8 Hz
6.41
triplet
3JSn-H = 45.1 Hz
Ha Ha
Ha Ha
2.12
3JSn-H = 46.5 Hz 3JSn-H = 33.0 Hz  
  Product Distribution Ratiosa 
Entry Reagent and Conditions 2.8 2.41 2.42 2.43 
1 Bu3SnH, AIBN, toluene, 80oC 21 36 13 30 
2 Bu3SnH, Et3B, toluene, rt trace 66 trace 34 
3 Bu3SnH, Pd(AsPh3)2Cl2, THF, rtb 42 0 32 26 
4 Bu3SnH, Pd(CH3CN)2Cl2, THF, rt trace 0 trace trace 
5 Bu3SnH, Pd(PPh3)4, THF, rt 24 0 76 0 
6 Bu3SnH, Pd(PPh3)2Cl2, THF, rt 30 0 70 0 
7 Bu3SnH, Pd(PPh3)2Cl2, THF, rtc 3 trace 97 0 
8 Bu3Sn(Bu)Cu(CN)Li2, THF, -78oC 0 0 100 0 
9 Bu3Sn(Bu)Cu(CN)Li2, THF/MeOH, -78oC 23 0 77 0 
Notes: (a) product distribution assessed via 1H NMR integration of characteristic 
vinyl proton signals; (b) ~10% conversion; (c) addition of 1 equiv. of Bu3SnH over 
30 min on 1 mmol scale. 
2.5.4.1 Radical Hydrostannylation 
 
Free-radical hydrostannylation of 2.12 with tributyltin hydride using thermal initiation 
(AIBN)117,118 resulted in the generation of all four possible vinyl stannanes with little stereo- or 
regio-control (entry 1). In contrast, low temperature initiation (Et3B/O2)89,119 provided the 
products 2.41 and 2.43, arising from trans addition, with only trace amounts of isomerisation 
(entry 2). 
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The kinetic preference for 2.41 over 2.43 (2:1) presumably reflects either the more rapid rate of 
addition proximal to the methoxy heteroatom or alternatively, that the incipient alkenyl radical is 
favourably stabilised adjacent to the alkyl group relative to the methoxy group. A trans 
mechanism for the tributyltin radical addition can be inferred from the kinetic products (entry 2), 
which degrade under the thermal reaction conditions (entry 1). It is apparent that neither the 
methoxy nor methyl group exerts a significant influence to generate a thermodynamically 
favoured product. 
 
2.5.4.2 Palladium-catalysed Hydrostannylation 
 
Palladium-catalysed hydrostannylations were conducted on a 1 millimolar scale with the 
dropwise addition of tributyltin hydride to a mixture of the alkyne 2.12 and a palladium catalyst 
in THF at room temperature.98 Solutions containing Pd(AsPh3)2Cl2 and Pd(CH3CN)2Cl2 as 
catalysts were observed to darken immediately, and hydrogen generation was observed from the 
solutions (entry 3 and 4). 1H NMR spectroscopy of sample aliquots indicated poor conversion to 
the vinyl stannane adducts in agreement with the rapid catalyst destruction. Trialkyltin hydrides 
have been observed to decompose under palladium catalysis to generate hydrogen and 
hexaalkylditins products with an accompanying darkening of the solution as palladium metal 
precipitates (Figure 2.18).120,121  
2 Bu3SnH H2
Pd(0)
Pd(s)
(Bu3Sn)2
 
Figure 2.18 Trialkyltin hydride decomposition under palladium catalysis. 
 
The use of Pd(PPh3)4 or Pd(PPh3)2Cl2 gave yellow solutions and clean conversion to the vinyl 
stannanes 2.8 and 2.42 in ratios of 24:76 and 30:70 respectively (entry 5 and 6). Interestingly, 
slow addition of the hydride (~30 min for the addition of 162 μL) resulted in a remarkable 
increase in regioselectivity, yielding 2.42 almost exclusively (entry 7). The preference for 2.42 
formation is perhaps a consequence of polarisation of the alkyne ether or of internal pre-
coordination of the palladium catalyst to the ether oxygen prior to hydrostannylation (see Figure 
2.15) as the methyl and methyl ester substituents could be anticipated to display similar steric 
properties. These results are similar to those obtained by Guibé,98 Lébl,122 and Kocieński106 on 
related alkoxyalkynes. 
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2.5.4.3 Stannylcupration 
 
Stannylcupration of terminal alkynes has been widely applied to the preparation of vinyl 
stannanes with high regio- and stereoselectivity; however internal alkynes that do not possess 
mesomeric, inductive or coordination effects have not been extensively investigated.94,123 
Oehlschlager et al. investigated the stannylcupration of ethoxy-acetylene (2.44) under both 
thermodynamic and kinetic quenching conditions, utilising 1H and 13C NMR spectroscopy to 
identify the reaction intermediates.124 The studies concluded that the observed regiochemistry of 
the stannylcupration adducts was a function of the reaction conditions. Under kinetic control, 
achieved by inclusion of MeOH in the solvent, higher 2.45 and lower order 2.46 stannylcuprates 
generate the vinyl copper species 2.47α, and its subsequent product 2.48α. Under 
thermodynamic control where the vinyl copper species were allowed to equilibrate before the 
addition of MeOH, a β-vinyl stannane 2.48β was obtained possibly due to a favourable 
intramolecular interaction between the ether oxygen and the copper species (2.47β) (Figure 
2.19). 
OEt
Bu3Sn(R2)Cu(CN)Lin
Cu(CN)R2Bu3Sn
Lin
R2(NC)Cu SnBu3
Lin
2.45: R2 = Bu, n=2
2.46: R2 = absent, n=1
OEtOEt
Bu3SnSnBu3
OEtOEt
Kinetic, -78oC, 
MeOH / THF solvent
Thermodynamic, 0oC,
THF / HMPA solvent,
 MeOH quench
2.44
2.47α
2.48α
2.47β
2.48β  
Figure 2.19 Stannylcupration mechanism proposed by Oehlschlager et al. 
 
In agreement with Oehlschlager’s proposals for the terminal stannylcupration of 
alkoxylacetylenes, the reaction of 2.12, under thermodynamic conditions led exclusively to the 
generation of β-vinyl stannane 2.42 (Entry 8). Reactions conducted under kinetic conditions 
using either 2.45 or 2.46 resulted in a mixture of the regioisomers 2.8 and 2.42 s (entry 9). It is 
apparent that although the methyl group is relatively small, it is still able to exert a considerable 
steric (and possibly electronic) effect. 
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The failure to achieve the desired E-α-vinyl stannyl ether 2.8 via free-radical, palladium-
catalysed hydrostannylation or stannylcupration methodology lead to the consideration of other 
synthetic methodologies.125-127  
 
2.5.5 Alkyne Hydrohalogenation 
 
Fortunately, a solution to the impasse encountered when attempting to prepare the regio- and 
stereodefined α–stannylvinyl ether 2.8 was presented with a publication by Jin and Yu.128 They 
reported that a highly stereospecific synthesis of α-halovinyl ethers (2.49) can be achieved when 
alkoxyalkynes were exposed to halo-trimethylsilanes at low temperature (Figure 2.20).  
R OR1
OR1
XH
RTMSX, MeOH,
CH2Cl2, -78oC
~ quantitative X = Br, I
2.49
OR1
RH
R
OR1
SnMe3H
R(i) t-BuLi
(ii) Me3SnCl
98% 2.50  
Figure 2.20  Hydrohalogenation of 1-alkoxyalkynes. 
  
The α-halo vinyl ethers (2.49) could engage in Stille, Sonagashira and carbonylation reactions in 
high yield. Furthermore, the reaction between the α-halo vinyl ether 2.49 and t-BuLi afforded α-
alkoxyl-vinyl lithium species quantitatively, with the retention of stereochemistry. The generated 
α-alkoxyl-vinyl lithium could engage in alkylation, acylation, conjugate addition reactions and 
importantly, transmetallation to α-stannyl vinyl ethers (2.50).128-130 
 
Using the protocol of Yu and Jin, iodotrimethylsilane131 was added slowly to a solution of 1-
methoxypropyne and methanol in dichloromethane at -78oC to successfully deliver the desired 1-
iodo-1-propenyl methyl ether in quantitative yield. The formation of a pink colouration in CDCl3 
indicated that the vinyl iodide species 2.6 was relatively unstable with respect to exposure to 
acid, light or atmospheric moisture. Removal of the dichloromethane solvent under an inert 
atmosphere and replacement with anhydrous diethyl ether allowed the low temperature (-98°C) 
lithium-halogen exchange to generate the α-alkoxyl-vinyl lithium 2.23 in-situ.132 This species 
could be trapped with the slow addition of Bu3SnCl to generate the desired E-α–stannane vinyl 
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ether 2.8 in high yield or transmetallated (vide infra) to allow subsequent coupling reactions to 
be performed in-situ (Scheme 2.7). 
OMeMe
I
Me
OMe
OMe
Me
SnBu3
SnBu3
Me
OMe
(i) (ii)
Li
Me
OMe (iii)
2.12 2.6 2.23
2.8
2.41  
Scheme 2.7 Preparation of vinyl iodide 2.6 and vinyl stannane 2.8. 
Reagents and yields: (i) MeOH (0.99 equiv), TMSI (0.99 equiv), CH2Cl2, -78oC ? rt; then evaporation of solvent 
[23oC / 12 mmHg]; (ii) t-BuLi, diethyl ether, -98oC ? -78oC, 30 min; (iii) Bu3SnCl, 2.8 69%, 2.41 17%. 
 
Although a small amount of the Z-α–stannane vinyl ether 2.41 was observed, excellent 
regiocontrol and stereocontrol was achievable with precise control of experimental conditions 
(particularly the internal temperature profile). The vinyl tin species 2.8 and 2.41 were isolated 
after careful flash column chromatography in 69% and 17% yield respectively. The use of 
basified silica, through the addition of triethylamine to both the eluting solvent and the silica 
slurry, was essential to minimise decomposition via proto-destannylation.59,112 
 
2.5.6 Preparation of the α-Alkoxy-ethene Coupling Partner  
 
As discussed in Section 2.5.2, the α-lithiation of 1-alkoxy-ethylene has been extensively utilised 
in synthesis. Low temperature deprotonation of commercially available ethoxy vinyl ether, 
followed by quenching of the lithio-anion 2.19 with tributyltin chloride generated the ethoxy 
stannane 2.51, in high yield. Alternatively, the in-situ transmetallation with zinc chloride allowed 
preparation of the vinyl zinc species 2.52 (Scheme 2.8).107,133 
Li
OEtOEt (i)
SnBu3
OEt(ii)
(iii)
ZnCl
OEt
2.51
2.52
2.19
 
Scheme 2.8 Preparation of ethoxy vinyl stannane 2.51 required for the florlide synthesis. 
Reagents and yields: (i) t-BuLi, ether, -98oC ? -30oC, 1 h; (ii) Bu3SnCl, -78oC ? rt, 87%; (iii) ZnCl2, ether. 
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2.6 Synthetic route to 2.7 and 2.9 
 
The synthesis of the α-functionalised vinyl stannane 2.7 and vinyl iodide 2.9 required the 
regioselective hydrostannylation or hydroiodination of a terminal alkyne, the methods for which 
were reviewed in Section 2.5.3. Preparation of the common intermediate 5-hexyn-1-ol (2.53), 
was performed via the method of Brandsma.115 Whilst numerous methods have been detailed for 
the functionalisation of terminal alkynes, it was important to investigate which protocols gave 
the best regiocontrol, stereocontrol and isolated yields, and whether the functionality introduced 
could survive subsequent synthetic manipulation. Towards this goal, two routes were 
investigated (Scheme 2.9). 
 
Route A features an initial alkyne functionalisation step followed by oxidation of the terminal 
alcohol to effect conversion to the desired coupling partner, N-methoxy-N-methyl-5-
tributylstannyl-5-hexenamide 2.7 or N-methoxy-N-methyl-5-iodo-5-hexenamide 2.9. Route B 
involves the initial oxidation and amide formation, followed by α-functionalisation to generate 
2.7 or 2.9 (Scheme 2.19). 
O
(i)
X
OH OH
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O
OMe
Me
X
N
O
OMe
Me
α-functionalisation
oxidation,
amidation
α-functionalisation
oxidation,
amidation
Route A
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X = I            2.9
X = SnBu3   2.7
(ii) (iii)
2.53
2.54
2.55 X = I
2.56 X = SnBu3
 
Scheme 2.9 Complementary synthetic routes to 2.7 and 2.9. 
Reagents and yields: (i) see ref. 115; (a) anhyd. HBr; (b) DHP, p-TsOH (cat); (c) lithium acetylide, NH3; (d) HCl 
(cat), EtOH, reflux; 4 steps 87%; (ii) (Bu3Sn)2, Pd(PPh3)4, DMF; (iii) I2, CH2Cl2. 
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2.6.1 ROUTE A 
2.6.1.1 Preparation of N-Methoxy-N-methyl-5-iodo-5-hexenamide 2.9 
 
The preparation of 2.55 from 5-hexyn-1-ol (2.53) had previously been reported by Weinreb et al. 
utilising the hydroiodination protocol of Ishii.134,135 Treatment of 2.53 with anhydrous hydroiodic 
acid in MeCN, generated via the reaction of TMSCl, NaI and H2O, was reported to give 2.55 in 
72% yield. In the author’s hands, however, a mixture of the desired product 2.55, variable 
amounts of the diiodo compound 2.57 and the double bond isomer 2.58 (~10-15%) were isolated 
(Scheme 2.10). 
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Scheme 2.10 Preparation of 2.9.  
Reagents and yields: (i) NaI (2.2 equiv), TMSCl (2.2 equiv), H2O (1.1 equiv), 5-hexyn-ol (1 equiv), MeCN, rt, 2 h; 
(ii) LiOH (5 equiv), H2O/dioxane (1:1) (83%); (iii) Jones’ reagent (1.2 equiv), acetone, 0oC (87%); (iv) (a) (COCl)2 
(1.2 equiv), CH2Cl2, cat DMF, 0oC; (b) N(Me)OMe.HCl (1.05 equiv), pyridine (2.2 equiv), CH2Cl2 (98%). 
 
The diiodohexene 2.57 could be readily isolated via column chromatography and selectively 
hydrolysed to 2.55 under basic conditions.136 However 2.55 and 2.58 were unable to be separated 
via chromatography or distillation. Examination of the original report’s supplementary 
information revealed that their isolated product 2.55, was also contaminated with ~15% of 
2.58.134 Efforts to improve the yield of 2.55 whilst minimising the formation of 2.57 and 2.58 
were uniformly unsuccessful. Limiting the amount of HI reduced the isolated yield of 2.55 to 
~20-30% without eliminating 2.58, and shorter reaction times resulted in the return of starting 
material. It was found that the hydroiodination reaction proceeded in the absence of added water, 
and even with the addition of 4Å molecular sieves, presumably via participation of the alcohol 
functional group forming a silyl ether to liberate HI (Scheme 2.10 - inset). The di-iodo species 
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2.57 could be generated exclusively in 84% yield when the reaction was run overnight with 3 
equivalents of HI. 
Protecting group strategies for the alcohol functional group were limited due to ability of HI to 
act as an ether and silyl cleaving agent.137 Hydroiodination of various derivatives (acetyl-
protected, 5-hexynoic acid and 5-hexynoate methyl ester) were unsuccessful in generating the 
desired material in synthetically useful yields. Alternative hydrohalogenative protocols have 
reported diminished yields (36-55%) or the significant formation of isomerised 2-alkenyl halides 
(10-25%) when performed on alkynols.135,138 
Optimised conditions were developed which provided access to 5-iodo-hex-5-ene-1-ol (2.55) in 
36-40 % yield (contaminated with ~2-5 % 5-iodo-hex-4-ene-1-ol 2.58 when 2 equivalents of 
anhydrous HI were used and the reaction time was restricted to 1 hour at ambient temperature. 
 
Oxidation of the vinyl iodide 2.55 was performed smoothly with Jones’ reagent,139 to yield the 
acid 2.59, which was converted to the Weinreb amide 2.9 using standard conditions.140 
Alternatively, the crude hydroiodination material could be oxidised and isolated by subsequent 
base/acid extraction without chromatography to give the purified acid 2.59 (64%, two steps). 
 
 
2.6.1.2 Preparation of N-Methoxy-N-methyl -5-tributylstannyl-5-
hexenamide 2.7 
 
Access to the vinyl stannane equivalent 2.7 was desirable to allow for the full investigation of the 
Stille cross-coupling reaction. Palladium-catalysed hydrostannylation of 2.53 gave good 
stereocontrol (syn-addition) but poor regiocontrol. Superior regioselectivity for the desired α-
adduct 2.56 was observed with stannylcupration protocols (Table 2.3). 
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Table 2.3 Hydrostannylation studies of 2.53. 
OH OH
SnBu3
OH
Bu3SnConditions
2.56 2.602.53  
 Reagent and Conditions 2.56a 2.60 
1 PdCl2(PPh3)2, Bu3SnH, THF 31 % 57% 
2 Bu3Sn.Cu.SMe2, THF, -48oCb,c 45% 11% 
3 Bu3Sn(Bu)Cu(CN)Li2, THF, -78oCd 73% 15% 
Notes: (a) refers to chromatographically pure isolated yields; (b) required the used of freshly 
prepared CuBr.Me2S; (c) stirred at -78oC, alkyne added in THF/MeOH, stirred at -63oC / 6 h; (d) 
stirred at -78oC / 2 h and quenched with the addition of MeOH. 
 
Guibe et al. reported that the palladium-catalysed hydrostannylation of alkynyl alcohols displays 
diminished α-regioselectivity for elongated carbon chains (n = 5-7). The increased geometric 
and torsional constraints associated with forming the larger palladacycle-heteroatom chelate ring 
(Figure 2.15 - 2.32) was postulated to be responsible for the reduced α-regioselectivity 
compared to small chain lengths.98 
 
Stannylcupration was successfully achieved using both the higher order stannylcuprate 
(Bu3Sn(Bu)Cu(CN)Li2) (2.45), and lower order stannyl copper reagents (Bu3Sn.Cu.SMe2) (2.61). 
Piers has reported that the stannylcupration of 2.53 and 1-chlorohex-5-yne with Me3Sn.CuSMe2 
proceeded regioselectively at the α-position in high yield (85% and 80% respectively, with 
regioisomeric material observed in ~2-10% yield).141-144 The tributyltin analogue 2.61 was 
observed to react under the stated conditions to give a crude mixture containing 2.53, 2.56 and 
2.60 in a ratio of 11:78:11. Column chromatography on basified silica gave 2.56 in an isolated 
yield of 45% (entry 2). 
Barbero reported that many of the limitations of lower order stannyl copper species such as 2.61 
could be overcome with the use of higher order stannylcuprates which display greater reactivity 
and stability.145 Dominguez reported that the reaction of 2.53 with Bu3Sn(Bu)Cu(CN)Li2 (2.45) 
gave an 62% isolated yield of 2.56, but did not comment on the generation of isomeric 2.60.34 In 
the author’s hands, the addition of stannyl cuprate 2.45 to a solution of 2.53 in THF at -78oC, 
which was then allowed to stir at -78oC for 2 hours and quenched with the addition of excess 
MeOH, generated a 5:1 regioselective mixture of 2.56:2.60. Following column chromatography, 
the α- and β-vinyl stannanes were isolated as pure colourless liquids in 73% and 15% yield 
respectively (entry 3). 
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Although it was shown that the use of stannylcuprates provide a convenient access to 5-
tributylstannylhex-5-ene-1-ol (2.56) and that such vinyl stannanes are amenable to further 
functional group manipulation,34,146 including the conversion to isomerically pure 5-iodo-hex-5-
ene-1-ol (2.55), further synthetic manipulation was not pursued, due to the success of 
stannylation of the Weinreb’s amide hexyne 2.54, (vide infra). 
 
 
2.6.2 ROUTE B 
2.6.2.1 Preparation of N-Methoxy-N-methyl-5-iodo-5-hexenamide 2.9 
 
In parallel with the functionalisation reactions of 5-hexyn-1-ol, studies were conducted on the 
alkyne amide 2.54, using similar hydroiodination and hydrostannylation conditions.  
Alkyne amide 2.54 was readily prepared in high yield, via a two step oxidation–amide formation 
protocol (Scheme 2.11). Hydroiodination of 2.54 using the conditions of Yu and Jin, when 
conducted with 3 equivalents of TMSI-MeOH, resulted in a crude 76:24 mixture of 2.9:2.54. 
Careful Kugelrohr distillation (95-100oC/0.2 mmHg) yielded the iodide 2.9 in 100% yield 
(b.r.s.m.) and 2.54, which could be recycled. The alternative procedure of Ishii, using TMSI 
generated via the reaction of TMS-Cl and NaI in acetonitrile, yielded isomerically impure 2.9 in 
an isolated yield of 38%. 
N
O
OMe
Me
OH
(i-ii)
2.54
N
O
OMe
Me
I
2.9
(iii)
2.53
 
Scheme 2.11 Preparation of vinyl iodide 2.9. 
Reagents and yields: (i) Jones’ reagent (1.2 equiv), acetone, 0oC, distillation, 99%; (ii) (a) (COCl)2 (1.2 equiv), 
CH2Cl2, cat. DMF, 0oC; (b) HN(Me)OMe.HCl (1.05 equiv), pyridine (2.2 equiv), CH2Cl2 (98%); (iii) TMSI (3 
equiv), MeOH (3 equiv), CH2Cl2, -78oC, Kugelrohr distillation, 2.9 76% (100% b.r.s.m.). 
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2.6.2.2 Preparation of N-Methoxy-N-methyl -5-tributylstannyl-5-
hexenamide 2.7 
 
Hydrostannylation of 2.54 was conducted using the protocols previously discussed (Table 2.4).  
 
Table 2.4 Hydrostannylation studies of alkyne 2.55. 
N
SnBu3
N
Bu3SnConditions
O O
OMe
Me
OMe
Me2.7 2.62
N
O
OMe
Me
2.54
 
 Reagent and Conditions 2.7a 2.62 
1 PdCl2(PPh3)2, Bu3SnH, THFb 31 57 
2 Bu3Sn.Cu.SMe2 32 10 
3 Bu3Sn(Bu)Cu(CN)Li2, THF, -78oC 61 20 
(a) All yields refer to isolated chromatographically pure yields; (b) Ratio of products assessed 
by 1H NMR integration, not isolated. 
 
The palladium-catalysed addition of tributyltin hydride displayed a regiochemical preference for 
the distal stannylation product 2.62 (entry 1), which was independent of the rate of hydride 
addition. 
Attempted stannylcupration utilising the lower order stannyl-cuprate Bu3Sn.Cu.SMe2 (2.61) gave 
a crude mixture comprised of 2.54, 2.7 and 2.62 in a ratio of 13:71:16. Chromatography gave 
isomerically pure 2.7 in an isolated yield of 32%. Castano et al. have reported that purification of 
stannane mixtures can be achieved by brief treatment of the crude mixtures with p-TsOH, which 
leads to the selective proto-destannylation of the more labile terminal vinyl stannane 
derivative.147 However, complete destannylation to yield the terminal alkene was observed when 
this treatment was applied. 
 
The use of the higher order stannylcuprate Bu3Sn(Bu)Cu(CN)Li2 (2.45) resulted in a mixture of 
2.7 and 2.62 in a ratio of 88:12. Chromatography on basified silica gave an isolated yield of 61% 
of 2.7 and an inseparable mixture comprised of 2.7 and 2.62. 
These results are in agreement with the previous synthetic studies by Piers143 and 
Oehlschlager,124,148 which indicated that internal stannanes are formed preferentially under 
thermodynamic conditions for both higher and lower order cuprates. 
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2.7 Summary of Coupling Fragment Preparation 
 
Synthetic generation of E-1-methoxy-1-iodopropene 2.6 was achieved from 1-methoxypropyne 
(2.12) under the conditions of Yu and Jin, with subsequent halogen-metal exchange allowing the 
isolation of E-1-methoxy-1-tributylstannylpropene 2.8 in excellent yield. Also of synthetic 
interest was the exclusive generation of the isomer 2.42 using palladium-catalysed 
hydrostannylation and stannylcupration techniques. These two complementary techniques allow 
stereoselective access to the two regioisomeric trans-alkoxy-vinyl stannane adducts 2.8 and 2.42. 
 
The vinyl iodide species 2.9 was obtained in excellent yield using a hydroiodination protocol. 
The analogous vinyl stannane amide 2.7 was prepared, utilising stannylcupration methodology, 
in good yield. 
 
The successful synthesis of complementary reactive partners 2.6/2.7 and 2.8/2.9 allowed 
investigations into the palladium-mediated cross-coupling reaction to proceed. 
 
SnBu3
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N
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Me
SnBu3
N
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I
I
OMe
Me
2.92.8
2.6 2.7
Me OMe
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Scheme 2.12 Summary of optimised routes to the preparation of coupling fragments 2.6, 2.8, 
2.9 and 2.7. 
Reagents and yields: (i) TMSI (1 equiv), MeOH (1 equiv), CH2Cl2, -78oC ? 0oC, quantitative; (ii) (i) n-BuLi, ether, 
-100oC ? -50oC; Bu3SnCl, 87% (from 2.12); (iii) Bu3Sn(Bu)Cu(CN)Li2, THF-MeOH, -78oC, 61%; (iv) TMSI (3 
equiv), MeOH (3 equiv), CH2Cl2, -78oC ? 23oC, 76%; (v) Bu3SnH, Pd(PPh3)2Cl2, THF, rt, 96%; (vi) 
Bu3Sn(Bu)Cu(CN)Li2, THF, -78oC, 99%. 
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2.8 Fragment Coupling Reactions 
2.8.1 Preparation of Dienes via Stille Coupling 
 
Successful synthesis of the complementary partners 2.6/2.7 and 2.8/2.9 allowed investigation of 
the transition metal-mediated coupling to form the diene system of amide 1.70. A large number 
of coupling conditions have been utilised to maximise yields in the occasionally capricious Stille 
reaction.18,32,149 A number of the more promising palladium catalyst and solvent systems were 
surveyed (Table 2.5). 
 
Table 2.5 Stille coupling of vinyl alkene fragments to form 1.70. 
X
Me
OMe
Y O
N
OMe
Me
O
N
OMe
Me
OMe
Me
X = I 2.6
2.8X = Bu3Sn
Y = I 2.9
2.7Y = Bu3Sn
conditions
1.70
catalyst
 
Entry Reagents Catalyst Conditionsa Resultsb 
1 2.6/2.7 Pd2(dba)3, CuI, AsPh3 NMP, 50oC n.rc 
2 2.8/2.9 PdCl2(PPh3)2 THF, 40oC 23%d,e 
3 2.8/2.9 Pd (PPh3)4 THF, 40oC n.r 
4 2.8/2.9 Pd(PPh3)4 Benzene, 80oC n.rd 
5 2.8/2.9 Pd(PPh3)2Cl2 DMF, 80oC 24% 
6 2.8/2.9 Pd(MeCN)2Cl2 DMF, 54oC 10% 
7 2.8/2.9 Pd2(dba)3, CuI, AsPh3 NMP, 54oC 71%e 
8 2.8/2.9 Pd2(dba)3, CuI, AsPh3 DMF, 54oC 73% 
9 2.8/2.9 Pd2(dba)3,  PtBu3 DMF, 54oC 42%e 
10 2.8/2.9 Pd2(dba)3,  PtBu3 NMP, 54oC 32%e 
Note (a) Reactions were performed on 0.25 mmol scale with 2.9/2.7 (1 equiv), 2.6/2.8 (1.1 equiv) and 
catalyst loadings of 5 mol % (Pd); 20 mol % AsPh3 or PtBu3; and 20 mol % CuI where relevant. All 
reactions were subjected to six successive freeze-pump-thaw cycles, protected from light in aluminium foil 
and stirred under dry Ar for 12 h at the stated temperature; (b) Progress of the reaction was monitored via 
1H NMR spectroscopy of sample aliquots. Yields refer to chromatographically pure isolated material. (c) 
Decomposition of 2.6. (d) Decomposition of 2.9 yielding a terminal olefin. (e) Conversion based on 1H 
NMR integration of olefinic proton ratios [2.9:1.70]. 
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It readily became apparent that the vinyl iodide 2.6 was unstable to the conditions required for 
coupling. The vinyl stannane 2.7 was quantitatively re-isolated from the reaction mixture (entry 
1). Consequently, focus was turned to 2.8 and 2.9 as coupling partners. 
 
Of the reaction conditions investigated, non-polar or ethereal solvents resulted in poor 
conversion rates and the decomposition of the vinyl iodide 2.9 to a terminal olefin (entries 2-4). 
The conditions described by Farina, utilising polar coordinating solvents (NMP or DMF), with 
ligands of lower denticity (As(PPh)3 or TFP) and CuI as a co-catalyst, resulted in clean 
conversion to the required diene system with no observed decomposition products.32,33 The 
reaction in DMF was observed to proceed to completion, allowing the isolation of the desired 
diene 1.70 in 73% yield after column chromatography (entry 8). The Stille coupling of fragments 
2.8 and 2.9 was found to be reproducible on a 5 millimole scale giving 58-73% yield of the diene 
system 1.70. Importantly, the reaction proceeded with complete retention of stereochemistry, 
with no isomerisation of either vinyl moiety detectable via 1H NMR spectroscopy. 
 
Application of the optimised coupling conditions to the cross-coupling of 2.51 and 2.9 resulted 
in efficient coupling to generate 1.81 in 63% yield (Scheme 2.13). 
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Scheme 2.14 Preparation of dienes 1.70 and 1.81 using Stille coupling.  
Reagents and yields: (i) 2.9 (0.8 equiv), 2.8 or 2.51 (1 equiv), Pd2(dba)3 5 mol %, AsPh3 20 mol %, CuI 20 mol %, 
DMF, 65°C, 12 h, 1.70 73%, 1.81 63%. 
 
An important aspect of the handling and purification of these diene compounds was the necessity 
to perform extractions and column chromatography under neutral or mildly basic conditions. 
Trace quantities of acid resulted in the decomposition of the methyl and ethyl-enol ethers to the 
parent ketone structures (Figure 2.21). 
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Figure 2.21 Acid catalysed decomposition of the enol-ether moiety. 
 
To avoid decomposition, it was found beneficial to quench reactions with an aqueous solution 
comprised of (10:1) saturated ammonium chloride and saturated sodium bicarbonate. Flash 
column chromatography was performed on triethylamine-basified silica gel, with the inclusion of 
1% triethylamine in the eluant. 
 
2.8.2 Preparation of Dienes via Negishi Coupling 
 
The preparation of the vinyl organozinc species 2.52, 2.64 and 2.65 was achieved via the in-situ 
transmetallation of the respective vinyl magnesium or vinyl lithium species with anhydrous 
ZnCl2 in ether.130,150,151 Palladium-catalysed cross-coupling of these vinyl zinc species with vinyl 
iodide 2.9 resulted in excellent yields for all three organo-zinc species (Scheme 2.14). 
OEt
ZnCl
MgBr
OEt
OMeMe
ZnCl
ZnCl
OMe
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N
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Me
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Me
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(iii) (ii)
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2.66
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Scheme 2.14 Preparation of dienes 1.70, 1.81 and 2.66 via Negishi coupling. 
Reagents and yields : (i) ZnCl2, THF; (ii) Pd(PPh3)4 5 mol %, THF, 2.9, rt, 12 h; (iii) (a) TMSI, MeOH, CH2Cl2, -
78oC ? rt, 1 h; (b) n-BuLi, -90oC ?-25oC; (c) ZnCl2, THF; (iv) (a) t-BuLi, -98oC, 30 min; (b) ZnCl2, THF; 2.66 
77%, 1.70 100%, 1.81 95%. 
 
Notable in this reaction sequence is the complete chemoselectivity of the organozinc reagents, 
neither undergoing nucleophilic attack at the amide functionality, nor deprotonating the acidic α-
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carbonyl proton. Excellent stereoselectivity was observed in the preparation of 1.70, with no 
products arising from isomerisation of any of the in-situ intermediates.  
The utility of the Negishi coupling is further enhanced by the ability to use excess zinc coupling 
reagent to ensure complete consumption of the vinyl iodide 2.9. A simplified work-up involving 
concentration of the reaction mixture under rotary evaporation to form a thick oil and extraction 
through a short plug of alumina gave the pure diene in high yield. In contrast, the reaction 
mixtures derived from Stille couplings require the use of extractive work-up and extensive 
column chromatography to remove tin by-products. 
 
The multiple consecutive transmetallations achieved in the preparation of 1.70 is striking. A 
regio- and stereoselective hydroiodination (i), lithium-halogen exchange (ii), transmetallation to 
zinc (iii) and then participation in the palladium-catalysed coupling cycle (iv) to effect coupling 
with vinyl iodide 2.9 (v) is achieved in excellent yield with complete retention of stereochemistry 
in a single reaction vessel (Figure 2.22). 
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Figure 2.22 One pot generation of the diene moiety via Negishi coupling. 
 
 
2.9 Preparation of the Diels-Alder Trienone Precursors 
 
The prepared diene amide systems 1.70, 1.81 and 2.66 were readily converted to Diels-Alder 
precursor trienones 1.69, 1.80 and 2.67 in a single step upon reaction with excess vinyl 
magnesium bromide in THF at room temperature (Scheme 2.15). 
Chapter Two – Preparation of IMDA Precursors  75
O
R2
R1
N
OMe
O
Me
R2
R1
2.66
1.70
1.81
2.67
1.69
1.80
R1 = H
R1 = Me
R1 = H
R2 = H
R2 = OMe
R2 = OEt
R1 = H
R1 = Me
R1 = H
R2 = H
R2 = OMe
R2 = OEt
(i)
 
Scheme 2.15  Preparation of Diels-Alder precursors. 
 Reagents and yields: (i) vinyl magnesium bromide (2 equiv), THF, rt, 12 h, 95-98%. 
 
N-Methoxy-N-methyl-amides (Weinreb amides) form stable metal chelating tetrahedral 
intermediates (2.68) upon reaction with an organometallic reagent which prevent subsequent 
addition to the nucleophilic carbonyl centre (Figure 2.23). Upon aqueous work-up, collapse of 
the tetrahedral intermediate delivers a ketone product, even in the presence of excess 
organometallic reagent.140 
R N
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Figure 2.23 Proposed chelate intermediate responsible for mono-alklation. 
 
The triene systems 1.69, 1.80 and 2.67 were sensitive to acid catalysed hydrolysis and 
polymerisation reactions when concentrated. However, the isolated triene systems could be 
stored frozen in benzene without discernable degradation over a period of several months. 
 
2.10 Summary 
 
A concise synthesis of three IMDA triene systems has been developed. This synthesis involved 
the regio- and stereoselective preparation of vinyl stannane and vinyl iodide species that were 
coupled utilising Stille and Negishi cross-coupling methodology. 
 
With the successful synthesis of the stereochemically pure Diels-Alder precursors investigation 
of the intramolecular type II Diels-Alder reaction was pursued. This work is detailed in Chapter 
Three. 
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Chapter Three 
The Diels-Alder Reaction Directed Towards the 
Synthesis of Bicyclic Natural Products 
 
3.1 The Diels-Alder Reaction 
 
The [4+2] cycloaddition of a 1,3-diene and an alkene was placed in a synthetic context by the 
work of Diels and Alder in 1928, who reported the reaction of several dienes and alkenes 
(Figure 3.1).1 The observed reaction constituted a concerted pericyclic rearrangement with the 
formation of two carbon σ-bonds and one π-bond. A more detailed mechanistic understanding of 
the Diels-Alder reaction was achieved with the development of frontier molecular orbital theory 
(FMO) and the Woodward-Hoffmann rules as they relate to concerted pericyclic reactions.2-6 
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Figure 3.1 [4+2] Cycloaddition of cyclopentadiene and benzoquinone discovered by Diels 
and Alder. 
 
The synthetic power of the Diels-Alder reaction lies in its ability to allow rapid access to highly 
functionalised stereodefined cyclohexene structures in a single operation from an acyclic 
precursor. Up to four contiguous centres and a double bond are created in a single stereospecific 
operation, in which the relative stereochemical relationships present in the diene and dienophile 
are conserved. High levels of regioselectivity and diastereoselectivity (endo vs. exo) are often 
possible.7,8  
 
Experimentally, the scope of the Diels-Alder reaction has been extended to include 
intramolecular reactions,9-11 transannular cyclisations (TADA)12 and hetero-Diels-Alder 
reactions. Synthetic efforts to improve the rate and yield have focused on the use of Brönsted and 
Lewis acid catalysis,8 high pressure,13 microwave, ultrasound and salt enhancement.14,15 
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At a strategic level, the application of a Diels-Alder reaction is a powerful tactic to employ as the 
key step in a synthesis due to its ability to greatly increase molecular complexity.16 This is 
evidenced by the extensive employment of Diels-Alder reactions in the synthesis of a wide range 
of natural products.7,17-20 
However, despite the enormous potential of the Diels-Alder reaction, isomer control remains as a 
serious limitation to its effective employment in solving synthetic problems. Efforts have been 
made to control the regioselectivity, enantioselectivity, and diastereoselectivity of the Diels-
Alder reaction employing chiral Lewis acids, chiral auxiliaries, chiral catalysts, Umpulong 
equivalents and intramolecular reactions, which define the correct geometrical orientation of the 
diene and dienophile components. 
 
The examples in Figure 3.2 and Figure 3.3 illustrate synthetic advances in the use of both the 
intermolecular and intramolecular Diels-Alder reactions to secure appropriate regiochemical and 
stereochemical dispositions of functionality, to provide a rigid scaffold for stereoselective 
elaboration and to form multiply fused bicyclic structures in the pursuit of natural products. 
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Figure 3.2 Synthetic advances in the application of the intermolecular Diels-Alder reaction 
to natural product chemistry. 
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In the first example (A), Woodward’s 1956 total synthesis of reserpine (3.1) opened with a Diels-
Alder reaction to form the critical E bicyclic system. The stereochemically pure ester group 3.2, 
derived from an endo-selective cyclisation, was used as a scaffold for the ensuing synthetic 
sequence establishing all five stereocentres in the E-ring.21,22 
 
Remarkable advances in controlling the absolute stereochemistry of the intermolecular Diels-
Alder reaction have been observed in the total syntheses of prostaglandins by the research group 
of Corey. In the initial approach, (B), a Lewis acid-catalysed Diels-Alder reaction between diene 
3.3 and ketene equivalent, 2-chloroacrylonitrile (3.4), afforded a racemic mixture of 3.5 with a 
random exo/endo distribution of the dienophile substituents.23 The (+)-ephedrine salt was used to 
resolve the mixture to the natural epimer.24 Successive advances utilising chiral auxiliaries25 and 
then asymmetric catalysis,26,27 such as the chiral oxazaborolidinone catalyst 3.7, that allows 
discrimination between the enantiotopic faces of the dienophile, have led to the preparation of 
adduct 3.8 with a high enantiomeric excess in excellent yield (C). The enantiomerically pure 
norbornen-2-one adducts 3.6 and 3.9 were advanced to form the natural (+)-prostaglandin F2α 
and related prostaglandins. 
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Figure 3.3 Sorensen’s application of an IMDA reaction en route to (+)-FR182877. 
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The recent synthesis of the unnatural epimer of the potent antitumour agent (+)-FR182877 (3.10) 
by Sorensen et al. readily demonstrates the powerful ability of the Diels-Alder reaction to form 
architecturally complex natural products from polyunsaturated macrocycles.28,29 Based on a 
biogenetic postulate, a Trost-Tsuji ring closure of 3.11 afforded the tetraene macrocycle 3.12, 
from which selenium incorporation and then oxidative-elimination forms the Diels-Alder 
precursor. A sequential tandem transannular Diels-Alder-transannular hetero-Diels-Alder 
reaction was observed to proceed under mild conditions to generate the seven new stereocenters 
and 5 new rings present 3.14. It was calculated that the desired E-isomer 3.13, arising from 
deselenation, was converted quantitatively to the (+)-FR182877 carbocyclic skeleton 3.14. Evans 
et al. reported a similar tandem transannular Diels-Alder reaction to form the natural epimer (-)-
FR182877.30 
 
3.2 Intramolecular Diels-Alder Reactions 
 
The [4+2] pericyclic reaction, as reported by Diels and Alder, was initially investigated in the 
context of the intermolecular reaction, focusing on the stereospecific and regiospecific union of 
two separate entities. By contrast, the intramolecular Diels-Alder (IMDA) reaction, where the 
diene is attached to the dienophile via a tether, was not investigated extensively until the 1960s. 
 
The first use of the IMDA reaction in the context of natural product synthesis was reported in 
1963, with the preparation of γ-apopicropodophyllin (3.15).31 The cinnamyl phenyl propiolate 
3.16, prepared via esterification of the respective E-cinnamyl alcohol and acid chloride, when 
subjected to vigorous conditions resulted in the desired intramolecular cyclisation (Figure 3.4). 
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Figure 3.4 The application of an IMDA to form γ-apopicropodophyllin (3.15).  
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3.2.1 Synthetic Advantages of the IMDA Reaction 
 
The synthetic advantages of utilising an intramolecular Diels-Alder reaction arise from the 
observation that many of the limiting electronic and steric requirements of the intermolecular 
Diels-Alder reaction, and the chemoselectivity and regioselectivity of the outcomes, can be 
favourably altered utilising an intramolecularly tethered triene system. The example in Figure 
3.4 illustrates the high regioselectivity achievable in IMDA reactions, primarily due to the 
torsional and geometric restrictions imposed by the dienophile tether. 
The pre-organisation and orientation of the diene and dienophile diminishes the entropy 
requirements relative to the analogous intermolecular reaction allowing the IMDA reaction to 
proceed more readily. In addition, by incorporating a stereocenter in the triene precursor, 
discrimination between the diastereotopic faces of the diene and dienophile can be achieved. 
These advantages have led to the extensive use of the IMDA in total synthesis and these 
applications have been reviewed.9,11,17,32-36 
 
3.2.2 Type I and Type II IMDA Reactions 
 
The IMDA reaction can be described as either type I or type II, depending on the position of 
attachment of the dienophile to the diene (Figure 3.5). 
 
Type I IMDA Type II IMDA12
1
2
3.17 3.18 3.19 3.20
 
 
Figure 3.5 Type I and Type II IMDA connectivity and products. 
 
The type I IMDA reaction, involving a C1 terminally connected diene and dienophile system 
(3.17), upon cyclisation forms a fused bicyclic ring system (bicyclo[n.4.0]alkene) with a 
connective bond in common (3.18). Type I reactions have been utilised to good effect in the 
preparation of a variety of organic targets and are well documented.33,34,37-39 
The type II IMDA reaction, which features C2 connectivity (3.19) and delivers a bridged bicycle 
(bicyclo[n.3.1]alkene) (3.20) upon cyclisation, in contrast, has received less synthetic attention.9 
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3.2.3 Regioselectivity  
 
Intermolecular Diels-Alder cyclisations of 2-substituted dienes and dienophiles with electron-
withdrawing groups display an intrinsic regiochemical bias favouring the 1,4-disubstituted 
product (3.21) over the 1,3-adduct (3.22) (A). This result is commonly interpreted in terms of 
FMO theory, through the calculated orbital coefficients of the HOMO diene – LUMO dienophile 
interaction.40 In contrast, type II IMDA reactions forming small bicyclic rings exhibit a 
preference for the formation of the meta-cycloadduct (3.23), in part, due to torsional and 
geometric strain incurred in meeting the requirements for the effective overlap interaction of the 
relevant orbitals (3.25 vs 3.26) and because the meta-regioisomer (3.23) contains the trans-
cycloalkene in the larger ring (3.27 vs 3.28) (vide infra) (B) (Figure 3.6).9 
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Figure 3.6 Divergent regiocontrol arising with an intramolecular tether. 
 
The difference in energy between the meta and para isomers 3.23 and 3.24 diminishes as the 
tether size increases and the IMDA cycloaddition is increasingly influenced by the steric, 
conformational and electronic factors that affect intermolecular pericyclic reactions. When the 
tether contains 3-5 atoms, the meta regioisomer is the exclusive product of cycloaddition 
regardless of the dienophile’s activation pattern, and the method of cyclisation (thermal or Lewis 
acid catalysis).9 
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3.2.4 Stereoselectivity 
 
Secondary orbital interactions between the diene and dienophile are attributed as the origins of 
stereoselectivity in the intermolecular Diels-Alder reaction. These interactions, although 
typically less than several kcal mol-1 in magnitude (3.29 vs 3.30), result in the predominant 
formation of the endo adduct under kinetic control.6 Type II IMDA reactions show complete 
stereoselectivity with cycloaddition taking place from a conformation where the tether occupies 
the endo position (3.31) affording an “out”-bridging adduct (3.32) as minimisation of torsional 
strain energy associated with the exo ether (3.34) dominates contributions from secondary orbital 
interactions (Figure 3.7). 
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Figure 3.7 Comparison of inter- and intramolecular stereoselectivity. 
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3.2.5 Bredt’s Rule 
 
An interesting theoretical aspect that has practical implications for the type II IMDA reaction is 
the observation that incremental contraction of the tether length (n), connecting the diene and 
dienophile (3.35), results in consecutively smaller bicyclo[n.3.1] fused systems with an olefinic 
bond at the bridgehead carbon (3.36) (Figure 3.8). 
Y
ZZ
(n)
[4+2]
(n)
3.36
3.35
Φ2YZ(n)Φ1
χ1
τ
χ2
3.37  
Figure 3.8 IMDA formation of bridgehead olefin bicyclo[n.3.1] systems. 
 
The tether constraint results in conformational distortion of the olefinic sp2 carbons away from 
the desired planar geometry giving rise to increased angular (Ф,χ) and torsional (τ) strain 
energies (3.37) and enhancing the chemical reactivity of the olefinic bond.9,41 Whilst not 
violating Bredt’s rule,** a bridgehead olefinic bond within a sufficiently restricted fused bicyclic 
skeleton can be viewed as representing a potentially strained molecular structure. This may allow 
more facile ring and bond rearrangement to relieve olefinic and ring strain associated with the 
double bond.  
 
3.3 Formation of Bridgehead Olefins via IMDA Reactions 
 
The type II IMDA and hetero-type II IMDA reactions have been extensively investigated and 
applied by K. Shea et al. to the formation of bridged bicyclic molecules.9,42  
Significant interest in the use of the IMDA reaction to form bridged bicyclic structures occurred 
in the wider synthetic community with the discovery of Taxol™ (paclitaxel) 1.743,44 and 
phomoidrides A and B.45-47 These natural products possess a bicyclo[5.3.1]undecene and a 
bicyclo[4.3.1]decene core, respectively. The extensive research endeavours directed towards 
these natural products serve as a rich and instructive source of routes to 
bicyclo[n.3.1]carbocycles, and the application of IMDA methodology to form such systems.48-50 
                                                 
**The empirical observation that carbon double bonds cannot form at the bridgehead of small bicyclic camphane 
[2.2.1] and pinane [3.1.1] ring systems is formally called Bredt’s rule. 
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Historically, the first examples utilising type II IMDA reactions to generate bridgehead alkene 
bicyclo[n.3.1]carbocyclic skeletons were achieved via the high temperature flow pyrolysis of 
activated and unactivated triene systems (Figure 3.9).9 Some of these molecules had previously 
been synthesised by pyrolytic elimination of bridgehead substituted ammonium salts,51 β-
lactones,52 and through intramolecular Wittig reaction53 during investigations to define the limits 
of Bredt’s rule and predict strain associated with bridgehead double bonds. 
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or (iv)
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(B)
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Figure 3.9 Shea’s IMDA studies on activated and unactivated triene systems. 
Reagents and yields: (i) flow pyrolysis, 455°C, 8s, 760 mmHg, N2 carrier gas, 55% [GC]; (ii) flow pyrolysis, 398°C, 
8s, 85% [GC]; (iii) 201°C, 15 min, 0.04-0.09 M xylene, sealed tube, 57% [GC]; (iv) 140°C, xylene, 30 mol % 
Proton-sponge®, 20 h, 57%; (v) Et2AlCl (0.5 equiv), CH2Cl2, 15 min, 21°C, 70%, (vi) Et2AlCl, CH2Cl2, 21°C, < 5 
min, 70%. 
 
Vigorous conditions were required for the thermally initiated IMDA reaction of unactivated 
triene systems (3.38) (400-500°C, gas phase, atmospheric pressure, with ca. 10-15s contact time) 
(Figure 3.9-A).54 The inclusion of activating substituents on the dienophile (2.67) was found to 
moderate the conditions necessary to achieve cycloaddition, giving increased yields under flow 
pyrolysis techniques and allowing the use of sealed tube solution-phase thermolysis (B).55,56 The 
synthetic utility was further extended with the use of Lewis acid catalysts that allowed low 
temperatures and short reaction times that are compatible with the construction of more highly 
functionalised bridged bicyclic structures (C) and (D).57 
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3.3.1 Stereoselective and Regioselective Elaboration of Bridged Bicyclic 
Olefins 
 
As illustrated in Figure 3.9, Shea et al. demonstrated that direct cyclisation of an acyclic 
precursor via an IMDA reaction was a feasible synthetic route to the formation of medium-sized 
rings. Such systems present a significant challenge to other routes of preparation due to high 
entropic and enthalpic barriers.58 Furthermore, the conformation restriction imposed by the 
bridged bicyclic skeleton enables stereoselective and regioselective elaboration to occur.59  
 
The synthesis of ledol (3.45), a plant derived sesquiterpene, via what was termed a bridged-to-
fused-ring interchange, illustrates many of these important aspects (Figure 3.10).59,60 
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Figure 3.10 Synthesis of ledol utilising an IMDA reaction.  
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The readily prepared IMDA triene precursor 3.41, when subjected to the Lewis acid 
diethylaluminium chloride at room temperature, cyclised rapidly to the corresponding bicyclic 
ring system 3.42. Stereoselective control was observed with the addition of MeLi to the carbonyl 
functional group occurring from the less sterically hindered exo face (Figure 3.10 - inset). The 
conformational bias resulted in the exclusive generation of the tertiary alcohol 3.46. Ozonolysis 
of the bridgehead alkene, followed by base-promoted aldol condensation provided the fused 
bicyclic system 3.47 in high yield. Exclusive addition from the convex face to generate a single 
diastereomer is again observed in both hydrogenation, to generate the ring fused stereochemistry 
(3.48), and during dibromocyclopropanation with Seyferth’s reagent. The synthetic sequence 
was readily concluded with gem-dimethylation and deprotection of the tertiary alcohol to 
generate ledol (3.45). 
 
Another unique aspect that arises for constrained bicyclic conformations, is the ability to perform 
regioselective alkylations (Figure 3.11).61 
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Figure 3.11 Regioselective alkylation of constrained bicyclic systems.  
 
Deprotonation of bicyclo[5.3.1]undecenone 3.49 gives the more highly substituted bridgehead 
enolate 3.50 under kinetic control, whilst the less substituted enolate 3.51 is achieved under 
thermodynamic control. The origin of this selectivity can be understood by consideration of both 
stereoelectronic and strain factors. The stereoelectronic requirement for kinetic deprotonation is 
optimal with a C-H dihedral angle of 90° relative to the carbonyl sigma plane. In the lowest 
energy conformation (MM2), the C1-Ha carbon-hydrogen bond is more closely aligned with the 
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carbonyl π-system, while both the C3 hydrogens bisect the carbonyl π-system (Figure 3.11 - 
inset). Stereoelectronic factors favour kinetic deprotonation of Ha resulting in the formation of a 
bridgehead enolate 3.50. However, enolate 3.50 is expected to be thermodynamically 
disfavoured due to the strain involved in formation of an additional bridgehead double bond. 
Under equilibrating thermodynamic control the C2-C3 enolate 3.51 is formed preferentially. 
 
This principle was utilised by Holton et al. en route to the synthesis of paclitaxel, where selective 
bridgehead functionalisation was achieved under kinetic control, even though the C3 hydrogen 
of 3.54 could be anticipated to be more acidic (Figure 3.12).62,63 
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88%
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Figure 3.12 Regioselective hydroxylation at the bridgehead position.  
 
The proposed syntheses of the nakafuran and florlide natural products, as illustrated in Scheme 
3.1, also makes use of these principles to introduce the C3 sidechain which will be elaborated 
into a furan moiety of the nakafurans and to establish the bridgehead hydroxylation observed in 
the florlide compounds. 
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Scheme 3.1 Conformational control leading to selective alkylation and hydroxylation. 
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3.4 IMDA Reactions Directed Towards the Bicyclo[4.3.1]-decene 
Core 
 
3.4.1 IMDA Cyclisation of Methoxy-triene 1.69 
 
The initial investigations of the IMDA cyclisation reaction were conducted on methoxy-triene 
1.69, directed towards synthesis of the nakafuran-type family of natural products (Scheme 3.1). 
As illustrated above, Shea’s synthesis of ledol and the studies utilising IMDA approaches to the 
synthesis of the paclitaxel and phomoidride natural products provides a rich source of protocols 
and methodology to achieve the desired cyclisation. 
 
When the triene 1.69 was subjected to standard Diels-Alder cyclisation conditions (toluene, 0.1 
M, reflux, 20 h; or toluene, 0.1 M, 150°C, sealed tube, 20 h), 1H NMR spectroscopy of the crude 
reaction mixtures indicated that a large amount of decomposition had occurred. Inspection of the 
1H NMR spectrum indicated that signals associated with the starting diene system remained but 
those of the enone dienophile were absent. Silica column chromatography was unable to isolate 
any discernable cyclised material (Table 3.1). 
 
Table 3.1 IMDA cyclisations of triene 1.69. 
Entry Reaction Conditionsa Yield %b 
1 Toluene (no BHT) dec. 
2 Toluene 35 
3 m-Xylene 36 
4 Benzene 68 
5 10 equiv BF3.Et2O, -78°C, CH2Cl2, 60 min. 46 
6 1 equiv Et2AlCl, -78°C to rt, CH2Cl2, 90 min. 79 
Note (a) Thermal IMDA reactions were conducted on 50 mg at 180°C in sealed 
tubes at 0.1 M, with ~1 mg BHT, 30 h. (b) Yields are for isolated 
chromatographically pure material. 
 
When the triene 1.69 was subjected to thermal cyclisation conditions, performed in sealed tubes 
at 180°C for 30 hours using degassed solvents and in the presence of a crystal of BHT as a 
radical inhibitor,59 clean consumption of the starting material was observed with minimal 
decomposition. A single product (3.55) was isolated in good yield as a colourless oil. 
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In contrast to thermal cyclisations of triene systems, which are known to require temperatures of 
at least 150°C for a practical rate of cyclisation, Lewis acid catalysis allows the reaction to 
proceed more readily, often at room temperature or below, and achieve greater control of 
endo/exo selectivity.11,57,64 
The addition of 10 equivalents of freshly distilled BF3.OEt2 to the triene system 1.69 in CH2Cl2 
at –78°C yielded the cyclised product 3.55 in 46% isolated yield, but exhibited significant 
decomposition.65,66 Exposure of the triene to 1 equivalent of Et2AlCl in CH2Cl2 at room 
temperature resulted in the clean conversion to cycloadduct 3.55, which was isolated in 79% 
yield after aqueous work-up and silica column chromatography. 
 
However, with clean isolation of the cyclised adduct 3.55, a significant problem became 
apparent. Inspection of the 1H NMR spectrum of the isolated material indicated that the 
anticipated doublet arising from the 3JHH coupling interaction of the C11 methyl group with the 
adjacent H-8 proton was absent; instead a singlet was present at δH 1.63 which integrated for 
three hydrogens (Figure 3.15). The clean disappearance of the signals associated with the vinylic 
protons of the starting material and the increased complexity of the 1H NMR spectrum, 
attributable to the conformational rigidity of the bicyclic system causing separation of the 
diastereotopic proton signals, supported the supposition that an IMDA reaction had occurred. 
Additionally, complete integration of the 1H NMR spectrum indicated that 18 hydrogen signals 
were present, identical to the starting material and the anticipated product, which was confirmed 
by high resolution mass spectroscopy. 
 
A full range of two-dimensional NMR experiments (COSY, HSQC, CIGAR, and 1D NOESY) 
were performed on the isolated cycloadduct 3.55. The results of these experiments led to the 
conclusion that, although the cyclised adduct contained the anticipated bicyclo[4.3.1]decene 
framework arising from a successful IMDA reaction, the double bond had isomerised from the 
desired Δ6,7 position (1.68) to the Δ7,8 position (3.55) (Figure 3.13). 
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Figure 3.13 IMDA cyclisation of triene 1.69 to give isolated isomerised IMDA adduct 3.55. 
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The important correlations observed in the CIGAR and the NOE experiments that allowed 
elucidation of molecular connectivity are depicted in Figure 3.14. The 1H NMR spectrum and 
chemical assignments based on HSQC JCH coupling and NOE correlations are depicted in 
Figure 3.15. 
Me
MeO
O
H
H
CIGAR NOE
1
2
3
4
5
6
7
8
9
10
11
12
Me
MeO
O
H
H
57.3
16.1
118.3
148.5
32.5
33.8
43.6
217.2
43.5
21.2
32.1
29.8
(a) (b)
 
Figure 3.14 (a) Important 2D NMR CIGAR and NOE correlations and (b) δC 13C chemical 
shift assignment for 3.55. 
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Figure 3.15 500 MHz 1H NMR of 3.55 recorded in CDCl3 with hydrogen assignments. 
 
Specific correlations that support the assignment of the isolated IMDA adduct as the Δ7,8-olefinic 
adduct 3.55 are: 
 
(i) COSY correlations from the broad singlet at δH 2.76 (H6) to δH 1.46 (H5a), δH 
2.06 (H5b), δH 1.62 (H11) and δH 2.03 (H10b); 
(ii) an NOE effect from the broad singlet at δH 2.76 (H6) to the singlet at δH 3.48 (C12 
–OMe) and the multiplets at δH 2.22 (H10a) and δH 2.03 (H10b) and, 
(iii) a strong CIGAR JCCH coupling from δC 118.3 (C8) to δH 1.62 (H11 – Me) and to 
the resonances at δH 2.50 (H9a) and δH 2.24 (H9b), in conjunction with a weak 
coupling to δH 2.42 (H1). 
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The spectroscopic assignment was supported by cyclopropanation of the isolated cycloadduct 
3.55 to give the cyclopropane 3.56. Acidic hydrolysis of the C7 methyl-ether, with concurrent 
cationic cyclopropane ring cleavage67,68 resulted in the preparation of the gem-dimethyl 
derivative 3.57. Under the reaction conditions, this diketo-intermediate was observed to undergo 
an acid-catalysed aldol reaction69 generating the novel indenone species 3.58. 
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Figure 3.16 Verification of structural assignment of 3.55 through cyclopropyl fragmentation 
to 3.57 and subsequent intramolecular aldol reaction. 
Reagents and yields: (i) ZnEt2, CH2I2, DCE, 40°C, 44 h, 66%; (ii) 10% HCl, EtOH, reflux, quantitative. 
 
The structural assignment of 3.58 was based on extensive 1D and 2D NMR spectroscopic 
experiments (COSY, HSQC, CIGAR, 1D NOESY and TOSCY) performed in CDCl3 and in 
C6D6, the presence of an alcohol adsorption in the IR spectrum (3437 cm-1) and HRMS data 
which indicated a molecular formula of C12H18O2 (194.1315), isomeric with the anticipated 
diketo species 3.57. Particularly informative CIGAR correlations and NOE enhancements are 
depicted in Figure 3.17. 
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Figure 3.17  (a) Important 2D NMR CIGAR correlations and NOE enhancements and (b) δC 
13C chemical shift assignment observed for 3.58 (in CDCl3). 
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Specific correlations that support the proposed assignment of 3.58 are:  
 
 (i) a strong CIGAR JCCH correlation for the quaternary centre at δC 85.2 (C7) to δH 
2.42 (br doublet, J = 7.2 Hz, C3), δH 0.90 (s, 3H, C11), δH 1.06 (s, 3H, C12) and 
δH 2.21 (m, C6); 
(ii) strong CIGAR JCCH correlations from the quaternary centre at δC 32.9 (C8) to δH 
0.90 (s, C11), δH 1.06 (s, C12) and 2.42 (br doublet, J = 7.2 Hz, C3) and, 
(iii) an NOE effect observed from the methyl singlet at δH 0.90 (s, 3H, C11) to the C3 
proton at δH 2.42 (distance = 2.931Å).†† 
 
The observed CIGAR correlation of the two methyl signals at δH 0.90 (C11) and δH 1.06 (C12) 
to δC 32.9 (C8), support the assignment of 3.56 as the Δ7,8 cyclopropane adduct, and by inference 
3.55 as the Δ7,8-olefinic adduct. 
 
3.4.1.1 Bridgehead Olefinic Isomerisation [Δ6,7 to Δ7,8] 
 
It is postulated that following the initial IMDA reaction to generate the desired Δ6,7 bridgehead 
olefin adduct 1.68, an olefinic bond isomerisation occurs that relieves the π-bond torsional strain 
associated with the bridgehead double bond and generates the Δ7,8 adduct 3.55 (Figure 3.13). 
 
This observation is in contrast to the extensive work of Shea et al. on triene systems which have 
been observed to undergo IMDA cyclisation leading to bridgehead olefinic adducts under a 
number of experimental conditions (see Figure 3.9).59 No instances of isomerisation products 
were reported, although it was noted that trienes such as 2.67 and 3.38 which lack a C7 
substituent were quite sensitive to Lewis acids and required thermal cyclisation conditions. The 
addition of 1,8-bis(dimethylamino)naphthalene (Proton-sponge®), a strong non-nucleophilic 
hindered base, resulted in a significant improvement in the isolated yield. Furthermore, in many 
instances the cycloadducts were not purified but taken as crude mixtures into subsequent reaction 
steps, which may indicate instability upon prolonged standing. 
 
Double bond isomerisation within bicyclo[4.3.1] systems is not without precedence. The 
research of Phillips et al., which was focused on synthetic routes to paclitaxel analogues, 
                                                 
††Distance from the C11 carbon to C3 proton (MM2 energy minimized; Chem3D, CambridgeSoft Corporation) 
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encountered a similar example of Δ6,7 ? Δ7,8 olefin isomerisation during an IMDA reaction 
(Figure 3.18).65,66 
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Figure 3.18 Δ6,7 ? Δ7,8 isomerisation observed by Phillips et al. 
 
The reaction of the triene substrate 3.59 with one equivalent of BF3.Et2O as a Lewis acid catalyst 
resulted in the isolation of a cycloadduct in which the double bond had migrated from the desired 
Δ6,7 position to the non-bridgehead Δ7,8 position (3.60). Partial desilylation was also observed 
(3.61). The assignment was confirmed by X-ray crystallography. The crystalline 4-nitrobenzoate 
ester 3.62 was prepared and the resulting X-ray structure revealed that the suspected 
isomerisation had taken place with protonation occurring from the accessible convex face. 
 
Phillips et al., proceeding on the assumption that the isomerisation was most likely caused by an 
acid-catalysed mechanism, conducted the reaction using freshly purified BF3.Et2O to remove any 
traces of adventitious moisture, however only the isomerised material was isolated. It was 
discovered that the addition of excess BF3.Et2O (10 equivalents) at low temperature resulted in 
the clean cyclisation of the triene 3.59 to the desired olefinic bridgehead adduct 3.63. The 
exposure of 3.63 to TBAF, or BF3.Et2O, at ambient temperature resulted in extensive 
decomposition and the observation of double bond migration (Figure 3.19). 
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Figure 3.19 Sequential IMDA cyclisation–olefin isomerisation. 
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The application of high-pressure (19 kbar, 25°C, 24 h) resulted in the 80% conversion of the 
triene 3.59 to the desired adduct 3.63 (as assessed by 1H NMR spectroscopy). Elevated 
temperature (16 kbar, 55°C, 64 h) resulted in complete isomerisation to the non-bridgehead Δ7,8 
position 3.60.  
 
3.4.1.2 Minimisation of Double Bond Isomerisation 
 
With these results in mind, efforts were made to prepare the Diels-Alder adduct 1.68, utilising a 
variety of different Lewis acid catalysts, additives and solvent systems, many of which had 
proven themselves successful in IMDA reactions directed toward the synthesis of paclitaxel and 
the core of the phomoidrides. 
64 h) 
As can be observed in Table 3.2, no cyclisation protocols could be found to successfully deliver 
the desired cycloadduct 1.68. 
 
The addition of additives such as BHT and Proton-sponge® to the thermally initiated 
cycloadditions resulted in a noticeable increase in yield, in agreement with the observation of 
Shea et al. (entries 1a-1c).59 Experimentation with BF3.Et2O, using variations of temperature, 
Lewis acid equivalents and quenching protocols uniformly returned only the Δ7,8 isomerised 
product 3.55. The preferential isolation of the non-isomerised Δ6,7 adduct was not observed with 
the use of excess reagent (entry 2b), as had been the experience of Phillips and co-workers. 
 
The use of alkylaluminium halides as Lewis acid catalysts has been advocated as a way of 
ensuring anhydrous conditions. This recommendation is based on the dual nature of these 
aluminium species as both Lewis acids and Brönsted bases. Extensive experimentation with 
catalytic equivalents employed, reaction time, temperature, and the quenching conditions were 
conducted on the IMDA precursor 1.69 using Et2AlCl as a Lewis acid. Quenching studies at 
variable temperatures indicated that the reaction did not proceed below -10°C, and that greater 
than 0.2 equivalents of the Lewis acid were required for a reaction to occur. Below these 
minimum conditions the starting triene could be recovered unchanged despite extended periods. 
Acidic quenching conditions (sat. aqueous NH4Cl, 1 M aqueous HCl) improved the isolated 
yield of the isomerised adduct, whereas quenching with base resulted in the production of a 
gelatinous precipitate that hindered extraction, presumably accounting for the diminished yield 
(entry 3 vs 4). 
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Table 3.2 IMDA cyclisation conditions performed on triene 1.69. 
MeO
H
OMe
MeO
H
OMe
H
ConditionsMeO
OMe
1.69 1.68 3.55  
Entry Reaction Conditionsa Results (%)b 
1a Thermal (Benzene, 160°C, 20 h) 3.55 (35) 
1b Thermal (Benzene, 30% Proton-sponge®, 160°C, 20 h) 3.55 (65) 
1c Thermal (Benzene, BHT, 160°C, 20 h) 3.55 (68) 
2a BF3.Et2O (1 equiv), -78°C, 30 min, NaHCO3 quench 3.55 (33) 
2b BF3.Et2O (10 equiv), -78°C, 30 min, NaHCO3 quench 3.55 (46) 
3 Et2AlCl (1 equiv), CH2Cl2, -78°C ? rt, NH4Cl quench 3.55 (79) 
4 Et2AlCl (1 equiv), CH2Cl2, -78°C ? rt, NaHCO3 quench 3.55 (51) 
5 Et2AlCl (1 equiv), CH2Cl2, 0°C, NaHCO3 quench C.M. 
6a Et2AlCl (0.5 equiv), CH2Cl2, 0°C, NaHCO3 quench C.M 
6b Et2AlCl (0.2 equiv), CH2Cl2, 0°C, NaHCO3 quench S.M. 
6c Et2AlCl (1 equiv), toluene, 0°C, NaHCO3 quench C.M 
7 Et2AlCl (1 equiv), temperature studies, NaHCO3 quench S.M.c 
8 SnCl4, CH2Cl2, -78°C, NaHCO3 quench 3.55 (14) 
9 TiCl4, CH2Cl2, -78°C, NaHCO3 quench Decomposition 
10 AlCl3, AlMe3, CH2Cl2, -78°C, NaHCO3 quench 3.55 (23) 
11 ZnCl2, DCE, 40°C S.M. 
11a ZnCl2, pyridine (10%), DCE, 40°C S.M. 
12 Sc(OTf)3, DCE, 40°C S.M. 
13 TMS-OTf, CH2Cl2, -40º Decomposition 
14 Eu(fod)3, CH2Cl2, 40°C S.M. 
15 Cr(III)(salen)Cl catalyst, DCE, 40°C S.M. 
Note: (a) Reaction performed on 20 mg 1.69, (dried by high vacuum azeotrope with toluene), at a 
concentration of 0.01 M, with 1 equiv. of Lewis acid, in anhydrous, deoxygenated solvents unless 
otherwise stated. (b) Values in parentheses refer to isolated chromatographically pure material; C.M. = 
complex mixture; S.M. = starting material as assessed by 1H NMR spectroscopy. (c) Only starting 
material was isolated at temperatures below -10°C. 
 
In a few instances, an unidentified material displaying complex 1H NMR aliphatic resonances at 
δH 1.7-2.8, a doublet at δH 1.19 (J = 6.8 Hz) and a singlet at δH 3.38 was observed. This 
compound was tentatively assigned as the desired Δ6,7 adduct 1.68. 
The increased complexity in the aliphatic region was analogous with the Δ7,8 adduct 3.55, where 
due to the conformational rigidity of the bicyclic skeleton, resolution of the diastereotopic 
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protons is observed. Crucially, the presence of a doublet at δH 1.12 implied the existence of a 
JHCCH coupling, such as that anticipated to occur between the adjacent protons upon C8 and C11 
of 1.68. The upfield shift of the doublet (attributed to the C11 methyl group) to δH 1.12 for the 
postulated IMDA adduct 1.68 is in agreement with the methyl group being attached to an sp3 
substituted centre, compared to δH 1.71 for the starting material 1.69 and δH 1.63 observed for 
the isomerised adduct 3.55 in which the methyl group is attached to an sp2 substituted carbon 
centre. 
These 1H NMR resonances were used as diagnostic signals in the assessment of product 
distributions arising from the cycloaddition reactions. However, this material constituted a minor 
component of the crude mixture (~ 2-5%) and was unable to be separated from the reaction by-
products.  
 
It was apparent that the use of the moderately Lewis acidic diethylaluminium chloride was 
unable to suppress the double bond isomerisation. Endeavours to obtain the desired cycloadduct 
consequently focused on two opposing strategies; the use of stronger Lewis acids at low 
temperature; and the use of milder Lewis acids at elevated temperatures. 
The use of strong Lewis acids (SnCl4, TiCl4, and AlCl3-AlMe3) at low temperature (-78°C) 
resulted in rapid IMDA reactions, delivering the isomer adduct 3.55 as the sole isolated product. 
Low yields were obtained due to significant decomposition of the enone under the reaction 
conditions (entries 8-10). 
Conversely, the use of mild Lewis acids such as the ZnCl2-pyridine mixture used by 
Fukuyama,70 the lanthanide catalyst Eu(fod)3 and Jacobsen’s catalyst, a chromium(III)- 
cyclohexane salen complex,71,72 resulted in no observed conversion, even when heated. Zinc 
chloride, with sub-stoichiometric quantities of pyridine added to moderate its acidity, after 5 
days at 40°C was observed to achieve ~10% conversion to a 1:1 mixture of double bond 
migration adduct 3.55 and a new product similar to that observed in the Et2AlCl experiments, 
however this material was unable to be separated from the starting material 1.69 or the double 
bond migration adduct 3.55. 
 
A number of products were extracted from the reaction mixtures, particularly when the reaction 
was quenched before all the starting material had been consumed, or when insufficient amounts 
of the Lewis acid were used. Two of these species have been tentatively characterised as arising 
from enol ether decomposition of the diene starting material and an inter-molecular Diels-Alder 
dimer adduct. 
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3.4.1.3 Mechanism of Double Bond Isomerisation 
 
Consideration of the mechanisms that could account for the observed double bond migration led 
to an acid-catalysed proton-migration as the most probable reaction pathway as depicted in 
Figure 3.20. 
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Figure 3.20 Proposed mechanism of Δ6,7 ? Δ7,8 olefin isomerisation. 
 
Double bond migrations are known to be catalysed by both protic and Lewis acids to form the 
most thermodynamically stable alkene.73 Phillips proposed an acid-catalysed isomerisation of the 
bridgehead olefin adduct 3.63 to the non-bridgehead adduct 3.60 proceeding through the 
intermediacy of a tertiary C7 carbocation resulting from protonolysis of the torsionally strained 
bridgehead alkene.66 The presence of a methyl enol ether substituent at C7 could be anticipated 
to stabilise an adjacent carbocation through delocalisation of the oxygen lone pair electrons to 
form a transient oxonium species, 3.64. The loss of a proton would either regenerate the starting 
alkene (-Ha, 1.68), or cause olefinic migration to occur (-Hb, 3.55). Thermodynamically, the 
elimination of Hb would be expected to be more favourable as it forms a tetra-substituted olefin, 
and more importantly relieves the angular and torsional strain associated with the bridgehead 
double bond. 
 
The dominant formation of the Δ7,8 isomerised IMDA adduct 3.55 under the conditions of Lewis 
acid catalysis (designed to ensure anhydrous aprotic conditions; Et2AlCl) and anhydrous 
thermally initiated conditions (i.e. in the absence of a coordinating Lewis acid) implied that the 
observed migration was independent of the additive and possibly a function of the substrate. 
Adventitious protonation may have occurred via interaction with the silica glass of the reaction 
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vessel or intermolecularly following decomposition of the triene substrate. Subsequent efforts to 
eliminate these factors are detailed below (vide infra). 
 
3.4.2 IMDA Cyclisation of Ethoxy-triene 1.80 
 
Olefin migration under acidic conditions favours formation of the most thermodynamically 
stable adduct. Both the Δ6,7 adduct and the Δ7,8 adduct arising from the IMDA cyclisation of 
methoxy-triene 1.69 are tetra-substituted and could be anticipated to possess similar 
thermodynamic stability. Consequently, the product distribution will be dominated by the 
contributions from the relief of torsional strain associated with the bridgehead olefin. 
 
The ethoxy-triene 1.80 upon cyclisation would generate the Δ6,7-olefinic bridgehead adduct 1.79, 
which contains a tetra-substituted alkene. The Δ7,8 adduct 3.65 arising from olefinic migration 
would contain a tri-substituted alkene. If the energy of stabilisation associated with the tetra-
substituted alkene was greater than the contribution derived from release of the bridgehead 
torsional strain, it might be possible to selectively isolate the desired Δ6,7 adduct 1.79 (Figure 
3.21).  
 
bond
migration EtO
H
O
EtO
O
EtO
H
O
IMDA
1.80 1.79 3.65  
Figure 3.21 IMDA reaction of ethoxy-triene 1.80 and potential isomerisation. 
 
The successful preparation of 1.79 would provide access to the florlide and florether natural 
products targets 1.41 and 1.43 as discussed in Scheme 1.9. A synthetic route that utilises 1.79 to 
intercept the nakafuran synthesis can also be readily devised (Scheme 3.2). Cyclopropanation 
followed by an acidic ring hydrolysis to establish the C6 bridgehead methyl and furan ring-
annulation would deliver the intermediate 3.66. Stereoselective mono-alkylation of 3.66 could 
reasonably be expected to occur adjacent to the C7 ketone to generate the endo disposition of the 
C11 methyl group observed in 1.65. 
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Scheme 3.2 Interception of the nakafuran route using florlide precursor 1.79. 
 
The ethoxy-triene 1.80 was subjected to thermal cyclisation conditions (50 mg, 0.01 M, cat. 
BHT, benzene, 160°C, 24 h) resulting in the clean conversion to the Δ7,8 adduct 3.65 as the sole 
observable product, which was isolated in 38% yield after column chromatography. The 
structural assignment was based on the presence of a vinylic sp2 doublet at δH 4.67 (J = 4.8 Hz), 
assigned as Ha, resulting from olefinic bond migration (Figure 3.22). 
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Figure 3.22 500 MHz 1H NMR spectrum of the IMDA cyclisation adduct 3.65. 
 
Conducting the reaction under thermal conditions with the inclusion of 0.3 equivalents of 
Proton-sponge®, similarly resulted in the isolation of the isomerised material 3.65 as the sole 
product. 
 
The use of the Lewis acids BF3.Et2O (1 equivalent, CH2Cl2, -78°C) and Et2AlCl (1 equivalent, 
CH2Cl2, -78°C) resulted in complete decomposition of the starting material with no observed 
cycloaddition product. 
 
The isolation of 3.65 as the sole product from the thermally initiated reactions and the complete 
decomposition of the triene starting material under Lewis acid conditions limited investigation of 
the cyclisation of 1.80.  
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3.4.3 IMDA Cyclisation of Vinyl-triene 2.67 
 
Preparation of the unsubstituted bridgehead bicyclic olefin 3.40 had previously been reported by 
Shea et al., via an IMDA cyclisation of the triene 2.67 (Figure 3.9). Importantly this work 
included detailed methods of preparation,59 and as such, replication of this protocol would serve 
to identify errors in the manipulation and methodology used in the attempted cyclisation of 1.69 
and 1.80. 
 
The vinyl triene 2.67, when subjected to the thermal cyclisation protocol utilised for methoxy-
triene 1.69 and ethoxy-triene 1.80, was observed to generate the bridgehead olefin 3.40 
exclusively. No evidence of the Δ7,8-olefinic isomer 3.67 could be observed in the 1H NMR 
spectrum of the crude reaction mixture (Figure 3.23). 
 
O O
Ha
O
Hb
Hc
(i)
3.402.67 3.67  
Figure 3.23 IMDA cyclisation of unsubstituted triene 2.67. 
Reagents and yields: (i) xylene, 30 mol % Proton-sponge®, 160°C, 16 h, 56%. 
 
In further agreement with the work of Shea et al., subjection of vinyl triene 2.67 to the Lewis 
acids BF3.Et2O (1 equivalent, CH2Cl2, -78°C) and Et2AlCl (1 equivalent, CH2Cl2, -78°C) 
resulted predominantly in decomposition, generating a large amount of polymeric material. 
 
3.4.4 Intermolecular Diels-Alder Reaction of Methoxy-triene 1.69 
 
A question of synthetic importance remained: whether the Δ6,7 enol ether functionality of the 
IMDA adduct 1.68 had a predisposition for olefinic migration to the Δ7,8 position in the absence 
of torsional strain imposed by the bicyclic ring system. Such a migration would indicate that a 
stabilisation energy associated with forming the Δ7,8 tetra-substituted double bond was also 
contributing to the observed olefinic migration for IMDA adduct 1.68. 
 
To investigate this possibility the intermolecular cyclisation of 1.70 was performed with the 
readily available dienophile, N-phenylmaleimide. The Diels-Alder reaction proceeded to 
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completion under remarkably mild conditions. Upon stirring a solution of 1.70 and the 
dienophile together at room temperature in toluene, a clean cyclisation occurred to furnish a 
single product 3.68 (Figure 3.24). 
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Figure 3.24 Intramolecular Diels-Alder cyclisation of 1.70. 
Reagents and yields: (i) 1.70 (1 equiv), N-phenylmaleimide (3 equiv), toluene, rt, 40 h, 46%.  
 
1H NMR spectroscopy performed upon the isolated adduct revealed a number of characteristic 
peaks including a doublet at δH 1.22 (J = 7.2 Hz, 3H), a non-first order quintet at δH 2.96 (1H) 
and two overlapping multiplets at δH 3.20-3.24 (2H). These signals were assigned respectively to 
the C11 methyl group, the C8 proton and the two maleimide-derived protons α to the imide 
carbonyls. The shift and the coupling constant of the C11 methyl group δH 1.22 (J = 7.2 Hz) is 
similar to that attributed to the Δ6,7-olefin adduct 1.68, δH 1.19 (J = 6.8 Hz), observed as a minor 
component in IMDA cyclisation of 1.69; and contrasts with that observed for the Δ7,8-olefin 
isomer [δH 1.68, s]. No evidence could be observed of an adduct resulting from the migration of 
the olefinic bond of 3.68 to the Δ7,8 position.  
 
This intermolecular reaction indicated both that 1.70 was an effective diene, with cyclisation 
occurring readily at room temperature and that the Δ6,7 ? Δ7,8 migration was not an inherent 
attribute of the cyclised cyclohexene adduct, but more probably a consequence of the increased 
torsional and geometric strain imposed by installing a bridgehead olefinic bond. 
 
3.5 Revised Synthetic Plan 
 
The inability to isolate the desired Δ6,7 bridgehead olefin adducts 1.68 and 1.79, arising from the 
Diels-Alder cyclisation of the methoxy- and ethoxy-triene systems, represented a serious set-
back to the proposed synthetic route. All experimental conditions investigated were 
unsuccessful. The apparent divergent reactivity of the C7 alkylether-substituted trienes 1.69 and 
1.80 when compared to the unsubstituted triene 2.67 is noteworthy and is summarised in Figure 
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3.25. The alkylether-substituted trienes gave exclusively the Δ7,8 bicyclo[4.3.1]decene product 
presumably due to acid-catalysed olefin migration following the initial IMDA reaction. 
Conversely, the reaction of the unsubstituted vinyl derivative of 2.67 resulted in the isolation of 
the initially anticipated Δ6,7 bicyclo[4.3.1]decene adduct 3.40 in agreement with the literature 
precedence. 
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Figure 3.25 Results for the IMDA cyclisation of compounds 1.68, 1.80 and 2.67. 
 
It was postulated that the presence of the enol ether group at the bridgehead olefin facilitated the 
observed Δ6,7 ? Δ7,8 migration through the presence of a transient oxonium intermediate (see 
Figure 3.20). To address this issue, a scheme was devised that envisaged substitution of the 
heteroatom at C7 of 1.63 for a homomethyl ether to give the homomethyl triene 3.69. It was 
anticipated that the diminished tautomeric ability of this substrate might retard or prevent the 
double bond isomerisation (Scheme 3.3). 
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Scheme 3.3 Modification of 1.63 via one carbon homologation. 
 
The successful application of this homologation approach is addressed in Chapter Four. 
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3.5.1 IMDA Cyclisation of Methoxy-triene 1.69: The Discovery of a 
Successful IMDA Cyclisation Route to Δ6,7-Olefinic Adducts 
 
The use of an IMDA cyclisation to prepare 7-alkylether-Δ6,7 bridged bicyclic structures amenable 
to the synthesis of the nakafuran family of natural products had been unsuccessful due to a facile 
and uncontrollable Δ6,7 ? Δ7,8 olefin migration. It was decided to conclude this synthetic work 
by focussing on the preparation of the 6-des-methyl nakafuran analogues from the readily 
accessible Δ7,8-olefin adduct 3.55, (Scheme 3.4). 
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Scheme 3.4 Proposed route to nakafuran analogues via Δ7,8 bridgehead olefin 3.55. 
 
Annulation of a furan moiety to the C2-C3 position of 3.55 utilising the C2 ketone would 
generate the intermediate 3.71. Wittig olefination of the pendant C7 ketone would yield the des-
methyl nakafuran-9 species 3.72. The 6-des-methyl butenolide 3.73 could be generated via 
oxidation of the furan ring with singlet oxidation under photolytic conditions. 
 
This route would also allow examination of the possibility of regioselectively introducing the C6 
bridgehead methyl group under alkylative conditions to generate 1.65, an intermediate in the 
originally proposed route (Scheme 1.8). 
 
However, almost as soon as the conclusion had been drawn that the preparation of 7-alkylether-
Δ6,7 bicyclo[4.3.1]decenes was not feasible under IMDA protocols, evidence of the contrary 
arose. 
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Towards the synthetic goals depicted in Scheme 3.4, a large quantity of the methoxy-triene 1.69 
was subjected to thermally initiated IMDA cycloaddition conditions. The triene material (2.22 
grams dissolved in 50 mL of xylene) was added over 8 hours to a refluxing solution of 750 mL 
of freshly distilled xylene containing 0.3 equivalents of Proton-sponge®. 1H NMR spectroscopy 
of aliquots removed from the bulk solution indicated that the starting material had been 
consumed after 40 hours. Evaporation of the excess solvent via low pressure distillation 
(60°C/24 mmHg; 25°C/0.01 mmHg) and flash column chromatography on basified silica was to 
yield, much to the chagrin of the author, 0.68 grams of Δ7,8 adduct 3.55 and 0.29 grams of a 2:3 
mixture comprising of the Δ7,8 adduct 3.55 and the non-isomerised Δ6,7 adduct 1.68! 
The presumed identity and acid lability of 1.68 was confirmed by subjecting a small fraction of 
this mixture to a 0.01 M aqueous HCl wash (10 seconds), followed by organic extraction. The 
only material present in the 1H NMR spectrum of the crude reaction mixture was the isomerised 
product 3.55. 
 
This mixture of Δ6,7 and Δ7,8-olefin isomers was not readily separated into its constituent parts. 
Conventional flash column chromatography on basified silica was unable to achieve sufficient 
separation. Analytical separation to two peaks could be observed using C18 reverse phase 
HPLC, with the isomerised product 3.55 and the desired adduct 1.68 displaying retention times 
of 19.5 and 21.2 minutes respectively on a 65% isocratic MeCN/H2O gradient. 
 
Transfer of the HPLC separation protocol to semi-preparative MPLC resulted in clean separation 
of the two adducts with retention times of 24.5-26.5 minutes and 29.5-31.5 minutes respectively, 
when 5 milligrams was eluted with 50% MeCN/H2O using a flow rate of 10 mL min-1 on a C18-
RP column. Evaporation of the elution solvent under rotary evaporation (24 mmHg) 
unfortunately resulted in complete isomerisation. Extraction of the aqueous solution containing 
the purified IMDA adduct 1.68 with Et2O (containing trace NEt3), followed by a careful work-up 
involving a distilled water wash, drying with Na2SO4 and evaporation, led to the successful 
isolation of the desired adduct 1.68, although partial isomerisation was observed to have 
occurred (1.68 80 % : 3.55 20 %). 
 
The successful preparation and isolation of the Δ6,7 bridgehead cycloadduct 1.68, albeit as a 
mixture of olefinic isomers, indicated that the compound 1.68 was indeed stable and isolable. 
Furthermore, this result suggested that conditions could indeed be found to minimise the acid 
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catalysed migration of the double bond. Experiments were performed to investigate the influence 
of the glassware surface and added base on the isomerisation reaction, as detailed in Table 3.3. 
 
Table 3.3 Variation of the thermal IMDA experimental conditions. 
MeO
H
OMe
MeO
H
OMe
H
Conditions
MeO
OMe
1.69 1.68 3.55
 
Entry Conditionsa Productsb 
1 PS (0.3) 38:62 
2 PS (1.0) 63:37 
3 SG 3:97 
4 SG, PS (1.0) 76:24 
5 PS (1.0), Base washed glassware 5:95 
6 SG, Hünig’s base (1.5) 12:88 
7 SG, 2,6-lutidine (1.5) dec. 
8 SG, Hünig’s basec 86:14 
9 SG, PS (1.25) 98:2 
Notes: (a) reactions were conducted on 50 mg of triene in 25 mL of 
xylene, 160°C, 2d; PS = Proton-sponge® (equivalents); SG = silylated 
glassware. (b) Ratio of 1.68 : 3.55, as determined by 1H NMR 
integration. (c) 25 mL of Hünig’s base was used as the solvent. 
 
The first observation to be made from Table 3.3, (entry 1) is that 0.3 equivalents of Proton-
sponge® is capable of preventing the olefinic isomerisation of 1.68 to 3.55. These results differ 
from the thermal cyclisation reactions previously conducted (Table 3.2, entry 1b), in which 1.68 
was not observable, in either aliquots from the crude reaction mixture or from isolated columned 
material. The source of these divergent outcomes from reactions conducted under ‘identical’ 
conditions was traced to the Proton-sponge®. 
 
The Proton-sponge® used in the initial experiments had been a ‘heritage’ chemical of unknown 
age. It was a crystalline material, which was analytically pure as assessed by 1H and 13C NMR 
spectroscopy, but possessed a slight pink tinge which remained despite repeated recrystallisation 
from a basic aqueous solution (saturated K2CO3) and distillation under reduced pressure 
(Kugelrohr, 150°C/0.2 mmHg). New material received from Aldrich Chemical Company was a 
white crystalline powder. Subsequent experimentation revealed that the ability of this new 
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Proton-sponge® to retard olefin isomerism diminished over time, presumably due to aerial 
oxidation or acidification, despite being stored under an argon atmosphere. Consequently, in 
order to prevent Δ6,7 ? Δ7,8 olefin migration it was found necessary to recrystallise and distill 
this new material immediately prior to use. 
 
Increasing the amount of Proton-sponge® employed in the IMDA reaction to 1 equivalent 
produced a corresponding decrease in the observable isomerisation (entry 1 vs. 2). Modification 
of the reaction vessel and reflux condenser’s glass surface via the sequential base-washing and 
silyl capping of any free hydroxyl residues was also observed to have a beneficial effect. Even in 
the absence of Proton-sponge®, the desired adduct could be observed, admittedly in a very low 
yield (entry 3). The inclusion of non-nucleophilic bases such as Hünig’s base as an additive or 
preferentially as the solvent resulted in a dramatic improvement (entries 6 and 8). The use of 2,6-
lutidine, a bulky amine base, however was observed to give complete decomposition, 
presumably due to nucleophilic attack on the enone of the triene system (entry 7). The best result 
was achieved when the reaction was run in silylated glassware in the presence of 1.25 
equivalents of Proton-sponge®, which gratifyingly delivered the desired IMDA cyclisation 
adduct in an isomeric ratio of 98:2 (1.68:3.55). Isolation could be achieved by simple 
evaporation under low pressure (60°C/24 mmHg; 25°C/0.1 mmHg) and careful flash column 
chromatography on basified silica with the inclusion of 2% NEt3 in the eluant. The spectrum of 
the isolated Δ6,7 bridgehead cycloadduct 1.68 is displayed in Figure 3.26, (c.f. 3.55, Figure 
3.15). 
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Figure 3.26 500 MHz 1H NMR spectrum of IMDA adduct 1.68 recorded in C6D6 with 
hydrogen assignments derived from 2D correlation spectroscopy; * = residual Proton-sponge®. 
 
The anticipated doublet, ascribed to the C11 methyl group, can clearly be seen at δH 1.19 (J = 6.8 
Hz). Extensive 2D NMR spectroscopy (COSY, HSQC, CIGAR, NOE) in conjunction with a 
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crystal structure solved for a Δ6,7-cyclopropanated derivative confirmed the anticipated structure. 
Of particular interest is the deshielding effect experienced by the hydrogen H5a observed at δH 
2.77 (dd, J = 3.9, 7.8 Hz). The δ-shift exhibited is considerably greater than H5b at δ 1.69 (upon 
the same carbon) and even the hydrogens H1, H3a and H3b adjacent to the C2 carbonyl. This 
observation would seem to indicate that H5a exists in a markedly different electronic 
environment. Subsequent theoretical modelling studies (Section 3.7) and the analysis of the 1H 
NMR spectrum obtained from the homomethyl IMDA cyclised adducts (Chapter 4) seem to 
confirm this assessment. 
 
The Δ6,7-olefinic adduct 1.68 was observed to be relatively stable to basic conditions, being 
recovered unchanged from alkylation reactions (vide infra), but rapidly isomerised to the Δ7,8-
olefinic material upon exposure to trace acid. The residual acidity of CDCl3 used as a solvent 
during NMR spectroscopy was observed to catalyse the isomerisation reaction, necessitating the 
use of d6-benzene or CDCl3 doped with 0.1% d5-pyridine in order to prevent olefinic 
isomerisation. 
 
3.5.2 IMDA Cyclisation of Ethoxy-triene 1.80 
 
Application of the optimised protocols discovered for clean cyclisation of methoxy-triene 1.69 to 
the cyclisation of the ethoxy-triene derivative 1.80 was also successful in delivering the desired 
Δ6,7-bridgehead cycloadduct 1.79 (Figure 3.27). 
 
EtO
O
EtO
H
O
1.80 1.79
(i)
 
Figure 3.27 Optimised cyclisation of ethoxy-triene 1.80 
Reagents and yields: (a) Proton-sponge® (1.25 equiv), xylene, silylated glassware, reflux, 40 h, 35%. 
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3.6 Functional Group Modification of the Δ6,7 IMDA Bridgehead 
Adduct 
 
With the hard-won Δ6,7-olefinic IMDA adduct 1.68 in hand, functionalisation of the carbocyclic 
core was investigated. Two reaction pathways were proposed as depicted in Scheme 3.5. 
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Scheme 3.5 Proposed route for the preparation of intermediate 1.66. 
 
Route A utilising regioselective C3 alkylation of 1.68 is based on the analogous reactions 
performed by Shea et al. which applied the conformational control afforded by the bicyclic 
skeleton to selectively alkylate the thermodynamic ring position. Subsequent cyclopropanation 
of the bridgehead olefin would yield 1.66. 
 
Alternatively, Route B depicts the initial cyclopropanation of 1.68 to secure the acid labile 
bridgehead olefin in position giving intermediate 3.74. This would allow more vigorous 
conditions to be investigated for the regioselective alkylation. 
 
 
3.6.1 Route A: Alkylation–Cyclopropanation 
 
As demonstrated by Shea et al. in Figure 3.11, the rigid conformation of the 
bicyclo[5.3.1]undecenone carbocyclic core allows kinetic discrimination to be achieved between 
the C1 bridgehead hydrogen (Ha) and the two C3 hydrogens, Hb and Hc. Thermodynamic 
Chapter Three – The Diels-Alder Reaction 118 
equilibration of the enolate favours alkylation of the more thermodynamically stable C2-C3 
enolate from the accessible exo-face. 
 
To investigate the validity of Shea’s bicyclo[5.3.1]undecenone studies to the alkylation of 
bicyclo[4.3.1]decenone, the initial alkylation studies were conducted on the Δ7,8 isomer 3.55, due 
to the availability of this compound and the noted acid lability of the bridgehead isomer 1.68. 
 
The installation of the butenolide functionality, or a synthetic analogue, via either an aldol 
reaction of the ketone with glyxoylic acid, or alkylation of a metallo-enolate was uniformly 
unsuccessful. Representative examples are illustrated in the Table 3.4. 
 
Table 3.4 Summary of attempted C3-alkylation of Δ7,8-IMDA isomer 3.55 
MeO
Ha
OMe
Hb
Hc MeO
OMe HO
O
MeO
Me O OHO
OH
3.55 3.75 3.76  
Entry Conditiona,b Resultc 
1 CHO-CO2H, morpholine, EtOH, Δ NR 
2 CHO-CO2H, Ac2O, pyridine, Δ NR 
3 CHO-CO2H, H3PO4, Benzene, Dean-Stark Dec. 
4 KHMDS, CHO-CO2Me NR 
5 KHMDS, BrCH2(OEt)2 NR 
6 KHMDS, ICH2(OEt)2 NR 
7 LDA, CHO-CH2OTHP NR 
8 LDA, ZnCl2, CHO-CH2OTHP NR 
9 KHMDS, allyl bromide, HMPA CM 
10 KHMDS, allyl iodide CM 
11 KHMDS, allyl bromide, equivalence studies CM 
12 KHMDS, methyl iodide d 
13 LDA, DMPU, methyl iodide d 
14 TBS-OTf, Hünig’s base d 
Note: (a) Reactions were conducted on a 20 mg scale, with ~1 equiv of reagents. If unsuccessful at 
the stated literature temperature, the external temperature was raised by 40°C; if still no reaction 
had occurred, then 3 equiv of reagents were used. (b) The first equivalent of KHMDS was added 
over 1 h to allow equilibration of the initially formed enolate, additional base was then added more 
rapidly (~ 10 min). (c) The reaction mixtures were assessed by 1H NMR spectroscopy and TLC of 
aliquots, with promising reactions subjected to column chromatography to isolate products. (d) see 
text for discussion. 
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No conditions could be found that would successfully and selectively alkylate the bridged 
carbocyclic core 3.55. 
 
The use of forcing conditions - such as elevated temperature, increasing the molar equivalents of 
the reagents and the incorporation of additives to the reaction mixture (HMPA, DMPU, LiI, 
ZnCl2) - results in no reaction. 1H NMR spectroscopy of aliquots taken from the reaction 
exhibited evidence of only the starting material or decomposition of the substrate. Many of these 
forcing conditions would not have been applicable to the correct Δ6,7 isomer 1.68, due to the 
acidic nature of the reagents. 
 
Some entries of note are the attempted alkylation of the potassium enolate of 3.55 with allyl 
bromide or allyl iodide (entries 9-11). No reaction was observed to proceed until in excess of 2 
equivalents of KHMDS were added. Quenching with excess allylating reagent resulted in the 
isolation of mono-, di- and tri-allylation products 3.77. Alkylation was observed to occur 
preferentially at the C1 bridgehead site (for mono-alkylation), with subsequent alkylation 
occurring at the C3 non-bridgehead position. Restricting the quantity of quenching agent resulted 
in the same ratio of allylation and significantly more unreacted starting material (Figure 3.28). 
 
Replication of the Shea quenching experiments under kinetic or thermodynamic conditions 
generated similar results (entries 12-13). Methylation was observed to occur in all positions, 
irrespective of the experimental conditions applied. However, due to the use of equimolar 
equivalents of base: ketone only mono-alkylation was observed distributed between all three 
positions. The use of LDA was observed to give poor reactivity, returning predominantly starting 
material. The attempted extension of the non-specific alkylation with more functionalised 
substrates (1-bromo-2,2’-diethoxyethane or 1-iodo-2,2’-diethoxyethane), under a variety of 
conditions was unsuccessful in yielding any product (entries 4-8). 
 
The exception to this lack of reactivity was the reaction of 3.55 with TBS-OTf at low 
temperature. The only product isolated was the bridgehead TBS silyl enol ether 3.78. This is in 
agreement with the alkylation studies that indicated that the C1 carbon was preferentially 
alkylated under kinetic control. 
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Figure 3.28 Attempted alkylation of 3.55. 
Reagents and yields: (i) KHMDS (2.2 equiv), -78°C ? 0°C, THF; then at -78°C allyl bromide or methyl iodide; (ii) 
TBS-OTf, Hünig’s base, CH2Cl2, -78°C, 87%. 
 
The apparent lack of reactivity of the IMDA Δ7,8-isomer 3.55 led to investigation of the 
alkylation reactions of the desired Δ6,7-isomer 1.68. Attempted alkylation of 1.68 using two 
equivalents of NaHMDS in THF at -78°C with HMPA as an additive was unsuccessful with a 
number of functionalised electrophiles (Figure 3.29). Only the starting material 1.68 could be 
isolated from these reactions, even upon reaction of the sodium enolate with aldehydes 3.79a-c 
which had been observed to successfully undergo aldol additions on related substrates.74 
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Figure 3.29 Alkylation studies of IMDA cycloadduct 1.68. 
Reagents and yields: (i) NaHMDS (2 equiv), HMPA (5 equiv), -78°C, 1 h; then electrophile (3 equiv), -78°C ? rt; 
(ii) KHMDS (0.98 equiv), THF, -20°C ? 0°C; then allyl bromide (1 equiv).  
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A lack of reactivity was also observed during attempted alkylation using 3.79d and 3.79e with 
HMPA or DMPU as an additive. Alkylation with the reactive electrophile allyl bromide using 
0.98 equivalents of KHDMS was non-regioselective, resulting in the isolation of a mixture of the 
mono (3.80a) and di-alkylated (3.80b) products and starting material (1.68) following column 
chromatography. 
 
The observed lack of reactivity for aldol addition and lack of regioselectivity in the case of allyl 
electrophiles prevented the use of this route to modify the central core. Furthermore, the 
introduction of only the highly reactive allyl species via alkylation did not advance the synthetic 
project, as reagents anticipated to react with the unactivated terminal alkene would also react 
with the activated and unstable bridgehead olefin.  
 
3.6.2 Route B : Cyclopropanation – Alkylation 
 
The use of the cyclopropanated adduct 3.74 allowed investigation of vigorous reagents and 
conditions to achieve the regioselective alkylation without the synthetically degradative process 
of Δ6,7 ? Δ7,8  olefinic isomerisation occurring. 
 
The traditional Simmons-Smith protocol (Zn-Cu couple, CH2I2, ethereal solvent)75,76 was 
unsuccessful in effecting the cyclopropanation of the Δ7,8 IMDA adduct 3.55. Modified protocols 
based on heterogeneous zinc catalysts were also unsuccessful, including the use of ultrasound 
and zinc activations.77-79  
 
The Furukawa modification, which utilises diethylzinc to generate the cyclopropanation species 
bis(halomethyl)zinc (3.81) was successful, although excess reagent was required to achieve 
complete conversion (Figure 3.30).80-82 Hydrolysis of the C7 methyl ether under acidic 
conditions was effective in revealing the intermediate cyclopropanol species (3.82) which 
proceeded via regioselective cyclopropane ring cleavage to deliver the gem-dimethyl diketone 
species 3.57. Acid-catalysed aldol reaction of this intermediate generated the indenone product 
3.58 as previously described. 
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Figure 3.30 Cyclopropanation of 3.55. 
Reagents and yields: (i) ZnEt2 (5 equiv), CH2I2 (10 equiv), DCE, 40°C, 16 h, 50%; (ii) conc. HCl (15%), EtOH, 
reflux, 12 h, quantitative. 
 
Application of the Furukawa cyclopropanation protocol to the Δ6,7-adduct cleanly converted the 
olefinic functionality to the cyclopropane adduct 3.74. No isomerism of the olefinic bond was 
observed under the reaction conditions, with starting isomeric ratios of 1.68:3.55 conserved in 
conversion to the cyclopropane adducts 3.74 and 3.56 respectively (Figure 3.31). 
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Figure 3.31 Cyclopropanation and hydrolysis of the bridged bicyclic olefins 1.68 and 3.55. 
Regents and conditions: (i) ZnEt2 (5 equiv), CH2I2 (10 equiv), DCE, 40°C, 16 h, 65%, (ii) conc. HCl (15%), EtOH 
(1:5), reflux, 12 h, quantitative; (iii) conc. HCl, EtOH (1:1), reflux, 12 h, 91%. 
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The two cyclopropane methyl ethers 3.56 and 3.74 showed differential hydrolysis selectivities. 
The Δ6,7-adduct 3.74 was stable to the conditions that effected the deprotection-ring cleavage of 
the Δ7,8-adduct 3.56. Consequently, effective separation could be achieved via selective mild 
hydrolysis to generate a mixture of 3.58 and 3.74 which were readily separated by column 
chromatography. The use of more acidic conditions effected the hydrolysis of the Δ6,7-adduct to 
generate the desired dimethyl diketone, which underwent an intramolecular aldol reaction in-situ 
to deliver the indenone species 3.83. This intermediate was fully characterised via 1D and 2D 
NMR spectroscopic techniques. Although generation of the novel indenone structures 3.58 and 
3.83 was an unexpected result, following the acidic hydrolysis of the methoxy-cyclopropane 
structures, it was not believed that this represented a problem within the anticipated synthetic 
route. Hydrolysis of the Δ6,7-cyclopropane was envisaged to occur after installation of the C2-C3 
furan moiety, which would prevent such an intramolecular reaction. 
 
Confirmation of the structural assignment of 3.74 was achieved via single crystal X-ray 
diffraction of the Δ6,7-cyclopropanated adduct 3.84 derived from the sequential reduction and 
conversion of 3.74 into a 3,5-dinitrobenzoyl ester to facilitate crystallisation (Figure 3.32).  
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Figure 3.32 Preparation of the crystalline species 3.84 via reduction and esterification. 
Reagents and yields: (i) (a) DIBAL-H, CH2Cl2, -78°C ? rt, 90%, α:β (5:1); (b) 3,5-dinitrobenzoyl chloride, 
pyridine, CH2Cl2, 34%. 
 
The structure, illustrated in Figure 3.33a, confirms a number of important assumptions in the 
synthetic route. As anticipated, the type II IMDA reaction had occurred in a meta-orientation 
with an endo-tether to yield the ‘out’ hydrogen Δ6,7 bicyclo[4.3.1]decene. The orientation of the 
cyclopropane ring relative to the bridging C10 atom, and the orientation of the C2 alcohol 
indicate that both cyclopropanation and hydride delivery had occurred from the less hindered 
convex face of the bridgehead adduct (Figure 3.33b). The C8 methyl group occupies an 
equatorial position within a cyclohexane boat-conformation indicating conservation of the 
established diene stereochemistry during the Diels-Alder reaction. 
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Figure 3.33a Crystallographic structure determined for cyclopropane adduct 3.84, [P21/c, Z = 
4, R = 3.6%], orientated to show the tricyclo[4.4.1.01,3]undecane core. The atom spheres are of 
an arbitrary radius. 
 
Figure 3.33b Horizontal view to show the exposed convex face within a cyclohexane boat 
structure, the relative orientation of the C2-alcohol, the C8-methyl group and the C6-C7 
cyclopropane. The C2 aryl ester has been removed for clarity. 
 
Efforts to obtain a crystal structure of the isomeric Δ7,8 cyclopropane species, derived from 3.56, 
were unsuccessful in providing a suitable crystal, despite trying a number of crystallisation 
solvents and methods. 
 
With the desired cyclopropane adduct 3.74 in hand, which had been demonstrated to 
regioselectively fragment to generate the desired C6 bridgehead methyl group, endeavours 
focused on the C3 regioselective alkylation. 
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However, efforts to alkylate the C3 position adjacent to the ketone, or engage it in a productive 
aldol reaction were unsuccessful. Synthetic methods attempted included alkylation of the 
potassium or sodium enolate with a number of electrophiles, the attempted use of C2 enamines, 
and aldol condensation with methyl glyoxylate. In all cases synthetically non-productive 
outcomes were obtained, including non-regioselective allyl alkylation and the return of starting 
material for the enamine and aldol condensation routes. 
 
3.7 Computational Model Studies  
 
In an effort to investigate the origins of the unexplained poor reactivity and lack of 
regioselectivity of the IMDA adducts 1.68, 3.55 and 3.74 towards alkylation, when compared 
with the research reported by Shea et al., theoretical molecular modelling studies were 
conducted. 
 
SPARTAN ’04, (Wavefunction Inc.), was used to determine minimum conformational geometies 
via a Monte-Carlo search (MMFF94) for a number of alkylation substrates, which were 
subsequently optimised at a higher level of theory (HF 6-31G*) to allow calculation of the 
thermodynamic parameters and geometry. 
 
Molecular mechanics force field (MMFF) models provide a good description of equilibrium 
geometries and conformations. The MMFF model describes molecules in terms of contributions 
arising from distortions to “ideal” bond distances (stretching), bond angles (bending) and 
torsional angles (torsional), together with contributions due to non-bonding van der Waals and 
Coulombic interactions. The derived value is commonly referred to as Strain energy, and 
although it does not reflect a thermodynamic parameter and cannot be used in thermodynamic 
calculations, it can give quantitative values of the differences in energy between related isomers 
and conformers.  
 
Thermodynamic properties such as heat of formation and solvation, and electronic properties 
such as electron and orbital distributions (HOMO and LUMO), can be calculated using semi-
empirical models such as AM1 and PM3, or higher level quantum-mechanical calculations 
performed with models such as Hartree-Fock and Density Functional theory. Theoretical 
modelling does not give correct absolute values as approximations inherent in the respective 
models give values constrained by the limitations and parameters imposed to make the model 
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solvable. However, the relative differences between calculated energies, when subjected to the 
same constraints, can give an indication of stability of different isomers and will more accurately 
represent real energy differences. 
 
The substrates depicted in Figure 3.34 and their C1,2 and C-2,3 enolates derived from 
deprotonation of either the Ha or Hb hydrogen respectively, were subjected to a MMFF Monte-
Carlo conformational search. In all cases, a single geometry was located as a conformational 
minimum, as anticipated for these rigid bicyclic structures. The model systems were then 
optimised through semi-empirical methods (AM1 and then Hartree-Fock [6-31G*]), from which 
thermodynamic properties could be obtained. These structures allowed comparison of the 
relative strain energy between the bridgehead and non-bridgehead olefin isomers; determination 
of the kinetically most acidic proton, as determined by measurement of the carbonyl - α-proton 
dihedral angle; and prediction of the thermodynamic product as assessed by the relative energies 
of the C1 vs. C3 enolate. A number of unexpected results emerged from these calculations 
(Table 3.5). 
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Figure 3.34 Bridged bicyclic molecular modelling substrates. 
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Table 3.5 Calculated theoretical parameters for compounds depicted in Figure 3.34 
   Dihedral Angleb,c  
Entry Compound Strain Energya Ha Hb Hc ΔE C1 to C3a 
1 3.49 27.1 94 (4) 142 (52) 29 (61) -5.8 
2 3.49b 25.5 106 (16) 159 (69) 45 (45) 1.4 
3 3.42 28.9 75 (15) 129 (39) 15 (75) -8 
4 3.42b 17.9 60 (30) 119 (29) 4 (86) -16.9 
5 1.68 33.8 15 (75) 3 (87) 117 (27) -6.6 
6 3.55 21.9 59 (31) 118 (28) 3 (87) -11 
7 3.74 28.3 48 (42) 110 (20) 5 (85) -7.6 
8 3.56 30.1 67 (23) 123 (33) 4 (86) 3.2 
9 3.40 27.1 76 (14) 130 (40) 16 (74) -8.4 
Notes: (a) Energy measurements are in kcal mol-1 (b) Dihedral angles were measured along the Hn-C-
C=O bond in degrees (c) The first value refers to the measured dihedral angle; the value in parentheses 
is displacement of the dihedral angle from perpendicular (90°) relative to the carbonyl σ bond. 
 
The values obtained for the 9-methyl bicyclo[5.3.1]dodec-7-ene (3.49 - entry 1) were in close 
agreement with those calculated by Shea et al. using MM2 determination of the lowest energy 
conformation.61 Shea rationalised the experimentally observed kinetic deprotonation and 
alkylation at the bridgehead C1 carbon (Figure 3.11), by noting that deprotonation is 
stereoelectronically optimal with a 90° C-H dihedral angle relative to the carbonyl σ-plane. The 
“CH-π overlap effect” which results from the overlap of the CH σ-bond with the carbonyl π-
orbitals contributes to the stabilisation of the enolate transition state and makes deprotonation of 
the C-H bond more facile. (Figure 3.35).83-85 
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Figure 3.35 Illustration of the CH-π overlap effect. 
 
As can be observed in Table 3.5, isomerisation of the bridgehead olefin to the non-bridgehead 
position within the cyclohexane ring, (3.49 vs. 3.49b), (3.42 vs. 3.42b) and (1.68 vs. 3.55) 
relieves the strain energy associated with the deformation of the alkene. In agreement with the 
hypotheses derived from Bredt’s rule, the magnitude of this strain is larger in smaller bicyclic 
ring systems (3.42, 1.68 vs. 3.49) where the expected olefin deformation is greatest. 
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Compounds 3.49, 3.49b, 3.42 and 3.40 (entries 1-3,9) have dihedral angles closest to 90° for the 
hydrogen Ha, favouring kinetic deprotonation at the C1 bridgehead carbon. The initially formed 
bridgehead enolate favours thermodynamic isomerisation to the C3 non-bridgehead enolate to 
release the unfavourable torsional strain for 3.49, 3.42 and 3.40. Intriguingly, these calculations 
imply that the C1 enolate is more favourable for the non-bridgehead olefin 3.49b than the C3 
enolate. Investigation of the geometry of 3.49b revealed considerable torsional twisting to 
accommodate the non-bridgehead enolate in the cyclooctane ring. 
 
Isomerisation of the bridgehead olefin, which conformationally restricted the bridged bicyclic 
system, to the non-bridgehead position can be observed to degrade the ability to distinguish 
between the C1 and C3 hydrogen dihedral angles (entries 1 vs. 2, 3 vs. 4, 5 vs. 6). This could be 
anticipated to lead to diminished kinetic discrimination between the C1 and C3 enolates, 
however the thermodynamic enolate still favours C3 in most cases. 
 
The noted exception to these observations and trends is 1.68 (entry 5). Despite containing a 
bridgehead olefinic bond, it exhibits poor dihedral discrimination between the C1 and C3 
hydrogens; 15° and 3° respectively. Although the Hc hydrogen has a good dihedral orientation 
(118°) with respect to the carbonyl system, it is orientated to the concave face of the bicyclic ring 
where approach by a base could be anticipated to be sterically hindered (Figure 3.36). 
Consequently, it could be anticipated that deprotonation at the C3 atom would be kinetically 
slow, hindering the establishment of the thermodynamic C2-C3 enolate anion. 
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Figure 3.36 MM2 energy minimised conformation of 1.68 which illustrates the concave 
nature and sterically hindered access to the Hc hydrogen. 
 
This theoretical prediction is in agreement with the experimental work performed on 1.68 in 
which the exclusive alkylation of the C3 position was not observed under conditions anticipated 
to preferentially select for the thermodynamic enolate. 
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Comparison of 1.68 with 3.42 revealed that the two models displayed different geometric 
conformational minima (Figure 3.37). To ensure that this conformational change was not due to 
the C8 methyl group, MMFF prediction of the energy minima for 3.85 was undertaken, in which 
the C8 methyl group is present and the C7 methyl-ether has been replaced with an isosteric ethyl 
group. 
 
Although the conformationally restricted cyclohexene group of 1.68 mapped cleanly onto the 
cyclohexene group of 3.85, it could readily be seen that the cycloheptane ring occupies a 
distorted chair structure in 1.68 (when viewed along the axis of Hb to Hf) (Figure 3.37-A), but an 
extended boat in 3.85 (Figure 3.37-B). The adoption of different conformational minima in the 
cycloheptane ring results in considerable differences in the observed dihedral angles. 
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Figure 3.37 Calculated structure for 1.68 (A) and 3.85 (B) showing the geometrical 
conformation adopted by the cycloheptane ring. 
 
Constraining 1.68 to occupy the cycloheptane conformation of 3.85, resulted in an increase in the 
calculated strain energy of 8.5 kcal mol-1, indicating that Figure 3.37-A was the conformational 
minimum geometry for 1.68, rather than that of Figure 3.37-B. This unexpected result contrasts 
with 3.42b and 3.55 which show very similar geometrical conformations, with the cycloheptane 
core occupying an extended boat structure (similar to Figure 3.37-B) and the cyclohexene 
groups possessing an essentially super-imposable bridged bicyclic core. 
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To investigate this phenomenon further, a number of model systems were briefly analysed using 
the MMFF model. The resulting minimised conformational models could be divided into three 
categories: 
(A) geometrical conformations similar to that observed for 3.85, 
(B) distorted conformations such as that observed for 1.68, and  
(C) a hydrogen-bonded model where the concave nature of the bicyclo[4.3.1] ring 
system puts the R1 hydrogen donor in close proximity (~2.1 Å) to the carbonyl oxygen. 
 
Table 3.6 Conformational minima adopted by bicyclo[4.3.1]decenes with differing R1 and 
R2 substituents and the calculated Ha-carbonyl dihedral angles. 
R1
OR2
He Hd
56
7
8
Ha  
(A) Standard Ha (B) Distorted Ha (C) H - Bonded Ha 
R1 = Me, R2 = OMe 72 R1 = OMe, R2 = Me (1.68) 15 R1 = Me, R2 = OH 91 
R1 = Me, R2 = H (3.42) 75 R1 = OH, R2 = Me 16 R1 = H, R2 = OH 90 
R1 = H, R2 = Me 72 R1 = H, R2 = OMe 16   
R1, R2 = Me 73     
R1 = Et, R2 = Me 74     
R1, R2 = H (3.40) 76     
R1 = OH, R2 = H 74     
 
From inspection of Table 3.6 it can be seen that Model A systems adopt an extended boat 
conformation similar to that depicted for 3.85 (Figure 3.37-B), which results in a dihedral Ha-
carbonyl angle of 72-76°. Such systems would favour selective deprotonation at Ha relative to 
Hb or Hc. The Model B systems, by contrast, have a distorted chair structure (as depicted in 
Figure 3.37-A) with a dihedral angle of 15-16° which prevents efficient discrimination between 
Ha and Hb. The unfavourable orientation of Ha and Hb with respect to the carbonyl π-system 
may be expected to retard the rate of proton abstraction.   
 
A distinct cause for the divergence of the conformational minima of Group B molecules relative 
to Group A is not readily apparent. Calculation of the orbital co-efficients of the Group B models 
displayed evidence of ionisation and hyperconjugation which extends the C6-C7 olefinic HOMO 
and LUMO surfaces onto the adjacent C5 carbon. The Hd hydrogen was observed to be planar 
with the olefinic Δ6,7 bond. This hyperconjugation was largely absent from the Group A and 
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Group C molecules, and may be responsible for the adoption of the unusual geometry observed 
within the cycloheptanone ring. Remarkably, this is in agreement with the 1H NMR spectrum 
acquired for 1.68 (Figure 3.26) which indicated that one of the C5 hydrogen atoms exists in a 
unique electronic environment, resulting in a significant deshielding effect, [Δδ (5a-5b) = 1.08 
ppm], possibly due to interaction with the adjacent Δ6,7-olefinic bond. 
 
Whether these models, derived from theoretical calculations, accurately depict the actual 
molecular conformational geometry is unknown. However, the unexpected conformation 
discovered for 1.68 may explain much of the aberrant reactivity with respect to the lack of 
regioselectivity in the enolate formation and alkylation, when compared to molecule 3.49 utilised 
by Shea et al. when demonstrating regioselective alkylation (Figure 3.11). 
 
3.8 Summary 
 
The IMDA reaction of three triene systems was investigated under both thermal and Lewis acid 
catalysed conditions. The cyclisation was observed to proceed in good yield to generate 
bicyclo[4.3.1]decene carbocyclic skeletons but was complicated by a facile acid-catalysed Δ6,7 ? 
Δ7,8 olefinic isomerisation for 7-alkoxy-trienes 1.69 and 1.80. The same isomerisation process 
was found not to affect the vinyl triene system 2.67 which gave the Δ6,7-bicyclo[4.3.1]decene 
skeleton without evidence of the Δ7,8-isomer. 
 
The use of greater than stoichiometric quantities of Proton-sponge® in silylated glassware was 
observed to retard the Δ6,7 ? Δ7,8 isomerisation allowing the isolation of the Δ6,7-olefinic adducts 
in good yield. Efforts to appropriately functionalise these adducts however, were uniformly 
unsuccessful, in contrast to the work of Shea et al. 
 
Molecular modelling conducted to explore the causes of this aberrant reactivity revealed an 
unexpected molecular conformation for the 7-alkoxy-IMDA adducts. This conformation was 
predicted to both diminish the kinetic discrimination between the bridgehead and ring protons 
and to retard the establishment of a thermodynamic enolate. 
 
 
 
Chapter Three – The Diels-Alder Reaction 132 
3.9 References for Chapter Three 
 
(1) (a) Diels, O.; Alder, K. Chem. Ber. 1929, 62B, 2087-2090. (b) Diels, O.; Alder, K.; 
Pries, P. Chem. Ber. 1929, 62B, 2081-2087. (c) Diels, O.; Alder, K.; Lubbert, W.; 
Naujoka, E.; Querberitz, F.; Rohl, K.; Segeberg, H. Liebigs Ann. Chem. 1929, 470, 62-
103. (d) Diels, O.; Alder, K. Liebigs Ann. Chem. 1928, 460, 98-122.  
(2) Hoffmann, R.; Woodward, R. B. Acc. Chem. Res. 1968, 1, 17-22. 
(3) Woodward, R. B.; Hoffmann, R. The Conservation of Orbital Symmetry; Verlag 
Chemie: Weinheim, 1970. 
(4) Ginsburg, D. Tetrahedron 1983, 39, 2095-2135. 
(5) Houk, K. N. Acc. Chem. Res. 1975, 8, 361-369. 
(6) Garcia, J. I.; Mayoral, J. A.; Salvatella, L. Acc. Chem. Res. 2000, 33, 658-664. 
(7) Nicolaou, K. C.; Snyder, S. A.; Montagnon, T.; Vassilikogiannakis, G. Angew. Chem., 
Int. Ed. Engl. 2002, 41, 1668-1698. 
(8) Corey, E. J. Angew. Chem., Int. Ed. Engl. 2002, 41, 1650-1667. 
(9) Bear, B. R.; Sparks, S. M.; Shea, K. J. Angew. Chem., Int. Ed. Engl. 2001, 40, 820-849. 
(10) Carruthers, W. Cycloaddition Reactions in Organic Synthesis; Pergamon Press: Oxford, 
1990. 
(11) Cycloaddition Reactions in Organic Synthesis; Kobayashi, S.; Jorgensen, K. A., Eds.; 
Wiley-VCH: Weinheim, 2002. 
(12) Marsault, E.; Toro, A.; Nowak, P.; Deslongchamps, P. Tetrahedron 2001, 57, 4243-
4260. 
(13) McCabe, J. R.; Eckert, C. A. Acc. Chem. Res. 1974, 7, 251-257. 
(14) Pindur, U.; Lutz, G.; Otto, C. Chem. Rev. 1993, 93, 741-761. 
(15) Kumar, A. Chem. Rev. 2001, 101, 1-19. 
(16) Corey, E. J.; Cheng, X.-M. The Logic of Chemical Synthesis; Wiley: New York, 1995. 
(17) Brocksom, T. J.; Nakamura, J.; Ferreira, M. L.; Brocksom, U. J. Braz. Chem. Soc. 2001, 
12, 597-622. 
(18) Nicolaou, K. C.; Sorensen, E. Classics in Total Synthesis; VCH: Weinheim, 1995. 
(19) Nicolaou, K. C.; Snyder, S. A. Classics in Total Synthesis. II,; Wiley-VCH: Weinheim, 
2003. 
(20) Nicolaou, K. C.; Montagnon, T.; Snyder, S. A. J. Chem. Soc., Chem. Commun. 2003, 
551-564. 
Chapter Three – The Diels-Alder Reaction 133 
(21) Woodward, R. B.; Bader, F. E.; Bickel, H.; Frey, A. J.; Kierstead, R. W. Tetrahedron 
1958, 2, 1-57. 
(22) Woodward, R. B.; Bader, F. E.; Bickel, H.; Frey, A. J.; Kierstead, R. W. J. Am. Chem. 
Soc. 1956, 78, 2023-2025. 
(23) Corey, E. J.; Weinshenker, N. M.; Schaaf, T. K.; Huber, W. J. Am. Chem. Soc. 1969, 91, 
5675-5677. 
(24) Corey, E. J.; Schaaf, T. K.; Huber, W.; Koelliker, U.; Weinshenker, N. M. J. Am. Chem. 
Soc. 1970, 92, 397-398. 
(25) Corey, E. J.; Ensley, H. E. J. Am. Chem. Soc. 1975, 97, 6908-6909. 
(26) Corey, E. J.; Imwinkelried, R.; Pikul, S.; Xiang, Y. B. J. Am. Chem. Soc. 1989, 111, 
5493-5495. 
(27) Corey, E. J.; Loh, T. P.; Roper, T. D.; Azimioara, M. D.; Noe, M. C. J. Am. Chem. Soc. 
1992, 114, 8290-8292. 
(28) Vosburg, D. A.; Vanderwal, C. D.; Sorensen, E. J. J. Am. Chem. Soc. 2002, 124, 4552-
4553. 
(29) Vanderwal, C. D.; Vosburg, D. A.; Weiler, S.; Sorensen, E. J. J. Am. Chem. Soc. 2003, 
125, 5393-5407. 
(30) Evans, D. A.; Starr, J. T. J. Am. Chem. Soc. 2003, 125, 13531-13540. 
(31) Klemm, L. H.; Gopinath, K. W. Tetrahedron Lett. 1963, 1243-1245. 
(32) Brieger, G.; Bennett, J. N. Chem. Rev. 1980, 80, 63-97. 
(33) Fallis, A. G. Can. J. Chem. 1984, 62, 183-234. 
(34) Ciganek, E. Org. React. (N.Y.) 1984, 32, 1-374. 
(35) Craig, D. Chem. Soc. Rev. 1987, 16, 187-238. 
(36) Roush, W. R. Advances in Cycloaddition 1990, 2, 91-146. 
(37) Oppolzer, W. In Comprehensive Organic Synthesis : Selectivity, Strategy, and 
Efficiency in Modern Organic Chemistry; Trost, B. M., Fleming, I., Eds.; Pergamon 
Press: Oxford, 1991; Vol. 5 Combining C-C (pi) Bonds, p 315-399. 
(38) Dell, C. P. Contemp. Org. Syn. 1997, 4, 87-117. 
(39) Dell, C. P. J. Chem. Soc., Perkin Trans. 1 1998, 3873-3905. 
(40) Fleming, I. Frontier Orbitals and Organic Chemical Reactions; Wiley: London, 1976. 
(41) For the historical reference see (a) Bredt, J.; Thouet, H.; Schmitz, J. Liebigs Ann. Chem. 
1924, 437, 1-13. For a delineation of principal factors governing stability in small 
carbocyclic systems see (b) Wiseman, J. R.; Pletcher, W. A. J. Am. Chem. Soc. 1970, 
92, 956-962. (c) Maier, W. F.; Schleyer, P. V. R. J. Am. Chem. Soc. 1981, 103, 1891-
Chapter Three – The Diels-Alder Reaction 134 
1900 and (d) Warner, P. M. Chem. Rev. 1989, 89, 1067-1093. For an insightful review 
on the concept of strain within organic molecules, included cyclopropane and 'Bredt-
like' structures see (e) Liebman, J. F.; Greenberg, A. Chem. Rev. 1976, 76, 311-365.  
(42) Sparks, S. M.; Vargas, J. D.; Shea, K. J. Org. Lett. 2000, 2, 1473-1475. 
(43) Wani, M. C.; Taylor, H. L.; Wall, M. E.; Coggon, P.; McPhail, A. T. J. Am. Chem. Soc. 
1971, 93, 2325-2327. 
(44) Kingston, D. G. I. J. Chem. Soc., Chem. Commun. 2001, 867-880. 
(45) Dabrah, T. T.; Harwood, H. J., Jr.; Huang, L. H.; Jankovich, N. D.; Kaneko, T.; Li, J.-
C.; Lindsey, S.; Moshier, P. M.; Subashi, T. A.; Therrien, M.; Watts, P. C. J. Antibiot. 
1997, 50, 1-7. 
(46) Dabrah, T. T.; Kaneko, T.; Massefski, W., Jr.; Whipple, E. B. J. Am. Chem. Soc. 1997, 
119, 1594-1598. 
(47) Spiegel, D. A.; Njardarson, J. T.; McDonald, I. M.; Wood, J. L. Chem. Rev. 2003, 103, 
2691-2727. 
(48) To date six successful syntheses of paclitaxel have been completed. Routes chosen to 
secure the challenging central B cyclooctane ring have featured epoxy alcohol 
fragmentation (Holton, Wender), McMurry-type pinacol coupling (Nicolaou), 
intramolecular Heck cyclisation (Danishefsky) and intramolecular Mukaiyama-type 
cyclisation (Kuwajima). See (a) Kingston, D. G. I. J. Chem. Soc., Chem. Commun. 
2001, 867-880, [refs. 92 - 97] and (b) Vazquez, A.; Williams, R. M. J. Org. Chem. 
2000, 65, 7865-7869, [ref. 3] for a complete list of references relating to these total 
syntheses.  
(49) Numerous applications and partial syntheses utilising an IMDA reaction to form the 
taxane A or C ring have been published, however a successful application of this 
strategy to a completed synthesis of the taxane natural product is yet to appear. See (a) 
Boa, A. N.; Jenkins, P. R.; Lawrence, N. J. Contemp. Org. Synthesis 1994, 1, 47-75. (b) 
Shea, K. J.; Davis, P. D. Angew. Chem. 1983, 95, 422-423. (c) Stec, M. M.; Gwaltney, 
S. L.; Burke, L. D.; Nguyen, H.; Shea, K. J. Tetrahedron Lett. 2003, 44, 9379-9382. (d) 
Brown, P. A.; Jenkins, P. R.; Fawcett, J.; Russell, D. R. J. Chem. Soc., Chem. Commun. 
1984, 253-255. (e) Jenkins, P. R. J. Braz. Chem. Soc. 1996, 7, 343-351. (f) Rubenstein, 
S. M.; Williams, R. M. J. Org. Chem. 1995, 60, 7215-7223. (g) Vazquez, A.; Williams, 
R. M. J. Org. Chem. 2000, 65, 7865-7869. (h) Laurent, A.; Villalva-Servin, N. P.; 
Forgione, P.; Wilson, P. D.; Smil, D. V.; Fallis, A. G. Can. J. Chem. 2004, 82, 215-226. 
(i) Villalva-Servin, N. P.; Laurent, A.; Fallis, A. G. Can. J. Chem. 2004, 82, 227-239. (j) 
Chapter Three – The Diels-Alder Reaction 135 
Winkler, J. D.; Kim, H. S.; Kim, S.; Penkett, C. S.; Bhattacharya, S. K.; Ando, K.; 
Houk, K. N. J. Org. Chem. 1997, 62, 2957-2962. (k) Fallis, A. G. Acc. Chem. Res. 
1999, 32, 464-474.  
(50) To date four total syntheses and 19 advanced synthetic approaches to Phomoidride A 
have been disclosured. The total syntheses of the Nicolaou and the Fukuyama groups 
employed an IMDA reaction to establish the bicyclo[4.3.1]decene core, see Spiegel, D. 
A.; Njardarson, J. T.; McDonald, I. M.; Wood, J. L. Chem. Rev. 2003, 103, 2691-2727.  
(51) Wiseman, J. R. J. Am. Chem. Soc. 1967, 89, 5966-5968. 
(52) Marshall, J. A.; Faubl, H. J. Am. Chem. Soc. 1967, 89, 5965-5966. 
(53) Becker, K. B. Helv. Chim. Acta 1977, 60, 81-93. 
(54) Shea, K. J.; Wise, S. J. Am. Chem. Soc. 1978, 100, 6519-6521. 
(55) Shea, K. J.; Wise, S. Tetrahedron Lett. 1979, 1011-1014. 
(56) Shea, K. J.; Wise, S.; Burke, L. D.; Davis, P. D.; Gilman, J. W.; Greeley, A. C. J. Am. 
Chem. Soc. 1982, 104, 5708-5715. 
(57) Shea, K. J.; Gilman, J. W. Tetrahedron Lett. 1983, 24, 657-660. 
(58) Illuminati, G.; Mandolini, L. Acc. Chem. Res. 1981, 14, 95-102. 
(59) Gwaltney, S. L., II; Sakata, S. T.; Shea, K. J. J. Org. Chem. 1996, 61, 7438-7451. 
(60) Gwaltney, S. L., II; Sakata, S. T.; Shea, K. J. Tetrahedron Lett. 1995, 36, 7177-7180. 
(61) Shea, K. J.; Sakata, S. T. Tetrahedron Lett. 1992, 33, 4261-4264. 
(62) Holton, R. A.; Kim, H. B.; Somoza, C.; Liang, F.; Biediger, R. J.; Boatman, P. D.; 
Shindo, M.; Smith, C. C.; Kim, S.; Nadizadeh, H.; Suzuki, Y.; Chunlin, T.; Phong, V.; 
Tang, S.; Zhang, P.; Murthi, K. K.; Gentile, L. N.; Liu, J. H. J. Am. Chem. Soc. 1994, 
116, 1599-1600. 
(63) Holton, R. A.; Somoza, C.; Kim, H. B.; Liang, F.; Biediger, R. J.; Boatman, P. D.; 
Shindo, M.; Smith, C. C.; Kim, S.; Nadizadeh, H.; Suzuki, Y.; Tao, C.; Vu, P.; Tang, S.; 
Zhang, P.; Murthi, K. K.; Gentile, L. N.; Liu, J. H. J. Am. Chem. Soc. 1994, 116, 1597-
1598. 
(64) Roush, W. R.; Gillis, H. R.; Ko, A. I. J. Am. Chem. Soc. 1982, 104, 2269-2283. 
(65) Phillips, A. J.; Morris, J. C.; Abell, A. D. Tetrahedron Lett. 2000, 41, 2723-2727. 
(66) Phillips, A. J. PhD Thesis, Univerisity of Canterbury (N.Z.), 1999. 
(67) Ireland, R. E.; Dawson, M. I.; Kowalski, C. J.; Lipinski, C. A.; Marshall, D. R.; Tilley, 
J. W.; Bordner, J.; Trus, B. L. J. Org. Chem. 1975, 40, 973-990. 
(68) Wenkert, E.; Berges, D. A. J. Am. Chem. Soc. 1967, 89, 2507-2509. 
(69) Momose, T.; Muraoka, O.; Masuda, K. Chem. Pharm. Bull. 1989, 37, 1645-1646. 
Chapter Three – The Diels-Alder Reaction 136 
(70) Waizumi, N.; Itoh, T.; Fukuyama, T. J. Am. Chem. Soc. 2000, 122, 7825-7826. 
(71) Dossetter, A. G.; Jamison, T. F.; Jacobsen, E. N. Angew. Chem., Int. Ed. Engl. 1999, 38, 
2398-2400. 
(72) Liu, P.; Jacobsen, E. N. J. Am. Chem. Soc. 2001, 123, 10772-10773. 
(73) Warner, P. M. Chem. Rev. 1989, 89, 1067-1093. 
(74) Zoretic, P. A.; Wang, M. Synth. Commun. 1996, 26, 2783-2796. 
(75) Denis, J. M.; Girard, C.; Conia, J. M. Synthesis 1972, 549-551. 
(76) Charette, A. B.; Beauchemin, A. Org. React. (N.Y.) 2001, 58, 1-415. 
(77) Simmons, H. E.; Smith, R. D. J. Am. Chem. Soc. 1959, 81, 4256-4264. 
(78) Shank, R. S.; Shechter, H. J. Org. Chem. 1959, 24, 1825-1826. 
(79) Schuchardt, U.; Nery, J. H. S.; Zuiani, M. A. J. Braz. Chem. Soc. 1991, 2, 61-65. 
(80) Furukawa, J.; Kawabata, N.; Nishimura, J. Tetrahedron 1968, 24, 53-58. 
(81) Denmark, S. E.; Edwards, J. P. J. Org. Chem. 1991, 56, 6974-6981. 
(82) Lebel, H.; Marcoux, J.-F.; Molinaro, C.; Charette, A. B. Chem. Rev. 2003, 103, 977-
1050. 
(83) Corey, E. J.; Sneen, R. A. J. Am. Chem. Soc. 1956, 78, 6269-6278. 
(84) Ndibwami, A.; Deslongchamps, P. Can. J. Chem. 1986, 64, 1788-1794. 
(85) Behnam, S. M.; Behnam, S. E.; Ando, K.; Green, N. S.; Houk, K. N. J. Org. Chem. 
2000, 65, 8970-8978. 
Chapter Four – Diels-Alder Homomethyl Substrates  137
Chapter Four 
Diels-Alder Homomethyl Substrates 
 
4.1 Homomethyl Homologation: Synthetic Plan 
 
Investigations directed towards the synthesis of the bicyclo[4.3.1]decane core of the nakafuran 
and florlide natural products, via an IMDA reaction of triene precursors 1.69 and 1.80, had 
shown the products to undergo a particularly facile Δ6,7 ? Δ7,8 olefinic isomerisation. It is 
postulated that this very rapid, acid-catalysed isomerisation is assisted by the enol-ether 
functionality, presumably via a transient oxonium intermediate (3.64) (Scheme 4.1 - Route A). 
The release of the strain associated with the bridgehead olefinic bond provides a thermodynamic 
driving force for this olefinic migration. 
 
To address this issue a scheme was devised that saw the substitution of the C7 enol-ether (1.69) 
for a homomethyl ether (3.69). The diminished tautomeric ability of the C7 methylene group was 
anticipated to retard or prevent the double bond isomerisation (Scheme 4.1 - Route B). 
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Scheme 4.1 Proposed IMDA cyclisation and subsequent olefinic isomerisation (Route A) and 
modified route incorporating a homomethyl extension (Route B). 
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4.1.1 Homomethyl Homologation: Retrosynthesis 
 
The one carbon homologation of the C7 methyl ether necessitated both the development of a new 
synthetic route to the synthesis of the triene substrate 3.69 and a new method to install the 
quaternary C6 methyl group with sufficient functionality at the C7 carbon. 
 
The synthetic route envisaged for the installation of the C6 bridgehead methyl group, via the 
simultaneous methyl ether deprotection and cyclopropanol fragmentation, as applied to adduct 
3.74 under acidic conditions, was no longer accessible to the homologated substrate 4.1. A 
synthetic plan was devised whereby radical scission of the allylic carbon-oxygen bond of 4.1 
would furnish an intermediate cyclopropylcarbinyl radical 4.2. Homoallyl-type rearrangement of 
this radical species would effect ring opening of the exo-cyclopropane bond to furnish the exo-
methylene bridgehead methyl adduct 4.3. Elaboration of this intermediate would intersect with 
the previously described synthetic route (Scheme 4.2). 
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Scheme 4.2 Modified fragmentation route utilising a cyclopropylcarbinyl ? homoallyl radical 
rearrangement. 
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Two retrosynthetic routes for the preparation of the triene system 3.69 were proposed and are 
depicted in Scheme 4.3. 
OR
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2.9
4.4
4.5
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Scheme 4.3 Retrosynthetic routes to homomethyl triene 3.69. 
 
Route A utilises a palladium-catalysed cross-coupling reaction to form the required σ-bond 
between the sp2 centres of vinyl iodide 2.9 and 2-functionalised but-2-en-1-ol 4.4. This coupling 
methodology was successfully applied during synthetic endeavours conducted towards the triene 
systems 1.66, 1.80 and 2.67 (Chapter 2.8). 
Route B by contrast, features an intriguing alternative disconnection. By employing an enyne-
metathesis reaction between an olefin and the alkyne substrate 4.5, it is possible to install the two 
diene sp2-centres from a single sp-precursor. This attractive route allows the rapid installation of 
the 1,3-diene substructure in a single step from an alkyne, the product of which can readily be 
advanced to the triene IMDA precursor 3.69. 
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4.2 Route A: Palladium-Catalysed Cross-Coupling 
 
The transition-metal catalysed coupling of the vinyl iodide 2.9 with a suitably substituted allylic 
alcohol 4.4 would result in the formation of the diene system 4.6 (Scheme 4.4). This adduct 
contains a methyl homologated C7 functional group when compared to the previously prepared 
enol-ether diene substrates generated via the coupling of 2.9 with 1.71. 
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Scheme 4.4 Synthetic route to 3.70 via palladium-catalysed cross-coupling. 
 
It was envisaged that the palladium-catalysed coupling could be achieved through the application 
of a Stille or Negishi coupling protocol. In the case of the Stille coupling this necessitates the 
preparation of the vinyl stannane species 4.4 (X = SnBu3); whereas the Negishi coupling 
fragment would be accessed via the zinc-transmetallation of the vinyl iodo-adduct (4.4, X = I). 
Advancement through the previously described synthetic steps would generate the homomethyl 
IMDA adduct 3.70. 
 
4.2.1 Preparation of Coupling Fragments 
 
Synthetic preparation of the vinyl iodide coupling partner 2.9 has previously been detailed in 
Section 2.6.2.1. The preparation of the homologated vinyl coupling partners 4.7-4.10 features 
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chemical transformations similar to those required to make the analogous vinyl ether coupling 
partners 1.71 and 1.82 (Scheme 4.5). 
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Scheme 4.5 Functionalised vinylic coupling targets for 4.7-4.10. 
 
4.2.1.1 Preparation of Iodo-Substituted Coupling Fragment 4.7 
 
The differentially protected 2-iodoprop-2-en-1-ols (4.7a-d), the homomethyl analogues of ethyl 
vinyl ether fragment 1.82, were prepared utilising the hydrohalogenation methodology 
previously discussed. In contrast to the attempts to prepare isomerically pure α-iodohexenols 
such as 2.55, which were hampered by double bond isomerisation, the exposure of propargyl 
alcohol to 2.4 equivalents of anhydrous HI, using the protocol of Ishii et al.,1 resulted in the 
isolation of the single product 4.7a, following column chromatography. The free alcohol was 
subsequently protected using standard synthetic protocols to yield the three differentially 
protected vinyl iodides 4.7b, 4.7c and 4.7d in high yield (Scheme 4.6). 
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P = TBS 4.7b
4.7c
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Scheme 4.6 Preparation of vinyl iodide coupling partners. 
Reagents and yields: (i) NaI, TMSCl, H2O, MeCN, 1 h, 51%; (ii) (a) TBSCl, imidazole, DMF, 98%, 4.7b; or (b) 
DHP, p-TsOH, CH2Cl2, 74%, 4.7c; or (c) MOM-Cl, DIPEA, CH2Cl2, 68%, 4.7d. 
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4.2.1.2 Preparation of Stannane Coupling Fragment 4.8 
 
The preparation of α-stannyl allylic alcohols from differentially protected propargyl ethers has 
previously been reported.2-5 As illustrated in Table 4.1, radical hydrostannylation protocols 
primarily give the terminal stannylated alkenes as thermodynamic E/Z mixtures (entry 1). 
Transition metal catalysts give clean cis addition, often with good to excellent regioselectivity at 
the α-position (entries 2-6).2-10 Recently, Muria and colleagues disclosed conditions that 
generate the Z-alkene adducts with high regio- and stereoselectivity (entries 7-8).11 
 
Table 4.1 Hydrostannylation of propargyl alcohol derivatives.  
 
SnBu3
OROR
OR
OR
Bu3Sn
SnBu3
E-β Z-βα
Bu3SnH
 
Entry R Conditions Yield α E-β Z-β Reference 
1 THP AIBN 71 10 45 16 2 
2 THP RhCl(CO)(PPh3)2 72 94 6 - 3 
3 THP MoBr(allyl)(CO)2(MeCN)2 - 64 36 - 4 
4 THP PdCl2(PPh3)2 68 67 33 - 4 
5 THP Mo(CO)3(CN-t-Bu)3 94 89 11 - 5 
6 Ac Mo(CO)3(CN-t-Bu)3 91 96 4 - 5 
7 H Bu2Sn(OTf)H; n-BuLi 85 1 - 99 11 
8 Me Bu2SnClH, AIBN; n-BuLi 95 9 - 86 12 
 
Guibe et al. reported the application of a molybdenum catalyst MoBr(allyl)(CO)2(MeCN)2 to the 
hydrostannylation of a number of alkynes (entry 3).4 The molybdenum complex showed 
comparable reactivity and slightly higher selectivity in favour of the α-stannylated product than 
palladium-catalysed reactions, especially with hindered alkynes. 
 
The laboratory of Kazmaier extended this research with the systematic modification of Mo(0) 
complexes.2,5,9,10,13 The replacement of three carbon monoxide ligands on Mo(CO)6, itself 
capable of moderate hydrostannylation ability, with isoelectric tert-butyl isonitrile ligands 
resulted in a significant increase in the yield and selectivity. The complex, Mo(CO)3(CN-t-Bu)3 
(4.11), displayed favourable regioselectivity, adding to the alkyne bond such that the sterically 
more demanding molybdenum moiety is located at the least hindered position (4.12).14 
Reductive elimination gives the α-stannylated adduct 4.13 (Figure 4.1). 
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Mo(CO)3(CN-t-Bu)3
Bu3SnH R
R
Mo(CO)3L(3-n)
Bu3Sn
H
R
Mo(CO)3L(3-n)Bu3Sn
H
R
HBu3Sn
(CN-t-Bu)n
4.11
4.12
Bu3Sn Mo(CO)3L(3-n)
H
4.13  
Figure 4.1 Proposed mechanism for the molybdenum-catalysed hydrostannylation of alkynes. 
 
Application of the protocol of Kazmaier et al. to a number of differentially protected propargyl 
alkynes resulted in the generation of the vinyl stannanes 4.8a-4.8d in good yield as displayed in 
Table 4.2 (entries 1-4). The observed hydrostannylations proceeded with excellent stereocontrol, 
due to the syn-addition of tributyltin hydride across the alkyne bond, although the regiocontrol 
was moderate (~6α : 1β). 
 
Table 4.2 Hydrostannylation of propargyl alcohol substrates. 
R R
SnBu3
RBu3Sn
4.8a
4.8b
4.8c
4.8d
R = OH
R = OMOM
R = OTHP
R = OTBS
α β
 
Entry R Conditionsa Conversionb Yieldc Compound 
1 OH 23°C 100 (85:15) 78% 4.8a 
2 OMOM 23°C 100 (85:15) 81% 4.8b 
3 OTHP 23°C 100 (90:10) 74% 4.8c 
4 OTBS 23°C 100 (79:21) 60% 4.8d 
5 2.54 23°C; 55°C 0 - 2.7 
Note: (a) Reactions were conducted on 1 mmol scale, Mo(CO)3(CN-t-Bu)3 (2 mol 
%), Bu3SnH (3 equiv), hydroquinone (10 mol %), THF, at room temperature for 16 h 
under Ar. (b) Conversion was determined by integration of the relevant 1H NMR 
signal for the allylic CH2; the value in parenthesis is the observed ratio of α:β vinyl 
stannane. (c) Yield refers to isolated chromatographically pure material.  
 
Attempted hydrostannylation of the alkyne amide 2.54 did not proceed at ambient temperature. 
No reaction was observed after 16 hours at elevated temperature (entry 5). Only a few instances 
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of the hydrostannylation of non-propargyl alkynes with the catalyst 4.11 have been reported in 
the literature and in these cases α-ketone or ester functionality has facilitated the reaction by 
activating the alkyne bond.5,15 
 
4.2.2 Negishi Cross-Coupling  
 
The advantages of the Negishi coupling in the preparation of the dienes 1.70, 1.81 and 2.67, 
relative to the Stille coupling protocols, prompted investigation of the palladium-catalysed 
coupling of the vinyl-zinc reagents 4.14. However, all attempted couplings of the α-
functionalised ethenyl alcohols 4.7b-4.7d to the vinyl iodide 2.9 using the Negishi coupling 
methodology were unsuccessful (Scheme 4.7). The vinyl iodide 2.9 was recovered unchanged 
from the reaction mixtures. No evidence of products derived from the decomposition of the α-
metallated intermediates could be detected, presumably due to their volatility upon aqueous 
work-up and extraction. 
 
OR
I
OR
Li
OR
ZnCl
(i) (ii) (iii) no reaction
R = MOM, THP, TBS
4.15 4.144.7b-d
 
Scheme 4.7 Attempted Negishi coupling of the α-vinyl iodides 4.7b–4.7d. 
Reagents and conditions: (i) n-BuLi, ether, -90°C ? -40°C; (ii) ZnCl2; (iii) Pd(PPh3)4, 2.9, THF, 25°C. 
 
The failure of these reactions can probably be traced to the decomposition of the vinyl-lithium 
(4.15) or vinyl-zinc species (4.14) prior to participation in the palladium-catalysed cross-
coupling reaction. It is postulated that decomposition occurs either via a rapid β-ether 
elimination to form an allene and an alkoxide (Figure 4.2 – i)16 or that the organolithium or 
organo-zinc species participate in a π-allylic rearrangement resulting in the formation of a 
stabilised π-allyl or alkoxyl-chelated metallocycle species (see Figure 2.12).17,18  
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OR
M
RO
(i)
R = alkyl
OR
I
OLi
Li
OH
E
E+
R = H
4.16
(ii)
n-BuLi
n-BuLi
(2 equiv)
 
Figure 4.2 (i) Decomposition of hydroxyl-protected α-metallo allylic alcohols via allene 
formation and (ii) productive application of di-lithio derivatives. 
 
Few instances have been reported in the literature of the successful application of α-metallo-
derivatives of protected allylic alcohols. Corey et al. reported that O,2-dilithio-derivative of 
allylic alcohol (4.16) can be effectively applied as a nucleophilic alkylation reagent, in which the 
lithio-alkoxide anion prevents competing allene formation.16 
 
Efforts to form the vinyl stannane species 4.8d via a low temperature halogen-lithium 
transmetallation of 4.7b, followed by quenching with tributyltin chloride, were similarly 
unsuccessful in yielding the desired product. 
 
4.2.3 Stille Cross-Coupling 
 
The Stille cross-coupling reactions of 4.8b and 4.8d with the vinyl iodide 2.9 were trialled under 
the previously optimised conditions, (Scheme 4.8). Poor conversions were observed in both 
cases, as assessed by analysis of the crude reaction mixtures via 1H NMR spectroscopy. 
Reactions conducted at 60°C for 16 hours gave incomplete conversion (~5%), with both the 
vinyl stannane and iodide starting materials still in evidence. Increasing the external bath 
temperature to 85°C for 8 hours resulted in an increase in conversion to 37% for 4.17 and 12% 
for 4.18. Also observed were vinylic signals attributed to double bond isomerisation or cine 
Stille coupling of the allylic component.19-21 Extended reaction at this temperature resulted in 
complete consumption of the starting materials but was accompanied by decomposition of the 
coupled product. 
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P = MOM 4.17
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Scheme 4.8 Preparation of homomethyl ethylene derivatives 4.17 and 4.18 via Stille coupling. 
Reagents and yields: (i) 4.8b or 4.8d (1.2 equiv), 2.9 (1 equiv), Pd2(dba)3 (5 mol %), AsPh3, (20 mol %), CuI (20 
mol %), DMF, 85°C, 16 h; 37% 4.17; 12% 4.18, [as assessed by 1H NMR spectroscopy]. 
 
It is plausible that conditions could be found that would optimise formation of the desired 
coupling product whilst minimising the undesirable decomposition and coupling pathways.22,23 
However, the success of an alternative synthetic route based on enyne metathesis, which 
delivered the diene system 4.6 in an isomerically pure fashion, meant that the Stille cross-
coupling route was not further pursued. 
 
4.2.4 Preparation of Coupling Fragment 4.10 
 
In light of the failure to effect a successful Negishi coupling of vinyl iodide 2.9 with the organo-
zinc derivatives of 2-iodopropenes 4.7b-4.7d, only the Stille catalysed cross-coupling was 
investigated for the 2-functionalised butyn-1-ol derivatives. 
 
Extensive studies have been carried out on the hydrostannylation of 1-alkynes (see Table 4.1), 
but the reactions of internal alkynes have received little attention.24,25 It is known that the 
hydrostannylation of 2-butyn-1-ol (4.19) and its protected derivatives generate different regio- 
and stereochemical product distributions dependent upon the nature of the alcohol protecting 
group and the method of hydrostannylation (Figure 4.3).26  
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SnBu3
OHBu3Sn
OHBu3Sn OH
SnBu3
Bu3SnH, AIBN
60oC, 1h
86% 10:1 Z/E
Bu3Sn(Bu)Cu(CN)Li2 (2.45) 
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THF/MeOH, -10oC, 12h
Pd(PPh3)2Cl2 (2 mol %)
Bu3SnH, THF, 20oC
71%
15% 42%
4.19
4.20Zα
4.20Eβ
4.20Eβ 4.20Eα
 
Figure 4.3 Hydrostannylation protocols for internal alkynes. 
 
Radical hydrostannylation of 4.19 conducted under pseudo-kinetic conditions gives almost 
exclusively the regio-isomer with the stannylated moiety closest to the hydroxyl group (4.20Zα) 
due to the polarising influence of the alcohol on the alkyne bond. Stannylcupration of 4.19 
performed using a proton-source such as methanol gives exclusively the regioisomer 4.20Eβ in 
good yields. Transition metal-catalysed reactions, by contrast, give regioisomeric mixtures 
derived from the syn-addition of tributyltin hydride across the alkyne bond with distributions 
dependent on the steric effects of the alkyne substituents.6 
 
Following the protocol of Betzer et al.7 the protected 2-butyn-1-ol derivatives 4.21a and 4.21b 
were subjected to palladium-catalysed hydrostannylation to yield regioisomeric mixtures of 
vinylic stannanes (Scheme 4.9). 
OR
Me OR
Me
Bu3Sn
OR
Me
SnBu3
(i)
4.10aβ4.10aR = TBS
 = THP
4.21a
4.21b 4.10bβ4.10b
R = TBS
 = THP  
Scheme 4.9 Preparation of vinyl stannane coupling partners 4.10a and 4.10b. 
Reagents and yields: (i) Pd(PPh3)2Cl2 (2 mol %), Bu3SnH, THF, 20°C; 4.10a 36%, 4.10aβ 21%; 4.10b 29%, 4.10bβ 
14%. 
 
Although TLC analysis and 1H NMR spectroscopy of the crude reaction mixtures indicated 
complete consumption of the alkyne, only moderate yields of the separated isomers 4.10a and 
4.10b were obtained following column chromatography despite the use of basified silica.  
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Attempted hydrostannylation of 4.21a using the molybdenum catalyst 4.11, a reagent in principle 
optimised for the hydrostannylation of terminal propargyl alcohols, was low yielding. Upon 
heating a solution of 4.21a and Bu3SnH at 55°C, in the presence of 2 mol % 4.11 and 10 mol % 
hydroquinone, marginal conversion was observed (~10%). The product distribution indicated the 
formation of a mixture of regioisomeric products favouring 4.10a (3:2). Increased reaction 
temperature, the use of additional catalyst and tributyltin hydride resulted in only a marginal 
improvement in the yield (~30%). Presumably the steric bulk of the tert-butyl isonitrile 
molybdenum complex restricts facile addition to the alkyne bond in the presence of the terminal 
methyl group. Upon column chromatography the isolated yield of the desired α-stannylated 
species 4.10a was observed to be 8.5%. 
 
4.2.5 Stille Cross-Coupling 
 
Subjection of vinyl stannane 4.10a and vinyl iodide 2.9 to the previously optimised palladium-
catalysed coupling conditions resulted in poor conversion and the formation of a 1:1 mixture of 
the E/Z diene adducts 4.22, resulting from isomerisation of the terminal methyl group. Extensive 
decomposition of the vinyl stannane 4.10a was inferred from the presence of unreacted starting 
material 2.9 in the 1H NMR spectrum of aliquots taken from the crude reaction mixture (Scheme 
4.10). 
N OMe
OTBS
Me
SnBu3
I O
Me
N OMe
O
Me
Me OTBS
(i)
4.222.94.10a
(ii)or
 
Scheme 4.10 Stille cross-coupling formation of the homomethyl diene system. 
Reagents and yields: (i) 4.10a (1.2 equiv), 2.9 (1 equiv), Pd2(dba)3 (5 mol %), AsPh3 (20 mol %), CuI (20 mol %), 
DMF, 60°C, 16 h;  (ii) 4.10a (1.2 equiv), 2.9 (1 equiv), CuTC (1.3 equiv), NMP, 0°C ? 23°C, 12 h, 24%. 
 
During synthetic studies directed towards facilitating the Stille reaction, Liebeskind et al. 
reported the copper chelate complex, copper thiophene carboxylate (CuTC), was capable of 
catalysing the cross-coupling of organostannanes and organo-halides in the absence of added 
palladium or nickel co-catalysts. The reactions were high yielding and were performed under 
very mild conditions.27-29 Synthetic work directed towards the preparation of the polysaturated 
sidechain of the florlide natural products (1.75) had revealed that the reagent CuTC was 
particularly effective in bringing about the reaction of substrates prone to isomerisation. 
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The reaction of vinyl stannane 4.10a with the vinyl iodide 2.9 mediated by stoichiometric 
quantities of CuTC was successful in achieving the desired Stille coupling in the absence of any 
observed olefinic isomerisation. Column chromatography resulted in the isolation of the 
homomethyl diene system 4.22 in a somewhat disappointing 24% yield. 
 
 
4.3 Summary of Palladium-Catalysed Cross-Coupling Routes 
 
Whilst the desired propenyl and butenyl coupling fragments were readily prepared via 
hydrostannylation and hydroiodination methodology, the coupling of these intermediates with 
vinyl amide 2.9 was particularly challenging. No coupling adducts could be observed arising 
from the Negishi coupling protocol and poor rates of conversion, complicated with 
isomerisation, hampered application of the Stille coupling methodology. 
 
The increased reactivity of allylic systems relative to vinyl systems is well known, with allylic 
systems often participating in π-allyl rearrangements and conjugate addition-displacement 
reactions.30 Allylic stannane systems such as 4.8 and 4.10, have seen only limited use in the 
synthetic literature and usually require the activation of the vinyl halide partner with an electron 
withdrawing group, or in the case of unactivated vinyl halides may require considerable 
optimisation of the coupling conditions to achieve acceptable yields.23,31-35 
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4.4 Route B: Enyne Metathesis 
 
Olefin cross-metathesis, a process by which alkylidene groups on alkenes are exchanged, has 
recently emerged as an enormously powerful strategy for carbon-carbon bond formation.36,37 
Olefin metathesis reactions catalysed by discrete organometallic complexes of [W], [Ta], [Re] 
and [Ti] have been investigated since the 1960s but it has been the advent of well defined [Mo] 
and [Ru] catalysts, that show appreciable olefin reactivity and functional group compatibility, 
that has stimulated the interest of synthetic organic chemists.  
 
In 1992 Grubbs and Fu published two seminal papers describing the application of ring-closing 
metathesis (RCM) to the synthesis of simple five, six and seven membered heterocyclic ring 
systems using Schrock’s molybdenum catalyst (4.23).38,39 This was followed in 1993 by the 
report of similar activity from a ruthenium-based metathesis catalyst (4.24).40 
 
In the decade following these publications an enormous body of work has emerged applying the 
principles of olefin metathesis to natural product chemistry, chemical biology and material 
science.36,37 Important variations of olefin cross-metathesis are depicted in Figure 4.4 which 
include (i) ring-closing metathesis (RCM), (ii) ring-opening metathesis (ROM), (iii) acyclic 
diene metathesis polymerisation (ADMET), (iv) ring-opening polymerisation metathesis 
(ROMP) and (v) cross-metathesis (CM). The related extension of these reactions between an 
olefin and an alkyne are (vi) ring-closing enyne metathesis (RCEYM) and (vii) enyne cross-
metathesis (EYCM). The synthetic complexity of metathesis adducts can also be enhanced by 
coupling two or more of these variations in tandem. 
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Figure 4.4 Types of olefin metathesis reactions. 
 
The remarkable progress in the development of metathesis reactions can be directly correlated to 
improvements in the functional group compatibility and reactivity of the catalysts. There are two 
main types of catalysts in use today. The first group, known as the Schrock catalysts, consist of 
molybdenum complexes such as 4.23 and related catalysts, whereas the second group which 
comprises of ruthenium complexes such as 4.24-4.26 and related catalysts are known as the 
Grubbs catalysts (Figure 4.5).  
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Figure 4.5 Commercially available metathesis catalysts. 
 
In general, the Schrock catalysts display greater reactivity and less substrate inhibition than the 
ruthenium catalysts, but suffer the major disadvantages of incompatibility with a wide range of 
functionalities, non-trivial preparation and air and moisture sensitivity; necessitating the use of 
rigorous organometallic techniques. 
In contrast, the Grubbs 1st generation catalyst 4.24, whilst displaying diminished reactivity 
relative to 4.23, is tolerant to a wide range of functional groups, is relatively insensitive to air, 
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moisture and other impurities and is readily accessible, either via synthesis or from commercial 
sources. A significant advancement was made with the displacement of one of the trialkyl 
phosphine ligands by an imidazolinylidene ligand to yield the 2nd generation Grubbs catalyst 
4.25, which displays increased rates of initiation and propagation, comparable to the Schrock 
catalysts.41 Complete displacement of the phosphine ligands led to 4.26, the robust Hoveyda-
Grubbs 2nd generation catalyst, which is air stable and amenable to column chromatography and 
purification.42 Numerous catalyst variants have also been investigated including the use of chiral 
ligands and solid supports.  
 
The high olefin selectivity and reactivity of the catalysts 4.23-4.26 minimises the necessity for 
protecting group manipulations within the construction of complex chemical targets. The 
advantages offered by catalytic RCM can be evidenced by the application of this methodology to 
the successful total syntheses of complex natural products such as ciguatoxin CTX3C,43,44 
brevetoxin B,45,46 cylindrocyclophanes,47,48 prelaureatin,49 manzamine,50,51 epothilones and 
numerous others.52 
 
4.4.1 Mechanism 
 
The generally accepted mechanism for olefin metathesis was proposed by Chauvin and proceeds 
through a sequence of formal [2+2] cycloaddition-cycloreversion reactions via alkenyl metal 
carbene and metallacyclobutane intermediates, such as those depicted in Figure 4.6.36 The 
catalytic cycle is reversible, with product formation driven by the entropic release of volatile 
ethene (RCM, CM). 
[M]=CH2
[M]
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R1
[M]
R1
CH2H2C R2
R1
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R1 R2Cross Metathesis
(CM)
[M]
R1
X
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4.27
4.28
4.29a
4.29
4.30
 
Figure 4.6 Proposed mechanism for carbene mediated cross-metathesis of alkenes. 
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Although a definitive mechanism is yet to be fully elucidated, experimental and theoretical 
calculations support this mechanistic interpretation (Figure 4.6).53 
 
4.4.2 Ring Closing Enyne Metathesis and Enyne Cross-Metathesis 
 
The bond reorganisation of an alkyne and an alkene to form a conjugated 1,3 diene can be 
divided into two categories (Figure 4.7).54 
(A) an oxidative cyclisation catalysed by low-valent transition metal salts55 and; 
(B) cyclisation achieved via transition metal carbenes such as the Grubbs catalyst.  
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Figure 4.7 Metal-catalysed cationic (Path A) and carbene enyne metathesis (Path B). 
 
The cyclisation process (Path A) catalysed by cationic [Pt] or [Pd] metal salts is often referred to 
as an enyne cycloisomerisation. The mechanism is postulated to proceed via the bidentate 
coordination of the enyne to the metal (i), followed by oxidative addition-cyclometalation to 
produce the metallacyclopentene 4.32 (ii). Reductive elimination produces a cyclobutene 4.33 
(iii) which relieves strain by undergoing an electrocyclic ring opening to deliver the 1,3-diene 
structure 4.34 (iv). 
 
The process utilising metal carbenes (Path B), referred to as an enyne metathesis, is believed to 
proceed via a mechanism similar to that proposed for the alkene metathesis reaction depicted in 
Figure 4.6. The metal methylidene carbene reacts with the alkyne, undergoing a [2+2]-
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cycloaddition to form the metallacyclobutene 4.35 (v). Upon ring opening (vi), the vinyl carbene 
complex 4.36 reacts intramolecularly with the tethered olefin to generate the metallocyclobutane 
4.37 (vii). Subsequent cycloreversion provides the 1,3-diene system and regenerates the 
propagating carbene (viii).54,56 
 
Intramolecular ring closing 1,n-enyne metathesis (RCEYM), which results in skeletal 
rearrangement to a 1,3-diene substituted cycloalkene (Figure 4.7 - Path B), has been applied to a 
number of natural products including, notably, longithorone A57 and (-)-stemoamide58 (Figure 
4.8). 
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Figure 4.8 The application of RCEYM by Mori et al. in the total synthesis of (-)- stemoamide. 
 
The related intermolecular enyne cross-metathesis (EYCM) has not been extensively 
investigated for, despite the remarkable promise that EYCM reactions offer, additional 
complications exist when compared to the unimolecular reaction which hinder the synthetic 
application.59 Slower bimolecular reaction rates allow competition from undesired diene and 
alkyne metathesis pathways, adducts display limited E/Z stereochemical control and geometric 
diene isomers are commonly generated for non-terminal alkynes. 
 
4.4.3 Ethylene Enyne Cross-Metathesis 
 
A noted exception to the unresolved issues of intermolecular alkene-alkyne cross metathesis is 
the application of ethylene reported by Mori et al. Ethylene gas employed at atmospheric 
pressure in the presence of a catalytic amount of 4.24 was reported to effect the EYCM reaction 
of a number of substrates featuring both terminal and internal alkynes to generate 1,3-substituted 
butadienes (4.38) (Figure 4.9).60 
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Figure 4.9 EYCM metathesis utilising ethylene. 
 
The use of ethylene eliminates the problems associated with multiple cross-metathesis reactions. 
All modes of the regiochemistry and stereochemistry of addition of the symmetrical alkene to the 
alkyne bond are degenerate, leading to a single product. 
 
Mori et al. demonstrated that ethylene EYCM presented an attractive route to 1,3-dienes, such as 
4.41, which could be productively utilised in subsequent Diels-Alder reactions (Figure 4.10).59 
The isolated yield of the 1,3-diene 4.41 was low in this instance, presumably due to undesirable 
competitive metathesis reactions involving cleavage or intramolecular CM cyclisation of the α,β 
unsaturated ester. 
 
MenO2C MenO2C
4.24 (5 mol %)
CH2=CH2 
CH2Cl2, rt, 45h MenO2C
240oC
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56%
10% (58% SM)
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Figure 4.10 Bicyclo[4.3.1]decene adducts prepared via EYCM-IMDA methodology. 
 
Diver et al. investigated the use of elevated ethylene pressures (up to 60 psi) in conjunction with 
the use of Grubbs second generation catalyst (4.25). Substantial improvements were obtained 
when compared to the use of Grubbs first generation catalyst (4.24) with atmospheric pressures 
of ethylene. Tolerance was observed to a wide range of functionality at the propargyl position 
providing access to a variety of 2-substituted butadienes. The improved yields were attributed to 
the enhanced turnover rate of the catalyst 4.25, a higher effective molar concentration of 
ethylene which minimized unfavorable heteroatom chelation (Figure 4.6 - 4.29a) and the ability 
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to drive the reaction to completion via mass action. Additionally, the greater thermal stability of 
4.25 allows the use of elevated temperature, without significant catalyst decomposition.61,62 
The use of an ethylene atmosphere was also discovered to be valuable in RCEYM and EYCM 
reactions where the ethylene was not incorporated into the cyclic product.63,64 It is postulated that 
ethylene maintains a high concentration of the active ruthenium methylidene catalyst [Ru=CH2] 
by reducing the number of unproductive catalyst resting states.  
 
As illustrated in Figure 4.10, the application of an ethylene EYCM reaction represents a highly 
succinct and efficient route to the preparation of the disubstituted 1,3-dienes. If such a reaction 
could be conducted on a substrate that lacked competing olefinic functionality, rapid entry to 
diene systems such as 3.69 could be achieved, whilst minimising undesirable CM reactions. 
 
 
4.5 Preparation of Diels-Alder Homomethyl Substrates 
 
4.5.1 Preparation of Trienes Directed Towards Florlide Precursors 
 
Applying the principles discussed in Section 4.4.3, a suitable retron for the diene functionality of 
3.69 is an alkyne motif, such as that of the structure 4.5.  
 
O
PO
OMe
O
PO
4.53.69
EYCM
Enyne metathesis  
Scheme 4.11 1,3-Diene to alkyne retrosynthesis using the EYCM transform. 
 
Methyl 7-hydroxyhept-5-ynoate (4.42) is an important intermediate in the synthesis of the α-side 
chain of prostaglandins.65-67 The preparation of methyl 7-hydroxyhept-5-ynoate protected as 
either the MOM- (4.43) or TBS-ether (4.44) commenced from commercially available propargyl 
alcohol using the method of Corey and Sachdev as detailed in Scheme 4.12.65 
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Scheme 4.12 Preparation of the homomethyl triene 4.48 and 4.49. 
Reagents and yields: (i) DHP (1.05 equiv), CH2Cl2, CSA, rt, 98%; (ii) n-BuLi (1.1 equiv), THF, Br-(CH2)3-Cl (1.5 
equiv), 0°C ? reflux, 82%; (iii) NaCN (1.1 equiv), DMSO, 75°C, 84%; (iv) (a) 10% aqueous NaOH, EtOH, reflux; 
(b) K2CO3, MeI, DMF; (c) PPTS, MeOH, 85% (three steps); (v) MOMCl, DIPEA, CH2Cl2, 100%; (vi) TBSCl, 
imidazole, DMF, 100%; (vii) see Table 4.3; (viii) Me2Al-N(OMe)Me, CH2Cl2, reflux, 12 h, 4.16, 73%; 4.17, 75%; 
(ix) vinyl-MgBr (2 equiv), THF, 12 h, 4.48, 94%; 4.49, 98%. 
 
The lithium-alkynide of THP-protected propargyl alcohol was alkylated with 1-bromo-3-chloro-
propane and the resultant chloride reacted with sodium cyanide in DMSO to give the alkynyl 
nitrile 4.45. Hydrolysis of the nitrile proceeded readily under basic conditions to yield the 
carboxylic acid, which was esterified with methyl iodide to yield the THP protected methyl 7-
hydroxyhept-5-ynoate. Hydrolysis of the THP protecting group proceeded cleanly in aqueous 
methanol with catalytic PPTS to deliver the desired methyl 7-hydroxyhept-5-ynoate 4.42. 
Protection under standard conditions gave the MOM or TBS ether adducts 4.43 and 4.44. The 
simultaneous nitrile hydrolysis-esterification and THP hydrolysis could be performed in a 
solution of concentrated H2SO4 and methanol to generate 4.42 in similar yields to the three step 
basic procedure but required in excess of 5 equivalents of H2SO4 with reflux for 4 days.  
 
The conversion of the internal alkyne moiety to the desired 1,3-diene system was readily 
accomplished by exposure of the alkyne to an ethylene atmosphere in the presence of Grubbs 
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catalyst 4.25. The conversion could be monitored by 1H NMR spectroscopy of sample aliquots 
by observing the disappearance of the propargyl singlet resonance, coupled with the appearance 
of the newly emergent vinylic protons. The optimisation of this reaction is detailed in Table 4.3. 
 
Table 4.3 EYCM of alkyne substrates under an ethylene atmosphere. 
RO
O
OMe RO OMe
O
Conditions
4.43
4.44
4.46
4.47= TBS
R = MOM
= TBS
R = MOM
 
Entry R Conditiona Yieldb 
1 H (4.42) Toluene, 1 atm, 4.25 (5 mol %), 80°C 0c 
2 MOM (4.43) Toluene, 1 atm, 4.25 (4 mol %), 55°C ? 80°C 86% 
3 MOM (4.43) Toluene, 1 atm, 4.25 (2 mol %), 80°C 96% 
4 TBS (4.44) Toluene, 1 atm, 4.25 (10 mol %), 80°C 87% 
5 TBS (4.44) DCE, 5.4 atm, 4.25 (2 mol %), 55°C 92% 
Note: (a) Reactions were conducted at 0.1 M in standard glassware with an ethylene filled 
balloon (pressure ~1 atm); or in a Parr benchtop Micro-reactor with internal pressure and 
temperature control (pressure >1 atm). Prior to reaction solutions were degassed and sparged 
with ethylene three times. Reactions were quenched via the addition of ethyl vinyl ether (10 
equiv). (b) Refers to chromatographically pure isolated material. (c) No reaction after 24 
hours. 
 
The initial EYCM reactions were conducted on the alkyne 4.43 in toluene, using an ethylene 
atmosphere supplied by an attached balloon (~1 atmosphere) (entry 2). No reaction was observed 
at ambient temperature. Heating to 55°C with 2 mol % 4.25 effected a clean conversion from the 
starting alkyne to the desired 1,3-diene system (4.46) over a period of 24 hours in approximately 
20% yield. Increasing the temperature to 80°C improved the conversion (~60 %), with two 
subsequent additions of 1 mol % catalyst over 24 hours achieving the complete consumption of 
the alkyne starting material. The diene system was readily isolated following evaporation of the 
solvent and purification of the crude mixture via silica column chromatography to yield 4.46 as a 
colourless oil in high yield. Under optimised conditions, the complete conversion of 4.43 to 4.46 
could be accomplished with 2 mol % 4.25 at 80°C in 6 hours, allowing the isolation of 4.46 in 
96% yield, (entry 3). The reaction of 4.44 under identical conditions gave lower rates of 
conversion (~10% with 2 mol % 4.25 at 55°C) and necessitated increased catalyst loading and 
prolonged reaction times to effect complete consumption (10 mol % 4.25 over 3 days; 5 mol % 
initially, with two subsequent additions of 2.5 mol % after 24 hour periods) (entry 4). The 
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desired 1,3-diene system 4.47 was isolated in high yield despite the prolonged reaction time. The 
unprotected alkyne did not undergo conversion, despite prolonged exposure to the metathesis 
catalyst (entry 1). 
 
The reactivity profile of the internal alkyne substrates 4.42-4.44 to enyne metathesis can be 
rationalised by comparison with the work of Mori et al. The kinetics of catalyst binding and turn-
over are known to be strongly influenced by the steric environment and chelating properties of 
groups present in the reaction substrate. The MOM-protected alkyne 4.43 displays similar 
catalyst loading requirements and time to effect complete conversion as those reported by Mori59 
and Diver61 when using catalyst 4.25 on internal alkyne substrates. The absence of EYCM 
reaction with the free alcohol 4.42 can be interpreted as due to the formation of a stable chelate 
intermediate between the propargyl alcohol and the ruthenium catalyst deactivating the catalytic 
cycle (Figure 4.6 - 4.29a). The increased steric bulk associated with the TBS protecting group of 
4.44 is presumably responsible for the diminished reactivity at the adjacent alkyne, necessitating 
prolonged reaction times and increased catalyst loading to effect the complete conversion. 
 
It was also noted that the rate of conversion was enhanced when a high surface-area to solvent 
ratio was employed. For example, a reaction utilising 15 mL of solvent proceeded more readily 
when stirred rapidly in a 100 mL reaction vessel, than in a 25 mL vessel, implying that the 
gaseous-exchange and diffusion of ethylene into the heated solvent might be a limiting factor. 
Indeed, the application of elevated ethylene pressures using a Parr high-pressure apparatus 
resulted in significant improvements to both the rate of reaction and isolated yield. Complete 
conversion of the alkyne 4.44 to the 1,3-diene 4.47 could be achieved in 92% yield, with 2 mol 
% 4.25 at 55°C, using an internal ethylene pressure of 80-85 psi in 36 hours (entry 5). The 
increased ethylene pressure and decreased temperature reflected favourably upon catalyst 
stability, enabling complete conversion to be achieved with the addition of a single charge of 
catalyst at the commencement of the reaction. 
 
With the desired 1,3-diene systems 4.46 and 4.47 in hand, the conversion of the terminal methyl 
ester to a Weinreb’s amide was investigated.  
Hydrolysis of the methyl ester under basic conditions caused concomitant decomposition of the 
diene functionality. Initial attempts to prepare the Weinreb’s amide derivative 4.17 via the 
reaction of methyl ester 4.46 with dimethylaluminium-N,O-dimethylhydroxylamine, prepared 
according to literature procedure at ambient temperature68 or 0°C,69,70 resulted in the isolation of 
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the desired amide (4.17), in conjunction with a significant number of impurities attributed to 
coupling of decomposed amine-alkylaluminate species. In order to eliminate side-product 
formation it was found necessary to prepare the amino-aluminate complex at -30°C, via the slow 
addition of trimethylaluminium to a pre-cooled slurry of the amine hydrochloride salt in 
dichloromethane, followed by warming to ambient temperature. The ester substrate was then 
added and the solution brought to reflux for 12 hours affording the desired amide materials 4.17 
and 4.18 in high yield.  
 
Addition of vinyl magnesium bromide to the diene systems 4.17 and 4.18 effected a selective 
mono-nucleophilic addition to the Weinreb’s amide functionality generating the IMDA 
homomethyl triene precursors 4.48 and 4.49 in high yield. The colourless oils, 4.48 and 4.49, 
were observed to be stable but to decompose upon prolonged standing at ambient temperature 
 
 
4.5.2 Preparation of Trienes Directed Towards the Nakafuran Precursors 
 
Examples of enyne metathesis reported to date have primarily focused on the intramolecular ring 
closing metathesis (RCEYM) and the intermolecular enyne cross-metathesis (EYCM) of 
terminal alkynes.36,56,71 In the first instance, the intramolecular nature of the RCEYM reaction 
controls the relative orientation of the alkene and alkyne functional groups achieving high regio- 
and stereocontrol in the bond reorganisation. The internal tether between the reactants results in a 
higher relative molecular concentration, whilst minimising the entropy requirements relative to 
the analogous bimolecular reaction. The intermolecular reaction (EYCM) by contrast suffers 
issues arising from both the bimolecular nature of the reaction and the formation of terminal 
alkene isomeric E/Z mixtures.72,73 The few reported examples of intermolecular EYCM of 
internal 1,2-dialkyl substituted alkynes have been restricted to symmetrical alkyne substrates or 
have utilised ethylene as an alkene. In both instances symmetry eliminates the formation or 
detection of geometrical isomers. Silyloxy- and borylated terminal alkynes, by contrast, have 
been observed to exhibit strong directing effects, delivering high regioselectivity.74,75 
 
The enyne metathesis of 4.5 utilising the symmetrical alkene ethylene results in the formation of 
the 1,3-diene 3.69 (R1 = H), which can be advanced synthetically to form the core structure 3.70 
(R1 = H). Functional modification of this bicyclic structure would lead to the florlide natural 
product family (Scheme 4.13). 
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Scheme 4.13 EYCM to generate precursors suitable to the synthesis of florlide and nakafuran 
natural products. 
 
Access to the nakafuran family requires the controlled stereochemical and regiochemical 
introduction of propene (R1 = Me) to the unsymmetrical alkyne 4.5 during an EYCM reaction. A 
number of difficulties were anticipated in such a reaction that would severely hinder the 
synthetic application (Figure 4.11).  
 
The initial [2+2] addition of the active ruthenium carbene 4.50 to the non-symmetric alkyne 4.51 
to form the ruthenacyclobutene 4.52 could be expected to be controlled by the dominant steric 
and electronic interactions of the alkene and alkyne substituents. For example, heteroatom 
coordination by a propargyl substituent (MOM, Ac) may favour formation of a chelate structure 
(4.53) which places the metal carbene complex adjacent to the chelating substituent, whereas 
non-chelating substituents may favour remote placement of the metal carbene to minimise steric 
interactions. The small steric size of the propene methyl group was predicted to provide little, if 
any, steric control on the metathesis cycle. In addition to regiochemical aspects, the relative 
orientation of the methyl group within the ruthenacyclobutene 4.52 will give rise to E/Z 
mixtures.  
Formation of di-substituted adducts may also arise due to the relative orientation of the propene 
unit upon formation of the ruthenacyclobutanes 4.54 and 4.55. Cycloreversion of 4.54 generates 
the mono-addition adducts 4.56 and 4.57 and the metal carbene 4.50, whereas 4.55 generates the 
di-substituted adduct 4.58. Subsequent CM of the adducts 4.56-4.58 may result in stereochemical 
and regiochemical scrambling. Nevertheless, it was decided to attempt such a reaction as it 
would allow rapid access to the desired diene system 4.22, which was only accessible in low 
yields via the Stille coupling previously investigated (Section 4.2.5). 
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Figure 4.11 Regio- and stereochemical adducts from the EYCM between an unsymmetric 
alkyne 4.51 and propene. 
 
In practice, the exposure of 4.44 to Grubbs catalyst 4.25 under an atmosphere of propene 
resulted in the isolation of an inseparable mixture of four isomeric diene products (Scheme 
4.14). A slight preference was observed for placement of the methyl group in the desired allylic 
β-position (R1 and R2). Presumably this is due to minimisation of the steric strain arising from 
interaction between the TBS protecting group and the bulky ruthenium metal centre. 
 
TBSO
O
OMe TBSO OMe
O
R1 R2
R4R3
4.44
(i)
 
Scheme 4.14 EYCM of 4.44 with propene. 
Reagents and yields: (i) 4.25 (4 mol %), toluene, 85°C, propene (1 atm), 48 h, 80%. Methyl position ratios: 26(R1): 
41(R2): 16(R3): 16(R4); determined via 1H NMR  integration. 
 
The poor regio- and stereocontrol observed in this reaction, accompanied by the inability to 
separate the isomers via silica flash column chromatography, meant that this synthetic route was 
not pursued further. 
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4.5.3 Attempted Enyne Metathesis Utilising Temporary Silicon Tethers 
 
An expedient solution to the lack of regiocontrol in intermolecular EYCM reactions was reported 
by Yao, who utilised the temporary silicon connection methodology devised by Stork76-78 to 
prepare a series of highly functionalised dienes through RCEYM (Figure 4.12).79,80 Treatment of 
the tethered enyne 4.59, prepared from the propargyl alcohol 4.60 and allylchlorodimethylsilane, 
with Grubbs catalyst 4.24 gave the cyclic product 4.61 in high yield. Oxidative cleavage of the 
silyl-tether using the protocol of Tamao81 gives access to the dihydroxylated diene adduct 4.62. 
Alternatively, the silyl-tethered 1,3-diene adduct 4.61 was demonstrated to be a competent 
substrate for the Diels-Alder reaction yielding a single diastereoisomer (4.63) upon reaction with 
maleimide under thermal conditions. 
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Figure 4.12 EYCM utilising a silyl tethered allyl group to establish regio- and stereocontrol. 
 
Utilising this concept, a modified RCEYM route incorporating a temporary silicon connection to 
promote formation of the desired β-regiochemistry and stereochemistry in the diene system is 
depicted in Scheme 4.15. Advancement of metathesis adduct 4.65 to a Diels-Alder triene 
precursor may readily be envisaged. A Type II IMDA cycloaddition of this substrate would 
generate the tricyclic bridgehead alkene and establish the desired stereochemistry at the C8 
position.82 Cleaving the silyl tether via reductive desilylation would liberate the desired bicyclic 
structure 4.67.79 
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Scheme 4.15 EYCM-temporary silicon tether route enabling the stereoselective installation of 
the C8 methyl. 
Reagents and yields: i) allyl-SiMe2Cl, DMAP, NEt3, 94%; (ii) 4.25 (2 mol %), DCM, 40°C, 4 h, 93%. 
  
The route depicted in Scheme 4.15 was briefly investigated via the conversion of the alkyne 4.42 
to the allyl silyl derivative 4.64 in high yield upon reaction with allylchlorodimethylsilane and 
NEt3. Exposure of the enyne 4.64 to Grubbs catalyst 4.25 (2 mol %) effected clean RCEYM to 
give the desired siloxane adduct 4.65 in high yield. 
 
In agreement with literature precedent,79,83,84 the formation of the seven-membered ring adduct 
4.66, arising via an endo mode of ring closure of the metallo-carbene intermediate 4.68 was not 
observed (Figure 4.13). 
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Figure 4.13 Preferential formation of 4.65 due to unfavourable torsional constraints and steric 
interactions associated with the formation of the endo transition state. 
 
Due to time constraints and the results described in Section 4.8 (vide infra) the advancement of 
this adduct (4.65) and the formation of the subsequent intermediates depicted in Scheme 4.15 
was not investigated further, but clearly this strategy could lead to the facile preparation of 4.67. 
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4.6 Diels-Alder Cyclisation of Homomethyl Trienes 
 
With the differentially protected triene precursors 4.48 and 4.49 in hand, the opportunity 
presented itself to investigate whether the C7-methyl extension was successful in retarding the 
Δ6,7 ? Δ7,8 olefinic migration previously observed for the 7-alkoxy triene substrates. The 
homomethyl triene substrates 4.48 and 4.49 were subjected to thermal and Lewis acid catalysed 
cyclisation conditions. Representative results are detailed in Table 4.4. 
 
Table 4.4 IMDA reactions of 4.48 and 4.49. 
H
O
RO
O
RO
Conditions
H
O
RO
4.48
4.49
R = MOM
R = TBS
4.69
4.71
4.70
4.72
 
Entry Conditionsa Yieldb,c 
1 – 4.48 Benzene (0.015 M), PS (0.3), 130°C, sealed tube, 36 h 45% (4.69) 
2 – 4.48 Benzene (0.04 M), PS (0.3), 160°C, sealed tube, 16 h 51% (4.69) 
3 – 4.48 BF3.Et2O (1 equiv), -78°C, 30 min, NaHCO3 quench C.M. 
4 – 4.48 BF3.Et2O (2 equiv), -78°C, 30 min, NaHCO3 quench C.M. 
5 – 4.48 Et2AlCl (1 equiv), CH2Cl2, 0°C, NaHCO3 quench NR 
6 – 4.48 Et2AlCl (2 equiv), CH2Cl2, 0°C, NaHCO3 quench C.M. 
7 – 4.49 Benzene (0.01 M), PS (0.25 M), sealed tube 160°C, 36 h 75% (4.71) 
8 – 4.49 Xylene (0.005 M), PS (0.25), 160°C, 40 h 78%d (4.71) 
9 – 4.49 DCE, ZnCl2.OEt2 (1 equiv), pyridine (10%), rt Dec. 
Note: (a) Reactions monitored via 1H NMR spectroscopy. Reactions in benzene at > 
80°C were conducted in Carius pressure tubes; reactions in xylene were conducted 
under an inert Ar atmosphere, using a standard reflux setup. PS = Proton-Sponge® 
(equivalents). (b) Isolated chromatographically pure material. (c) S.M. = starting 
material, C.M. = complex mixture, N.R. = No reaction. (d) Two step yield from 4.18. 
 
The thermally initiated IMDA reaction of 4.48 in the presence of 0.3 equivalents of Proton-
sponge® resulted in clean conversion to a single product (entry 1). 1H NMR spectroscopy of the 
isolated adduct (Figure 4.14-B) indicated a number of promising aspects when compared to the 
starting triene material (Figure 4.14-A). Elevation of the temperature from 130°C to 160°C 
decreased the time required for complete consumption of the stating materials from 36 to 16 
hours (entry 2).  
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Figure 4.14 500 MHz 1H NMR spectra of triene 4.48 (A) and IMDA adduct 4.69 (B); 
(* = residual water in CDCl3 NMR solvent). 
 
The proton signals from δH 5.00-6.37, correlating to the vinylic 1,3-diene and the enone system, 
and the clearly resolved quintet at δH 1.80 and triplets at δH 2.30 and δH 2.60, arising from the 
three carbon tether, had disappeared. They had been replaced by a number of heavily coupled, 
but resolvable, aliphatic signals from δH 1.38-2.93. Additionally, the allylic CH2 and methoxy-
methyl signals, previously present as singlets at δH 4.22 and δH 4.65 in the triene material 4.48 
(spectrum A) had been split into two pairs of doublets centred at δH 3.97 and δH 4.55 respectively 
(spectrum B). This evidence pointed towards the successful cyclisation of 4.48 to generate the 
IMDA adduct 4.69. The increased 1H NMR spectral complexity and the resolution of individual 
diastereotopic hydrogen, upon forming a bicyclo[4.3.1]decane ring system, had previously been 
observed in the analogous cyclisation of 1.69 to form the methoxy-IMDA derivatives 1.68 and 
3.55. 
Importantly, the spectrum lacked a vinylic proton signal that would arise following a Δ6,7 ? Δ7,8 
isomerisation to the non-bridgehead adduct 4.70. The proposed assignment was subsequently 
confirmed by subjecting 4.69 to a full range of one and two-dimensional NMR spectroscopic 
experiments. 
 
The cycloaddition reactions of 4.48 conducted in the presence of the Lewis acid catalysts 
BF3.Et2O or Et2AlCl were dominated by complex decomposition products and exhibited 
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evidence of Δ6,7 ? Δ7,8 olefinic isomerisation. The use of two equivalents of BF3.Et2O resulted in 
the predominant decomposition of the triene starting material, with trace evidence of only the 
Δ7,8 cycloadduct 4.70 in the crude reaction mixture. The application of one equivalent of Et2AlCl 
was ineffective in catalysing the IMDA reaction at 0°C, whereas two equivalents resulted in the 
generation of both the Δ6,7 and Δ7,8 cycloadducts in trace quantities dominated by decomposition 
products. Consequently, investigation of the IMDA reaction of the homomethyl analogues were 
restricted to thermally initiated conditions. This is in agreement with the work of Shea et al. 
where vinyl substituted diene system displayed noted sensitivity to Lewis acid catalysts, 
resulting in diminished yields relative to the thermally initiated conditions.85 
 
Subjection of the TBS protected triene 4.49 to thermal cyclisation conditions was also successful 
in bringing about the desired IMDA reaction in good yield (entry 7). No material arising from 
bridgehead olefinic migration was observed. The IMDA cyclisation could be successfully 
scaled-up from ~100 mg (employing benzene in a Carius resealable pressure tube) to 5 g (0.015 
mol) utilising refluxing xylene at atmosphere pressure without a loss in isolated yield (entry 8).  
The slow addition of the triene 4.49 over 8 hours, using a syringe pump, into a dilute (0.005 M) 
solution of refluxing xylene was found to eliminate a minor impurity (~2-5%) arising from 
intermolecular dimerisation. 
 
The cyclisation of 4.49 under the mild Lewis acid conditions described by Fukuyama for the 
preparation of the phomoidride core86 was very slow, with competing reactions such as enone 
decomposition and dimerisation dominating the reaction products (entry 9). 
 
The successful thermally initiated IMDA cyclisation of the homomethyl trienes 4.48 and 4.49, 
without observable double bond isomerisation is significant. It supports the hypothesis that the 
C7 ether functionality was a significant factor contributing to the Δ6,7 ? Δ7,8 olefinic 
isomerisation previously observed for 1.69 and 1.80. The improved stability of the Δ6,7 IMDA 
adducts 4.69 and 4.71 is further illustrated by the fact that these reactions were conducted 
chronologically before the importance of the purity and requirement for greater than 
stoichiometric quantities of Proton-sponge® was fully appreciated. The reactions were 
performed with only 0.25 or 0.3 equivalent of the ‘old’ Proton-sponge®; conditions which had 
been demonstrated as ineffective in retarding the double bond isomerisation in the C7 alkylethers 
1.68 and 1.79. Furthermore, an aqueous acidic wash (0.05 M HCl) facilitated the removal of 
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residual Proton-sponge® from the crude reaction mixture without initiating the double bond 
migration previously observed. 
 
 
4.7 Cyclopropanation Studies 
 
As discussed in Scheme 4.2, the use of a C7-homomethyl adduct requires modification of the 
fragmentation route employed to generate the desired C6 quaternary methyl group and the C7 
exo-methylene group. Specifically, it was envisaged that installation of the bridgehead 
cyclopropane 4.74 would be guided by the allyl alcohol functionality of 4.73. Subsequent radical 
fragmentation of the cyclopropane moiety, initiated at the homomethyl functional group, would 
simultaneously establish the C6-methyl group and the C7 double bond to deliver 4.76 (Scheme 
4.16). 
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Scheme 4.16 Allyl directed cyclopropanation and subsequent ring fragmentation. 
 
4.7.1 Cyclopropanation of Methoxy-Methyl Adduct 4.69 
 
Removal of the MOM protecting group from the IMDA adduct 4.69 prior to cyclopropanation 
proved problematic. Common literature methods employing acidic reagents, such as catalytic 
concentrated HCl in MeOH; p-TsOH in t-BuOH or CBr4 in i-PrOH87 did not effect cleavage at 
ambient temperature. Increasing the reaction temperature or the proportion of acidic reagent 
resulted in slow consumption of the MOM adduct 4.69, but generated considerable 
decomposition including double bond isomerisation, as assessed by the appearance of vinylic 
signals attributable to a C8 vinyl proton. The use of alkyl-thiols in conjunction with magnesium 
bromide was reported by Lee and co-workers to effect the cleavage of MOM and MEM ethers 
under mild non-acidic conditions.88 The reported conditions of 2.5 equivalents of ethanethiol and 
3 equivalents of MgBr2 in diethyl ether at room temperature were unsuccessful in achieving the 
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desired hydrolysis. The use of excess reagent (15 equivalents) resulted in MOM ether cleavage 
with the generation of unidentified decomposition products. 
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Figure 4.15 Attempted deprotection of the MOM ether 4.69. 
 
Due to the difficulties described in the preceding deprotection step, cyclopropanation studies 
were performed on the MOM protected IMDA adduct 4.69. Furukawa’s reagent, 
bis(iodomethyl)zinc (3.81), generated in-situ from diethylzinc and diiodomethane, was used 
under an atmosphere of oxygen to cyclopropanate the bridgehead olefin.89-91 Although no 
reaction was observed with 2 equivalents of this cyclopropanation reagent, the use of 3 
equivalents resulted in consumption of the starting material and led to the isolation of two 
products in high yield in a 1:1 ratio. The isolated adducts were identified as the desired 
bridgehead cyclopropane adduct 4.77 and a product arising from bridgehead cyclopropanation 
and exo-methylene replacement of the C2 ketone 4.78 (Scheme 4.17). Reducing the amount of 
cyclopropanating reagent resulted only in diminished rates of conversion, whilst delivering 4.77 
and 4.78 in a similar ratio (~1:1), indicating that cyclopropanation and exo-methylene formation 
were on a competitive time scale. 
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Scheme 4.17 Cyclopropanation of 4.69 using the Furukawa reagent. 
Reagents and yields: (i) Et2Zn (3 equiv), CH2I2 (6 equiv), toluene, O2, 40°C, 4.77 42%, 4.78 49%. 
 
Prior observation of exo-methylene formation mediated by Furukawa’s reagent is, to the author’s 
knowledge, unknown. Related gem-dimetallic species have been reported as effective 
methylenation reagents of enolisable ketones, including the Takai olefination, Oshima-Lombardo 
reaction and Nysted reagent (Figure 4.16).92 To achieve high synthetic yields the gem-dimetallic 
methylene reagent is usually further activated by the addition of a Lewis acid, commonly TiCl4, 
which increases the nucleophilicity of the methylene carbon favouring attack and exo-methylene 
formation at carbonyl centres.93 In contrast, the Furukawa reagent, postulated to be the 
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bis(iodomethyl)zinc species 3.81, is anticipated to display electrophilic properties, favouring 
cyclopropanation of olefinic bonds. 
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Figure 4.16 (i) Carbonyl olefination reagents and comparison of the active methylene centre in 
the (ii) Takai methylenation reagent and (iii) Furukawa cyclopropanating reagent.  
 
Fried et al. reported an example of exo-methylene formation during the attempted Simmons-
Smith cyclopropanation of the β-hydroxy-estren-3-one 4.80.94,95 Methylenation of the C3 
carbonyl to form 4.81 was observed when 4.80 was refluxed in ether with a large excess of zinc-
copper couple and diiodomethane. The proposed mechanism for this transformation featured 
chelation of the bis(iodozinc)methylene reagent 4.82 to the 11β-hydroxyl group, temporarily 
tethering the methylene reagent within bonding distance of the C3 carbonyl (4.83), from where 
nucleophilic attack and oxide elimination generated the exo-methylene group. In contrast, the 
reagent I-Zn-CH2I (4.84), prepared with one equivalent of Zn in excess CH2I2, afforded the 
angular methylation product 4.85, via a postulated Δ3,5(10)-dienol (4.86) formed by Lewis acids 
present in solution (Figure 4.17). 
 
Matsubara et al. subsequently demonstrated both the generality of this reaction and the 
importance of the intramolecular heteroatom coordination in achieving exo-methylene 
formation.96-98 
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Figure 4.17 Observation of exo-methylene formation on β-hydroxy-steroids by Fried et al. 
Reagents and conditions: (i) Zn-Cu couple, CH2I2, ether, reflux, 4 h, then addition of 4.80; (ii) Zn-Cu couple, ether, 
addition of 4.80 in CH2I2 over 1 h at reflux. 
 
Inspection of the geometry of the cyclopropanated adduct 4.77 reveals that the allylic alcohol 
methoxy-methyl protecting group displays considerable flexibility in orientation, having the 
potential to exist in close proximity to the concave face of the C2 carbonyl. Chelation of the 
dialkylzinc to the ether oxygens forms an intermediate (4.87) in which the tethered zinc 
methylene reagent may be assisted to undergo a nucleophilic attack at the C2 carbonyl. 
Subsequent oxide elimination yields the exo-methylene group observed in 4.78 (Figure 4.18).  
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Figure 4.18 MOM coordination of the zinc methylenating reagent and directed exo-methylene 
formation from the concave face. 
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Although the reaction was conducted using the Furukawa cyclopropanating reagent 3.81, it is 
plausible that the active olefination species could be either the methoxy-methyl ether coordinated 
to a dialkyl zinc (3.81)or a geminal dizinc species (4.82) generated via a Schlenk equilibrium. 
 
The role of the allylic MOM group in promoting the methylenation of the C2 ketone is supported 
by a number of observations. No C2 olefination products were observed with the free alcohol or 
TBS protected alcohol, indicating the potential importance of chelation of the organozinc species 
(vide infra). Additionally, no product arising from the exclusive methylenation of the C2 ketone 
in the absence of C6-C7 olefin cyclopropanation was observed, perhaps indicating that the 
spatial orientation of the chelated-zinc reagent relative to the carbonyl group (4.87) was only 
obtained upon conversion of C7 from an sp2 to an sp3 centre via cyclopropanation. 
The moderate yields of 4.77 coupled with the difficulty in removing the MOM protecting group 
from either the Δ6,7-olefinic adduct 4.69 or the cyclopropanated adduct 4.77 lead to investigation 
of the TBS analogue. 
 
4.7.2 Cyclopropanation of TBS-Protected IMDA Adduct 4.71  
 
Concern about the potential for Δ6,7 ? Δ7,8 olefinic isomerisation observed when attempting to 
remove the MOM protecting group, saw cyclopropanation attempts focus on the TBS protected 
species 4.71. 
 
Furukawa conditions were not successful in introducing the cyclopropane functionality to 4.71 
even with excess reagent and prolonged heating. Low conversion was observed, accompanied by 
significant decomposition as determined by the appearance of new allylic CH2 peaks in the 1H 
NMR spectrum. A number of modifications reported to accelerate the cyclopropanation reaction 
were also ineffective.99,100 
 
Modified Simmons-Smith conditions, comprising the slow addition of diiodomethane to a 
sonicated solution of the olefin 4.71 and activated metallic zinc (admixed with 2% cuprous 
chloride) in ether resulted in a slow reaction to give complete conversion in 12 hours, as assessed 
by 1H NMR analysis (Scheme 4.18).101 Disappointingly however, the isolated yield was only 
37%, which dropped precipitously on scale-up to 12%. 
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Scheme 4.18 Cyclopropanation of 4.71 under modified Simmons-Smith conditions. 
Reagents and yields: (i) Zn (20 equiv), CuCl (2 mol %), ether, sonication, 35°C; addition of CH2I2 (10 equiv over 8 
h), 37%. 
 
Presumably steric hindrance by the TBS protecting group is responsible for the poor reactivity 
and slow rate of cyclopropanation of the allylic double bond; with adsorption of the adduct 4.89 
onto the excess zinc reagent responsible for the low isolated yields. Removal of the TBS 
protecting group was expected to eliminate the steric obstruction and provide an allylic alcohol 
to act as a directing group. 
 
4.7.3 Allylic Alcohol Directed Cyclopropanation 
 
The use of allylic alcohols to achieve stereoselective and asymmetric cyclopropanation has been 
extensively investigated.89,102,103 It is postulated that prior coordination of the zinc reagent to the 
allylic hydroxyl group facilitates stereoselective facial addition of the methylene reagent to the 
neighbouring alkene via a concerted [2+1] mechanism (4.90). This interaction promotes both the 
rate of reaction and controls the stereochemistry of the product to deliver predominantly syn 
orientated adducts (Figure 4.19). Protection of the allylic alcohol diminishes the directing ability 
and for sufficiently bulky substituents (TBS) results in reversal of the stereochemistry due to 
steric effects. 
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Figure 4.19 Stereoselectivity of cyclopropanation due to allylic alcohol directing effects. 
 
The deprotection of 4.71 to reveal the free hydroxyl Δ6,7-olefin adduct 4.73 was readily achieved 
with TBAF in THF. No double bond migration was observed. However attempted 
cyclopropanation of 4.73, using a number of synthetic protocols including modified Simmons-
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Smith protocols (Zn/CuCl/CH2I2 under reflux or sonication; Zn-Ag couple),99 Furukawa 
conditions (ZnEt2/CH2I2)90 and modified zinc carbenoids (ZnEt2/CH2I2/TFA;100 
ZnEt2/CH2I2/2,4,6-trichlorophenol104) were ineffective in achieving useful synthetic yields. 
 
After extensive investigation success was achieved using the modification reported by Charette 
et al., involving the pre-chelation of diethylzinc to dimethoxyethane (c.f. 4.87) with subsequent 
CH2I2 addition generating the complex Zn(CH2I)2.DME (4.91) (Scheme 4.19-A).105,106 This 
reagent resulted in clean cyclopropanation of 4.73 in 4 hours at room temperature to yield the 
desired cyclopropanated adduct 4.92 in 73% yield, accompanied by the methyl ether (4.93), 
which was produced in 13% yield and must arise from methylation of the allylic alcohol 
(Scheme 4.19-B). 
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Scheme 4.19 (A) Preparation of DME.Zn(CH2I)2 complex 4.91; (B) Deprotection and 
cyclopropanation to generated 4.92. 
Regents and Yields: (i) TBAF, THF, 0°C ? rt, 80%; (ii) 2 equiv Zn(CH2I)2.DME, CH2Cl2, -15°C ? rt, 4 h, 73% 
4.92; 13% 4.93. 
 
 
4.8 Cyclopropylcarbinyl Radical Ring Fragmentations  
 
As detailed in Scheme 4.2, the fragmentation of the newly installed Δ6,7 cyclopropane ring via a 
cyclopropylcarbinyl radical required the functionalisation of the C7 homomethyl alcohol. The 
approach pursued involved generating a primary radical via the deoxygenative-fragmentation of 
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an S-methyl dithiocarbonate (xanthate ester) under free radical conditions as devised by Barton 
and McCombie.107-109 
 
Fragmentation of cyclopropylcarbinyl radical systems via a homoallyl-type rearrangement is 
known to be a facile process, with the release of bond strain providing a thermodynamic driving 
force for the rearrangement.110 The kinetics of prototypical systems have been studied by many 
research groups111,112 and synthetic applications have been found in ring expansion, ring opening 
and annulation reactions.113 
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Figure 4.20 Radical fragmentation of prototypical homomethyl-cyclopropanes. Kinetic rates for 
reactions conducted at 25°C. 
 
The radical fragmentation pathway for a prototypical homomethyl-cyclopropane 4.94 (R = H) is 
depicted in Figure 4.20. Initiation of fragmentation begins with the homolytic generation of a 
radical at the C1 position (4.95) which can undergo fragmentation of either bond a (C2-C4) or 
bond b (C2-C3) generating a homoallyl radical 4.96, which is reduced to 4.97 via hydrogen 
abstraction. 
 
Substitution of the cyclopropane skeleton (R ≠ H) renders the bond cleavage non-equivalent, 
generating the regioisomeric products 4.98a and 4.98b. The nature of the substituents can have a 
large effect on the absolute and relative rates of cleavage of either the a or b bond and 
consequently on the preferred regiochemistry of opening. 
 
With respect to 4.92, two potential non-equivalent fragmentation routes exist for the primary 
cyclopropylcarbinyl radical 4.100, generated via radical deoxygenation of the xanthate ester 
4.99. Path A features C7-C13 cyclopropane bond homolysis, exo to the cyclohexane ring, to 
generate a primary radical centred at C13 (4.101). Radical hydrogen abstraction delivers the 
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desired C6 bridgehead methyl group 4.102 observed in the target structure 1.22 and 1.73. Path B, 
in contrast, fragments the internal C6-C7 bond to form a C6-centred tertiary radical (4.103), 
which gives the seven-membered ring expanded product 4.104 upon reduction (Scheme 4.20). 
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Scheme 4.20 Radical fragmentation pathways for xanthate ester 4.99. 
Reagents and yields: (i) NaH; CS2; MeI, 74%; (ii) R3SnH, initiator. 
 
The preferential generation of 4.102 or 4.104 will depend upon the relative bond fragmentation 
rates of the cyclopropylcarbinyl radical 4.100 and the stability of the generated radicals and 
reduced adducts.  
 
4.8.1 Xanthate Functionalised Cyclopropane Ring Fragmentation 
 
The xanthate functional group was introduced to the allylic position of 4.92 in good yield via 
sequential reaction with sodium hydride, dimethyl sulfide and quenching with methyl iodide, to 
generate the S-methyl dithiocarbonate 4.99 as a yellow oil (Scheme 4.20). 
 
Radical deoxygenation conducted under thermally initiated fragmentation conditions (Bu3SnH, 
AIBN, benzene, reflux, 2 h) resulted in the conversion of the xanthate material into two products, 
both of which displayed an exocyclic methylene group, in a ratio of 5:1. 
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Initial attempts to determine the structure of the isolated species via 1D and 2D NMR correlation 
spectroscopy were hampered by the co-elution of stannane residues and volatility of the 
compounds. Inclusion of a reduction step prior to work-up generated the C2 secondary alcohol 
which was of diminished volatility and allowed separation of two major products from the co-
eluting stannane residues. Based on the established work of Shea et al., who demonstrated that 
reduction of related bicyclic ketones affords predominantly the stereoisomer whereby reduction 
takes place from the beta-face,85 it was initially presumed that these reduced adducts were 4.105 
and 4.106 (Scheme 4.21). 
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Scheme 4.21 Xanthate radical fragmentation under thermal conditions. 
Reagents and yields: (i) (a) Bu3SnH, AIBN, 80°C, 2 h; (b) DIBAL-H, toluene, -78°C, 1 h, 4.106 63%, 4.107 13%; 
(ii) 3,5-dinitrobenzoyl-Cl, DMAP, NEt3, 54%, (iii) PDC (2 equiv), CH2Cl2, quantitative. 
 
Structural assignment of the two alcohol products via 2D NMR spectroscopic techniques was 
unsuccessful due to considerable overlap of the diastereotopic proton signals in the 1H NMR 
spectra. Previously distinct 1H NMR resonances due to the conformational rigidity of the 
cyclopropyl-bicyclic ring system, or as a result of proximity to the carbonyl functionality, were 
lost upon radical fragmentation and reduction. However, a crystal structure was successfully 
obtained of the major product, following condensation of 4.106 with 3,5-dinitrobenzoyl chloride. 
This allowed unambiguous assignment of 4.108 as the seven-membered ring expanded product 
(Figure 4.21). 
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Figure 4.21a  Crystallographic structure determined for the fragmentation adduct 4.108 [P-1, Z 
= 2, R = 3.4%]. 
 
Figure 4.21b The bicyclo[4.4.1]undecanone carbocyclic core, illustrating reduction of the C2 
ketone from the less sterically hindered convex face. The crystallisation group (DNB) has been 
removed for clarity. 
 
Efforts to obtain a suitable single crystal of the minor product for use in X-ray crystal analysis 
were unsuccessful, with the DNB-adduct instead obtained as an oil under a number of 
crystallisation procedures. Oxidation of the minor alcohol product with PDC in CH2Cl2 
generated the ring expanded adduct (4.104) in quantitative yield. This demonstrated that the 
reduction had resulted in the isolation of the two diastereomeric alcohols, 4.106 and 4.107, both 
of which contained the bicyclo[4.4.1]undecanone core, rather than the desired 
bicyclo[4.3.1]decanone core. The presumed exocyclic ring cleavage adducts 4.102 and 4.105 
could not be isolated in sufficient purity to allow comprehensive spectroscopic analysis. 
 
Disappointingly, with the crystal structure of the major adduct in hand, it was apparent that the 
radical fragmentation had proceeded predominantly with scission of the C6-C7 endo bond 
(4.103) rather than the desired C7-C13 exo bond (4.101). This unexpected setback necessitated 
the further investigation of this fragmentation in an effort to enhance the formation of the desired 
bridgehead methyl adduct 4.102. 
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4.8.2 Prior Literature Fragmentation Studies 
 
Although cyclopropyl ring opening is well understood for simple substituted monocyclic systems 
such as 4.94, incorporation into a bicyclo[n.1.0] framework introduces factors of increased 
conformational rigidity, ring strain and different rates of ring opening and reclosure.114-116 The 
literature on radical cyclopropane ring cleavage reveals a preference for exocyclic opening upon 
kinetic (n = 3-6) and thermodynamic grounds (n = 4-6) which contrasts with the cationic 
preference for endocyclic ring opening.116,117 However, most of these studies have been based 
upon systems in which the generated radical is located within the carbocyclic ring system. 
 
4.8.2.1 Synthetic Examination of Cyclopropylcarbinyl Fragmentation 
 
(i) Kurth 
The preferential formation of the ring-expanded product 4.104, via an endocyclic radical 
fragmentation, can be put in context by consideration of the research conducted by Kurth et al., 
who had reported that variable distributions of six- and seven-membered ring systems were 
generated upon fragmentation of 1-bicyclo[4.1.0]heptanylmethyl radicals (4.109) (Figure 
4.22).118 
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Figure 4.22 Fragmentation of cyclopropylcarbinyl xanthates fused to a cyclohexane core. 
 
Fragmentation of cyclopropane species 4.110a at 150°C, with [0.4 M] Bu3SnH as a reducing 
agent, resulted in a 1:1 ratio of adducts 4.113 and 4.114. Preferential kinetic formation of the 
ring expanded secondary radical 4.112 was observed by increasing the concentration of Bu3SnH, 
from [0.4 M] to ≥ [0.8 M] which resulted in the near exclusive formation of 4.114 (>95:5). 
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Interestingly, the preferred fragmentation pathway for the cyclopropylcarbinyl radical 4.109 
could be influenced by substituents and geometrical constraints imposed on the cyclohexane 
ring. 1,3-Dioxolane 4.110b formed a mixture of 4.113 and 4.114 (57:43) at high reducing agent 
concentrations, (Bu3SnH = [0.43 M]), but displayed a preference for 4.113 (68:32) at low 
hydride concentrations, (Bu3SnH = [0.05 M]). 
 
Kurth et al. subsequently examined the cyclopropylcarbinyl radical system 4.116 to determine 
both the rate constants for the cyclopropylcarbinyl rearrangement and conducted theoretical 
calculations on the preferred transition state and intermediate radical structure.119 
 
Kinetic analysis was conducted upon the fragmentation of 4.116, derived from the photolytic 
cleavage of N-hydroxypyridine-2-(1H)-thione homomethyl cyclopropyl ester 4.117 in the 
presence of either tributyltin hydride or thiophenol as a reducing agent over a range of 
temperatures (-75°C to +59°C) (Figure 4.23).120 At all temperatures, the 3-methylenecycloheptyl 
radical 4.119 was formed 3.2-3.8 times faster than the non-expanded 2-methylenecyclohexyl-1-
methyl 4.118. A slight equilibration of the primary 4.118 and secondary radical 4.119 was 
observed by restricting the reducing agent concentration.  
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Figure 4.23 Endo- and exocyclic cyclopropylcarbinyl radical fragmentation. 
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(ii) Motherwell and Clive 
It is perhaps pertinent at this point to contrast the work of Kurth et al,. which focused on the 
fragmentation of 1-bicyclo[4.1.0]heptanylmethyl radicals (4.116), with that of Motherwell et 
al.114,116,121 and Clive et al.117 who have investigated the fragmentation of 6-bicyclo[4.1.0]-
heptanyl radicals (4.122). In the first instance, the incipient radical is exo to the bicyclic ring 
system (4.116) whereas in the second, the radical centre is embedded within the bicyclo[n.1.0] 
system (4.122) (Figure 4.24).  
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Figure 4.24 1-Bicyclo[4.1.0]heptanylmethyl radical 4.116 and 2-bicyclo[4.1.0]heptanyl radical 
4.122. 
 
In cases such as 4.123, an example of the radical system 4.122, restricted rotation of the C1-C2 
bond due to conformational rigidity and ring strain causes a strong stereoelectronic preference 
for exocyclic ring opening generating the product 4.124 exclusively (Figure 4.25).117,122  
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Figure 4.25 Exocyclic fragmentation of ring centred radical. 
Reagents and yields: (i) (a) Me2S=CHCO2Et, 73%; (b) NaBH4, CeCl3.7H2O, MeOH, 85%; (c) Bu3P, PhSeCN, 80%; 
(ii) Bu3SnH, AIBN, benzene, 92%. 
 
This obviously contrasts with the radical structure 4.116 in which rotation of the C1 radical-
bearing centre allows overlap of the SOMO with either the C2-C3 or C2-C4 β-cyclopropyl 
bonds; allowing access to both homoallylic 4.118 and 4.119 radical fragmentation routes. 
 
(iii) Prunet 
Prunet and colleagues made use of a cyclopropylcarbinyl rearrangement during synthetic studies 
directed towards the C15-C25 spiroketal subunit of bafilomycin A1.123 Barton-McCombie radical 
deoxygenation of 4.125 proceeded readily to furnish the exocyclic vinyl derivative 4.126 with no 
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detectable trace of the corresponding ring expanded product. Due to a facile endocyclic double 
bond migration, the crude material was submitted to a hydroboration-oxidation protocol to 
generate spirocyclic alcohol 4.127 as a single diastereoisomer in high yield (Figure 4.26). In this 
instance the tetrahydropyran ring oxygen may play a significant role in determining the dominant 
stereoelectronic effect in radical fragmentation. 
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Figure 4.26 Cyclopropylcarbinyl cleavage to stereoselectively establish an exo-methyl group. 
Reagents and yields: (i) Bu3SnH, AIBN, toluene, reflux; (ii) BH3.THF; H2O2, NaOH; 85% two steps. 
 
4.8.2.2 Theoretical Examination of Cyclopropylcarbinyl Fragmentation 
 
The opening of conformationally unrestricted cyclopropylcarbinyl systems (4.94) has been 
investigated in the context of radical clocks in mechanistic studies124 and in preparative 
chemistry.113 
A qualitative interpretation of the preferred regiochemistry of opening is provided by frontier 
molecular orbital theory. The SOMO p-orbitals of the cyclopropylcarbinyl radical, through 
rotation of the C1-C2 bond, preferentially interact with the vicinal cyclopropyl LUMO σ-bond 
which achieves the best overlap and allows the greatest stabilising radical delocalisation into the 
cyclopropane ring.125 The nature of the substitution pattern, in conjunction with steric effects, 
allows stereoelectronic differentiation between the two cyclopropyl bonds resulting in a 
preferential regioselective cleavage.126-128 
 
However, a priori prediction of product distributions arising from conformationally restricted 
cyclopropylcarbinyl systems is not a trivial matter. The number of influencing variables, such as 
(i) primary, secondary or tertiary radical character, (ii) substituent stabilisation, (iii) relief of 
strain derived from eclipsing interactions and (iv) the preferred orientation and overlap of the 
radical SOMO with the β-cyclopropyl exo or endo bond, often mean that no specific factor can 
be isolated as the dominant effect.  
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Theoretical examination of the radical system 4.116 by Kurth et al. using PMP4/6-31G*//HF/6-
31G* level of theory to correlate stereoelectronic variables with the observed rearrangement of 
cyclopropylcarbinyl radical 4.116 to 4.118 and 4.119 were essentially inconclusive.119 Although 
the origins of the regioselectivity remained obscure, the results derived from these calculations 
suggested formation of 4.121 was favoured both thermodynamically by ~1-2 kcal mol-1 and 
kinetically by ~3.0 kcal mol-1 for all levels of theory. It was postulated that the formation of 
4.119 was favoured primarily due to the reduction of eclipsing interactions in the transition state 
between the cyclopropyl substituents and due to thermodynamic stabilisation associated with the 
formation of a secondary radical centre from the primary incipient radical. 
 
The Kurth studies emphasised the importance of accurate conformational analysis when 
endeavouring to predict the product distributions arising from conformationally restricted 
cyclopropylcarbinyl radicals. As such the radical fragmentation of 4.99 bears significant 
structural differences. 
Firstly, although the radical fragmentation of 4.99 generates a 1-bicyclo[4.1.0]-heptanylmethyl 
radical (4.116), the fusion of this moiety within a second bicyclic ring could be expected to 
significantly influence the conformation of the incipient radical, the relative alignment of the 
SOMO orbital and the stability of the reduced product (c.f. 4.110a vs. 4.110b). 
Secondly, whereas the radical intermediate derived from an endocyclic cleavage in the Kurth 
studies (4.119) is of secondary nature, the product of an endocyclic cleavage of 4.100 is a tertiary 
radical. The stabilisation of the radical 4.103 (derived from an endo primary ? tertiary 
rearrangement) could be anticipated to provide a significant thermodynamic advantage compared 
to the primary ? primary radical transition associated with exocyclic fragmentation to yield 
4.101. 
 
4.8.3 Theoretical Investigation of the Cyclopropyl Fragmentation of 4.99  
 
The preference of 4.99 for endo or exo bond cleavage, leading to cycloheptyl ring expansion or 
C6 bridgehead methyl formation respectively, was further investigated both theoretically and 
synthetically. 
 
Preliminary semi-empirical and HF/6-31G* theoretical calculations were conducted with Spartan 
software to investigate the orientation of the C12 methyl radical relative to the cyclopropane ring 
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and to determine the extent of hyperconjugation of the radical centre into the cyclopropane ring 
system (Table 4.5). 
 
Table 4.5 Selected electron spin-density overlap values for 4.100.  
O
6
7
8
13 5
10
9
12
 
Position C12 C7 C6 C8 C13 C5 C9 C10 
Spin Density 1.0732 -0.1401 0.0988 0.0133 0.0711 -0.0064 0.0037 0.0060 
 
As can be observed, partial spin hyperconjugation has occurred from the incipient C12 methyl 
radical into the adjacent quaternary C7 centre, with subsequent delocalisation occurring 
predominantly into the cyclopropane structure (C6, C13) as opposed to the cyclohexane ring 
(C8). The attenuation of spin character is then rapid (C5, C9, C10 vs C8, C13, C6). In agreement 
with the modelling studies of Kurth, greater spin delocalisation can be observed at C6, favouring 
formation of the tertiary radical and the ring-expanded seven-membered adduct, than into the 
C13 bond which would favour the desired six membered ring. Inspection of the energy 
minimised conformation of 4.100 shows a partial twisting of the C12 SOMO towards the C6-C7 
bond (9.6°), indicating the potential for preferential overlap. 
However, a caveat should be noted, that the relative orbital-alignment of the SOMO will be more 
important for a transition state that is more ‘reactant-like’, whereas radical stability and 
conformational strain will contribute more significantly if the transition state is more ‘product-
like’ when determining the product distributions of rearrangement.129 
 
4.8.4 Synthetic Investigation of Cyclopropyl Fragmentation of 4.99 
 
The Preferential fragmentation of 4.99 to generate the seven-membered ring adduct 4.104 was an 
unexpected difficulty arising from adopting a homomethyl cyclopropane strategy. It was hoped 
that modification of the reaction conditions, reagents or substrates might sufficiently shift the 
ratio to favour generation of the six-membered ring 4.102 in a synthetically useful fashion. 
Efforts directed towards this approach are displayed in Table 4.6. 
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Table 4.6 Radical fragmentation conditions. 
O
OMeS
S
OO
4.99 4.102 4.104  
Entry Substrate Reagent Conditionsa, 
Ratio 
(4.102:4.104) 
kHc 
1 4.99 n-Bu3SnH (3) AIBN, benzene 1 : 4 7.4 x 105 
2 4.99 Ph3SnH (3) AIBN, benzene 0 : 1 3.1 x 106 
3 4.99 Me3SnH (6) AIBN, benzene 0 : 1 2.9 x 105 
4 4.99 Et3SiH (3) AIBN, benzene n.r. 5.2 x 103 
5 4.99 Et3SiH (solvent) Benzoyl peroxide 0 : 1  
6 4. 99 Et3SiH (solvent) 
Benzoyl peroxide, 
dodecanethiol 
1:4  
7 4. 99 n-Bu3SnH (3) BEt3, tolueneb 1 : 4  
8 4. 99 n-Bu3SnH (3) BEt3, MeOHb n.r  
9 4. 99 n-Bu3SnH (3) BEt3, THF b 0 : 1  
10 4. 99 n-Bu3SnH (3) BEt3, hexaneb 0 : 1  
11 4.134α n-Bu3SnH (3) AIBN, benzene 0 : 1  
12 4.134β n-Bu3SnH (3) AIBN, benzene 0 : 1  
Note: (a) Reactions performed by combining the xanthate (1 equiv), hydride (3 equiv) and radical 
initiator (0.1 equiv) in the stated solvent at room temperature and heating to reflux. Monitored via 
TLC. (b) Conducted at -78°C with addition of (0.1 equiv) of BEt3 and then portionwise addition of dry 
air over 1 h whilst allowing to warm to room temperature. (c) Literature values for the rate of hydrogen 
abstraction from the hydrogen source by the t-Bu radical in cyclohexane at 25°C.130 
 
a) Hydrogen Donor Source (Entries 1-6) 
To promote reduction of the primary radical 4.101, in preference to the sterically hindered 
tertiary radical 4.103, the use of sterically demanding hydride reagents was investigated.131 
Barton-McCombie radical deoxygenation conducted under thermal conditions utilising 
triphenyltin hydride, tri-n-butyltin hydride, trimethyltin hydride or triethylsilane gave differing 
results. 
 
Radical fragmentation conducted with tributyltin hydride as a reducing agent resulted in a 1:4 
mixture of the adduct 4.102 to 4.104 (entry 1), whereas the use of both sterically demanding 
(entry 2) and a non-demanding hydrogen sources (entry 3) resulted in the exclusive formation of 
the seven-membered ring. Two factors may account for this observed bimodal reactivity. The 
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rate of radical hydrogen abstraction from the trialkyltin hydrides increases by a factor of ten 
along the series Me3SnH < n-Bu3SnH < Ph3SnH (see the values of kH in Table 4.6), whilst the 
steric bulk also increases over this range.130 Calculations by Kurth and colleagues, based on 
kinetic data, have indicated that the rate constants for the homoallyl ? cyclopropylcarbinyl 
radical rearrangements (4.118 and 4.119 to 4.116) are in the order of 6 x 106 to 9.6 x 106 s-1. As 
such, it is possible that thermolysis in the presence of Ph3SnH results in a rapid trapping of the 
kinetic product 4.104 without equilibration of the radical intermediates 4.101 and 4.103. In 
contrast, the small steric bulk of Me3SnH allows close approach of the hydride to the tertiary 
radical centre of 4.103, resulting in rapid reduction and ring expansion. n-Bu3SnH, which is of 
moderate steric hindrance and has a rate of radical hydrogen abstraction of a similar order to the 
rearrangement processes, allows equilibration of the radical intermediates 4.101 and 4.103 
resulting in the isolation of a mixture of reduced products. 
 
To investigate whether equilibration of the primary radical (4.101) and the tertiary radical 
(4.103) was occurring under the reaction conditions, triethylsilane, which has a rate constant of 
hydrogen abstraction several orders of magnitude slower than the cyclopropylcarbinyl radical 
rearrangement, was utilised. Triethylsilane has previously been reported to effect the radical 
deoxygenation of xanthate esters under forcing conditions132-135 or with the inclusion of alkyl 
thiols to effect polarity reversal catalysis.136 
Under the standard conditions used for the stannane reductions (3 equivalents of triethylsilane, 
AIBN, benzene, reflux) no reaction was observed (entry 4). When triethylsilane was used as the 
solvent, with stoichiometric quantities of benzoyl peroxide as the initiator, complete 
consumption of the starting material occurred to generate the seven-membered ring exclusively. 
Two other products were identified – the free alcohol resulting from reduction of the xanthate 
functionality and a product arising from radical trapping of the triethylsilyl xanthate addition 
intermediate (entry 5). The inclusion of a catalytic amount of dodecanethiol, to effect polarity 
reversal catalysis, resulted in a mixture of adducts in the ratio 4:1 favouring the ring expanded 
adduct. A significant amount of unidentified adducts were also formed during this thermolysis. 
 
b) Temperature and Solvent (Entries 7-10) 
Clive and Daigneault reported that thermal deoxygenation of the xanthate and phenylseleno-
decalin derivatives 4.128 and 4.129, which lack an electron withdrawing group on the 
cyclopropane skeleton, were best conducted at moderate to low temperatures (-20 °C to 25°C) to 
suppress the significant amount of ring expansion observed when the reaction was performed in 
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refluxing benzene. However, even under optimised conditions a minor amount (~5%) of the 
ring-expanded product 4.131 was observed. Ring expansion was proposed to proceed via 
formation of the more thermodynamically stable tertiary radical under equilibrating conditions 
(Figure 4.27).117 
 
X = OC(S)SMe
    = SePh
(i)
4.128
4.129
X
4.130 4.131
 
Figure 4.27 Temperature dependent fragmentation. 
Reagents and yields: (i) (a) Bu3SnH, AIBN, benzene, 80°C, mixture of 4.130:4.131; (b) Bu3SnH, sunlamp, -5°C, 
4.130 84%; 4.131, 7%; c) Bu3SnH, BEt3, -5°C, 4.130, 85%; 4.131, 4%. 
 
Although radical intermediates are generally considered to be insensitive to the solvent medium 
and polarity, instances have been observed where solvent effects have a significant influence on 
the product distribution and selectivity.137 Solvent and temperature studies were conducted 
simultaneously using the BEt3/O2 radical initiation system which allows low-temperature radical 
initiation.138  
 
The reactions were conducted at -78°C in the stated solvent (Table 4.6) and allowed to warm to 
room temperature whilst being monitored via TLC. Radical fragmentation of 4.99 was not 
observed to occur until the reaction temperature approached 0°C. Examples in the literature 
indicate that the radical fragmentation of primary xanthates, via the Barton-McCombie method, 
is temperature sensitive due to the requirement for the formation of a highly enthalpic primary 
radical species 4.132 from a reversible stannane addition adduct 4.133 (Figure 4.28).  
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Figure 4.28 Xanthate radical fragmentation. 
 
In all cases the observed radical fragmentation results were inferior to those provided by the 
thermal system of entry 1. The reaction performed in toluene gave the same isomeric ratio as 
entry 1 as well as generating a number of decomposition products (entry 7). The use of THF was 
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observed to exclusively generate 4.104 with considerable amounts of decomposition. No reaction 
was observed in MeOH. 
 
3) Substrate (Entries 11-12) 
As discussed previously, elements of torsional strain, orbital alignment and stereoelectronic 
effects may influence the preferred fragmentation route taken by an incipient radical. It was 
plausible that modification of the bicyclic core to reduce the ring strain could result in the 
adoption of a conformer that could favourably influence these factors and increase the isomeric 
ratio in favour of 4.102. 
 
Reduction of the C2 ketone group, in the presence of the C12 xanthate, was selectively achieved 
using sodium borohydride in aqueous ethanol to yield a 2:1 mixture of the diastereoisomeric C2 
alcohols 4.134α and 4.134β, which could be separated by careful column chromatography 
(Scheme 4.22).  
 
O
OMeS
S
OH
OH
OMeS
S
(i) (ii)
4.134α/β 4.106/4.1074.99  
Scheme 4.22 Preparation and fragmentation of alcohol substrate 4.134α/β.  
Reagents and yields: (i) NaBH4, EtOH, 30%; (ii) Bu3SnH, AIBN, benzene. 
 
Disappointingly, radical fragmentation of both alcohol stereoisomers 4.134α and 4.134β resulted 
in exclusive formation of the ring-expanded adduct, accompanied by a number of unidentified 
decomposition products. Identification of the fragmentation products 4.106 and 4.107 was made 
by comparison with the reduction products derived from the fragmentation–reduction protocol 
depicted in Scheme 4.21. 
 
4.8.5 Substrate Modified Routes 
 
The above studies indicated that the fragmentation of the cyclopropyl xanthate species 4.99 
could not be controlled on a synthetically useful level with the formation of the cycloheptanyl 
radical 4.104 favoured both kinetically and thermodynamically over the desired methyl 
cyclohexane radical 4.101. 
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In an effort to promote the desired C7-C13 endo cyclopropylcarbinyl fragmentation an 
alternative methodology was investigated which focused on stabilisation of the primary radical 
intermediate 4.101. 
 
4.8.5.1 Stabilised Cyclopropanes 
 
The radical fragmentation pathway depicted in Scheme 4.23 illustrates the transformation of the 
incipient primary cyclopropylcarbinyl radical 4.135 to either the C13 primary radical 4.136 or 
the C6 tertiary radical 4.137 via two competing pathways. 
In the case of Y = H, it is evident that formation of the thermodynamically favourable tertiary 
radical 4.137 dominates via C6-C7 cleavage. If scission of the C6-C13 bond could be 
thermodynamically favoured, by stabilising the radical at the C13 position with an electron-
withdrawing group (4.136, Y = EWG), productive generation of the desired carbocyclic skeleton 
4.138 might be realised. Removal of the control group (Y) would then yield the desired 
carbocyclic core 4.102. Towards this goal the preparation of a gem-dichlorocyclopropane species 
was investigated. 
O
Y
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O Y
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Scheme 4.23 Controlled radical fragmentation via inductive stabilisation at C13. 
 
4.8.5.2 gem-Dichlorocyclopropane Preparation 
 
A gem-dihalocyclopropane system was investigated on the basis of two assumptions. Firstly, it 
was anticipated that the electronegativity of the halide atoms would inductively the C13 primary 
radical derived from C6-C13 cleavage (4.136) and, secondly, that dehalogenation of the resultant 
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primary alkyl dihalide 4.138 could be effected under similar conditions to those required to 
cleave the initial cyclopropane structure.  
Sydnes et al. reported the radical induced reduction of various 1,1-dihalo-2-
haloalkylcyclopropanes.139 Among these studies, the radical fragmentation of 1,1-dichloro-2-
bromomethyl cyclopropane structures (4.140) were reported to give alkenes (4.141) derived from 
a cyclopropylmethyl ? 3-butenyl radical rearrangement as depicted in Figure 4.29. 
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Figure 4.29 Radical fragmentation of gem-dihalocyclopropanes. 
Reagents: (a) Bu3SnH, AIBN. 
 
The nature and regiochemistry of the halide incorporation is important to achieving this 
rearrangement as scission of the [Br-C] bond proceeded more readily than the [Cl-C] bond and 
the cyclopropyl position (R1) was more reactive than the homomethyl position (R2). For 
example, reductive dehalogenation of 1,1-dibromo- and 1,1-dichloro-2-chloroalkylcyclopropanes 
was observed to proceed exclusively at the cyclopropyl position with retention of the 
cyclopropane structure (4.142). 
 
Within the context of Scheme 4.23, it was anticipated that radical fragmentation of the gem-
dichlorocyclopropane species 4.135 (Y = Cl) would generate the stabilised primary 
dichloromethane species 4.136 (Y = Cl), with hydrogen capture yielding the desired 
bicyclo[4.3.1] ring structure 4.138 (Y = Cl). Additionally, it is known that exhaustive reduction 
of alkyl halides to the corresponding alkane can be achieved with excess tributyltin hydride 
under radical conditions.140 It was hoped that these two processes, radical fragmentation-
rearrangement (4.135 ? 4.138) and halide reduction (4.138 ? 4.102), could be conducted in 
tandem to reveal the desired exo-methylene C6-bridghead methyl bicyclic structure 4.102. 
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Towards this goal the gem-dichlorocyclopropane fragmentation precursors were prepared as 
depicted in Scheme 4.24. 
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O
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Scheme 4.24 Preparation of xanthate- and bromo-1,1-dichlorocyclopropanes 4.145 and 4.146. 
Reagents and yields: (i) 50% NaOH, CHCl3, TEBAC, 84%; (ii) TBAF (1.1 equiv), 94%; (iii) (a) NaH, THF, (b) 
imidazole, CS2, (c) MeI, 64%; (iv) PPh3.Br2, CH2Cl2, 72%. 
 
The synthetic route commenced with the clean installation of a gem-dichlorocyclopropane 
moiety in high yield via a dichlorocarbene addition to the Δ6,7 olefinic bond of 4.71 under phase-
transfer conditions.141 Removal of the TBS protecting group was readily achieved upon exposure 
to TBAF generating the free alcohol 4.144 which crystallised following silica column 
chromatography. X-ray crystallographic data obtained from a single large crystal confirmed the 
anticipated structure of 4.144 (Figure 4.30). 
 
 
 
Figure 4.30 (a) Crystallographic structures determined for the dichloro-cyclopropane adduct 
4.144, [P-1, Z = 2, R = 2.6%]. (b) Orientation showing the convex nature of the bicyclo-
[4.4.1.01,3]undecane core. 
(a) (b) 
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Inspection of the crystal structure confirms that electrophilic attack by the dichlorocarbene 
species had occurred exclusively from the convex face of 4.71 to yield a gem-
dichlorocyclopropane (Figure 4.26-a). The geometrical conformation closely resembles that 
previously observed for 3.84 (Figure 3.33b). 
The close proximity of the C7 homomethyl alcohol to the C2 carbonyl on the concave face of the 
carbocyclic skeleton is illustrated in Figure 4.30-b. This observation provides support for the 
proposed mechanism of chelation-directed exo-methylene formation while attempting to 
cyclopropanate the MOM protected Δ6,7 olefinic adduct 4.69 (see Figure 4.18). 
 
The homomethyl alcohol functionality of 4.144 was subsequently converted to the xanthate ester 
4.145 or the homomethyl bromide 4.146 in high yield. No decomposition products were 
observed during these transformations. 
 
4.8.5.3 Radical Fragmentation of gem-Dichlorocyclopropane Adducts 
 
Radical fragmentation of the gem-dichlorocyclopropane structure was initially conducted on the 
xanthate ester 4.145 under thermal initiation conditions (Bu3SnH/AIBN) (Scheme 4.25). 
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Scheme 4.25 Radical fragmentation xanthate 4.145. 
Reagents: (i) Bu3SnH (3 equiv.), AIBN, toluene, reflux. 
 
Exposure of 4.145 to thermally initiated radical conditions with three equivalents of tributyltin 
hydride resulted in the generation of a complex mixture of products, as assessed by 1H NMR 
spectroscopy. No trace of the fully reduced adduct 4.102 (R = H), or the anticipated 
intermediates derived from cyclopropylcarbinyl fragmentation in the absence of reductive 
dehalogenation 4.147 and 4.148 were found. Critically, a singlet ascribable to the 
dichloromethylene proton (Scheme 4.25- Ha) arising from C6-C13 exo fragmentation could not 
be discerned. Increasing the quantity of Bu3SnH to ten equivalents did not result in an 
appreciable improvement in the product distribution or the appearance of the fully dehalogenated 
adduct 4.102. It is probable that the rate of xanthate cleavage is slower than the reductive 
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dehalogenation of the gem-dichlorocyclopropane substituents, resulting in the possibility of 
alternative cyclopropyl fragmentation pathways. 
The thermally initiated radical fragmentation of bromo gem-dichlorocyclopropane 4.146 in the 
presence of excess tributyltin hydride and AIBN was successful in regioselectively cleaving the 
cyclopropane bond, as assessed by 1H NMR spectroscopy. Disappointingly, the exclusive 
product isolated from this reaction was assigned as the ring expanded adduct 4.148, 
contaminated with co-eluting stannane residues (Scheme 4.26). 
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Scheme 4.26. Radical fragmentation of alkyl bromide 4.146.  
Reagents and yields: (i) Bu3SnH (5 equiv), AIBN (5 mol %), toluene, 80°C, 4.148, 100% conversion via 1H NMR; 
(ii) Zn (10 equiv), cat. AcOH, EtOH, reflux, 4.148, 83%. 
 
The reaction of 4.146 with activated zinc powder, in the presence of a trace amount of acetic 
acid, similarly delivered near exclusive formation of the endo-fragmentation adduct 4.148. A 
minor product was also observed under these reactions conditions, with similar polarity and 
elution characteristics to 4.148. However, this adduct did not exhibit the anticipated singlet 
ascribable to the dichloromethylene proton Ha of 4.147 and is presumably derived from mono-
dechlorination of the adduct 4.148. 
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4.9 Summary of Cyclopropylcarbinyl Radical Fragmentations 
Within the Bicyclo[4.3.1]decane Framework 
 
A succinct and high yielding route to differentially substituted 1,3-dienes was developed that 
utilised an EYCM reaction between ethylene and a readily prepared alkyne. These diene systems 
were advanced to form homomethyl IMDA triene precursors that were subjected to thermal 
cyclisation conditions. 
In contrast to the 7-alkoxy-triene systems investigated in Chapter Three, the homomethyl 
IMDA adducts were not prone to Δ6,7 ? Δ7,8 olefinic migration when conducted under thermal 
conditions allowing the clean isolation of Δ6,7-bridgehead olefinic adducts. These results, in 
conjunction with the observed acid stability of the homomethyl IMDA adducts, lends support to 
the hypothesis that the previously observed migration proceeded via a transient oxonium-
intermediate. 
 
Investigation of the radical-induced fragmentation of the bicyclo[4.1.0]heptanylmethyl system 
embedded within a bicyclo[4.3.1]decane framework revealed that ring expansion adducts, 
derived from a C6-C7 endo-fragmentation, dominate adducts derived from the desired C6-C13 
exo-fragmentation. 
Various synthetic approaches including modification of the reaction conditions, modification of 
the substrate and endeavours to favourably stabilise the primary radical derived from exo 
cleavage were unsuccessful. 
The preferential endo-fragmentation of 4.99 and it’s related analogues (4.134 and 4.146) can 
probably be traced to a number of factors. These include, principally, the stability of the tertiary 
intermediate 4.103 following endocyclic cleavage and possibly the conformational pre-alignment 
of the C12 SOMO radical orbital with the C6-C7 endo cyclopropane bond. 
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Chapter Five 
Summary of Research and Future Studies 
 
While the total synthesis of the nakafuran and florlide families of natural products has not been 
achieved, a number of key issues have been addressed. The information gained from this 
research allows some conclusions to be reached and permits the development of a refined 
synthetic strategy directed towards total syntheses of these natural products. 
 
 
5.1 Nakafuran Synthesis – Summary 
 
It was established that the type II IMDA reaction provides a convenient and succinct route to the 
preparation of bicyclo[4.3.1]decene ring systems with variable functionality at the C7 and C8 
carbons from acyclic precursors (Figure 5.1). 
 
Preparation of vinyl stannane coupling fragments via the hydrostannylation of their respective 
alkyne precursors was investigated under radical initiated, palladium-catalysed, stannylcupration 
and hydroiodination/transmetallation protocols. These differing methodologies were observed to 
give products with distinct regio- and stereoselectivities. 
Preparation of the analogous vinyl iodide species via hydroiodination with the reagent derived 
from TMS-Cl/NaI/H2O was hampered by competing olefinic migration, halogenation reactions 
and low yields. The use of the reagent derived from TMS-I/MeOH at low temperature was found 
to circumvent many of these problems, proceeding in high yield, to give excellent regio-, 
chemio- and stereoselectivities. 
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Figure 5.1 Development of a succinct route to bicyclo[4.3.1]decene ring systems. 
 
The prepared fragments were successfully coupled utilising palladium-catalysed cross-coupling 
methodology to give access to the desired diene amide systems. A remarkably high yielding one-
pot synthesis of substituted diene systems via a Negishi coupling protocol was developed. This 
organozinc methodology constitutes a considerable advance over the analogous organotin (Stille) 
coupling methodology in terms of the preparation of the coupling partners, purification issues 
and synthetic yield. 
 
Whilst the IMDA cyclisation of the above triene systems proceeded under thermal conditions in 
high yield, the 7-alkoxy-cyclised adducts were susceptible to a facile Δ6,7 ? Δ7,8 olefinic 
migration in the presence of trace amounts of acid. This isomerisation hindered the planned 
synthetic approach. The rigorous elimination of acidic species with greater than stoichiometric 
quantities of Proton-sponge® enabled the isolation of the desired Δ6,7 IMDA adduct with 
excellent regiocontrol. However, somewhat disappointingly, neither the Δ6,7 IMDA adduct, the 
Δ7,8 IMDA adduct nor cyclopropanated derivatives could be coerced to undergo selective 
alkylation at the C3 carbon centre. 
 
Molecular modelling studies performed upon the IMDA adducts implied that a critical difference 
existed between these bicyclo[4.3.1]decene species and the bicyclo[5.3.1]undecene ring system 
from which analogue was drawn when formulating the original synthetic plan. Specifically, the 
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7-methoxy-IMDA adduct 1.68 adopts a unique conformational geometry in which unfavourable 
carbonyl-hydrogen dihedral angles thwart the regioselective deprotonation under kinetic 
conditions or the establishment of the anticipated non-bridgehead enolate under thermodynamic 
conditions. 
 
 
5.2 Florlide Synthesis - Summary 
 
The observation that Δ6,7 ? Δ7,8 olefinic migration occurred with the 7-alkoxy substituted IMDA 
adducts 1.68 and 1.79 and not with the vinyl IMDA adduct 3.40 lead to the hypothesis that the 
intermediacy of a C7-oxonium ion may facilitate this rearrangement with relief of bridgehead 
torsional strain providing the thermodynamic impetus for this isomerisation. Following this 
rationale, an intermediate was envisaged (3.70) that saw substitution of the 7-alkoxy moiety by a 
homomethyl group, which was anticipated to display diminished tautomeric ability (Figure 5.2). 
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Figure 5.2 Olefinic migration via an oxonium intermediate (Path A) vs carbocation 
formation for the homomethyl analogue (Path B). 
 
Initial attempts to synthesise these homomethyl triene precursors via either Stille or Negishi 
coupling methodology were hampered by decomposition of the allylic coupling fragments. An 
alternative strategy that made use of recently developed enyne metathesis chemistry, however, 
was successful in generating these 1,3-disubstituted diene systems in excellent yield from simple 
alkyne precursors. The subsequently derived Δ6,7 IMDA adducts were shown to be considerably 
more stable to acidic conditions than the analogous 7-alkoxy-derivatives. This synthetic 
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observation lends support to the postulated involvement of an oxonium-type intermediate (3.64) 
in the facile olefinic migration previously observed. 
 
The homomethyl IMDA adducts were advanced through subsequent synthetic steps to generate a 
range of Δ6,7-cyclopropane derivatives. Ultimately however, the exo-cyclopropylcarbinyl 
fragmentation, devised to establish the 6-methyl-bicyclo[4.3.1]decane ring system 4.102, was not 
synthetically viable. The predominant formation of the bicyclo[4.4.1]undecane system 4.104 via 
endo-cleavage was observed, presumably due to preferential stabilisation afforded by the endo-
tertiary radical relative to the exo-primary radical (Figure 5.3). 
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Figure 5.3 Enyne metathesis and cyclopropylcarbinyl fragmentation. 
 
Molecular modelling studies performed upon the radical intermediate 4.100, in conjunction with 
literature studies on the parent bicyclo[4.1.0]heptanylmethyl radical 4.116, indicated a 
preference for endo-bond cleavage.1 
Synthetic efforts to increase the ratio of 4.102 relative to 4.104 via modification of the reaction 
conditions and modification of the substrate to favourably stabilise the primary radical derived 
from exo-cleavage were unsuccessful. 
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5.3 Nakafuran Synthesis – Future Studies 
 
5.3.1 Side Chain Pre-Inclusion  
 
From the preceding studies it is evident that, in order to complete the synthesis of the nakafuran 
systems it will be necessary to incorporate the C3 side-chain functionality prior to the type II 
IMDA reaction. With the pre-inclusion of appropriate substituents upon the diene 1.70, this 
strategy should be applicable to the installation of both the desired furan and C6-bridgehead 
methyl functionality, intersecting with the originally envisaged retrosynthetic plan (Figure 5.4). 
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Figure 5.4 Proposed modified synthetic route incorporating pre-inclusion of the C3 
sidechain. 
 
5.3.2 Diene-Dienophile Transposition 
 
The synthetic problems encountered within this thesis, to a large extent, were derived from the 
need to regioselectively install the Δ6,7 bridgehead olefin and then subsequently to effect an exo-
bond selective cyclopropyl-ring opening to establish the C6 bridgehead methyl group. In theory, 
both of these issues could be eliminated by the transposition of the diene and dienophile 
functionality within the triene tether. 
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Figure 5.5 Proposed diene-dienophile transposition route. 
 
As depicted in Figure 5.5, an IMDA cyclisation of the triene system 5.1 would generate the 
bicyclo[4.3.1]decane system with a Δ1,9 bridgehead olefin (5.2) whilst simultaneously installing 
the required C6 quaternary methyl group. As the Δ1,9-olefinic bond would ultimately be 
hydrogenated, en route to the targeted natural products, isomerisation of this intermediate would 
not present a synthetic concern. The installation of the furan moiety could be envisaged to 
proceed via a similar synthetic sequence to that utilised by White et al. in the reported synthesis 
of 2,3-dihydropallescensin 1.35 (Scheme 1.5).2 
 
In support of this proposed synthetic route, recent work by Chan et al. demonstrated the 
feasibility of an IMDA reaction on a similar system (5.4) to give the Δ1,9-olefinic adduct (5.5) as 
a single product in high yield. No isomerisation of the olefinic bond was reported (Figure 5.6).3 
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Figure 5.6 Illustration of the principle of diene-dienophile transposition from the work of 
Chan et al. 
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5.4 Florlide Synthesis – Synthetic Application of the endo-
Selective Cleavage 
 
Bicyclo[4.4.1]undecane ring systems are rare in nature. To the best of the author’s knowledge 
only four natural products have been isolated that contain this structural motif within their 
carbocyclic framework. The unusual cyclocitrinols (5.6-5.9), examples of  C25 steroids 
containing a bicyclo[4.4.1] A/B ring system, were isolated from both the terrestrial and marine 
fungus Penicillium citrinum4 and the terrestrial fungus Penicillim janthinellum5 (Figure 5.7). 
The absolute stereostructure was established via a combination of X-ray crystallographic 
analysis and application of modified Mosher’s method6 upon the acetyl adduct 5.8, resulting in a 
revision of the previously ascribed structure.7 A tentative biosynthesis was proposed based upon 
the rearrangement of ergosterol 5,8-endoperoxide which co-occurred in the fermentation broth.5 
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Figure 5.7 Novel steroids containing a bicyclo[4.4.1]undecane ring system. 
 
Given the demonstrated tendency of the bicyclo[4.1.0]heptanylmethyl radical 4.100 to ring open 
via an endo-cleavage it may be possible to incorporate this rearrangement in the design of a 
concise synthesis of these novel steroids (Figure 5.8). 
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Figure 5.8 Potential application of radical endo-cleavage to the synthesis of the 
cyclocitrinols. 
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Chapter Six 
Experimental Details 
 
6.1 General Experimental 
 
6.1.1 Reagents and Solvents 
 
Reagents and solvents used in reactions were purified according to well-established procedures.1 
In particular, anhydrous tetrahydrofuran (THF) and diethyl ether (Et2O) were freshly distilled 
from sodium benzophenone ketyl immediately prior to use. Toluene, dichloromethane (CH2Cl2), 
pyridine, N,N-diisopropylamine, acetonitrile (MeCN), triethylamine (NEt3), N,N-diisopropyl–N-
ethylamine (Hünig’s base),  1,2-dimethoxyethane (DME), hexamethylphosphoramide (HMPA) 
and 1,3-dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidinone (DMPU) were freshly distilled from 
calcium hydride. 1,2-Dichloroethane (DCE) was distilled from phosphorous pentoxide and 
stored over 4Å molecular sieves under an argon atmosphere. Acetone was dried over activated 
4Å molecular sieves for 24 h, then distilled into a dry vessel under an argon atmosphere. N,N-
Dimethylformamide (DMF) and dimethylsulfoxide (DMSO) were sequentially dried over two 
batches of freshly activated 4Å molecular sieves (2 x 24 h), before being stored under argon over 
a third batch of 4Å molecular sieves. Prior to use, the DMF solvent was evacuated (~0.1 mmHg) 
for 15 min to remove residual dimethylamine. Anhydrous methanol and ethanol were distilled 
from their respective magnesium alkoxides and stored over 4Å molecular sieves under an argon 
atmosphere. Dry 1-methyl-2-pyrrolidinone (NMP) was purchased from Aldrich, stored under 
nitrogen or argon and used without further purification. Petroleum ether used consisted of the 
fraction with a boiling range of 50-70°C. 
 
Solutions of n-butyllithium and t-butyllithium in hexanes were titrated in THF with standardised 
2-butanol, using 1,10-phenanthroline as an indicator.2 Solutions of lithium-, sodium- and 
potassium bis(trimethylsilyl)amide were titrated with 2-butanol using 2,2’-bipyridine as an 
indicator3. Copper(I) iodide was purified by refluxing in CH2Cl2 in a Soxhlet apparatus for 24 h, 
and stored in the dark under an argon atmosphere. Trimethylsilyl chloride (TMSCl) and boron 
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trifluoride diethyl etherate (BF3.OEt2) were distilled from calcium hydride. Chloromethyl methyl 
ether (MOM-Cl) was prepared according to the literature procedure4
 
and stored in the freezer. 
The palladium catalysts [Pd(PPh3)2Cl2, Pd(PPh3)4, Pd2(dba)3, Pd(AsPh3)2Cl2 and 
Pd(MeCN)2Cl2],5,6 CuBr.SMe26 and Mo(tert-BuNC)3(CO)37 were prepared according to 
literature procedure. Copper thiophene carboxylate (CuTC) was prepared via the method of 
Liebeskind et al.8 2,2’-Azobisisobutyronitrile (AIBN) was prepared according to literature 
methods and stored in the freezer.9 The Dess-Martin periodinane (DMP) was prepared by the 
modified methods of Ireland and Liu.10 Diethylzinc (Et2Zn) was prepared as detailed by Foster 
and Cole-Hamilton11 on a 0.2 mol scale to yield pure diethylzinc (20.77 g, 0.168 mol, 84%) 
which was dissolved in distilled toluene to give a ~1.2 M stock solution and stored at -8°C under 
Ar. 1,1-Diethoxy-2-bromoethane and 1,1-diethoxy-2-iodoethane were prepared via literature 
methods.12,13 The MOM, THP and benzyl protected acetaldehydes 3.79a-3.79c were prepared via 
ozonolysis of their respective bis-protected-1,4-but-2-ene precursors.14 Grubbs 2nd generation 
catalyst, 4.25 was purchased from Strem or Aldrich and stored under an argon atmosphere at 
0°C. Allyl(chloro)dimethylsilane was prepared via the method of Chihi and Weber.15  
 
Unless otherwise stated, all reactions were performed in oven- or flame-dried glassware under an 
atmosphere of argon or nitrogen with the reaction temperature referring to the external bath 
temperature. All organic extracts were washed with brine and dried over anhydrous sodium 
sulfate. After filtration of the solutions to remove solids, the solvents were evaporated under 
reduced pressure on a Büchi rotary evaporator (~12 mmHg). When necessary, a high-vacuum 
pump (~0.1 mmHg) was used to remove the last traces of solvent from purified compounds. 
Evaporation under an inert atmosphere was achieved using a three way tap connected to a 
vacuum source and an inert atmosphere. 
 
6.1.2 Chromatography and Small-Scale Distillation 
 
Analytical thin-layer chromatography (TLC) was conducted on aluminium-backed Merck 
Kieselgel KG60F254 silica plates, plastic-backed Macherey-Nagel Polygram® SIL G/UV254 silica 
plates or Fluka aluminium-backed alumina type H plates. The developed TLC plates were 
visualised under short- or long-wave ultraviolet (UV) light, and/or exposure to iodine in a vapour 
chamber followed by staining with aqueous potassium permanganate or a phosphomolybdic acid 
(PMA) dip.  
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Flash chromatography was routinely carried out upon Merck Silica 60 (40-63 µm) using the 
procedure of Still et al.16 For acid sensitive compounds, chromatography was performed with 1% 
NEt3 in the eluting solvent on basified silica, prepared by the addition of NEt3 to a slurry of silica 
in the eluting solvent until the odour of NEt3 could be discerned. Alumina flash chromatography 
was performed on Laporte Alumina, Grade H (100-200 mesh). Solvents used for 
chromatography were purified by simple distillation. 
 
Small scale (bulb-to-bulb) distillation was performed under low vacuum (~10-12 mmHg) or high 
vacuum (~0.1 mmHg) in a Büchi Kugelrohr apparatus. 
 
6.1.3 Spectroscopic Techniques 
 
The 1H NMR spectra were obtained on either a Varian UNITY 300 or Varian INOVA 500 
spectrometer, operating at 300 MHz and 500 MHz respectively at 23°C. The 13C NMR were 
recorded on a Varian UNITY 300 NMR spectrometer operating at 75 MHz, typically with a 
delay (d1) of 1-3 seconds. 2D NMR experiments were carried out on a Varian INOVA 500 
spectrometer fitted with an Inverse Detection Probe and Pulsed Field Gradient Driver, operating 
at 500 MHz. Assignments of H and C signals were determined on the basis of COSY, TOCSY, 
HSQC, HMBC or CIGAR experiments. In some cases difference-NOE or 1D NOESY 
experiments were employed if uncertainty regarding structural assignments remained. Due to 
non-first order coupling between the diastereotopic protons in the bicyclic[4.3.1]carbocyclic 
adducts, peaks are listed over the range which they occur in ppm and are characterised according 
to the following designations: s (singlet), d (doublet), t (triplet), q (quartet), qn (quintet), m 
(multiplet) or combinations thereof. 
 
Chemical shifts are reported in parts per million (ppm) on the δ scale, and were referenced to 
residual protonated solvent peaks: CDCl3 referenced to CHCl3 at δH 7.25 and CDCl3 at δC 77.0; 
C6D6 at δH 7.27 and δC 128.3. Tetramethylsilane (TMS) was used as an internal standard at δH 
0.0. For acid sensitive compounds 0.2% v/v C5D5N (deuteriopyridine) was added to the CDCl3 
solvent. 
 
Infrared spectra (IR) were obtained on a Shimadzu FTIR-8201 PC spectrometer. Spectra of oils 
were run neat on KBr plates. Solid materials were dissolved in a minimum of CH2Cl2, applied to 
Chapter Six – Experimental Details  
 
214 
the plates as a solution and then evaporated under a N2 stream. Values of selected peaks are 
reported in wavenumbers (cm-1). 
High Resolution Electron Impact Mass Spectra (HREIMS) was conducted on a Kratos 
MS80RFA Mass Spectrometer operating in electron ionisation (EI) mode at 70 eV, using a 4 kV 
accelerating potential and 250°C source temperature. 
High Resolution Electrospray Ionisation Mass Spectra (HRESIMS) were obtained from a 
Micromass LCT spectrometer, with a probe voltage of 3200 V and temperature of 150°C. A 
nebuliser gas flow of 160 L/hr and desolvation gas flow of 520L/hr were used in conjunction 
with a source temperature set at 80°C. The carrier solvent was 50% MeCN/H2O at 20 μL/min 
(for direct injection mode). A 10 μL injection of sample was made from a 10 μg/mL solution. 
Positive ESI mass spectra were recorded after the addition of sodium iodide or formic acid to the 
sample prior to analysis. Only molecular ions (M+) and other major fragments are reported. 
 
Melting points (mp) were obtained using a Büchi 510 Cambridge Instruments Gallen™ III hot 
stage melting point apparatus and are uncorrected.  
 
6.1.4 Nomenclature 
 
The nomenclature used in this thesis is in accordance with the IUPAC recommendations.17 In 
some circumstances, due to the need for consistency and clarity, the naming of some compounds 
described in this dissertation deviates from IUPAC nomenclature. This in no way creates an 
ambiguity in the naming of compounds, and is in accord with the IUPAC recommendations in 
such a situation. The bicyclo[4.3.1]dec-6-en-2-one core 3.40 will be used as the basis for all 
derivatives regardless of functional groups. 
 
O1
2
3
45
6
7
8
9
10
3.40
O
HO
4.74
1
2
3
45
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7
8
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10
11
12
13
HR
 
 
For example 4.74 (R = H) 
IUPAC: 3-Hydroxymethyl-tricyclo[4.4.1.01,3]undecan-7-one 
This Thesis: 7-Hydroxymethyl-tricyclo[4.3.1.16,7]undecan-2-one 
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6.2 Experiments Described in Chapter Two 
 
1-(Tributylstannyl)propan-1-one (2.10) 
SnBu3
O
2.10
H
O
 
Acyl stannane 2.10 was prepared via the method of Migita et al.18 in variable yield (20-54%) and 
stored under an Ar atmosphere protected from light at -8°C. This material was unstable with 
respect to light, oxygen and prolonged heating. Values from the 1H NMR spectrum of  the 
distilled adduct were in close agreement with the reported values.18 
 
1H NMR (500 MHz, CDCl3): δ 0.87-0.94 (m, 9H), 1.28-1.39 (m, 6H), 1.47-1.57 (m, 9H), 1.47-
1.67 (m, 6H), 2.61 (q, J = 7.3 Hz, 2H). 
LRMS (GCMS/EI): calc. C15H32OSn: 348.1475; obs. 291 (C11H23OSn; M+ - n-Bu, calc. 291); 
307 (C11H23O2Sn; oxidation product EtCO-O-SnBu3 – n-Bu, calc. 307). 
 
 
1-Phenylbutane-1,2-dione (2.17) and 1-(4-Methoxyphenyl)butane-1,2-dione (2.18) 
SnBu3
O
2.10
O
O
Cl
O
RR
R = H
= OMe 2.18
2.17
 
Acyl stannane 2.10 (200 mg, 0.58 mmol, 1.1 equiv), benzoyl chloride (74 mg, 0.52 mmol) and 
Pd(PPh3)2Cl2 (20 mg, 5 mol %) were dissolved in toluene (5 mL) in a Pyrex tube. The mixture 
was subjected to a freeze/pump/thaw cycle (x 3), sealed under an argon atmosphere and heated at 
100°C for 16 h protected from light. Upon the observed precipitation of palladium black within 
the solution, the tube was carefully opened, quenched with saturated aqueous KF solution and 
extracted with Et2O (10 mL x 3). The solvent was removed under reduced pressure and the 
residue purified by flash chromatography on silica gel, eluting with 5% EtOAc/petroleum ether, 
to give the α,β-diketone 2.17 as a colourless oil (34.5 mg, 66%). 
An identical method was used to prepare the methoxy-adduct 2.18: Acyl stannane 2.10 (200 mg, 
0.58 mmol, 1.1 equiv), 4-methoxybenzoyl chloride (89 mg, 0.52 mmol) and Pd(PPh3)2Cl2 (20 
mg, 5 mol %) were reacted in toluene to give, after purification, 2.18 as a colourless oil (51.2 
mg, 51%). 
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2.17: 1H NMR (500 MHz, CDCl3): δ 1.19 (t, J = 7.2 Hz, 3H), 2.91 (q, J = 7.2 Hz, 2H), 7.49 (t, J 
= 7.8 Hz, 1H), 7.63 (m, 2H), 7.97 (d, J = 8.4 Hz, 2H).19 
2.18: 1H NMR (500 MHz, CDCl3): δ 1.17 (t, J = 7.3 Hz, 3H), 2.89 (q, J = 7.3 Hz, 2H), 3.87 (s, 
3H), 6.95 (d, J = 8.9 Hz, 2H), 7.96 (d, J = 8.8 Hz, 2H). 
 
 
1-Methoxypropyne (2.12) 
CHO OMeMe
2.12  
Adapted from the method of Nooi and Arens.20 
A stirred solution of distilled propionaldehyde (108.2 mL, 1.5 mol) and methanol (60.8 mL, 1.5 
mol) was saturated with anhydrous HCl gas (3 equiv) under cooling in an ice/NaCl salt bath (-
10°C). Upon completion, the organic layer was separated from the lower aqueous layer and dried 
over CaCl2 and filtered to afford a light yellow oil (150.9 g, 93%). This liquid was stirred 
vigorously at 0°C in a flask equipped with a pressure-equalising dropping funnel and a drying 
tube. Bromine (69.5 mL, 1.35 mol, 1 equiv), purified by shaking with conc. sulfuric acid, was 
added sufficiently slowly to allow decolourisation of the solution. The HCl gas generated was 
vented through the drying tube. Following complete addition, a small amount of anhydrous 
CaCl2 was added and remaining HCl gas removed by gentle evacuation at 0°C. The light yellow 
solution was filtered to remove residual CaCl2 and added over 30 min to a refluxing solution of 
N,N-diethylaniline (330 mL, 2.0 mol, 1.5 equiv) and benzene (200 mL). This solution was heated 
at 120°C for 12 h, resulting in the formation of a black solution. The cooled reaction mixture, 
which solidified, was quenched by vigorously shaking with a mixture of ice (600 g), conc. 
aqueous HCl solution (150 mL) and Et2O (200 mL). The aqueous phase was extracted with Et2O 
(3 x 150 mL) and the combined organic fractions washed successively with 2 M aqueous HCl 
solution (100 mL) until the aqueous extract was colourless, with water (100 mL) until neutral 
and dried over MgSO4. Evaporation of the excess organic solvent was performed in vacuo such 
that the bath temperature did not exceed 30°C. The resultant crude product was fractionally 
distilled under reduced pressure through a Vigreux column to separate the cis- and trans-1-
methoxy-2-bromopropenes (cis: 45-48°C / 20 mmHg; trans: 56-62°C / 20 mmHg). Fractions 
composed primarily of the trans species, as assessed by 1H NMR spectroscopy, were combined 
and added to freshly powdered KOH (5 equiv) and heated with care to effect distillation until the 
reaction vessel was dry. A light vacuum was applied to ensure complete removal of the distillate. 
The received fractions were dried over MgSO4 and redistilled in a well-lagged 30 cm Vigreux 
column to yield a colourless liquid (34.4 g, 51% over 4 steps). 
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bp: 66.5 / 760 mmHg; (lit. 65.7-66.3°C / 760 mmHg).20 
FTIR (film, KBr, cm-1): 2946, 2934, 2287, 1457, 1260, 1175, 1055, 962, 722. 
1H NMR (500 MHz, CDCl3): δ 1.70 (t, J = 1.5 Hz, 3H), 3.79 (d, J = 1.5 Hz, 3H). 
13C NMR (75 MHz, CDCl3): δ 1.2, 31.4, 64.9, 89.6. 
 
 
Iodotrimethylsilane21 
TMS-O-TMS TMS-I  
 
A flame-dried two-necked 100 mL flask equipped with a magnetic stirring flea, a wide bore 
reflux condenser and a solid addition tube was assembled such that all glass joints were wrapped 
internally with Teflon tape. The reaction vessel was charged with aluminium powder (5.6 g, 0.21 
mol), hexamethyldisiloxane (21.2 mL, 0.1 mol) and sparged with argon gas for 2 min. The 
mixture was heated to 60°C and solid iodine (50.8 g, 0.2 mol) was introduced in small portions 
such that the vigorously exothermic reaction was controlled. Upon complete addition, the 
temperature was increased to 140°C and the solution refluxed for 1.5 h. The mixture was cooled 
sufficiently to allow replacement of the addition tube with a one-piece distillation apparatus, and 
the reflux condenser with a glass stopper. Distillation was effected via heating with a flame to 
yield a colourless distillate which was collected over freshly abraded and cut copper foil pieces. 
Upon completion the collection vessel was sealed with a Telfon tape wrapped glass stopper and 
the iodotrimethylsilane (29.5 g, 74%) stored in the freezer wrapped in aluminium foil over self-
indicating granular silica desiccant. 
 
CAUTION: Iodotrimethylsilane is moisture-sensitive, light-sensitive and extremely corrosive. It 
should be handled with care, out of direct sunlight and ideally in a darkened environment. The 
reaction vessel used to prepare TMSI should be carefully quenched at 0°C with the portion-wise 
addition of ice chips which results in a vigorous exotherm and the evolution of acidic gases. 
 
 
5-Hexyn-1-ol (2.53) 
OTHP
O
2.53
OH
(i) HBr
(ii) DHP, p-TsOH
(iii) LiCCH, NH3
(vi) p-TsOH,
     MeOH
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Prepared via the addition of lithium acetylide to 2-(4-bromobutoxy)-tetrahydro-2H-pyran at -
33°C on a 1.25 mol scale as described in detail by Brandsma.22 Hydrolysis of the THP protecting 
group was performed in aqueous methanol with catalytic p-TsOH. Work-up and distillation 
yielded 2.53 as a colourless oil. The yield was 87% for the 3 steps. 
 
2-(Hex-5-ynyloxy)-tetrahydro-2H-pyran 
FTIR (KBr, cm-1): 3298, 2943, 2870, 1439, 1354, 1200, 1138, 1123, 1076, 1034, 988, 633. 
1H NMR (500 MHz, CDCl3): δ 1.49-1.87 (m, 14H), 1.95 (t, J = 2.5 Hz, 2H), 2.23 (td, J = 7.0, 
2.5 Hz, 2H), 3.41 (dt, J = 10.0, 6.0 Hz, 1H), 3.48-3.53 (m, 1H), 3.76 (dt, J = 10.0, 6.0 Hz, 1H), 
3.86 (m, 1H), 4.58 (t, J = 4.0 Hz, 1H). 
13C NMR (75 MHz, CDCl3): δ 18.1, 19.5, 25.2, 25.4, 28.7, 30.6, 62.1, 66.7, 68.3, 84.2, 98.6. 
 
5-Hexyn-1-ol (2.53)22 
bp: 76-77°C / 12 mmHg; (lit. 73-75°C / 15 mmHg).  
FTIR (film, KBr, cm-1): 3298, 2943, 2870, 1435, 1456, 1063, 1038, 991, 640. 
1H NMR (500 MHz, CDCl3): δ 1.53-1.64 (m, 2H), 1.65-1.70 (m, 2H), 1.95 (t, J = 2.0 Hz, 1H), 
2.22 (dt, J = 2.5, 7.0 Hz, 2H), 3.66 (t, J = 6.5 Hz, 2H). 
13C NMR (75 MHz, CDCl3): δ 17.8, 24.5, 31.2, 61.4, 68.4, 84.1. 
 
 
5-Iodohex-5-en-1-ol (2.55)23 
OH OH
I
2.552.53  
Chlorotrimethylsilane (7.77 mL, 0.061 mol) was added dropwise to a solution of dry NaI (9.18 g, 
0.061 mol) dissolved in MeCN (80 mL) and the resultant white solution stirred for 5 min. Water 
(558 μL, 0.0306 mol) was added dropwise to generate a yellow solution, followed after 5 min by 
the rapid addition of 2.53 (5 g, 0.051 mol). The reaction was stirred for 2 h at room temperature 
protected from light. The mixture was quenched with a 1:1 solution of saturated aqueous 
NaHCO3 and saturated aqueous Na2S2O3 and extracted with Et2O (100 mL x 3). The solvents 
were removed under reduced pressure and the residue purified by flash chromatography on silica 
gel, eluting with 20% EtOAc/petroleum ether, to give the vinyl iodide 2.55 as a yellow oil, (5.43 
g, 47%). 
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FTIR (KBr, cm-1): 3342, 2939, 2866, 1616, 1429, 1175, 1121, 1063, 893. 
1H NMR (500 MHz, CDCl3): δ 1.53-1.60 (m, 4H), 2.40 (t, J = 7.0 Hz, 2H), 3.64 (dt, J = 2.5, 6.5 
Hz, 2H), 5.68 (d, J = 1.0 Hz, 1H) 6.02 (t, J = 1.5 Hz, 1H). 
13C NMR (75 MHz, CDCl3): δ 25.2, 31.0, 44.8, 62.1, 112.1, 125.5. 
HRMS (EI): calc. for C6H11IO: 225.9855; obs. 207.9750 (C6H9I; M+ - H2O, calc: 207.9748), 
99.0809 (C6H11O; M+ - I, calc: 99.0810). 
 
 
5-Hexynoic acid24 
OH OH
O
2.53  
Alcohol 2.53 (6.22 g, 0.063 mol) in acetone (300 mL) at 0°C was stirred rapidly by mean of a 
mechanical stirrer whilst Jones’ reagent (2.775 M solution) was added dropwise until a 
noticeable retention of an orange colour (~1.15 equiv) was observed. Excess Jones’ reagent was 
added (0.05 equiv) and the reaction stirred for 2 h at room temperature. The reaction was 
quenched at 0°C via the addition of isopropyl alcohol causing the precipitation of a fine green 
powder. The mixture was filtered though a plug of Celite® and the solid residues washed with 
acetone (4 x 25 mL). The combined organic layers were evaporated to yield a green oil, which 
was dissolved in EtOAc (50 mL) and the solution washed with H2O until colourless. Evaporation 
yielded 5-hexynoic acid as a colourless oil (7.29 g, 99%). 
 
bp: 74°C / 0.1 mmHg, (lit. 95-96°C / 6 mmHg).25 
FTIR (KBr, cm-1): 3298, 2947, 2918, 1711, 1414, 1246, 644. 
1H NMR (500 MHz, CDCl3): δ 1.85 (m, 2H), 1.97 (t, J = 2.6 Hz, 1H), 2.28 (dt, J = 2.6, 6.9 Hz, 
2H), 2.51 (t, J = 7.5 Hz, 2H). 
13C NMR (75 MHz, CDCl3): δ 17.5, 23.1, 32.4, 69.2, 82.9, 179.1. 
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5-Iodohex-5-enoic acid (2.59) 
OH OH
OI I
2.55 2.59  
The Jones’ oxidation of 2.55 was performed via the method described for the preparation of 5-
hexynoic acid. The vinyl iodide 2.55 (1.02 g, 4.5 mmol) was converted quantitatively to 2.59 
(1.08 g, 100%) which was isolated as a colourless oil. 
 
FTIR (KBr, cm-1): 3433, 2943, 1709, 1620, 1427, 1412, 1276, 1246, 1207, 1173, 899. 
1H NMR (500 MHz, CDCl3): δ 1.87 (qn, 2H), 2.37 (t, J = 7.4 Hz, 2H), 2.46 (t, J = 7.1 Hz, 2H), 
5.75 (s, 1H), 6.07 (s, 1H). 
13C NMR (75 MHz, CDCl3): δ 23.6, 32.0, 43.9, 110.5, 126.3, 179.2. 
HRMS (EI): calc for C6H9IO2: 238.9569; obs. 238.9583. 
 
 
N-Methoxy-N-methylhex-5-ynamide (2.54) 
OH
O
N
O
OMe
Me
2.54  
Oxalyl chloride (10.73 mL, 123.1 mmol) was added dropwise to a solution of 5-hexynoic acid 
(6.90 g, 61.5 mmol) dissolved in CH2Cl2 (250 mL) at 0°C, followed by the addition of 4 drops of 
dry DMF. The solution was warmed to room temperature and stirred for 1 h protected with a 
CaCl2 drying tube. The mixture was briefly heated until no more bubbles were observed, cooled 
to room temperature and the excess solvent and oxalyl chloride removed under reduced pressure 
to yield a yellow oil. This oil was redissolved in CH2Cl2 (250 mL) and cooled to 0°C before 
N,O-dimethylhydroxylamine hydrochloride (6.6 g, 67.7 mmol) was added in one portion and 
stirred into the solution. Pyridine (14.75 mL, 0.148 mol) was added dropwise over 5 min and the 
reaction mixture allowed to warm to room temperature over 3 h. Evaporation of the solvent gave 
a white crystalline solid that was dissolved in Et2O/CH2Cl2 (2:1) (300 mL) and the organic layer 
washed successively with 1 M aqueous HCl solution (3 x 100 mL), saturated aqueous NaHCO3 
solution (100 mL) and brine. The solvent was removed under reduced pressure and the residue 
purified by flash chromatography on silica gel, eluting with 20% EtOAc/petroleum ether, to give 
amide 2.54 as a colourless oil (7.86 g, 82%). 
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bp: 93-95°C / 0.1 mmHg. 
FTIR (KBr, cm-1): 3296, 3254, 2941, 1661, 1418, 1387, 1180, 995, 669. 
1H NMR (500 MHz, CDCl3): δ 1.86 (qn, 2H), 1.96 (t, J = 2.5 Hz, 1H), 2.29 (td, J = 2.5, 7.0 Hz, 
2H), 2.58 (t, J = 7.0 Hz, 2H), 3.18 (s, 3H), 3.69 (s, 3H). 
13C NMR (75 MHz, CDCl3): δ 17.6, 22.9, 30.1, 31.9, 60.9, 68.7, 83.5, 173.6. 
HRMS (EI): calc for C8H13NO2: 155.0946; obs. 155.0946. 
 
 
5-Iodo-N-methoxy-N-methylhex-5-enamide (2.9) 
N
OMe
O
Me
N
OMe
O
Me
I
2.92.54  
Iodotrimethylsilane (13.6 mL, 0.096 mol, 3 equiv) was added dropwise to a solution of 2.54 (5 g, 
0.032 mol) and dry MeOH (3.92 mL, 0.096 mol, 3 equiv) dissolved in CH2Cl2 (125 mL) at -
78°C. The mixture was stirred for 20 min at -78°C and then allowed to warm to room 
temperature wrapped in aluminium foil over 3 h. The mixture was poured into a solution 
comprised of water (90 mL), saturated aqueous NaHCO3 (90 mL) and saturated aqueous 
Na2S2O3 (20 mL) and extracted with CH2Cl2 (50 mL x 2). The organic solvent was removed 
under reduced pressure to give 9.06 g of a crude product composing of 2.9 and 2.54 in a ratio of 
4:1 (as assessed via 1H NMR spectroscopy). Kugelrohr distillation led to the isolation of the 
starting alkyne 2.54 (1.23 g, 24%; 95°C/0.1 mmHg) and then pure vinyl iodide 2.9 as an orange 
oil (6.98 g, 76%, [100 % b.r.s.m.]; 103°C/0.1 mmHg). 
 
From 2.7 via tributyltin-iodine exchange. 
A solution of iodine (45.8 mg, 0.18 mmol, 2 equiv) in CH2Cl2 (3 mL) was added dropwise to the 
stannane 2.7 (40.2 mg, 0.09 mmol) dissolved in CH2Cl2 (10 mL) at 0°C such that the purple 
colour disappeared after the addition of each drop. Upon the attainment of a faint orange colour 
the solution was stirred at 0°C for 30 min, at which point TLC indicated complete conversion. 
The solution was quenched via the addition of saturated aqueous Na2S2O3 solution (10 mL) and 
extracted with Et2O (10 mL x 3). The solvents were removed under reduced pressure and the 
residue purified by flash chromatography on silica gel, eluting with 30% EtOAc/petroleum ether, 
to give vinyl iodide 2.9 as a colourless oil (26 mg, 100%). 
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From 2.59 via amidation. 
The amidation of 2.59 was performed via the method described for the preparation of N-
methoxy-N-methylhex-5-ynamide 2.54. As such, 2.59 (3.68 g, 15.4 mmol) was first converted to 
the acid chloride via the action of oxalyl chloride (2.68 mL, 30.7 mmol, 2 equiv) and a catalytic 
amount of DMF (2 drops). Subsequent reaction with N,O-dimethylhydroxylamine hydrochloride 
salt (1.80 g, 18.4 mmol, 1.2 equiv) in the presence of pyridine (3.7 mL, 36.8 mmol, 2.4 equiv), 
followed by aqueous work-up, resulted in the isolation of 2.9 as a colourless liquid (3.92 g, 
89%). 
 
bp: 103-105°C / 0.1 mmHg. 
FTIR (KBr, cm-1): 2937, 1665, 1616, 1418, 1387, 1178, 1117, 995, 897. 
1H NMR (500 MHz, CDCl3): δ 1.85 (qn, 2H), 2.41 (t, J = 7.0 Hz, 2H), 2.46 (t, J = 7.0 Hz, 2H), 
3.17 (s, 3H), 3.67 (s, 3H), 5.71 (s, 1H), 6.05 (d, J = 1.5 Hz, 1H). (500 MHz, C6D6): δ 1.97 (qn, 
2H), 2.30 (m, 2H), 2.38 (t, J = 7.0 Hz, 2H), 2.95 (s, 3H), 3.10 (s, 3H), 5.65 (s, 1H), 5.81 (s, 1H). 
13C NMR (75 MHz, CDCl3): δ 23.4, 29.6, 31.9, 44.2, 61.0, 111.2, 125.7, 173.4. 
HRMS (EI): calc. for C8H14INO2: 283.0069; obs: 222.9620 (C6H9IO; M+ - N(OMe)Me, calc: 
222.9620); 156.1025 (C8H14NO2, M+ - I, calc: 156.1025). 
 
 
Alkyne Hydrostannylation Reactions 
 
The preparation of a number of vinyl stannane species was conducted via the hydrostannylation 
or metallostannylation of their respective alkyne precursors. Four general protocols were utilized 
as described below. The percentage yields refer to isolated yields of homogeneous material as 
assessed by 1H NMR spectroscopy and TLC. Additional unique reactions that result in the 
overall hydrostannylation will be detailed independently. 
 
Protocol A: Radical Hydrostannylation26,27 
(a) Thermal initiation: Bu3SnH (1.1 equiv) and AIBN (0.1 equiv) were added to a solution of the 
alkyne (1 equiv) in toluene and heated at 80°C for 8 h. The solution was cooled, concentrated in 
vacuo and the residue purified by flash chromatography on NEt3-deactivated silica gel. 
(b) Low and ambient temperature initiation: BEt3 (5 mol %) was added in one portion to a 
solution of Bu3SnH (1.1 equiv) and the alkyne (1 equiv) in toluene at 0°C. Dry air was 
introduced beneath the solvent surface via syringe, in 1 mL portions every 10 min, whilst the 
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reaction was monitored via TLC. Upon completion, the solution was concentrated in vacuo and 
the residue purified by flash chromatography on NEt3-deactivated silica gel. 
 
Protocol B: Transition metal-catalysed28,29 
(a) Bu3SnH (1.05 equiv) was added dropwise to a solution of the alkyne (1 equiv) and the 
palladium catalyst (2 mol %) in THF at room temperature over 2 min. Completion of the reaction 
was signified by a darkening of the solution and the evolution of H2 gas. The solutions were 
stirred for an additional 2 h, concentrated in vacuo and the residue purified by flash 
chromatography on NEt3-deactivated silica gel. 
(b) Bu3SnH (3 equiv) was added in one portion to a solution of the alkyne (1 equiv), Mo(t-
BuNC)3(CO)3 (2 mol %) and hydroquinone (10 mol %) in THF at room temperature and mixture 
stirred for 6 h. The reaction was monitored via TLC and 1H NMR spectroscopy of sample 
aliquots. Upon completion, the solution was concentrated in vacuo and the residue purified by 
flash chromatography on NEt3-deactivated silica gel.  
 
Protocol C: Lower order stannylcupration: Bu3SnCu.Me2S (2.61)30 
A solution of Bu3SnCu.Me2S was prepared via the following protocol: n-BuLi (1 equiv of a 1.6 
M solution in hexanes) was added dropwise to a solution of (Bu3Sn)2 (1 equiv) in THF at 0°C. 
The solution was stirred for 15 min at 0°C and then cooled to -48°C. Solid CuBr.Me2S was 
added in one portion and the mixture was stirred at -48°C for 10 min to give a dark red solution 
before being cooled to -78°C. 
To this stannylation reagent was added the alkyne substrate (0.5 equiv) in a mixture of THF and 
dry MeOH (60 equiv) and the solution allowed to stir at -78°C for 12 h. Quenching was 
performed via the addition of a saturated aqueous solution of NH4Cl/NH4OH (5:1) and Et2O and 
the resultant biphasic mixture stirred vigorously for 1 h. The solution was extracted with Et2O (x 
3) and the organic layer washed with saturated aqueous NH4Cl/NH4OH (5:1) and then H2O. The 
solution was concentrated in vacuo and the residue purified by column chromatography on NEt3-
deactivated silica gel. 
For successful reaction it is necessary to ensure that the CuBr.Me2S complex is of a white 
crystalline form; a pink colouration indicates evaporation of Me2S and decomposition to 
insoluble Cu(I) and Cu(II) salts.6 When performing stannylcupration reactions, a colour change 
from yellow (stannyllithium) to dark red/black (stannylcuprate) is a good indicator of the 
successful preparation of the desired Cu-Sn species. The formation of a green or brown solution 
represents unfavourable speciation in solution and results in diminished yield or reaction failure. 
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Protocol D: Higher order stannylcupration: Bu3Sn(Bu)Cu(CN)Li2 (2.45)31 
(a) Thermodynamic: n-BuLi (2.2 equiv of a 1.6 M solution in hexanes) was added to a 
suspension of CuCN (1.1 equiv) in THF at -78°C. The solution was warmed to -40°C and stirred 
for 30 min before cooling to -78°C. Bu3SnH (2.2 equiv) was added and the solution stirred at -
40°C for 30 min. The solution was cooled to -78°C and the alkyne (1 equiv) added via cannula 
as a solution in THF, before stirring for 2 h at -78°C. MeOH (30 equiv) was added and the 
solution stirred for an additional 6 h at -78°C. Quenching was performed at -78°C via the 
addition of a saturated aqueous solution of NH4Cl/NH4OH (5:1) and Et2O and the mixture 
allowed to warm to room temperature with vigorous stirring. The solution was extracted with 
Et2O (x 3) and the organics washed with saturated aqueous NH4Cl/NH4OH (5:1) solution and 
then H2O. The solution was concentrated in vacuo and the residue purified by column 
chromatography on NEt3-deactivated silica gel. 
(b) Kinetic: Identical procedure to (a) except that the alkyne is added in a solution of 
THF/MeOH (30 equiv) to prevent equilibration of the intermediate vinyl cuprate species. 
 
(E)-Tributyl(1-methoxyprop-1-enyl)stannane (2.8), (Z)-Tributyl(1-methoxyprop-1-enyl)-
stannane (2.41), (E)-Tributyl(1-methoxyprop-1-en-2-yl)stannane (2.42) and (Z)-Tributyl(1-
methoxyprop-1-en-2-yl)stannane (2.43) 
Me OMe
OMe
SnBu3
Me
OMe
Me
SnBu3
OMe
Me
SnBu3
SnBu3
OMe
Me
2.12
2.8 2.41
2.42 2.43  
Using Protocol A-a (80°C, 12 h); stannylation of 2.12 (140 mg, 2 mmol) in toluene (10 mL) led 
to the isolation of a mixture of products in the ratio 21 (2.8): 36 (2.41): 12 (2.42): 30 (2.43) in 
92% combined yield (665 mg). 
Using Protocol A-b (23°C, 2 h); stannylation of 2.12 (70 mg, 1 mmol) in toluene (5 mL) led to 
the isolation of a mixture of products in the ratio 66 (2.41): 34 (2.43) in 94% combined yield 
(342 mg). 
Using Protocol B-a (23°C, 30 min); stannylation of 2.12 (140 mg, 2 mmol) in THF (6 mL) gave 
a mixture of products in the ratio 30 (2.8): 70 (2.42) as assessed by 1H NMR spectroscopy.  
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Stannylation of 2.12 (70 mg, 1 mmol) in THF (3 mL) with the slow addition of Bu3SnH (275 mg 
in 700 μL of THF, 0.95 equiv added over 30 min via syringe pump) led to the isolation of 2.42 as 
the sole observable product (320 mg, 96%). 
Using Protocol D-a; stannylcupration of 2.12 (35 mg, 0.5 mmol) in THF (5 mL) led to the 
isolation of the single isomer 2.42 (178 mg, 99%). 
Using Protocol D-b; stannylcupration of 2.12 (35 mg, 0.5 mmol) in THF (5 mL) gave a mixture 
of products in the ratio 23 (2.8): 77 (2.42) as assessed by 1H NMR spectroscopy. 
 
Hydroiodination – Transmetallation reaction 
OMe
Me
I
2.6
Me OMe
OMe
SnBu3
Me
SnBu3
OMe
Me
2.12 2.8 2.41  
Iodotrimethylsilane (1.28 mL, 9 mmol) was added dropwise to a solution of 2.12 (700 mg, 10 
mmol) and dry MeOH (365 μL, 9 mmol) in CH2Cl2 (25 mL) at -78°C (internal temperature). The 
solution was stirred for 20 min at -78°C and then warmed to room temperature over 1 h, 
protected from light with aluminium foil. The solvent was evaporated off at 5°C under an inert 
atmosphere to leave a pale yellow oil. Freshly distilled Et2O (45 mL) was added and the vessel 
cooled to -94°C. t-Butyllithium (13.2 mL of a 1.5 M solution in hexane, 19.8 mmol, 2.2 equiv) 
was added dropwise and the solution stirred for 20 min at -94°C. Tributyltin chloride (2.69 mL, 
9.9 mmol) was added dropwise and the reaction mixture slowly allowed to warm to room 
temperature in the cold bath over 8 h. The mixture was quenched with H2O (100 mL) and 
extracted with Et2O (3 x 50 mL). The solvent was removed under reduced pressure and the 
residue purified by flash chromatography on NEt3-basified silica gel, eluting with 100% pentane, 
to give first 2.41 and then 2.8 as a colourless oil (2.83 g, 87%). 
 
(E)-1-Iodo-1-methoxyprop-1-ene (2.6) 
A pale yellow oil which is stable at ambient temperature under an Ar atmosphere but readily 
decomposes to release iodine vapour upon exposure to atmospheric moisture. 
FTIR (KBr, cm-1): 2931, 2361, 2342, 1641, 1456, 1306, 1190, 1103, 1074, 918, 669. 
1H NMR (500 MHz, CDCl3): δ 1.61 (d, J = 6.9 Hz, 3H), 3.43 (s, 3H), 5.34 (q, J = 6.9 Hz, 1H). 
13C NMR (75 MHz, CDCl3): δ 13.2, 60.9, 113.7, 120.8. 
LRMS (GCMS): calc for C4H7IO: 197.9542; obs. 198 (M+), 127 (I+), 71 (M+-I). 
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(E)-Tributyl(1-methoxyprop-1-enyl)stannane (2.8) 
Rf: 0.34 (Pentane). 
FTIR (KBr, cm-1): 2959, 2928, 2874, 2855, 1456, 1197, 1113, 667. 
1H NMR (500 MHz, CDCl3): δ 0.89 (t, J = 7.5 Hz, 9H), 0.93 (m, 6H), 1.32 (m, 6H), 1.50 (m, 
6H), 1.64 (d, J = 6.5 Hz, 3H), 3.54 (s, 3H), 4.63 (m, 1H). 
13C NMR (75 MHz, CDCl3): δ 10.4, 10.9, 13.6, 27.3, 29.0, 59.5, 117.0, 164.6. 
HRMS (EI): calc. for C16H34OSn: 362.1632; obs. 305.0931 (C12H25OSn; M+ - Bu, calc: 
305.0927). 
 
(Z)-Tributyl(1-methoxyprop-1-enyl)stannane (2.41) 
Rf: 0.47 (Pentane). 
FTIR (KBr, cm-1): 2957, 2930, 2874, 2855, 1612, 1464, 1194, 1138, 1090, 988, 692. 
1H-NMR (500 MHz): δ 0.88 (t, J = 7.5 Hz, 9H), 0.96 (m, 6H), 1.31 (m, 6H), 1.51 (m, 6H), 1.59 
(d, J = 6.5 Hz, 3H), 3.44 (s, 3H), 5.26 (t of q, J = 6.5 Hz, 3JSn-H = 46.5 Hz, 1H). 
13C NMR (75 MHz, CDCl3): δ 10.1, 13.7, 14.3, 27.3, 29.1, 54.7, 105.4, 166.4. 
HRMS (EI): calc. for C16H34OSn: 362.1632; obs. 305.0927 (C12H25OSn; M+ - Bu, calc: 
305.0927). 
 
(E)-Tributyl(1-methoxyprop-1-en-2-yl)stannane (2.42) 
FTIR (KBr, cm-1): 2957, 2926, 1622, 1464, 1211, 1128, 1103. 
1H NMR (500 MHz, CDCl3): δ 0.84-0.89 (m, 15H), 1.27-1.34 (m, 6H), 1.44-1.51 (m, 6H), 1.74 
(d, J = 1.3 Hz, 3H), 3.60 (s, 3H), 5.62 (tdd, J = 0.4, 1.68 Hz, 3JSn-H = 33.0 Hz, 1H). 
13C NMR (75 MHz, CDCl3): δ 9.0, 11.2, 13.7, 27.4, 29.1, 58.9, 108.5, 149.8. 
HRMS (EI): calc. for C16H34OSn: 362.1632; obs. 305.0927 (C12H25OSn; M+ - Bu, calc: 
305.0927). 
 
(Z)-Tributyl(1-methoxyprop-1-en-2-yl)stannane (2.43) 
1H NMR (500 MHz, CDCl3): δ 0.89 (t, J = 7.4 Hz, 15H), 0.96 (m, 6H), 1.31 (m, 6H), 1.49 (m, 
6H), 1.72 (s, 3H), 3.45 (s, 3H), 6.41 (t, 3JSn-H = 45.1 Hz, 1H). 
13C NMR (75 MHz, CDCl3): δ 9.5, 9.9, 27.4, 27.5, 29.3, 58.3, 111.3, 152.0. 
 
 
Chapter Six – Experimental Details 227 
 
5-(Tributylstannyl)hex-5-en-1-ol (2.56) and (E)-6-(Tributylstannyl)hex-5-en-1-ol (2.60) 
OH
SnBu3
2.56
OH
2.53
OH
2.60
Bu3Sn
 
Using Protocol B-a (23°C, 30 min); stannylation of 2.53 (98 mg, 1 mmol) in THF (3 mL) gave a 
mixture of products in a ratio of 1 (2.56): 2 (2.60) in 93% isolated combined yield (362 mg). 
Using Protocol C; stannylcupration of 2.53 (50 mg, 0.51 mmol) led to the isolation of 2.56 (89.5 
mg, 45%) and 2.60 (22 mg, 11%). 
Using Protocol D-a; stannylcupration of 2.53 (22.3 mg, 0.23 mmol) led to the isolation of 2.56 
(64 mg, 73%) and 2.60 (13 mg, 15%). 
 
5-(Tributylstannyl)hex-5-en-1-ol (2.56)31 
FTIR (KBr, cm-1): 3333, 2957, 2928, 2872, 2855, 1464, 1456, 1070, 912. 
1H NMR (500 MHz, CDCl3): δ 0.88 (t, J = 7.5 Hz, 12H), 1.20 (t, J = 5.5 Hz, 2H), 1.30 (m, 6H), 
1.39-1.59 (m, 10H), 2.26 (dt, J = 7.5 Hz, 3JSn-H = 23.0 Hz, 2H), 3.64 (dd, J = 6.5, 12.0 Hz, 2H), 
5.10 (t of t, J = 3.0 Hz, 3JSn-H = 32.0 Hz, 1H), 5.66 (td, J = 3.0 Hz, 3JSn-H = 70.0 Hz, 1H). 
13C NMR (75 MHz, CDCl3): δ 9.5, 13.6, 25.5, 27.4, 29.1, 32.3, 40.0, 62.7, 125.1, 155.1. 
HRMS (EI): calc. for C18H38OSn: 390.1945; obs. 333.1234 (C14H29OSn; M+ - Bu, calc: 
333.1240). 
 
(E)-6-(tributylstannyl)hex-5-en-1-ol (2.60) 
The 1H NMR spectroscopic data obtained for 2.60 was in agreement with the reported literature 
values.32 
1H-NMR (500 MHz): δ 0.88 (m, 15H), 1.26-1.62 (m, 16H), 2.16 (m, 2H), 3.65 (m, 2H), 5.8-6.0 
(m, 2H). 
 
 
N-Methoxy-N-methyl-5-(tributylstannyl)hex-5-enamide (2.7) and (E)-N-methoxy-N-
methyl-6-(tributylstannyl)hex-5-enamide (2.62) 
N
O
OMe
Me
N
O
OMe
Me
SnBu3
2.72.54
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O
OMe
Me
2.62
Bu3Sn
 
Using Protocol B-a (23°C, 30 min); stannylation of 2.54 (155 mg, 1 mmol) in THF (3 mL) led to 
isolation of 2.7 (138 mg, 31%) and 2.62 (253 mg, 57%). 
Chapter Six – Experimental Details  
 
228 
Using Protocol C; stannylcupration of 2.54 (79.1 mg, 0.51 mmol) led to the isolation of 2.7 (72 
mg, 32%) and 2.62 (23 mg, 10%). 
Using Protocol D-a, stannylcupration of 2.54 (500 mg, 3.2 mmol) in THF (30 mL) and MeOH 
(27 equiv) led to the isolation of 2.7 (0.866 g, 61%) and 2.62 (0.284 g, 20%). 
 
N-Methoxy-N-methyl-5-(tributylstannyl)hex-5-enamide (2.7) 
FTIR (KBr, cm-1): 2957, 2928, 2872, 2855, 1676, 1464, 1420, 1379, 999, 912. 
1H NMR (500 MHz, CDCl3): δ 0.88 (t, J = 7.5 Hz, 9H), 1.30 (m, 6H), 1.47 (m, 6H), 1.72 (qn, 
2H), 2.28 (t, J = 7.5 Hz, 2H), 2.39 (t, J = 7.5 Hz, 2H), 3.16 (s, 3H), 3.66 (s, 3H), 5.13 (t, 3JSn-H = 
70.0 Hz, 1H), 5.68 (t , 3JSn-H = 30.0 Hz, 1H). 
13C NMR (75 MHz, CDCl3): δ 9.4, 13.6, 24.1, 26.1, 27.0, 31.3, 32.1, 40.6, 61.1, 125.3, 154.6, 
174.4. 
HRMS (EI): calc for C20H41NO2Sn: 447.2159; obs. 390.1455 (C16H32NO2Sn; M+ - Bu, calc: 
390.1455). 
 
(E)-N-Methoxy-N-methyl-6-(tributylstannyl)hex-5-enamide (2.62) 
FTIR (KBr, cm-1): 2955, 2928, 1674, 1462, 1416, 1381, 1177, 999. 
1H NMR (500 MHz, CDCl3): δ 0.87 (m, 15H), 1.23-1.34 (m, 12H) 1.48 (m, 6H), 1.75 (qn, 2H), 
2.16-2.34 (m, 2H), 2.42 (t, J = 7.5 Hz, 2H), 3.18 (s, 3H), 3.67 (s, 3H), 5.93 (m, 2H). 
13C NMR (75 MHz, CDCl3): δ 9.3, 13.6, 23.6, 27.3, 29.3, 31.1, 32.1, 37.2, 61.1, 128.1, 148.5, 
174.5. 
HRESIMS (E+): calc for C20H41NO2Sn: 448.2237 (MH+); obs. 448.2238. 
 
 
(Z)-N,6-Dimethoxy-N-methyl-5-methyleneoct-6-enamide (1.70) 
Via Stille coupling: see Table 2.5 for a summary of the catalysts, additives, solvents and 
experimental conditions used. The optimised procedure is as follows: 
OMe
Me
SnBu3 N
O
OMe
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I
N
O
OMe
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OMe
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2.8 2.9 1.70  
Stannane 2.8 (0.42 g, 1.15 mmol), vinyl iodide 2.9 (0.283 g, 1 mmol), Pd2(dba)3 (46 mg, 5 mol 
%), AsPh3 (61 mg, 20 mol %) and CuI (38 mg, 20 mol %) were combined and evacuated at 0.2 
mmHg for 30 min. Dry DMF (6 mL) was added and the mixture deoxygenated via subjection to 
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six freeze/pump/thaw cycles, wrapped in aluminium foil and stirred at 55°C for 16 h. At this 
time the solution was cooled and quenched via the addition of 100 mL of a solution comprised of 
saturated aqueous NH4Cl and water (1:1) and extracted with Et2O. The solvent was removed 
under reduced pressure and the residue purified by flash chromatography on NEt3-basified silica 
gel, eluting with 20% EtOAc/petroleum ether with 1% NEt3, to give 1.70 as a yellow oil (0.169 
g, 73%).  
 
Via Negishi coupling: 
N
O
OMe
Me
I
N
O
OMe
Me
OMe
Me
2.9 1.70
OMeMe
2.12  
Into a 250 mL flask equipped with a three-way tap and a low-temperature thermometer, were 
added sequentially 1-methoxypropyne 2.12 (2.47 g, 35.3 mmol), dry CH2Cl2 (54 mL) and dry 
MeOH (859 μL, 21.2 mmol). After cooling to -80°C (internal temperature; maintained with a 
N2/MeOH slush bath) the flask was protected from light with a foil shield and TMSI (3.02 mL, 
21.2 mmol) added dropwise, with vigorous stirring, to give an orange solution. This solution was 
stirred at -78°C for 20 min and then allowed to warm to room temperature, protected in foil over 
1 h. [Note: It is essential that the temperature should be maintained between -85°C to -75°C 
during the addition of TMSI. Within this temperature range addition can be relatively rapid ~1-2 
mL/min. Above -70°C a noted exotherm is present upon the addition of each drop and results in 
the decomposition of the vinyl iodide species 2.6, as evidenced by the formation of an dark 
orange solution upon the evaporation of the CH2Cl2 and the failure of the subsequent cross-
coupling step]. 
The CH2Cl2 solvent was evaporated under reduced pressure (~20 mmHg, 5°C water bath) 
through the take-off adaptor, to give the vinyl iodide 2.6 as light yellow solution. Et2O (108 mL) 
was added and the solution cooled to -100°C in a N2/MeOH slush bath.  
n-Butyllithium (13.25 mL of a 1.6 M solution in hexanes, 21.2 mmol) was added dropwise, 
ensuring that the temperature did not exceed -85°C. The solution was then stirred sequentially at 
-90°C for 50 min and at -40°C for 20 min. ZnCl2 (25.4 mL of a 1 M solution in Et2O, 25.4 
mmol) [prepared by heating ZnCl2 in vacuo at 0.1 mmHg with a flame until molten, allowing to 
cool under Ar and dissolving in freshly distilled Et2O] was added, creating a white solution 
which was stirred at -30°C for 15 min. The vinylzinc species was transferred via cannula to a 
aluminium foil wrapped solution of the vinyl iodide 2.9 (2 g, 7.07 mmol) and Pd(PPh3)4 (408 
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mg, 0.35 mmol, 5 mol %) in THF (80 mL) and allowed to stir at room temperature for 16 h. The 
reaction mixture was concentrated via rotary evaporation to ~50 mL and quenched with the 
addition of a 10:1 solution of saturated aqueous NaHCO3/saturated aqueous Na/K-tartrate (250 
mL). The aqueous mixture was extracted with Et2O (3 x 100 mL) and EtOAc (50 mL). The 
solvents were removed under reduced pressure and the residue purified by flash chromatography 
on alumina, eluting with 15% Et2O/petroleum ether with 1% NEt3, to give 1.70 as a yellow oil 
(1.56 g, 97%). 
This reaction was successfully scaled to 10 g (35 mmol) of 2.9 to deliver 1.70 in excellent yield 
(7.6 g, 94%). 
 
FTIR (KBr, cm-1): 2939, 1666, 1605, 1416, 1385, 1304, 1080, 995, 899. 
1H NMR (500 MHz, CDCl3): δ 1.69 (d, J = 7.0 Hz, 3H), 1.81 (qn, 2H), 2.20 (t, J = 7.5 Hz, 2H), 
2.43 (t, J = 7.0 Hz, 2H), 3.17 (s, 3H), 3.51 (s, 3H), 3.66 (s, 3H), 4.92 (s, 1H), 5.21 (q, J = 7.0 Hz, 
1H), 5.24 (d, J = 1.5 Hz, 1H); (500 MHz, C6D6): δ 1.78 (d, J = 7.0 Hz, 3H), 2.07 (qn, 2H), 2.35 
(t, J = 7.0 Hz, 2H), 2.44 (t, J = 7.0 Hz, 2H), 2.99 (s, 3H), 3.13 (s, 3H), 3.46 (s, 3H), 5.08 (s, 1H), 
5.34 (q, J = 7.0 Hz, 1H), 5.55 (d, J = 2.0 Hz, 1H). 
13C NMR (75 MHz, CDCl3): δ 10.7, 23.2, 31.1, 31.9, 32.3, 58.7, 61.0, 109.8, 111.2, 141.5, 
155.5, 174.2. 
HRESIMS (E+): calc for C12H21NO3: 228.1599 (MH+); obs. 228.1515. 
 
 
 
N-Methoxy-N-methyl-5-methylene-6-oxo-octanamide (2.61) 
N
O
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2.611.70  
A noted degradation product was 2.61, arising from the acidic hydrolysis of the methyl enol-
ether of 1.70. This hydrolysis was observed to occur readily during column chromatography on 
non-deactivated silica (i.e. not NEt3 washed), in CDCl3 (in the absence of deuteriopyridine) and 
upon exposure to acidic conditions (0.05 M aqueous HCl).  
 
FTIR (KBr, cm-1): 2939, 1676, 1460, 1416, 1385, 1178, 1103, 995, 941. 
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1H NMR (500 MHz, CDCl3): δ 1.08 (t, J = 7.3 Hz, 3H), 1.74 (qn, 2H), 2.31 (t, J = 7.8 Hz, 2H), 
2.42 (t, J = 7.4 Hz, 2H), 2.70 (qn, J = 7.3 Hz, 2H), 3.16 (s, 3H), 3.66 (s, 3H), 5.75 (s, 1H), 6.00 
(s, 1H). 
13C NMR (75 MHz, CDCl3): δ 8.2, 23.1, 30.2, 30.7, 31.2, 32.0, 61.0, 106.9, 123.6, 147.8, 202.2. 
HRESIMS (E+): calc. for C11H19NO3: 214.1443 (MH+); obs. 214.1445. 
 
 
(Z)-8-Methoxy-7-methylenedeca-1,8-dien-3-one (1.69) 
N
O
OMe
Me
OMe
Me
O
OMe
Me
1.691.70  
Vinylmagnesium bromide (6.42 mL of a 1 M solution in THF, 6.42 mmol, 2 equiv) was added 
dropwise to a solution of amide 1.70 (0.729 g, 3.21 mmol) in THF (50 mL) at 0°C and allowed 
to stir at room temperature for 12 h. The mixture was quenched via addition to a solution 
comprised of saturated aqueous NH4Cl (100 mL) and H2O (100 mL) and extracted with pentane 
(2 x 50 mL) and EtOAc (2 x 25 mL). The solvents were removed under reduced pressure to give 
a brown oil that was analytically pure upon inspection via 1H NMR spectroscopy. The material 
could be purified by flash chromatography on alumina, eluting with 100% pentane with 1% 
NEt3, to give 1.67 as a colourless oil (0.256 g, 73%). 
 
FTIR (KBr, cm-1): 2936, 1701, 1684, 1616, 1402, 1080, 964. 
1H NMR (500 MHz, CDCl3): δ 1.71 (d, J = 7.0 Hz, 3H), 1.81 (qn, 2H), 2.19 (t, J = 7.5 Hz, 2H), 
2.61 (t, J = 7.5 Hz, 2H), 3.52 (s, 3H), 4.91 (s, 1H), 5.20 (q, J = 7.0 Hz, 1H), 5.26 (d, J = 1.5 Hz, 
1H), 5.82 (d, J = 10.5 Hz, 1H), 6.21 (d, J = 17.5 Hz, 1H), 6.35 (dd, J = 10.5, 17.5 Hz, 1H); (500 
MHz, C6D6): 1.77 (d, J = 7.0 Hz, 3H), 1.89 (qn, 2H), 2.19 (t, J = 7.5 Hz, 2H), 2.28 (t, J = 7.0 Hz, 
2H), 3.44 (s, 3H), 5.00 (s, 3H), 5.24 (q, J = 7.0 Hz, 1H), 5.29 (d, J = 10.5 Hz, 1H), 5.52 (d, J = 
2.0 Hz, 1H), 5.95 (d, J = 17.5 Hz, 1H), 6.17 (dd, J = 10.5, 17.5 Hz, 1H ).  
13C NMR 75 MHz, CDCl3): δ 10.7, 22.5, 32.1, 38.7, 58.7, 109.9, 111.5, 127.8, 136.4, 141.5, 
155.5, 200.4; (75 MHz, C6D6): δ 11.0, 23.0, 32.6, 39.0, 58.5, 109.9, 111.9, 126.8, 136.8, 142.5, 
156.4, 198.8. 
HRMS (EI): calc. for C12H18O2: 194.1307; obs. 194.1309. 
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(Z)-10-Methoxy-9-methylenedodec-10-en-5-one 
N
O
OMe
Me
OMe
Me
O
OMe
Me
1.70  
The butyl addition derivative of 1.70 was prepared for 1H NMR spectroscopic comparison with 
the proposed product arising from conjugate addition of an ethyl group from Et2AlCl to the α,β-
unsaturated system of triene 1.69. 
n-Butyllithium (165 μL of a 1.6 M solution in hexanes, 0.26 mmol) was added dropwise to a 
solution of amide 1.70 (50 mg, 0.22 mmol) in THF (10 mL) at -78°C and stirred for 30 min. The 
reaction was warmed to room temperature and quenched with the addition of a saturated solution 
of aqueous NH4Cl (50 mL) and extracted with EtOAc (20 mL x 3). The solvent was removed 
under reduced pressure and the residue purified by flash chromatography on NEt3-basified silica 
gel, eluting with 10% EtOAc/petroleum ether with 1% NEt3, to give the butyl addition adduct as 
a colourless oil (85.6 mg, 72%). 
 
1H NMR (500 MHz, C6D6): δ 0.92 (t, J = 7.3 Hz, 3H), 1.27 (m, 2H), 1.58 (qn, 2H), 1.79 (d, J = 
6.9 Hz, 3H), 1.87 (m, 2H), 2.08 (t, J = 7.4 Hz, 2H), 2.12 (t, J = 7.2 Hz, 2H), 2.21 (t, J = 7.6 Hz, 
2H), 3.46 (s, 3H), 5.03 (s, 1H), 5.29 (q, J = 6.9 Hz, 1H), 5.54 (s, 1H). 
 
 
(l-Ethoxyetheny1)tributylstannane (2.51) 
OEt
SnBu3
OEt
2.51  
Prepared via the method of Gadwood et al.33 with generation of the intermediate 1-lithio-1-
ethoxyethene utilising the modification of Overmann et al.34 
t-BuLi (10 mL of a 1.5 M solution in pentane, 15 mmol) was added dropwise over 5 min to a 
solution of ethyl vinyl ether (2.86 mL, 30 mmol) in THF (20 mL) at -78°C. The resultant 
solution was stirred at -78°C for 30 min and warmed to -22°C for 30 min causing the yellow 
solution to decolourise. The solution was cooled to -78°C and n-Bu3SnCl (2.7 mL, 10 mmol) 
added dropwise over 5 min. After stirring at -78°C for 20 min the reaction was warmed to room 
temperature and quenched with water (10 mL). Hexane (100 mL) was added and the organic 
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phase washed with water (3 x 20 mL). The solvent was removed under reduced pressure and the 
residue purified by Kugelrohr distillation to give 2.51 as a colourless liquid (3.12 g, 86%). 
 
b.p: 120-122°C / 0.1 mmHg; (lit. 75-85°C / 0.005 mmHg).33 
FTIR (KBr, cm-1): 2959, 2928, 1570, 1462, 1377, 1180, 1045, 968, 806, 691, 667. 
1H NMR (500 MHz, CDCl3): δ 0.87-0.96 (m, 15H), 1.25 (t, J = 7.0 Hz, 3H), 1.33 (qn, 6H), 1.49-
1.59 (m, 6H), 3.69 (q, J = 7.0 Hz, 2H), 4.04 (s, 1H), 4.67 (s, 1H). 
13C NMR (75 MHz, CDCl3): δ 9.7, 13.6, 14.5, 27.2, 28.9, 61.9, 95.3, 172.8. 
HRMS (EI): calc. for C16H34OSn: 362.1632; obs. 305.0932 (C12H25OSn, M+ - Bu, calc: 
305.0927). 
 
 
6-Ethoxy-N-methoxy-N-methyl-5-methylenehept-6-enamide (1.81) 
 
Via Stille coupling: Coupling was conducted under the optimised conditions determined for the 
preparation of 1.70. 
N
O
OMe
Me
I
N
O
OMe
Me
OEt
2.9 1.81
OEt
SnBu3
2.51  
Stannane 2.51 (0.50 g, 1.38 mmol), vinyl iodide 2.9 (0.325 g, 1.15 mmol), Pd2(dba)3 (53 mg, 5 
mol %), AsPh3 (70 mg, 20 mol %) and CuI (44 mg, 20 mol %) were subjected to the previously 
described conditions. Work-up and purification of the crude material by flash chromatography 
on NEt3-basified silica gel, eluting with 20% EtOAc/petroleum ether with 1% NEt3, gave 1.81 as 
a yellow oil (0.165 g, 63%). The ethoxy-adduct 1.81 was observed to be more prone to acid-
catalysed hydrolysis than the analogous methoxy-adduct 1.70. 
 
 
 
Via Negishi Coupling:  
N
O
OMe
Me
I
N
O
OMe
Me
OEt
2.9 1.81  
t-BuLi (14.13 mL of a 1.5 M solution in pentane, 21.2 mmol, 3 equiv) was added dropwise to a 
solution of ethyl vinyl ether (13.49 mL, 0.143 mol, 20 equiv) in THF (60 mL) at -78°C to 
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generate a bright yellow solution which was warmed to room temperature over 1 h. ZnCl2 (3.37 
g in 20 mL of THF, 27 mmol, 3.5 equiv) was added via cannula and the solution stirred at room 
temperature for 40 min. Vinyl iodide 2.9 (2 g, 7.06 mmol) and Pd(PPh3)4 (400 mg, 0.34 mmol, 5 
mol %) dissolved in 10 mL of THF) was added via cannula and the solution stirred for 14 h at 
room temperature. The reaction was quenched via the addition of a 10:1 mixture of saturated 
aqueous NaHCO3/ Na/K-tartrate solution (200 mL) and extracted with Et2O (3 x 50 mL) and 
EtOAc (50 mL). The solvents were removed under reduced pressure and the residue purified by 
flash chromatography on NEt3-basified silica, eluting with 25% EtOAc/petroleum ether with 1% 
NEt3, to give 1.81 as a yellow oil (1.56 g, 99%). 
 
FTIR (KBr, cm-1): 2978, 2937, 1168, 1586, 1479, 1461, 1414, 1383, 1198, 1177, 1069. 
1H NMR (500 MHz, C6D6): δ 1.19 (t, J = 7.0 Hz, 3H), 2.14 (qn, J = 7.4 Hz, 2H), 2.45 (t, J = 6.2 
Hz, 2H), 2.50 (t, J = 7.6 Hz, 2H), 2.98 (s, 3H), 3.11 (s, 3H), 3.58 (q, J = 7.0 Hz, 2H), 4.17 (s, 
1H), 4.64 (s, 1H), 5.16 (s, 1H), 5.93 (s, 1H). 
13C NMR (75 MHz, C6D6): δ 14.9, 24.4, 30.9, 31.8, 32.5, 33.6, 61.0, 63.2, 83.9, 113.2, 144.0, 
160.4. 
HRESIMS (E+): calc for C12H21NO3: 228.1599 (MH+); obs. 228.1599. 
 
 
8-Ethoxy-7-methylenenona-1,8-dien-3-one (1.80) 
N
O
OMe
Me
OEt
O
OEt
1.81 1.80  
Vinylmagnesium bromide (3.94 mL of a 1 M solution in THF, 3.94 mmol, 2 equiv) was added 
dropwise to a solution of 1.81 (0.447 g, 1.97 mmol) in THF (40 mL) at 0°C and allowed to stir at 
room temperature for 2 h. The reaction was quenched with addition of saturated aqueous NH4Cl 
solution (100 mL) and extracted with EtOAc (3 x 30 mL). The solvent was removed under 
reduced pressure to quantitatively return 1.80 as a pale brown oil that was analytically pure upon 
inspection via 1H NMR spectroscopy. The residue could be purified by flash chromatography on 
alumina eluting with 99% pentane:1% NEt3 to give 1.80 as a colourless oil, but in considerably 
reduced yields (0.249 g, 65%). 
 
FTIR (KBr, cm-1): 2930, 1707, 1682, 1443, 1367, 1178, 1113. 
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1H NMR (500 MHz, CDCl3) δ 1.19 (t, J = 7.0 Hz, 3H), 1.95 (qn, 2H), 2.28 (t, J = 7.0 Hz, 2H), 
2.34 (t, J = 7.5 Hz, 2H), 3.58 (q, J = 7.0 Hz, 2H), 4.14 (s, 1H), 4.54 (d, J = 2.5 Hz, 1H), 5.07 (s, 
1H), 5.27 (dd, J = 1.0, 10.5 Hz, 1H), 5.90 (d, J = 2.5 Hz, 1H), 5.93 (dd, J = 1.0, 17.5 Hz), 6.15 
(dd, J = 10.5, 17.5 Hz, 1H); (500 MHz, C6D6) δ 1.19 (t, J = 7.0 Hz, 3H), 1.95 (m, 2H), 2.29 (t, J 
= 7.2 Hz, 2H), 2.34 (t, J = 7.6 Hz, 2H), 3.58 (q, J = 7.0 Hz, 2H), 4.15 (s, 1H), 4.54 (d, J = 2.3 Hz, 
1H), 5.07 (s, 1H), 5.27 (dd, J = 1.2, 10.6 Hz, 1H), 5.90 (d, J = 2.2 Hz, 1H), 5.93 (dd, J = 1.2, 
17.6 Hz, 1H), 6.15 (dd, J = 10.6, 17.6 Hz, 1H). 
13C NMR (75 MHz, C6D6): δ 14.9, 24.4, 31.8, 32.5, 33.6, 61.0, 63.2, 83.9, 113.2, 144.0, 160.4. 
HRMS calc. for C12H18O2: 194.1307; obs. 194.1310. 
 
 
N-Methoxy-N-methyl-5-methylenehept-6-enamide (2.66) 
N
O
OMe
Me
I
N
O
OMe
Me
2.662.9  
Vinylmagnesium bromide (5.3 mL of a 1 M solution in THF, 5.3 mmol) was added dropwise to 
a solution of ZnCl2 (6.18 mL of a 1 M solution in Et2O, 6.2 mmol) in THF (25 mL) at 0°C and 
allowed to stir at room temperature for 1 h. The resultant vinyl zinc species was added via 
cannula to a solution of vinyl iodide 2.9 (0.5 g, 1.77 mmol) and Pd(PPh3)4 (120 mg, 0.103 mmol, 
5 mol %) in THF (5 mL) and stirred at room temperature for 12 h. The reaction was quenched 
via the addition of a 10:1 mixture of saturated aqueous NaHCO3/ Na/K-tartrate solution (100 
mL) and extracted with Et2O (2 x 30 mL) and EtOAc (30 mL). The solvents were removed under 
reduced pressure and the residue purified by flash chromatography on alumina, eluting with 20% 
Et2O/petroleum ether, to give 2.66 as a yellow oil (0.267 g, 83%). 
 
FTIR (KBr, cm-1): 2939, 2341, 1666, 1416, 1385, 1180, 995, 899. 
1H NMR (500 MHz, C6D6): δ 2.07 (qn, 2H), 2.38 (t, J = 7.5 Hz, 2H), 2.42 (t, J = 6.5 Hz, 2H), 
2.98 (s, 3H), 3.12 (s, 3H), 5.08 (s, 2H), 5.10 (d, J = 10.5 Hz, 1H), 5.43 (d, J = 17.5 Hz, 1H), 6.46 
(dd, J = 10.5, 17.5 Hz, 1H). 
13C NMR (75 MHz, C6D6): δ 23.7, 31.7, 31.0, 32.5, 61.0, 114.0, 116.5, 139.5, 146.8, 174.4. 
HRESIMS (E+): calc for C10H17NO2: 184.1337 (MH+); obs. 184.1335. 
 
 
Chapter Six – Experimental Details  
 
236 
7-Methylene-nona-1,8-dien-3-one (2.67)35 
O
N
O
OMe
Me
2.672.66  
Vinylmagnesium bromide (28 mL of a 0.783 M solution in THF, 22 mmol) was added dropwise 
to a solution of 2.66 (2 g, 10.9 mmol) in THF (100 mL) at 0°C and allowed to stir at room 
temperature for 12 h. The mixture was quenched via the addition of saturated aqueous NH4Cl 
solution (100 mL) and extracted with EtOAc (3 x 50 mL). The solvents were removed under 
reduced pressure to give a brown crude material that was pure upon inspection by 1H NMR 
spectroscopy. Purification via flash chromatography on NEt3-basified silica, with 5% 
EtOAc/petroleum ether with 1% NEt3, gave the triene 2.67 (0.788 g, 47%). 
 
FTIR (KBr, cm-1): 2939, 2897, 1701, 1682, 1616, 1595, 1402, 1367, 1101, 991, 962, 897. 
1H NMR (500 MHz, CDCl3): δ 1.84 (qn, 2H), 2.25 (t, J = 7.5 Hz, 2H), 2.62 (t, J = 7.3 Hz, 2H), 
5.01 (d, J = 20.9 Hz, 1H,) 5.07 (d, J = 10.8 Hz, 1H), 5.25 (d, J = 17.3 Hz, 1H), 5.82 (dd, J = 1.1, 
10.6 Hz, 1H), 6.22 (dd, J = 1.1, 17.3 Hz, 1H), 6.36 (dd, J = 10.6, 17.3 Hz, 1H). 
13C NMR (75 MHz, CDCl3): δ 22.0, 30.5, 38.9, 113.4, 116.1, 127.8, 136.4, 138.4, 145.4, 200.5. 
HRMS (EI): calc. for C10H14O: 150.1045; obs. 150.1045. 
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6.3 Experiments Described in Chapter Three 
 
7-Methoxy-8-methylbicyclo[4.3.1]dec-7-en-2-one (3.55) 
O
MeO
Me
O
OMe
Me
1.69 3.55  
Thermal Conditions: 
Methoxy-triene 1.69 (88.6 mg, 0.46 mmol) and a small crystal of BHT (~5 mg) were placed in a 
pressure tube and dissolved in benzene (5 mL). The sample was degassed with Ar for 5 min, 
sealed and heated at 170°C for 9 h. The tubes were opened and the solvent removed under 
reduced pressure. Purification via flash chromatography on silica, eluting with 10% 
EtOAc/petroleum, gave the Δ7,8-olefinic adduct 3.55 as a colourless oil (60.1 mg, 68%). 
 
Lewis Acid Catalysed:  
(a) BF3.OEt2: Freshly distilled BF3.OEt2 (782 μL, 6.2 mmol, 10 equiv) was added dropwise to a 
solution of triene 1.69 (122 mg, 0.62 mmol) in CH2Cl2 (10 mL) at -78°C and stirred for 2 h at -
78°C. The reaction was quenched at -78°C via the addition of a saturated NaHCO3 solution (10 
mL), allowed to warm to room temperature and extracted with Et2O (3 x 10 mL). The combined 
organic solvents were removed under reduced pressure and the residue purified via flash 
chromatography on silica, eluting with 4% EtOAc/petroleum ether to give the Δ7,8-olefinic 
adduct 3.55 as a colourless oil (56 mg, 46%). 
(b) Et2AlCl: Et2AlCl (173 μL of a 1.5 M solution in heptane, 0.26 mmol) was added dropwise to 
a solution of triene 1.69 (51.2 mg, 0.26 mmol) in CH2Cl2 (10 mL) at -78°C. The resultant 
solution was stirred at -78°C for 10 min and allowed to warm to room temperature over 2 h. The 
reaction was quenched via the addition of a saturated NH4Cl solution (10 mL), stirred vigorously 
for 1 h to solubilise the gelatinous precipitate and extracted with CH2Cl2 (3 x 10 mL).The 
solvents were removed under reduced pressure and the residue purified via flash chromatography 
on silica, eluting with 4% EtOAc/petroleum ether, to give the Δ7,8-olefinic adduct 3.55 as a 
colourless oil (41 mg, 79%). 
 
FTIR (KBr, cm-1): 2931, 1697, 1450, 1350, 1196, 1142, 1011. 
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1H NMR (500 MHz, CDCl3): δ 1.38 (qn, 1H), 1.46 (tt, J = 3.3, 13.0 Hz, 1H), 1.62 (s, 3H), 1.71-
1.78 (m, 1H), 2.00-2.10 (m, 2H), 2.23 (m, 2H), 2.38-2.43 (m, 2H), 2.50 (d, J = 16.7 Hz, 1H), 
2.68 (dt, J = 1.9, 12.7 Hz, 1H), 2.76 (broad s, 1H), 3.47 (s, 3H). See Figure 3.15. 
13C NMR (75 MHz, CDCl3): δ 16.1, 21.2, 29.8, 32.1, 32.5, 33.8, 43.5, 43.6, 57.4, 118.3, 148.5, 
217.2. 
HRMS (EI) calc. for C12H18O2: 194.1307; obs. 194.1309. 
 
 
7-Ethoxybicyclo[4.3.1]dec-7-en-2-one (3.65) 
O
EtOO
OEt
1.80 3.65  
Ethoxy-triene 1.80 (55.3 mg, 0.28 mmol) and Proton-sponge® (18.3 mg, 0.09 mmol, 0.3 equiv) 
were placed in a pressure tube and dissolved in benzene (5 mL). The sample was degassed with 
Ar for 5 min, sealed and heated at 160°C for 24 h. The tubes were opened and the solvent 
removed under reduced pressure. Purification via flash chromatography on silica, eluting with 
15% EtOAc/petroleum ether, gave the Δ7,8-olefinic adduct 3.65  as a colourless oil (34 mg, 62%). 
 
FTIR (KBr, cm-1): 2936, 2880, 1697, 1660, 1448, 1380, 1190. 
1H NMR (500 MHz, CDCl3): δ 1.23 (t, J = 7.0 Hz, 3H), 1.32 (q, 1H), 1.46 (tt, J = 3.5, 13.4 Hz, 
1H), 1.72 (m, 1H), 2.07 (dddd, J = 0.9, 3.9, 7.4, 14.3 Hz, 1H), 2.14-2.26 (m, 3H), 2.39-2.44 (m, 
2H), 2.56 (d, J = 3.9 Hz, 1H), 2.63 (qt, J = 1.9, 5.8, 16.4 Hz, 1H), 2.68 (ddd, J = 2.0, 14.0, 17.3 
Hz, 1H), 3.57 (qd, J = 7.0, 9.4 Hz, 1H), 3.70 (qd, J = 7.0, 9.4 Hz, 1H), 4.67 (d, J = 4.6 Hz, 1H). 
See Figure 3.22. 
13C NMR (75 MHz, CDCl3): δ 14.4, 20.8, 27.3, 29.3, 32.4, 35.1, 43.3, 43.7, 61.6, 95.2, 154.0, 
217.3. 
HRMS (EI): calc. for C12H18O2: 194.1307; obs. 194.1308. 
 
Bicyclo[4.3.1]dec-6-en-2-one (3.40) 
OO
2.67 3.40  
The triene 2.67 (37.4 mg, 0.25 mmol) and Proton-sponge® (16.0 mg , 0.07 mmol, 0.3 equiv) 
were placed in a Carius resealable pressure tube and subjected to a freeze/pump/thaw cycle (x 4). 
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The tube was sealed and heated at 160°C for 20 h. Upon cooling, the solvent was removed under 
reduced pressure and the residue purified by flash chromatography on silica gel, eluting with 5% 
Et2O/petroleum ether, to give 3.40  as a colourless oil (21.3 mg, 56%).  
 
The spectroscopic data obtained was in agreement with that previously reported by Shea et al.35 
FTIR (KBr, cm-1): 2943, 2864, 1699, 1447, 1317, 1171, 1038, 959, 854. 
1H NMR (500 MHz, CDCl3): δ 1.44-1.53 (m, 1H), 1.79-1.87 (m, 2H), 1.99-2.11 (m, 4H), 2.19 
(dt, J = 5.8, 11.5 Hz, 1H), 2.29 (ddd, J = 2.7, 5.9, 11.5 Hz, 1H), 2.36 (ddd, J = 1.6, 6.6, 12.0 Hz, 
1H), 2.53 (tdd, J = 1.6, 3.4, 13.2 Hz, 1H), 2.60-2.63 (m, 1H), 2.88 (ddd, J = 3.0, 11.6, 13.3 Hz, 
1H), 5.54 (d, J = 7.0 Hz, 1H). 
13C NMR (75 MHz, CDCl3): δ 21.2, 24.2, 31.8, 32.4, 35.8, 41.8, 47.1, 123.7, 145.0, 216.7. 
HRMS (EI): calc. for C10H14O: 150.1045; obs. 150.1046. 
 
 
N-Methoxy-4-(6-methoxy-7-methyl-1,3-dioxo-2-phenyl-2,3,3a,4,7,7a-hexahydro-1H-
isoindol-5-yl)-N-methylbutanamide (3.68) 
N
OMe
OMe
Me
O
Me
N
OMe
OMe
Me
O
Me
N
O
O
H
H
1.70 3.68  
N-Phenylmaleimide (45.8 mg, 0.26 mmol) and 1.70 (20 mg, 0.088 mmol) in toluene (5 mL) were 
stirred at room temperature for 24 h. The solvent was removed under reduced pressure and the 
residue purified by flash chromatography on NEt3-basified silica, eluting with 20% 
EtOAc/petroleum ether with 1% NEt3, to give 3.68 as a cream solid (16.3 mg, 46%).  
 
FTIR (KBr, cm-1): 2939, 1713, 1659, 1501, 1458, 1385, 1192, 995, 918, 733. 
1H NMR (500 MHz, C6D6): δ 1.35 (d, J = 7.0 Hz, 3H), 1.87 (m, 1H), 2.00 (m, 1H), 2.22 (m, 
2H), 2.37 (m, 2H), 2.61 (m, 4H), 2.70 (dd, J = 4.8, 15.6 Hz, 1H), 2.98 (s, 3H), 3.13 (s, 3H), 3.32 
(s, 3H), 7.12 (t, J = 7.5 Hz, 1H), 7.27 (m, 2H) 7.54 (d, J = 7.6 Hz, 2H). (500 MHz, CDCl3): δ 
1.22 (d, J = 7.2 Hz, 3H), 1.65-1.75 (m, 2H), 2.15-2.19 (m, 2H), 2.40 (t, J = 6.9 Hz, 2H), 2.45-
2.49 (m, 1H), 2.59-2.64 (m, 1H), 2.96 (qn, 1H), 3.15 (s, 3H), 3.20-3.24 (m, 2H), 3.50 (s, 3H), 
3.65 (s, 3H), 7.23 (d, J = 8.3 Hz, 2H), 7.37 (t, J = 7.7 Hz, 1H), 7.45 (t, J = 7.7 Hz, 1H). 
13C NMR (75 MHz, C6D6): δ 13.1, 23.0, 26.9, 29.5, 31.6, 32.1, 32.4, 39.7, 45.8, 58.5, 60.6, 
118.5, 126.7, 128.2, 129.0, 133.0, 152.9, 174.1, 176.7, 178.3; (75 MHz, CDCl3): δ 12.7, 22.3, 
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25.9, 28.8, 31.0, 31.3, 31.7, 38.9, 45.2, 58.1, 60.7, 117.5, 126.0, 128.1, 128.7, 131.5, 152.2, 
173.8, 176.8, 178.6. 
HRESIMS (E+): calc. for C22H28N2O5: 401.2077 (MH+); obs. 401.2075. 
 
 
Silylation of Glassware 
Glassware to be used for the IMDA cyclisation reaction, including the reaction flask, magnetic 
stirring bar and reflux condenser, were silylated utilising the following protocol: The glassware 
was soaked in an alcoholic sodium hydroxide solution for 30 min [12 mL of H2O containing 12 g 
NaOH diluted into 100 mL of ethanol], washed with distilled water until neutral, with two small 
portions of EtOH (5 mL) and then placed in an electric oven for 1 h to dry. The glassware was 
cooled under argon and filled with a solution of 5% v/v Me2SiCl2 in CH2Cl2 and allowed to soak 
for 30 min. The silylation mixture was removed, the glassware washed with anhydrous CH2Cl2 
(5 mL x3) and then filled with MeOH and allowed to soak for 1 h. The silylated glassware then 
was drained and dried overnight at 120°C. 
 
Purification of Proton-Sponge® 
The white crystalline solid was dissolved in a minimum of aqueous 1 M HCl solution and then 
triturated with a solution of saturated aqueous K2CO3 solution at 0°C causing a white suspension 
to form. After stirring for 1 h, the precipitate was collected and washed with distilled water until 
the washings were neutral. Distillation of this material via Kugelrohr (95°C / 0.1 mmHg) 
afforded a colourless liquid, which crystallised to a white solid upon cooling.  
 
 
7-Methoxy-8-methyl-bicyclo[4.3.1]dec-6-en-2-one (1.68) 
O
MeO
Me
O
OMe
Me
1.69 1.68  
Triene 1.69 (400 mg, 2.06 mmol), Proton-sponge® (551 mg , 2.57 mmol, 1.25 equiv) and 5 mL 
of xylene were placed in a silylated round bottom flask with a reflux condenser and 
azeotropically dried via evacuation at 0.1 mmHg, until all the xylene had evaporated. Xylene (75 
mL) was added and the reaction brought to reflux for 42 h. Upon cooling, the solvent was 
removed under reduced pressure (60°C / 24 mmHg / 23°C / 0.1 mmHg). The residue was 
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purified by flash chromatography on NEt3-basified silica gel, eluting with 5% Et2O/petroleum 
ether with 1% NEt3, to give 1.68 as a colourless oil (320.6 mg, 80%). 
 
FTIR (KBr, cm-1): 3381, 2936, 2870, 1699, 1657, 1456, 1256, 1157, 804. 
1H NMR (500 MHz, CDCl3): δ 1.19 (d, J = 6.8 Hz, 3H), 1.67-1.76 (m, 4H), 1.85 (td, J = 8.1, 
12.9 Hz, 1H), 2.12 (m, 3H), 2.30 (m, 2H), 2.52 (m, 1H), 2.77 (dd, J = 3.9, 7.8 Hz, 1H), 3.38 (s, 
3H). 
13C NMR (75 MHz, CDCl3): δ 15.5, 30.2, 30.4, 30.6, 31.8, 35.4, 41.7, 47.1, 60.5, 122.2, 155.0, 
213.6. 
HRMS (EI): calc. for C12H18O2: 194.1307; obs. 194.1308. 
 
 
7-Ethoxy-bicyclo[4.3.1]dec-6-en-2-one (1.79) 
O
EtOO
OEt
1.80 1.79  
Using the method described for the cyclisation of 1.69, the triene 1.80 (34.0 mg, 0.18 mmol) and 
Proton-Sponge® (37 mg, 0.22 mmol, 1.25 equiv) were dissolved in xylene (10 mL) and heated 
to reflux for 42 h. Evaporation of the solvent and flash chromatography on NEt3-basified silica 
gel, eluting with 2.5% Et2O/petroleum ether with 1% NEt3, gave 1.79 as a colourless oil (14.9 
mg, 35%). 
 
1H NMR (500 MHz, CDCl3): δ 1.14 (t, J = 7.0 Hz, 3H), 1.40-1.47 (m, 2H), 1.86-1.93 (m, 1H), 
1.94-2.14 (m, 2H), 2.16 (br s, 1H), 2.19-2.22 (m, 2H), 2.31-2.36 (m, 2H), 2.47 (dt, J = 2.5, 11.1 
Hz, 1H), 2.62-2.69 (m, 1H), 2.88 (t, J = 9.4 Hz, 1H), 3.54 (dq, J = 5.3, 7.0 Hz, 2H). 
13C NMR (75 MHz, C6D6): δ 15.6, 21.5, 22.4, 23.6, 27.3, 29.6, 37.3, 44.8, 62.6, 112.4, 148.9, 
211.4.  
HRMS (EI): calc. C12H18O2: 194.1307; obs. 194.1310. 
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7-Methoxy-8-methyl-tricyclo[4.3.1.17,8]undecan-2-one (3.56) 
MeO
OMe
MeO
OMe
3.563.55  
Et2Zn (2.27 mL of a 1.236 M solution in toluene, 2.8 mmol, 5 equiv) was added dropwise to a 
solution of 3.55 (110.5 mg, 0.56 mmol) in DCE (20 mL) at -20°C and stirred for 30 min. CH2I2 
(0.458 mL, 5.6 mmol, 10 equiv) was added dropwise and the solution allowed to warm to room 
temperature and stirred for 16 h resulting in the formation of a white precipitate. The mixture 
was quenched via the addition of a saturated solution of aqueous NH4Cl (50 mL) and extracted 
with Et2O (3 x 10 mL). The solvents were removed under reduced pressure and the residue 
purified via flash chromatography on silica, eluting with 10% EtOAc/petroleum ether, to give 
3.56 as a colourless oil (78.3 mg, 67%). 
 
FTIR (KBr, cm-1): 2933, 2868, 2360, 1699, 1456, 1180, 1141, 1049. 
1H NMR (500 MHz, CDCl3): δ 0.38 (d, J = 5.3 Hz, 1H), 0.45 (d, J = 5.3 Hz, 1H), 1.12 (s, 3H), 
1.42 (m, 1H), 1.61 (m, 2H), 1.75 (m, 1H), 1.87 (m, 2H), 2.12 (d, J = 15.1 Hz, 1H), 2.25 (m, 2H), 
2.56 (m, 2H ), 2.70 (d, J = 3.1 Hz, 1H), 3.22 (s, 3H). 
13C NMR (75 MHz, CDCl3): δ 19.6, 20.9, 21.4, 22.8, 27.5, 30.7, 31.9, 34.5, 42.8, 43.2, 53.6, 
65.7, 216.2. 
HRMS (EI): calc. for C13H20O2: 208.1463; obs. 208.1469. 
 
 
7-Methoxy-8-methyl-tricyclo[4.3.1.16,7]undecan-2-one (3.74) 
MeO
OMe
MeO
OMe
1.68 3.74  
Et2Zn (4.08 mL of a 1.236 M solution in toluene, 5.05 mmol, 5 equiv) was added dropwise to a 
solution of 1.68 (196 mg, 1 mmol) in DCE (10 mL) at -20°C. After stirring for 15 min at -20°C, 
CH2I2 (0.813 mL, 10.1 mmol, 10 equiv) was added dropwise and the solution allowed to stir at 
room temperature for 16 h resulting in the precipitation of a white material. The mixture was 
quenched with saturated Na/K-tartrate solution, stirred vigorously for 1 h and extracted with 
CH2Cl2 (30 mL x 3). The solvent was removed under reduced pressure and the residue purified 
by flash chromatography on silica, eluting with 20% EtOAc/petroleum ether, to give 3.74 as a 
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colourless oil (136 mg, 65%). No isomerisation of the Δ6,7-olefinic bond or cyclopropanation 
products arising from isomerisation were observed under these reaction conditions. 
 
If a mixture of the Δ6,7 and the Δ7,8 alkenes 1.68 and 3.55 (76.5 mg, 0.39 mmol, ratio 62:38) was 
subjected to the stated cyclopropanation conditions, retention of the relative isomeric ratios was 
observed via 1H NMR spectroscopy. The isolation of the desired adduct 3.74 could be facilitated 
by refluxing the crude cyclopropanation mixture in acidic EtOH for 6 h (50 mL; 10:1 EtOH / 
conc. aqueous HCl solution), under which conditions the selective hydrolysis of the Δ7,8 
cyclopropane adduct 3.56 occurred. The solution was diluted with H2O and extracted with Et2O 
(20 mL x 3). Removal of the solvent under reduced pressure and purification of the residue by 
flash chromatography on silica, eluting with 10% EtOAc/petroleum ether, gave 3.74 as a 
colourless oil (43.2 mg, 65%, two steps). 
 
FTIR (KBr, cm-1): 2937, 2872, 1695, 1458, 1261, 1223, 1178, 1105, 1074. 
1H NMR (500 MHz, CDCl3): δ 0.29 (d, J = 5.6 Hz, 1H), 0.77 (d, J = 5.6 Hz, 1H), 1.06 (ddd, J = 
1.2, 5.6, 15.1 Hz, 1H), 1.13 (d, J = 6.8 Hz, 3H), 1.23 (m, 1H), 1.45-1.52 (m, 2H), 1.66-1.72 (m, 
2H), 1.85 (ddd, J = 4.4, 11.7, 14.2 Hz, 1H), 1.92 (ddd, J = 5.9, 7.6, 13.5 Hz, 1H), 2.09 (dd, J = 
1.1, 15.1 Hz, 1H), 2.49-2.64 (m, 2H), 3.30 (s, 3H). 
13C NMR (75 MHz, CDCl3): δ 16.3, 23.1, 24.3, 25.2, 30.1, 32.0, 33.3, 35.0, 41.6, 45.2, 57.7, 
66.8, 217.8. 
HRMS (EI): calc. for C13H20O2: 208.1463; obs. 208.1461 
 
 
7a-Hydroxy-7,7-dimethyl-octahydro-1,5-methano-inden-8-one (3.58) 
MeO
OMe
3.56
Me
Me
O
HO
H
HO
O
3.58
1
2
3
456
7
8
9
10
12
11
 
A solution of cyclopropane 3.56 (12 mg, 0.058 mmol) in EtOH (25 mL) and conc. aqueous HCl 
solution (5 mL) was heated to reflux for 12 h, whilst monitoring via TLC. Upon completion the 
mixture was quenched via addition to a saturated aqueous NaHCO3 solution (50 mL) and 
extracted with Et2O (20 mL x 3). The solvent was removed under reduced pressure and the 
residue purified by flash chromatography on silica, eluting with 20% EtOAc/petroleum ether, to 
give 3.58 as a colourless oil (11.2 mg, 98%). 
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FTIR (KBr, cm-1): 3437, 2951, 2870, 1709, 1462, 1366, 1319, 1281, 1099, 1069. 
1H NMR (500 MHz, CDCl3): δ 0.92 (s, 3H, H11), 1.07 (s, 3H, H12), 1.18-1.24 (m, 2H, H10a, H4a), 
1.47-1.62 (m, 3H, H5, H9a, H9b,), 1.96 (m, 1H, H10), 2.10 (br s, 1H, H1), 2.14-2.23 (m, 3H, H5, 
H4b, H6), 2.44 (d, 1H, H3); (500 MHz, C6D6): δ 0.98 (s, 3H), 0.97-1.03 (m, 1H), 1.09 (s, 3H), 
1.10-1.16 (m, 1H), 1.40 (dd, J = 3.3, 13.6 Hz, 1H), 1.49 (td, J = 2.6, 13.6 Hz, 1H), 1.68 (dd, J = 
10.5, 13.3 Hz, 1H), 1.75-1.81 (m, 1H), 2.09-2.13 (m, 1H), 2.15 (d, J = 2.1 Hz, 1H), 2.22-2.37 
(m, 2H), 2.62 (d, J = 8.0 Hz, 1 H). See Figure 3.17. 
13C NMR (75 MHz, CDCl3): δ 25.9 (C5), 27.1 (C11), 27.2 (C12), 31.5 (C4), 31.7 (C10), 32.9 
(C8), 37.5 (C6), 41.6 (C9), 42.3 (C1), 55.1 (C3), 85.2 (7), 218.0 (C2); (75 MHz, C6D6): δ 26.8, 
27.8, 27.9, 32.3, 32.4, 33.6, 38.3, 42.3, 43.2, 56.0, 85.6, 217. 
HRMS (EI): calc. for C12H18O2: 194.1307; obs. 194.1315. 
 
 
7a-Hydroxy-3a,7-dimethyl-octahydro-1,5-methano-inden-8-one (3.83) 
MeO
OMe
3.74
H
OMe
Me
HO
3.83
Me O
HO
H
Me
1
2
3
456
7
8
9
10
11
12
 
A solution of cyclopropane 3.74 (23.1 mg, 0.11 mmol) in EtOH (5 mL) and conc. aqueous HCl 
(5 mL) was heated to reflux of 12 h, whilst monitoring via TLC. The reaction was quenched via 
addition to a solution of saturated aqueous NaHCO3 (40 mL) and extracted with Et2O (30 mL x 
3). The solvent was removed under reduced pressure and the residue purified by flash 
chromatography on silica, eluting with 20% EtOAc/petroleum ether, to give 3.83 as a colourless 
oil (21 mg, 91%). Methyl-ether hydrolysis-cyclopropane fragmentation with concomitant aldol 
addition was similarly observed by exposure of 3.74 to TMSI (2 equiv) in CH2Cl2 at 0°C in 
quantitative yield. 
 
FTIR (KBr, cm-1): 3470, 2951, 2870, 1715, 1456, 1375, 1288, 1099, 679.  
1H NMR (500 MHz, CDCl3): δ 1.00 (d, J = 5.1 Hz, 3H), 1.09 (s, 3H), 1.25 (d, J = 7.1 Hz, 1H), 
1.35-1.40 (m, 1 H), 1.51-1.59 (m, 3H), 1.87 (dt, J = 5.2, 12.0 Hz, 1H), 2.00-2.05 (m, 2H), 2.11 
(s, 1H), 2.12-2.17 (m, 1H), 2.56 (d, J = 8.6 Hz, 1H). 
13C NMR (75 MHz, CDCl3): δ 18.1 (C11), 20.5 (C12), 24.9 (C5), 27.8 (C8), 34.9 (C9), 38.9 
(C10), 40.0 (C5), 42.1 (C1), 43.0 (C6), 54.9 (C3), 83.3 (C7), 217.7 (C2). 
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HRMS (EI): calc. for C12H18O2: 194.1307; obs. 194.1310. 
 
 
7-Methoxy-8-methyl-tricyclo[4.3.1.16,7]undecan-2-ol  
MeO
OMe
MeO
OHMe
MeO
OHMe
3.74 α β  
DIBAL-H (1.07 mL of a 1 M solution, 1.1 mmol, 2 equiv) was added dropwise to a solution of 
ketone 3.74 (107 mg, 0.52 mmol) in toluene (10 mL) at -78°C. The solution was allowed to stir 
for 30 min at -78°C and then 1 h at room temperature. The reaction was quenched via addition to 
a solution of saturated aqueous Na/K-tartrate (100 mL), stirred vigorously for 1 h and extracted 
with CH2Cl2 (30 mL x 3). The solvent was removed under reduced pressure and the residue 
purified by flash chromatography on silica, eluting with 10% EtOAc/petroleum ether, to give the 
diastereoisomers α (75.4 mg, 70%) and β (16.3 mg, 15%) and a mixture of both isomers (5.3 mg, 
5%) as colourless oils. 
 
α-Alcohol 
FTIR (KBr, cm-1): 3371, 2931, 1458, 1227, 1065, 1034. 
1H NMR (500 MHz, CDCl3): δ 0.14 (d, J = 5.4 Hz, 1H), 0.49 (d, J = 5.4 Hz, 1H), 0.89 (dd, J = 
6.7, 14.8 Hz, 1H), 1.13 (s, 3H), 1.21 (ddd, J = 6.1, 10.7, 13.2 Hz, 1H), 1.31-1.48 (m, 5H), 1.59-
1.73 (m, 5H), 2.28 (m, 1H), 3.29 (s, 3H), 3.63 (ddd, 1H, J = 3.2, 4.9, 11.0 Hz, 1H). 
13C NMR (75 MHz, CDCl3): δ 16.8, 22.2, 22.8, 23.4, 27.3, 28.3, 28.6, 30.4, 35.8, 36.5, 57.6, 
67.2, 78.9. 
HRMS (EI): calc. for C13H22O2: 210.1620; obs. 210.1627 
 
β-Alcohol 
FTIR (KBr, cm-1): 3379, 2932, 1458, 1219, 1096, 1057, 1011, 671. 
1H NMR (500 MHz, CDCl3): δ 0.19 (d, J = 5.4 Hz, 1H), 0.55 (d, J = 5.4 Hz, 1H), 0.75 (dd, J = 
5.8, 14.7 Hz, 1H), 0.93 (dt, J = 6.0, 13.5 Hz, 1H), 1.10 (d, J = 6.6 Hz, 3H), 1.17-1.25 (m, 1H), 
1.29-1.46 (m, 3H), 1.56-1.73 (m, 4H), 1.82-1.92 (m, 1H), 2.01-2.06 (m, 1H), 2.08 (d, J = 14.8 
Hz, 1H), 3.30 (s, 3H), 3.66 (m, 1H). 
13C NMR (75 MHz, CDCl3): δ 16.7, 17.3, 22.7, 24.3, 26.1, 28.0, 28.5, 32.0, 35.3, 38.7, 57.7, 
67.1, 73.7. 
HRMS (EI): calc. for C13H22O2: 210.1620; obs. 210.1618 
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7-Methoxy-8-methyl-tricyclo[4.3.1.16,7]undecan-2-yl 3,5-dinitrobenzoate (3.84) 
MeO
OMe
MeO
OHMe
NO2
O
O2N
3.84α-alcohol  
3,5-Dinitrobenzoyl chloride (250 mg, 1.08 mmol, 3 equiv) dissolved in CH2Cl2 (1 mL) was 
added via cannula to a solution of the above prepared α-alcohol (75.4 mg, 0.36 mmol), Et3N 
(250 μL, 1.8 mmol, 5 equiv) and DMAP (8.8 mg, 0.07 mmol, 0.2 equiv) in CH2Cl2 (5 mL) at 
0°C. The solution was allowed to warm to room temperature and stirred for 12 h. The solvent 
was removed under reduced pressure and the residue purified by flash chromatography on silica, 
eluting with 5% EtOAc/petroleum ether, to give 3.84 as a yellow solid (49.3 mg, 34%). 
The solid was recrystallised from an Et2O:petroleum ether solution and subjected to X-ray 
diffraction to obtain the crystallographic structure depicted in Figure 3.33. [P21/c, Z = 4, R = 
3.6%]. 
 
mp: 162°C. 
FTIR (KBr, cm-1): 3101, 2939, 2870, 1724, 1628, 1547, 1462, 1346, 1281, 1169, 1072, 968, 
910, 729. 
1H NMR (500 MHz, CDCl3): δ 0.24 (d, J = 5.5 Hz, 1H), 0.60 (d, J = 5.5 Hz, 1H), 1.03 (dd, J = 
6.6, 15.0 Hz, 1H), 1.19 (d, J = 6.4 Hz, 3H), 1.21-1.29 (m, 1H), 1.39-1.47 (m, 1H), 1.51-1.60 (m, 
1H), 1.64 (dd, J = 5.3, 13.6 Hz, 1H), 1.67-1.73 (m, 1H), 1.78-1.86 (m, 1H), 1.95 (dd, J = 11.9, 
24.5 Hz, 1H), 2.58 (dt, J = 5.4, 10.8 Hz, 1H), 3.36 (s, 1H), 5.07 (dt, J = 3.4, 11.8 Hz, 1H), 9.09 
(m, 1H), 9.19 (dd, J = 1.6, 2.5 Hz, 1H). 
13C NMR (75 MHz, CDCl3): δ 16.7, 21.9, 22.7, 23.2, 27.2, 27.7, 27.8, 28.3, 33.8, 35.8, 57.7, 
67.0, 83.9, 122.0, 129.2, 134.6, 148.5, 161.6.  
HRMS (EI): an accurate mass could not be obtained. A single ion with a m/z of 195 (C7H3N2O5) 
derived from cleavage of the 3,5-dinitrobenzoyl ester bond was observed. 
 
 
2-tert-Butyldimethylsilyloxy-(7-methoxy-8-methylbicyclo[4.3.1]deca-1,7-diene (3.78) 
MeO
OMe
MeO
OTBSMe
3.55 3.78  
Chapter Six – Experimental Details 247 
 
TBS-OTf (130 μL, 0.56 mmol) was added dropwise to a solution of 3.55 (50 mg, 0.26 mmol) 
and Et3N (142 μL, 1.04 mmol) in Et2O (5 mL) at 0°C. The solution was allowed to warm to 
room temperature and stirred for 5 h before being quenched via the addition to saturated aqueous 
NaHCO3 solution (20 mL) and extracted with Et2O (10 mL x 3). The solvent was removed under 
reduced pressure and the residue purified by flash chromatography on alumina, eluting with 2% 
and then 20% EtOAc/petroleum ether to give 3.77 as a colourless oil (68 mg, 87%). 
 
FTIR (KBr, cm-1): 2955, 2930, 2858, 1701, 1464, 1253, 1136, 839, 780. 
1H NMR (500 MHz, C6D6): δ 0.22 (s, 3H), 0.25 (s, 3H), 1.12 (s, 9H), 1.49-1.55 (m, H), 1.66-
1.73 (m, 1H), 1.76-1.84 (m, 1H), 1.92 (s, 3H), 1.96 (ddd, J = 3.0, 5.7, 14.4 Hz, 1H), 2.06 (dd, J 
= 5.3, 12.4 Hz, 1H), 2.12-2.18 (m, 1H), 2.49-2.52 (m, 1H), 2.60 (dt, J = 1.7, 12.2 Hz, 2H), 2.87 
(t, J = 12.7 Hz, 1H), 3.22 (d, J = 16.2 Hz, 1H), 3.38 (s, 3H). 
13C NMR (75 MHz, C6D6): δ -3.95, -3.89, 17.1, 18.8, 23.6, 26.3, 32.9, 33.4, 33.6, 35.1, 35.4, 
57.7, 116.7, 121.7, 147.4, 153.4.  
 
 
Allylation of 7-methoxy-8-methylbicyclo[4.3.1]dec-7-en-2-one (3.77) 
MeO
OMe
MeO
OMe
H
R1
R2
R3  R1 
 R1+R2 / R1+R3
 R1+R2+R3
mono:
di:
tri
allylation 
position
3.55 3.77  
KHMDS (0.927 μL of a 0.5 M solution in toluene, 0.44 mmol, 3 equiv) was added dropwise over 
90 min to a solution of the ketone 3.55 (30 mg, 0.15 mmol) in THF (2 mL) and HMPA (0.4 mL, 
20% v/v) at 0°C. The solution was stirred for 30 min at room temperature and then cooled to 0°C 
before the addition of allyl bromide (68 μL, 0.77 mmol, 5 equiv). The reaction was stirred for 12 
h at room temperature before quenching with saturated aqueous NH4Cl solution and extraction 
with EtOAc (10 mL x 3). The solvent was removed under reduced pressure and the residue 
purified by flash chromatography on silica, eluting with 3% EtOAc/pentane to give the tri-
allylated adduct (8 mg, 19%), two di-allylated adducts (15.4 mg, 43%) and monoallylated adduct 
(4.9 mg, 14%) as colourless oils. The structures of the di- and tri-allylated adducts were 
confirmed by 2D NMR spectroscopy. 
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1,3,3’-Triallyl-7-methoxy-8-methylbicyclo[4.3.1]dec-7-en-2-one 
1H NMR (500 MHz, CDCl3): δ 1.39-1.43 (m, 1H), 1.56 (s, 3H), 1.69 (m, 1H), 1.84 (ddd, J = 1.0, 
6.7, 14.6 Hz, 1H), 1.90 (ddd, 1H, J = 3.1, 7.5, 11.2 Hz, 1H), 1.96 (d, J = 16.3 Hz, 1H), 2.09 (dd, 
J = 7.4, 13.8 Hz, 1H), 2.16 (dd, J = 7.0, 13.9 Hz, 1H), 2.23-2.36 (m, 5H), 2.43 (dd, J = 6.7, 14.5, 
Hz, 2H), 2.50 (dd, J = 7.5, 14.5 Hz, 1H), 2.80 (s, 1H), 3.46 (s, 3H), 4.93-5.12 (m, 6H), 5.67 (m, 
3H). 
13C NMR (75 MHz, CDCl3): δ 15.8, 27.0, 30.1, 32.6, 35.4, 36.6, 41.9, 42.4, 45.7, 50.8, 55.1, 
57.0, 117.0, 117.4, 118.2, 118.3, 133.1, 134.1, 135.7, 148.1, 216.8. 
 
1,3,-Diallyl-7-methoxy-8-methylbicyclo[4.3.1]dec-7-en-2-one (as a 1:1 mixture of R1+R2 and 
R1+R3 diastereoisomers) 
1H NMR (500 MHz, CDCl3): δ 1.13 (m, 2H), 1.24 (m, 1H), 1.44 (m, 2H), 1.53-1.66 (m, 3H), 
1.58 (s, 3H), 1.60 (s, 3H), 1.73-1.84 (m, 4H), 1.84-1.98 (m, 2H), 2.00-2.09 (m, 2H), 2.13-2.43 
(m, 7H), 2.51-2.69 (m, 4H), 2.70 (br s, 1H), 2.76 (br s, 1H), 3.43 (s, 3H), 3.48 (s, 3H), 4.93-5.07 
(m, 8H), 5.60-5.72 (m, 4H). 
13C NMR (75 MHz, CDCl3): δ 15.6, 16.2, 27.0, 28.1, 28.9, 29.5, 31.6, 31.7, 33.3, 34.70, 34.74, 
35.8, 38.1, 39.2, 42.4, 44.6, 45.5, 49.4, 49.5, 54.7, 56.9, 57.6, 116.3, 116.4, 117.8, 118.1, 118.4, 
118.5, 132.9, 133.3, 135.2, 136.9, 148.5, 148.6, 216.8, 217.3.  
 
1-allyl-7-methoxy-8-methylbicyclo[4.3.1]dec-7-en-2-one 
1H NMR (500 MHz, CDCl3): δ 1.37 (q, J = 13.2 Hz, 1H), 1.41 (q, J = 13.2 Hz, 1H), 1.59 (s, 
3H), 1.71-1.77 (m, 1H), 1.79-1.88 (m, 2H), 1.97 (dd, J = 7.8, 13.2 Hz, 1H), 2.06 (dd, J = 3.2, 
13.2 Hz, 1H), 2.18 (dd, J = 1.6, 14.3 Hz, 1 H), 2.24 (dd, J = 7.5, 13.3 Hz, 1 H), 2.32 (dd, J = 
7.3, 11.2 Hz, 1 H), 2.49 (dd, J = 1.6, 16.3 Hz, 1 H), 2.56 (t, J = 11.4 Hz, 1 H), 2.82 (s, 1 H), 3.46 
(s, 1 H), 5.04 (dd, J = 13.5, 18.5 Hz, 1 H), 5.68 (m, 1H). 
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6.4 Experiments Described in Chapter Four 
 
2-Iodoprop-2-en-1-ol (4.7a)36 
OH OH
I
OP
I
= TBS
= MOM
= THP
P4.7a 4.7b
4.7c
4.7d  
Chlorotrimethylsilane (15.2 mL, 0.12 mol) was added dropwise to a solution of NaI (17.9 g, 0.12 
mol) dissolved in MeCN (100 mL) at room temperature. After stirring for 10 min, H2O (1.08 
mL, 0.06 mol) was added, followed after 5 min by propargyl alcohol (2.91 mL, 0.05 mol). The 
solution was stirred for 1 h and then quenched with the addition of H2O (200 mL) and extracted 
with Et2O (50 mL x 3). The combined organic phases were washed with saturated aqueous 
Na2S2O3 solution (20 mL), H2O (50 mL) and brine. The solvent was removed under reduced 
pressure and the residue purified by flash chromatography on alumina, eluting with 20% 
Et2O/pentane, to give 4.7a (4.7 g, 51%). 
 
FTIR (KBr, cm-1): 3325, 2916, 2857, 1629, 1443, 1400, 1231, 1146, 1034, 903, 648 
1H NMR (500 MHz, CDCl3): δ 4.17 (t, J = 1.4 Hz, 3H), 5.86 (m, 1H), 6.38 (q, J = 1.7 Hz, 1H). 
13C NMR (75 MHz, CDCl3): δ 70.6, 110.1, 124.4. 
HRMS (EI): calc. for C3H5IO: 183.9385; obs. 183.9385. 
 
Hydroxyl-protected derivatives of 4.7a were prepared using standard protection methodology.37 
 
tert-Butyl(2-iodoallyloxy)dimethylsilane (4.7b)38: prepared via the reaction of 4.7a (3 g, 16.3 
mmol) with TBS-Cl (2.70 g, 17.9 mmol, 1.1 equiv) and imidazole (2.44 g, 35.9 mmol, 2.2 equiv) 
in sufficient DMF to effect dissolution (8 mL). After stirring for 2 h, aqueous work-up and 
extraction with Et2O gave a quantitative return of the silylated adduct (4.9 g, 100%). 
 
FTIR (KBr, cm-1): 2955, 2932, 2858, 2361, 1628, 1470, 1258, 1134, 1084, 841, 780. 
1H NMR (500 MHz, CDCl3): δ 0.08 (s, 6H), 0.91 (s, 9H), 4.16 (t, J = 1.8 Hz, 2H), 5.80 (q, J = 
1.6 Hz, 1H), 6.41 (dd, J = 1.8, 3.6 Hz, 1H). 
13C NMR (75 MHz, CDCl3): δ -5.3, 18.3, 25.8, 71.0, 109.7, 122.8. 
HRMS (EI): calc. for C9H19IOSi: 298.0250; obs. 240.9544 (C5H10IOSi, M+ - tBu, calc: 
240.9546). 
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2-Iodo-3-(methoxymethoxy)prop-1-ene (4.7c): MOM-Cl (0.42 mL, 5.44 mmol, 2 equiv) was 
added to a solution of 4.7a (500 mg, 2.72 mmol) and Hünig’s base (1.18 mL, 6.79 mmol, 2.5 
equiv) in CH2Cl2 (5 mL) at 0°C. The solution was stirred at room temperature for 12 h, quenched 
with H2O and extracted with Et2O. The combined organics were washed with 1 M aqueous HCl 
solution followed by evaporation of the solvent under reduced pressure to give the title product 
as a colourless oil (0.546 g, 88%). 
 
FTIR (KBr, cm-1): 3452, 2889, 1628, 1447, 1400, 1215, 1153, 1103, 1045, 995, 907. 
1H NMR (500 MHz, CDCl3): δ 3.39 (s, 3H), 4.13 (m, 2H), 4.66 (d, J = 0.8 Hz, 2H), 5.90 (m, 
1H), 6.38 (m, 1H). 
13C NMR (75 MHz, CDCl3): δ 55.5, 74.2, 95.0, 105.9, 126.3.  
GCMS (EI): calc. for C5H9IO2: 227.9647; obs. 228. 
 
2-(2-Iodoallyloxy)-tetrahydro-2H-pyran (4.7d): DHP (496 μL, 5.44 mmol, 2 equiv) was added 
to a mixture of 4.7a (508 mg, 2.76 mmol) and p-TsOH (52 mg, 0.27 mmol, 10 mol %) in CH2Cl2 
(10 mL) at 0°C. The mixture was stirred for 1 h at 0°C and then at room temperature for 12 h. 
The solution was quenched with H2O and extracted with Et2O. The solvent was removed under 
reduced pressure and the residue purified by flash chromatography on silica, eluting with 10% 
EtOAc/petroleum ether, to give the THP protected adduct (551 mg, 74%). 
 
FTIR (KBr, cm-1): 2943, 2870, 1616, 1350, 1123, 1076, 1034, 980, 903, 872. 
1H NMR (500 MHz, CDCl3): δ 1.50-1.69 (m, 4H), 1.71-1.77 (m, 1H), 1.80-1.90 (m, 1H), 3.50-
3.54 (m, 1H) 3.86 (m, 1H), 4.24 (td, J = 1.3, 14.0 Hz, 1H), 4.10 (td, J = 1.3, 14.1 Hz, 1H), 4.68 
(t, J = 3.4 Hz, 1H), 5.88 (d, J = 1.1 Hz, 1H), 6.38 (q, J = 1.5 Hz, 1H). 
13C NMR (75 MHz, CDCl3): δ 18.9, 25.2, 30.2, 61.9, 73.7, 96.9, 106.7, 125.6. 
HRMS (EI): calc. for C8H13IO2: 267.9960: obs. 266.9893 (C8H12IO2, M+-H, calc: 266.9882), 
166.9324 (C3H4I, M+-OTHP, calc: 166.9358), 141.0910 (C8H13O2, M+-I, calc: 141.0916). 
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Hydrostannylation of Propargyl Alcohol Derivatives 
OR OR
SnBu3
ORBu3Sn
4.8a
4.8b
4.8c
4.8d
R = OH
R = OMOM
R = OTHP
R = OTBS
4.8a-β
4.8b-β
4.8c-β
4.8d-β  
Hydrostannylation of propargyl alcohol and its protected derivatives was performed using the 
molybdenum catalyst Mo(t-BuNC)3(CO)3 and the method described in Protocol B–b. The 
protected propargyl alcohols were prepared via standard protection methodology.37 
 
2-(Tributylstannyl)prop-2-en-1-ol (4.8a) and (E)-3-(Tributylstannyl)prop-2-en-1-ol (4.8a-β) 
Stannylation of propargyl alcohol (56 mg, 1 mmol) in THF (1 mL) led to the isolation of 4.8a 
(271 mg, 78%) and 4.8a-β (3.8 mg, 1%) as colourless oils. The spectroscopic data acquired for 
these compounds were in agreement with reported literature values.39 
 
2-(Tributylstannyl)prop-2-en-1-ol (4.8a)39  
FTIR (KBr, cm-1): 3314, 2959, 2938, 1462, 1377, 1022, 918, 667. 
1H NMR (500 MHz, CDCl3): δ 0.86-0.94 (m, 15H), 1.31 (qd, J = 7.3, 14.4 Hz, 6H), 1.45-1.52 
(m, 6H), 4.27 (tt, J = 5.9 Hz, 3JSn-H = 30.0 Hz, 2H), 5.24 (dt, J = 1.7 Hz, 3JSn-H = 61.5 Hz, 1H), 
5.87 (dt, J = 1.8 Hz, JSn-H =128.9 Hz, 1H). 
13C NMR (75 MHz, CDCl3): δ 9.4, 13.6, 27.3, 29.1, 69.4, 122.7, 154.7. 
 
(E)-3-(Tributylstannyl)prop-2-en-1-ol (4.8a-β)39 
1H NMR (500 MHz, CDCl3): δ 0.86-0.90 (m, 15H), 1.30 (qd, J = 7.3, 14.5 Hz, 6H), 1.39-1.52 
(m, 6H), 4.16 (dd, J = 3.5, 5.6 Hz, 2H), 6.13-6.21 (m, 2H). 
 
 
Tributyl(3-(methoxymethoxy)prop-1-en-2-yl)stannane (4.8b) 
Stannylation of 3-(methoxymethoxy)prop-1-yne (500 mg, 5 mmol) in THF (5 mL) led to the 
isolation of 4.8b as a colourless oil (1.58 g, 81%). 
 
FTIR (KBr, cm-1): 2955, 2938, 2874, 1462, 1150, 1107, 1049, 922. 
1H NMR (500 MHz, CDCl3): δ 0.85-0.92 (m, 15H), 1.30 (qd, J = 7.3, 14.4 Hz, 6H), 1.44-1.52 
(m, 6H), 3.36 (s, 3H), 4.18 (td, J = 1.7 Hz, 3JSn-H = 16.3 Hz, 2H), 4.62 (s, 2H) 5.26 (tdd, 1H, J = 
1.6, 4.2 Hz, 3JSn-H = 31.6 Hz, 1H), 5.88 (tdd, 1H, J = 1.8, 4.4 Hz, 3JSn-H = 66.2 Hz, 1H). 
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13C NMR (75 MHz, CDCl3): δ 9.5, 13.7, 27.3, 29.1, 55.2, 74.2, 95.5, 125.7, 152.0.  
HRMS (EI): calc. for C13H27O2Sn: 392.1737; obs. 335.1045 (C13H27O2Sn, M+ - Bu, calc: 
335.1033). 
 
 
Tributyl(3-(tetrahydro-2H-pyran-2-yloxy)prop-1-en-2-yl)stannane 4.8c 
Stannylation of 2-(prop-2-ynyloxy)-tetrahydro-2H-pyran (140.2 mg, 1 mmol) in THF (1 mL) led 
to the isolation of 4.8c as a colourless oil (140 mg, 32%), (60% b.r.s.m.). 
 
FTIR (KBr, cm-1): 2955, 2938, 2870, 1462, 1119, 1080, 1030, 976. 
1H NMR (500 MHz, CDCl3): δ 0.85-0.98 (m, 15H), 1.26-1.34 (m, 6H), 1.42-1.64 (m, 10H), 
1.67-1.74 (m, 1H), 1.80-1.88 (m, 1H), 3.48-3.53 (m, 1H), 3.83-3.88 (m, 1H), 4.04 (dtt, J = 1.7, 
12.8, Hz, 3JSn-H = 16.5 Hz, 1H), 4.39 (dtt, J = 1.7, 12.8 Hz, 3JSn-H = 16.5 Hz, 1H), 4.63 (t, J = 3.4 
Hz, 1H), 5.24 (dtt, J = 1.8, 2.6 Hz, 3JSn-H = 30.5 Hz, 1H), 5.89 (dtt, J = 1.8, 2.6 Hz, 3JSn-H = 66.9 
Hz, 1H).  
13C NMR (75 MHz, CDCl3): δ 9.6, 13.7, 19.2, 25.5, 27.4, 29.1, 30.5, 61.7, 74.2, 97.9, 124.2, 
152.4.  
HRMS (EI): calc. for C20H40OSn: 432.205; obs. 375.1354 (C16H31O2Sn, M+ - Bu, calc: 
375.1346). 
 
 
tert-Butyldimethyl(2-(tributylstannyl)allyloxy)silane (4.8d) 
Stannylation of tert-butyldimethyl(prop-2-ynyloxy)silane (500 mg, 2.9 mmol) in THF (5 mL) led 
to the isolation of 4.8d (817 mg, 60%) and 4.8d-β (59 mg, 4%) as colourless oils. 
 
FTIR (KBr, cm-1): 2955, 2928, 2855, 1462, 1254, 1076, 853, 775.  
1H NMR (500 MHz, CDCl3): δ 0.05 (s, 6H), 0.86-0.91 (m, 15H), 0.90 (s, 9H), 1.30 (qd, J = 7.3, 
14.5 Hz, 6H), 1.44-1.51 (m, 6H), 4.27 (tt, J = 1.9 Hz, 3JSn-H = 12.7 Hz, 2H), 5.16 (tdd, 1 H, J = 
1.9, 4.6 Hz, 3JSn-H = 32.4 Hz, 1H), 5.85 (tdd, 1H, J = 2.0, 4.7 Hz, 3JSn-H = 64.8 Hz, 1H). 
13C NMR (75 MHz, CDCl3): δ -5.3, 9.5, 13.7, 18.5, 26.0, 27.4, 29.2, 69.7, 121.9, 154.8.  
HRMS (EI): calc. for C21H46OSiSn: 462.2340; obs. 405.1631 (C17H37OSiSn, M+ - Bu, calc: 
405.1636). 
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(But-2-ynyloxy)(tert-butyl)dimethylsilane (4.21a) and 2-(But-2-ynyloxy)-tetrahydro-2H-
pyran (4.21b) 
MeRORO
4.21a
4.21b
R = TBS
R = THP  
 
(But-2-ynyloxy)(tert-butyl)dimethylsilane (4.21a)40 
n-BuLi (10.2 mL of a 1.6 M solution in hexanes, 16.3 mmol, 1.1 equiv) was added dropwise to 
tert-butyldimethyl(prop-2-ynyloxy)silane (2.54 g, 14.9 mmol) in THF (100 mL) at -50°C and 
stirred at -50°C for 2 h. Methyl iodide (0.93 mL, 45 mmol, 3 equiv) was added in one portion 
and the solution warmed to room temperature and stirred for 6 h. The mixture was quenched 
with the addition of saturated aqueous NH4Cl solution (100 mL) and H2O (300 mL) and 
extracted with CH2Cl2 (20 mL x 3). The solvents were removed under reduced pressure to give 
4.21a as light yellow liquid (2.57 g, 92%).  
 
The spectroscopic data was in agreement with the reported literature values.40 
FTIR (KBr, cm-1): 2932, 2858, 1466, 1369, 1254, 1146, 1080, 1103, 837, 779. 
1H NMR (500 MHz, CDCl3) δ 0.10 (s, 6H), 0.90 (s, 9H), 1.82 (t, J = 2.3 Hz, 3H), 4.26 (q, J = 
2.3 Hz, 2H). 
13C NMR (75 MHz, CDCl3): δ -5.3, 3.4, 18.3, 25.8, 51.8, 77.7, 80.8. 
 
 
2-(But-2-ynyloxy)-tetrahydro-2H-pyran (4.21b) 41 
Prepared via the method described above: 2-(Prop-2-ynyloxy)-tetrahydro-2H-pyran (2.92 g, 20.8 
mmol) was reacted with n-BuLi (15.6 mL of a 1.6M solution in hexanes, 25 mmol, 1.1 equiv) 
and the lithio species quenched with methyl iodide (6.5 mL, 104 mmol) to give the title 
compound upon work-up (3.14 g, 98%).  
 
FTIR (KBr, cm-1): 2943, 2870, 1443, 1346, 1265, 1119, 1026, 903. 
1H NMR (500 MHz, CDCl3): δ 1.48-1.82 (m, 6H), 1.84 (t, J = 2.3 Hz, 1H), 3.51 (td, J = 4.8, 
10.3 Hz, 1H), 3.77-3.86 (m, 1H), 4.14 (dq, J = 2.2, 15.2 Hz, 1H), 4.26 (dq, J = 2.2, 15.2 Hz, 1H), 
4.78 (t, J = 3.3 Hz, 1H).  
13C NMR (75 MHz, CDCl3): δ 3.1, 18.8, 25.1, 29.9, 54.1, 61.4, 74.7, 81.5, 96.2.  
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(E)-tert-Butyldimethyl(2-(tributylstannyl)but-2-enyloxy)silane (4.10a) and (E)-tert-
butyldimethyl(3-(tributylstannyl)but-2-enyloxy)silane (4.10a-β) 
TBSO
Me
SnBu3
Me
TBSO TBSO
Me
SnBu3
4.21a 4.10a 4.10a-β  
Prepared using Protocol B-a (23°C, 12 h); stannylation of 4.21a (147 mg, 0.8 mmol) in THF (5 
mL) led to the isolation of the products 4.10a (137.5 mg, 36%) and 4.10a-β (80.8 mg, 21%). 
 
(E)-tert-Butyldimethyl(2-(tributylstannyl)but-2-enyloxy)silane (4.10a) 
FTIR (KBr, cm-1): 2955, 2928, 2856, 2365, 1464, 1258, 1082, 853, 835, 779. 
1H NMR (500 MHz, CDCl3) δ 0.06 (s, 6H), 0.82-0.87 (m, 4H), 0.87 (t, J = 7.5 Hz, 9H), 0.91 (s, 
9H), 1.29 (m, 6H), 1.34-1.52 (m, 18H), 1.63 (ddt, J = 1.3, 6.8, 5.5 Hz, 3H), 4.36 (tdd, J = 1.2, 2.3 
Hz, 3JSn-H = 35.0 Hz, 2H), 5.54 (td, J = 2.5, 6.5 Hz, 1H). 
13C NMR (75 MHz, CDCl3): δ -5.3, 10.1, 13.7, 15.3, 18.6, 26.2, 27.5, 29.3, 64.7, 131.5, 148.0. 
HRMS (EI): calc. for C22H48OSiSn: 476.2496; obs. 419.1773 (C18H39OSiSn, M+- Bu, calc: 
419.1792). 
 
(E)-tert-butyldimethyl(3-(tributylstannyl)but-2-enyloxy)silane (4.10a-β)42 
FTIR (KBr, cm-1): 2928, 2959, 2855, 1462, 1377, 1254, 1088, 1042, 837, 775, 667. 
1H NMR (500 MHz, CDCl3): δ 0.06 (s, 6H), 0.85-0.93 (m, 15H), 0.90 (s, 9H), 1.27-1.37 (m, 
12H), (q, J = 7.8 Hz, 6H), 1.44-1.51 (m, 6H), 1.60-1.67 (m, 6H), 1.82 (t, 3JSn-H = 45.0 Hz, 3H), 
5.51 (d, J = 4.3 Hz, 2H), 5.64 (t, 3JSn-H = 68.0 Hz, 1H). 
13C NMR (75 MHz, CDCl3): δ -5.1, 9.0, 13.6, 17.5, 25.9, 27.4, 27.8, 29.1, 60.0, 139.1, 140.7. 
 
 
(E)-Tributyl(1-(tetrahydro-2H-pyran-2-yloxy)but-2-en-2-yl)stannane (4.10b) and (E)-
Tributyl(4-(tetrahydro-2H-pyran-2-yloxy)but-2-en-2-yl)stannane  (4.10b-β) 
THPO
Me
SnBu3
Me
THPO THPO
Me
SnBu3
4.21b 4.10b 4.10b-β  
Prepared using Protocol B-a (23°C, 12 h); stannylation of 4.21b (103 mg, 0.67 mmol) in THF (5 
mL) led to the isolation of the products 4.10b (85.1 mg, 29%) and 4.10b-β (40.3 mg, 14%). 
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(E)-Tributyl(1-(tetrahydro-2H-pyran-2-yloxy)but-2-en-2-yl)stannane (4.10b)43  
FTIR (KBr, cm-1): 2955, 2924, 2361, 2341, 1026. 
1H NMR (500 MHz, CDCl3): δ 0.87 (t, J = 7.5 Hz, 9H), 1.29 (m, 6H), 1.39-1.74 (m, 17H), 1.67 
(dt J = 1.0, 6.5 Hz, 3H), 1.79-1.89 (m, 1H), 3.52 (ddt, J = 1.5, 4.0, 11.5 Hz, 1H), 3.84 (t, 1H), 
4.04 (tddd, J = 1.5, 2.5, 13.0, 17.0 Hz, 1H), 4.54 (tddd, J = 1.3, 2.4, 13.0, 17.2 Hz, 1H), 4.65 (t, J 
= 3.5 Hz, 1H), 5.63 (tq, J = 2.3, 6.5 Hz, 1H). 
13C NMR (75 MHz, CDCl3): δ 10.0, 13.7, 15.5, 19.1, 25.5, 27.4, 29.2, 30.5, 61.5, 69.3, 98.3, 
133.4, 143.9. 
HRMS (EI): calc. for C17H34O2Sn: 446.2007; obs. 389.1505 (C17H33O2Sn, M+- Bu, calc: 
389.1503). 
 
Tributyl(4-(tetrahydro-2H-pyran-2-yloxy)but-2-en-2-yl)stannane  (4.10b-β)44 
FTIR (KBr, cm-1): 2955, 2926, 2361, 2341, 1024. 
1H NMR (500 MHz, CDCl3): δ 0.88 (t, J = 7.5 Hz, 9H), 1.30 (qd, J = 7.5, 14.5 Hz, 6H), 1.39-
1.62 (m, 8H), 1.69-1.75 (m, 2H), 1.80-1.88 (m, 2H), 1.87 (t, J = 1.0 Hz, 3H), 3.50 (m, 1H), 3.89 
(ddd, J = 3.0, 7.5, 11.0 Hz, 1H), 4.168 (dd, J = 6.5, 12.5 Hz, 1H), 4.28 (dd, J = 5.4, 12.6 Hz, 1H), 
4.62 (dd, J = 3.5, 4.0 Hz, 1H), 5.67-5.71 (m, 1H). 
13C NMR (75 MHz, CDCl3): δ 9.1, 13.7, 19.5, 19.6, 25.5, 27.4, 29.1, 30.7, 62.4, 63.1, 97.9, 
136.5, 142.8. 
HRMS (EI): calc. for C17H34O2Sn: 446.2007; obs. 389.1501 (C17H33O2Sn, M+- Bu, calc: 
389.1503). 
 
 
(Z)-6-((tert-Butyldimethylsilyloxy)methyl)-N-methoxy-N-methyl-5-methyleneoct-6-enamide 
(4.22) 
N
OMe
O
Me
OTBSMe
N
OMe
O
Me
OTBSMe
SnBu3
I
4.222.94.10a  
A solution of 2.9 (106 mg, 0.37 mmol) and 4.10a (268 mg, 0.56 mmol) in NMP (5 mL) was 
degassed with Ar for 5 min at 0°C. Solid CuTC (142 mg, 0.75 mmol) was added in one portion 
and the reaction allowed to warm to room temperature with stirring over 12 h. The mixture was 
quenching via addition of saturated aqueous NH4Cl solution (100 mL) and extracted with Et2O 
(25 mL x 3). The combined organic layers were washed successively with 1 M aqueous HCl 
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solution (20 mL) and H2O (20 mL x 5) to remove residual NMP. The solvent was removed under 
reduced pressure and the residue purified by flash chromatography on silica, eluting with 10% 
EtOAc/petroleum ether, to give the 4.22 as a colourless oil (30 mg, 24%) followed by unreacted 
2.9 (60 mg, 56% recovery). 
 
FTIR (KBr, cm-1): 2955, 2932, 2856, 1665, 1462, 1414, 1387, 1254, 1178, 1080, 1003, 837, 
775. 
1H NMR (500 MHz, CDCl3): δ 0.05 (s, 6H), 0.09 (s, 9H), 1.76 (d, J = 6.9 Hz, 3H), 1.73-1.79 (m, 
2H), 2.29 (t, J = 7.5 Hz, 2H), 2.40 (t, J = 7.1 Hz, 2H), 3.17 (s, 3H), 3.66 (s, 3H), 4.32 (s, 2H), 
4.87 (s, 1H), 5.11 (s, 1H), 5.74 (q, J = 6.9 Hz, 1H). 
13C NMR (75 MHz, CDCl3): δ -5.3, 13.8, 18.3, 23.2, 25.9, 31.4, 32.2, 33.7, 58.8, 61.1, 111.4, 
124.5, 126.0, 139.2, 147.6, 174.2. 
HRESIMS (EI): calc. C18H35NO3Si: 342.2465 (MH+); obs. 342.2472. 
 
 
Methyl 7-hdroxyhept-5-ynoate (4.42) 
THPO HO
OMe
O
THPO R
R = Cl
= CN
= CO2H
= CO2Me
4.42
 
Prepared by the method initially reported by Corey and Sachdev45 as detailed by Haynes et al.46 
and by Luo and Negishi.47 Spectroscopic details of all intermediates were in agreement with 
those reported in the literature. 
 
2-(6-Chlorohex-2-ynyloxy)-tetrahydro-2H-pyran46 
n-BuLi (343 mL of a 1.6M solution in hexanes, 0.55 mol) was added dropwise to a solution of 2-
(prop-2-ynyloxy)-tetrahydro-2H-pyran48 (70 g, 0.5 mol) in THF (500 mL) at -30°C over 1 h. The 
solution was stirred at -15°C for 30 min, 0°C for 30 min and then treated with the dropwise 
addition of 1-bromo-3-chloropropane (74.2 mL, 0.75 mol) in THF (100 mL). The resultant 
mixture was stirred at -30°C for 30 min and then heated to reflux for 16 h. The reaction was 
quenched with the addition of H2O (100 mL) and the solvents removed under reduced pressure 
to give a dark brown liquid which was diluted into H2O (1.5 L) and extracted with Et2O (200 mL 
x 4). Evaporation of the solvent and distillation under reduced pressure gave a pre-run of 1-
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bromo-3-chloropropane (45-60°C / 0.1 mmHg) followed by the alkyl-chloride as a colourless 
liquid (88.5 g, 82%). 
bp: 86-88°C / 0.1 mmHg, [lit. 112-114°C / 0.25 mmHg)47 
FTIR (KBr, cm-1): 2943, 2870, 1443, 1346, 1204, 1119, 1076, 1022, 903. 
1H NMR (500 MHz, CDCl3): δ 1.47-1.64 (m, 4H), 1.72 (tt, J = 3.2, 10.1 Hz, 1H), 1.77-1.85 (m, 
1H), 1.94 (qn, J = 6.6, 6.7 Hz, 2H), 2.40 (t, J = 6.8 Hz, 2H), 3.49-3.53 (m, 1H), 3.62 (t,  J = 6.4 
Hz, 2H), 3.79-3.84 (m, 1H), 4.17 (d, J = 15.3 Hz, 1H), 4.26 (d, J = 15.3 Hz, 1H), 4.77 (t, J = 3.3 
Hz, 1H). 
13C NMR (75 MHz, CDCl3): δ 16.0, 18.9, 25.2, 30.1, 31.1, 43.4, 54.2, 61.7, 76.7, 84.2, 96.5. 
 
7-(Tetrahydro-2H-pyran-2-yloxy)hept-5-ynenitrile46 
The above obtained alkyl chloride (83.1 g, 0.38 mol) was added dropwise to a solution of dry 
NaCN (20.8 g, 0.42 mol) in DMSO (300 mL) at 50°C such that the internal temperature did not 
exceed 65°C [Note: mild exotherm]. The solution was heated to 80°C for 48 h, cooled and 
quenched with the addition of H2O (2 L). The aqueous layer was extracted with Et2O (200 mL x 
4) and the combined organic layers washed with H2O (200 mL x 3) to remove residual DMSO. 
Evaporation of the solvents under reduced pressure gave a black oil which was distilled under 
reduced pressure to give the alkyl nitrile product as a colourless oil (65.5 g, 82%). 
 
bp: 120°C / 0.1 mmHg, [lit. 105-108°C at / 0.015 mm Hg]46 
FTIR (KBr, cm-1): 2943, 2870, 1442, 1346, 1119, 1022, 907, 733. 
1H NMR (500 MHz, CDCl3): δ 1.48-1.64 (m, 4H), 1.69-1.76 (m, 1H), 1.77-1.89 (m, 4H), 2.40 
(t, J = 6.7 Hz, 2H), 2.48 (t, J = 7.2 Hz, 2H), 3.49-3.54 (m, 1H), 3.82 (m, 1H), 4.19 (d, J = 15.4 
Hz, 1H), 4.29 (d, J = 15.4 Hz, 1 H), 4.76 (t, J = 3.3 Hz, 1H). 
13C NMR (75 MHz, CDCl3): δ 16.4, 18.3, 19.4, 24.8, 25.7, 30.6, 54.7, 62.3, 78.3, 83.9, 97.1, 
119.5. 
 
7-(Tetrahydro-2H-pyran-2-yloxy)hept-5-ynoic acid47 
The above obtained alkyl cyanide (5 g, 24.1 mmol) was heated to reflux in a solution of EtOH 
(150 mL) and 10% aqueous NaOH (150 mL) until the evolution of ammonia ceased (ca. 36 h). 
The mixture was cooled, diluted with ice-cold H2O (250 mL), acidified with conc. aqueous HCl 
solution and then extracted with Et2O (100 mL x 3). Evaporation of the solvent gave the title 
compound as a colourless oil (5.1 g, 94%) 
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FTIR (KBr, cm-1): 3105, 3047, 2943, 2870, 2361, 1709, 1439, 1204, 1118, 1022, 903. 
1H NMR (500 MHz, CDCl3): δ 1.47-1.75 (m, 6H), 1.83 (qn, 2H), 2.30 (t, J = 6.9 Hz, 2H), 2.47 
(t, J = 7.4 Hz, 2H), 3.47-3.54 (m, 1H), 3.80-3.85 (m, 1H), 4.18 (d, J = 15.3 Hz, 1H), 4.27 (d, J = 
15.3 Hz, 1H), 4.79 (t, J = 3.3 Hz, 1H). 
13C NMR (75 MHz, CDCl3): δ 18.0, 18.9, 23.3, 25.2, 30.1, 32.6, 54.4, 61.8, 76.7, 85.0, 96.5, 
178.6. 
 
Methyl 7-(tetrahydro-2H-pyran-2-yloxy)hept-5-ynoate47 
A solution of crude 7-(tetrahydro-2H-pyran-2-yloxy)hept-5-ynoic acid (6.23 g, 27.6 mmol) in 
DMF (100 mL) was treated with anhydrous K2CO3 (5.7 g, 41.4 mmol) and methyl iodide (2.6 
mL, 41.4 mmol). After stirring for 12 h at room temperature, the solution was quenched with 
H2O (300 mL) and extracted with Et2O (100 mL x 3). The solvent was removed under reduced 
pressure to give the title compound as a colourless oil (6.09 g, 92%). 
 
FTIR (KBr, cm-1): 2947, 2870, 1740, 1439, 1362, 1203, 1161, 1119, 1026. 
1H NMR (500 MHz, CDCl3): δ 4.19-1.65 (m, 4H), 1.70-1.76 (m, 1H), 1.83 (qn, 2H), 2.29 (tt, J = 
2.1, 7.0 Hz, 2H), 2.43 (t, J = 7.4 Hz, 2H), 3.48-3.54 (m, 1H), 3.67 (s, 3H). 
13C NMR (75 MHz, CDCl3): δ 18.0, 18.9, 23.5, 25.1, 30.0, 32.5, 51.3, 54.2, 61.7, 76.5, 84.9, 
96.4, 173.2.  
 
Methyl 7-hydroxyhept-5-ynoate (4.42)46 
The above obtained ester (6 g, 25.0 mmol) in MeOH (100 mL) was treated with catalytic PPTS 
(150 mg, 2 mol %) and allowed to stir at room temperature for 12 h. The solution was quenched 
via the addition of saturated aqueous NaHCO3 solution (100 mL) and extracted with Et2O (100 
mL x 3). The solvent was removed under reduced pressure and the product distilled to give 4.42 
(3.51 g, 90%). 
 
bp: 120°C / 0.1 mmHg, [lit. 105-108°C / 0.015 mm Hg].47 
FTIR (KBr, cm-1): 3425, 2951, 2924, 1736, 1439, 1669, 1127, 1161, 1015. 
1H NMR (500 MHz, CDCl3): δ 1.81 (m, 2H), 2.27 (t, J = 6.9 Hz, 2H), 2.42 (t, J = 7.4 Hz, 2H), 
3.65 (s, 3H), 4.21 (s, 2H). 
13C NMR (75 MHz, CDCl3): δ 17.8, 23.4, 32.4, 50.4, 51.3, 79.2, 84.1, 173.6  
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Methyl 7-(methoxymethoxy)hept-5-ynoate (4.43) 
MOMO
CO2Me
HO
CO2Me
4.42 4.43  
MOM-Cl (0.974 mL, 12.8 mmol) was added dropwise to a solution of 4.42 (1 g, 6.4 mmol) and 
Hünig’s base (2.79 mL, 16.0 mmol) in CH2Cl2 (20 mL) at 0°C and stirred at room temperature 
for 12 h. The reaction mixture was quenched with the addition of saturated aqueous NaHCO3 
solution (50 mL) and extracted with Et2O (50 mL x 3). The organic layer was washed with 1 M 
HCl solution (10 mL) and the solvent removed under reduced pressure. Purification of the 
residue by flash chromatography on silica gel, eluting with 20% EtOAc/petroleum ether, gave 
4.43 as a colourless oil (1.28 g, 100%).  
 
FTIR (KBr, cm-1): 2951, 2893, 1740, 1439, 1373, 1215, 1153, 1045, 991, 921. 
1H NMR (500 MHz, CDCl3): δ 1.83 (qn, J = 7.2 Hz, 2H), 2.29 (tt, J = 2.2, 6.9 Hz, 2H), 2.43 (t, J 
= 7.4 Hz, 2H), 3.36 (s, 3H), 3.66 (s, 3H), 4.18 (t, J = 2.2 Hz, 2H), 4.68 (s, 2H). 
13C NMR (75 MHz, CDCl3): δ 17.9, 23.5, 32.5, 51.3, 54.3, 55.2, 76.2, 85.3, 94.4, 173.2.  
HRMS (EI): calc. for C10H16O4: 200.1049; obs. 170.0935 (C9H14O3, M+ - OCH2, calc: 
170.0943), 155.0690 (C8H11O3, M+-CH2OMe, calc: 155.0708). 
 
 
Methyl 7-(tert-butyldimethylsilyloxy)hept-5-ynoate (4.44) 
HO
OMe
O
TBSO
OMe
O
4.42 4.44  
The alkynyl alcohol 4.42 (4.6 g, 29.5 mmol), TBDMS-Cl (4.9 g, 32.5 mmol, 1.1 equiv) and 
imidazole (4.4 g, 65.0 mmol, 2.2 equiv) were sequentially placed in a dry flask with a magnetic 
stirring bar and flushed with argon. Sufficient dry DMF (~14 mL) was then added to effect 
solution and the reaction stirred at room temperature for 12 h. The reaction was diluted into 200 
mL of pentane and washed with H2O (3 x 50 mL). The solvent was removed under reduced 
pressure and the residue purified by flash chromatography on silica gel, eluting with 10% 
EtOAc/petroleum ether, to give 4.44 as a colourless oil (7.3 g, 92%).  
 
FTIR (KBr, cm-1): 2932, 2859, 1744, 1439, 1370, 1254, 1138, 1080, 837, 779. 
1H NMR (500 MHz, CDCl3): δ 0.10 (s, 6H), 0.90 (s, 9H), 1.82 (q, J = 7.1 Hz, 2H), 2.27 (tt, J = 
2.2, 6.9 Hz, 2H), 2.43 (t, J = 7.5 Hz, 2H), 3.67 (s, 3H), 4.29 (dd, J = 2.0 Hz, 4.1 Hz, 2H). 
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13C NMR (75 MHz, CDCl3): δ -5.2, 18.1, 18.2, 23.6, 25.7, 32.6, 51.3, 51.7, 79.5, 83.8, 173.3. 
HRMS (EI): calc. for C14H26O3Si: 270.1651; obs. 239.1453 (C13H23O2Si, M+- OMe, calc: 
239.1467), 213.0953 (C10H17O3Si, M+- t-Bu, calc: 213.0947). 
 
 
Methyl 6-((methoxymethoxy)methyl)-5-methylenehept-6-enoate (4.46) 
MOMO
OMe
O
MOMO OMe
O
4.43 4.46  
The alkyne 4.43 (400 mg, 2.04 mmol) was dissolved in toluene (40 mL) and sparged with 
ethylene for 5 min. Grubbs II catalyst 4.25 (34 mg, 0.04 mmol, 2 mol %) was added and the 
flask sealed under an ethylene atmosphere maintained by an attached balloon. The solution was 
heated at 80°C for 6 h with vigorous stirring resulting in complete consumption of the starting 
alkyne, as assessed by 1H NMR spectroscopy. The reaction was quenched via the addition of 
ethyl vinyl ether (0.5 mL) and the solvent removed under reduced pressure and the residue 
purified by flash chromatography on silica, eluting with 10% EtOAc/petroleum ether, to give 
4.46 as a colourless oil (440 mg, 96%). 
 
FTIR (KBr, cm-1): 2951, 2889, 1740, 1597, 1439, 1150, 1107, 1053, 914. 
1H NMR (500 MHz, CDCl3): δ 1.80 (qn, J = 7.5 Hz, 2H), 2.32 (t, J = 7.5 Hz, 2H), 2.30 (t, J = 
7.5 Hz, 2H), 3.37 (s, 3H), 3.66 (s, 3H), 4.22 (d, J = 1.8 Hz, 2H), 4.65 (s, 2H), 5.00 (s, 1H), 5.15 
(s, 1H), 5.27 (s, 1H), 5.28 (s, 1H). 
13C NMR (75 MHz, CDCl3): δ 23.3, 33.0, 33.1, 51.1, 55.0, 68.0, 94.2, 112.6, 113.9, 142.6, 
144.3, 173.5. 
HRMS (EI): calc. for C10H16O4: 228.1361; obs. 198.1259 (C11H18O3, M+ - OCH2, calc. 
198.1256), 184.1101 (C10H16O3, M+ - CH2OMe, calc. 184.1099) 
 
 
Methyl 6-((tert-butyldimethylsilyloxy)methyl)-5-methylenehept-6-enoate (4.47) 
TBSO
OMe
O
TBSO OMe
O
4.44 4.47  
 
Chapter Six – Experimental Details 261 
 
Atmospheric Ethylene Pressure: 
The silyl-alkyne 4.44 (5 g, 18.5 mmol) was dissolved in toluene (100 mL) in a 250 mL flask 
equipped with a magnetic stirring bar and sparged with ethylene for 5 min. Grubbs II catalyst 
4.25 (785 mg, 0.93 mmol, 5 mol %) was added and the flask sealed under a ethylene atmosphere 
maintained by an attached balloon. The solution was heated at 80°C for 12 h with vigorous 
stirring. The reaction was monitored via 1H NMR spectroscopy of 100 μL sample aliquots. If 
necessary, additional catalyst (1 mol %) was added portion-wise to ensure complete conversion. 
Upon completion the reaction was cooled and quenched with the addition of ethyl vinyl ether (2 
mL). Evaporation of the solvent yielded a black oil which was purified by flash chromatography 
on silica, eluting with 7.5% EtOAc/petroleum ether, to give 4.47 as a colourless oil (4.62 g, 
84%). 
 
High Pressure:  
To a Parr stainless steel reaction vessel (with internal pressure and temperature control) was 
added 4.44 (1 g, 3.7 mmol), Grubbs II catalyst 4.25 (62 mg, 0.07 mmol, 2 mol %) and DCE (50 
mL). The assembled reactor vessel was purged with ethylene (x 3), sealed and pressurised to 80 
psi. The reactor was heated to 55°C, resulting in an increase in pressure to 109 psi, and stirred for 
24 h. A sample aliquot indicated complete conversion after 24 h, as assessed by 1H NMR 
spectroscopy. The solution was quenched with the addition of ethyl vinyl ether (2 mL) and the 
solvent evaporated under reduced pressure to yield a black oil. Purification of this material via 
flash chromatography on silica, eluting with 7.5% EtOAc/petroleum ether, gave 4.47 as a 
colourless oil (1.02 g, 92%). 
 
FTIR (KBr, cm-1): 2955, 2858, 1744, 1597, 1462, 1254, 1169, 1096, 903, 837, 775. 
1H NMR (500 MHz, CDCl3): δ 0.07 (s, 6H), 0.91 (s, 9H), 1.79 (qn, 2H), 2.28 (t, J = 7.8 Hz, 2H), 
2.31 (t, J = 7.7 Hz, 2H), 3.66 (s, 3H), 4.29 (s, 2H), 4.91 (s, 1H), 4.99 (s, 1H), 5.19 (s, 1H), 5.33 
(s, 1H). 
13C NMR (75 MHz, CDCl3): δ -5.3, 23.5, 33.2, 33.4, 51.4, 55.3, 68.3, 95.5, 112.9, 114.2, 142.8, 
144.5, 173.8. 
HRMS (EI): calc. for C16H30O3Si: 298.19642; obs. 283.1719 (C15H27O3Si, M+ - Me, calc: 
283.1730), 241.1257 (C12H21O3Si, M+ - tBu, calc: 241.1260). 
 
 
Chapter Six – Experimental Details  
 
262 
N-Methoxy-6-((methoxymethoxy)methyl)-N-methyl-5-methylenehept-6-enamide (4.17) 
MOMO N
O
OMe
Me
MOMO OMe
O
4.46 4.17  
Me3Al (16.4 mL of a 2 M solution in toluene, 32.9 mmol) was added dropwise to a stirred 
suspension of N,O-dimethylhydroxylamine hydrochloride (3.34 g, 34.2 mmol) in CH2Cl2 (150 
mL) at -40°C and allowed to warm to room temperature over 1 h. A solution of MOM-ester 4.46 
(3.00 g, 13.2 mmol) in CH2Cl2 (20 mL) was added via cannula and the solution refluxed for 16 
h. The cooled reaction mixture was quenched with a saturated aqueous solution of Na/K-tartrate 
(100 mL) and stirred vigorously for 1 h resulting in separation of the mixture into two clear 
layers. The aqueous layer was extracted with CH2Cl2 (50mL x 3) and the combined organic 
layers evaporated under reduced pressure to give a yellow oil. The crude material was purified 
by flash chromatography on silica, eluting with 40% EtOAc/petroleum ether, to give 4.17 as a 
colourless oil (2.49g, 73%) and returned starting material 4.46 (0.255 g, 8.5%). 
 
FTIR (KBr, cm-1): 3503, 2939, 2889, 1666, 1443, 1416, 1385, 1150, 1107, 1053, 995, 918. 
1H NMR (500 MHz, CDCl3): δ 1.81 (q, 2H), 2.32 (t, J = 7.3 Hz, 2H), 2.43 (t, J = 7.2 Hz, 2H), 
3.16 (s, 3H), 3.37 (s, 3H), 3.66 (s, 3H), 4.22 (s, 2H), 4.65 (s, 2H), 5.01 (s, 1H), 5.14 (s, 1H), 5.27 
(s, 1H), 5.31 (s, 1H). 
13C NMR (75 MHz, CDCl3): δ 23.0, 31.1, 31.9, 33.3, 55.1, 60.9, 68.2, 96.3, 112.5, 114.0, 142.7, 
144.7. 174.1. 
HRESIMS (EI): calc. for C13H23NO4 (MH+): 258.1705; obs. 257.0740 (C13H23NO4, MH+ -H, 
calc: 257.1627). 
 
 
6-((tert-Butyldimethylsilyloxy)methyl)-N-methoxy-N-methyl-5-methylenehept-6-enamide 
(4.18) 
TBSO N
O
OMe
Me
TBSO OMe
O
4.47 4.18  
Prepared using the procedure detailed for the preparation of 4.17. The amino-aluminate species, 
prepared from Me3Al (10.06 mL of a 2 M solution in toluene, 20.1 mmol) and N,O-
dimethylhydroxylamine hydrochloride (2.06 g, 21.1 mmol) in CH2Cl2 (100 mL), was reacted 
with the silyl ester 4.47 (3.00 g, 10.1 mmol) at reflux for 16 h. Upon work-up, the crude yellow 
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oil was passed through a 5 cm silica plug, eluting with 50% Et2O/petroleum ether, to give 4.18 as 
a colourless oil (2.62 g, 80%). 
 
FTIR (KBr, cm-1): 2955, 2932, 2858, 1670, 1462, 1412, 1385, 1254, 1096, 1003, 899, 837, 780. 
1H NMR (500 MHz, CDCl3): δ 0.07 (s, 6H), 0.91 (s, 9H), 1.81 (qn, 2H), 2.31 (td, J = 7.4, 0.7, 
2H), 2.42 (t, J = 7.3 Hz, 2H), 3.17 (s, 3H), 3.66 (s, 3H), 4.30 (t, J = 1.5 Hz, 2H), 4.93 (s, 1H), 
4.99 (s, 1H), 5.23 (m, 1H), 5.33 (t, J = 1.3 Hz, 1H). 
13C NMR (75 MHz, CDCl3): δ -5.5, 18.2, 23.2, 25.8, 31.2, 32.0, 33.8, 61.0, 63.6, 110.9, 111.2, 
144.9, 145.3, 174.4. 
HRESIMS (EI): calc. for C17H34NO3Si: (MH+) 328.2308; obs. 328.2182. 
 
 
8-((Methoxymethoxy)methyl)-7-methylenenona-1,8-dien-3-one (4.48) 
MOMO N
O
OMe
Me
MOMO
O
4.17 4.48  
Vinyl magnesium bromide (0.39 mL of a 1 M solution in THF, 0.389 mmol) was added 
dropwise to a solution of 4.17 (50 mg, 0.19 mmol) in THF (10 mL) at 0°C. The solution was 
warmed to room temperature and then refluxed for 1 h. The mixture was cooled to 0°C and 
quenched with saturated aqueous NH4Cl solution (20 mL) and extracted with Et2O (20 mL x 3). 
The combined organic extracts were evaporated under reduced pressure to give 4.48 as a brown 
oil which was analytically clean as assessed by 1H NMR spectroscopy. The brown discolouration 
was removed upon purified by flash chromatography on silica, eluting with 10% 
EtOAc/petroleum ether, to give 4.48 as a colourless oil (45.7 mg, 94%). 
 
FTIR (KBr, cm-1): 2939, 2885, 1682, 1597, 1404, 1150, 1103, 1049, 918. 
1H NMR (500 MHz, CDCl3): δ 1.81 (qn, J = 7.4 Hz, 2H), 2.30 (t, J = 7.5 Hz, 2H), 2.60 (t, J = 
7.3 Hz, 2H), 3.37 (s, 3H), 4.22 (d, J = 0.8 Hz, 1H), 4.65 (s, 2H), 5.00 (s, 1H), 5.15 (s, 1H), 5.28 
(s, 1H), 5.30 (s, 1H), 5.80 (dd, J = 1.1, 10.6 Hz, 1H), 6.20 (dd, J = 1.1, 17.7 Hz, 1H), 6.34 (dd, J 
= 10.6, 17.7 Hz, 1H). See Figure 4.14-A 
13C NMR (75 MHz, CDCl3): δ 22.3, 33.2, 38.7, 55.2, 68.3, 95.4, 112.7, 114.2, 127.7, 136.4, 
142.7, 144.7, 200.4. 
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8-((tert-Butyldimethylsilyloxy)methyl)-7-methylenenona-1,8-dien-3-one (4.49) 
TBDMSO N
O
OMe
Me
TBDMSO
O
4.494.18  
Vinyl magnesium bromide (5.85 mL of a 0.783 M solution in THF, 4.584 mmol) was added 
dropwise to 4.18 (500 mg, 1.53 mmol) in THF (50 mL) at 0°C. The solution was warmed to 
room temperature and stirred for 16 h. The mixture was quenched with saturated aqueous NH4Cl 
solution (100 mL) and extracted with Et2O (50 mL x 3). The solvents were removed under 
reduced pressure and the crude material purified by flash chromatography on silica, eluting with 
10% EtOAc/petroleum ether, to give 4.49 as a colourless oil (440 mg, 98%).  
 
FTIR (KBr, cm-1): 2932, 2855, 1682, 1597, 1466, 1404, 1258, 1096, 903, 841, 779. 
1H NMR (500 MHz, CDCl3): δ 0.07 (s, 6H), 0.91 (s, 9H), 1.80 (qn, J = 7.4 Hz, 2H), 2.29 (t, J = 
7.5 Hz, 2H), 2.58 (t, J = 7.3 Hz, 2H), 4.30 (t, J = 1.4 Hz, 2H), 4.91 (s, 1H), 4.99 (d, J = 5.0 Hz, 
1H), 5.21 (d, J = 1.2 Hz, 1H), 5.32 (s, 1H), 5.80 (dd, J = 1.1, 10.6 Hz, 1H), 6.20 (dd, J = 1.1, 
17.7 Hz, 1H), 6.34 (dd, J = 10.6, 17.7 Hz, 1H). 
13C NMR (75 MHz, CDCl3): δ -5.4, 18.3, 22.5, 25.86, 25.94, 33.7, 39.9, 63.7, 111.1, 111.5, 
127.9, 136.5, 144.8, 145.3, 200.5. 
 
 
Methyl 7-(allyldimethylsilyloxy)hept-5-ynoate (4.64) 
O
O
OMeSi
HO
O
OMe
4.42 4.64  
Allylchlorodimethylsilane (470 μL, 3.84 mmol) was added dropwise to a solution of 4.42 (500 
mg, 3.20 mmol) and NEt3 (1.35 ml, 9.61 mmol) in CH2Cl2 (25 mL) at 0°C and stirred for 12 h. 
The reaction mixture was quenched via addition to a saturated solution of aqueous NaHCO3 (100 
mL) and extracted with Et2O (50 mL x 3). The solvents were removed under reduced pressure 
and the crude material purified by flash chromatography on silica, eluting with 5% 
EtOAc/petroleum ether, to give 4.64 as a colourless oil (765 mg, 94%).  
 
FTIR (KBr, cm-1): 2955, 2872, 1742, 1631, 1437, 1371, 1254, 1161, 1078, 839. 
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1H NMR (500 MHz, CDCl3): δ 0.16 (s, 6 H), 1.67 (d, J = 8.0 Hz, 2 H), 1.79-1.86 (qn, 2H), 2.28 
(t, J = 6.7 Hz, 2H), 2.43 (t, J = 7.4 Hz, 2H), 3.67 (s, 3 H), 4.28 (s, 2 H), 4.85-4.93 (m, 2H), 5.77-
5.85 (m, 1H). 
13C NMR (75 MHz, CDCl3): δ -2.5, 18.2, 23.6, 24.3, 32.7, 46.1, 51.4, 79.0, 84.3, 113.8, 133.7, 
173.4. 
 
 
Methyl 5-(2,2-dimethyl-3,6-dihydro-2H-1,2-oxasilin-5-yl)hex-5-enoate (4.65) 
O
O
OMeSi O OMe
Si
4.64 4.65
O
 
Grubbs II catalyst 4.25 (6.6 mg, 7.8 μmol, 2 mol %) was added to a solution of allylsilyl-alkyne 
4.64 (100 mg, 3.93 mmol) dissolved in CH2Cl2 (25 mL) and the reaction mixture heated to 
reflux, whilst being monitored via 1H NMR spectroscopy. Upon completion (ca. 3 h), the 
reaction was cooled to room temperature and concentrated under reduced pressure. The black oil 
was purified by flash chromatography on silica, eluting with 5% EtOAc/petroleum ether, to give 
4.65 as a colourless oil (93 mg, 93%). 
Whilst this material was stable in CDCl3, the use of deuteriopyridine-doped CDCl3 resulted in 
instantaneous decomposition to an unknown compound and the formation of a pink solution. 
 
1H NMR (500 MHz, CDCl3): δ 0.16 (s, 6H), 1.35-1.38 (m, 2H), 1.71-1.78 (qn, 2H), 2.23 (t, J = 
7. 6 Hz, 2H), 2.28 (t, J = 7.5 Hz, 2H), 3.65 (s, 3H), 4.50-4.52 (m, 2H), 4.78 (s, 1H), 4.79 (s, 1H), 
6.00-6.05 (m, 1H). 
13C NMR (75 MHz, CDCl3): δ -1.1, 12.3, 23.3, 33.0, 33.5, 51.0, 63.4, 109.7, 122.1, 137.0, 
145.4, 173.4. 
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7-((Methoxymethoxy)methyl)bicyclo[4.3.1]dec-6-en-2-one (4.69) 
MOMO
O
O
MOMO
H
4.48 4.69  
MOM-triene 4.48 (264 mg, 1.03 mmol), Proton-sponge® (66 mg, 0.31 mmol, 0.3 equiv) and 
benzene (20 mL) were placed in a resealable Carius tube and sparged with argon for 10 min. The 
tube was sealed and heated at 160°C for 40 h. Upon cooling, the solvent was removed under 
reduced pressure and the crude material taken up in Et2O (20 mL) and washed with 1 M aqueous 
HCl solution (5 mL) and water (20 mL). The residue was purified by flash chromatography on 
silica, eluting with 15% EtOAc/petroleum ether, to give 4.69 as a colourless oil (135.5 mg, 
51%). 
 
FTIR (KBr, cm-1): 2943, 2874, 1701, 1442, 1146, 1099, 1045, 941, 918. 
1H NMR (500 MHz, CDCl3): δ 1.38-1.48 (m, 1H), 1.80-1.95 (dddd, J = 2.7, 6.1, 11.6, 13.2 Hz, 
2H), 1.99-2.15 (m, 4H), 2.19 (dd, J = 8.1, 14.2 Hz, 1H), 2.30 (ddd, J = 2.8, 5.5, 11.6 Hz, 1H), 
2.56 (ddd, J = 1.4, 3.5, 13.2 Hz, 1H), 2.62 (td, J = 2.7, 8.5 Hz, 1H), 2.77 (dd, J = 5.8, 12.6 Hz, 
1H), 2.89 (ddd, J = 3.1, 11.6, 13.5 Hz, 1H), 3.34 (s, 3H), 3.83 (d, J = 11.2 Hz, 1H), 4.11 (d, J = 
11.2 Hz, 1H), 4.53 (d, J = 6.6 Hz, 1H), 4.57 (d, J = 6.6 Hz, 1H); See Figure 4.14-B. 
13C NMR (75 MHz, CDCl3): δ 23.98, 24.00, 30.9, 32.5, 33.0, 41.9, 46.6, 55.2, 65.5, 95.3, 130.8, 
141.7, 216.2. 
HRMS (EI): calc. for C13H20O3: 224.1412; obs. 223.1334 (C13H19O3, M+ - H, calc: 223.1339). 
 
 
7-((tert-Butyldimethylsilyloxy)methyl)bicyclo[4.3.1]dec-6-en-2-one (4.71) 
TBSO
O
O
TBSO
H
4.714.49  
Small scale - Pressure Tube: 
TBS-triene 4.49 (100.8 mg, 0.34 mmol), Proton-sponge® (21.8 mg, 0.10 mmol, 0.3 equiv) and 
benzene (10 mL) were placed in a resealable Carius tube and sparged with argon for 5 min. The 
tube was sealed and heated at 160°C for 40 h. The solvent was removed under reduced pressure 
and the crude material taken up in Et2O (10 mL) and washed with 0.5 M aqueous solution HCl (2 
mL) and water (5 mL). The residue was purified by flash chromatography on silica, eluting with 
10% EtOAc/petroleum ether, to give 4.71 as a colourless oil (73.5 mg, 73%). 
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Large scale:  
A solution of TBS-triene 4.49 (2.5 g, 8.5 mmol) in xylene (50 mL) was added over 8 h, via 
syringe pump, to a refluxing solution of Proton-sponge® (0.43 g, 2.0 mmol) in xylene (1.5 L). 
The mixture was refluxed for 40 h at which time complete consumption of the triene material 
was observed to have occurred as assessed by 1H NMR spectroscopy of sample aliquots. The 
solvent was removed under reduced pressure, the residue dissolved in Et2O (100 mL) and 
washed with 0.5 M aqueous HCl solution (20 mL) and water(20 mL x 2). The residue was 
purified by flash chromatography on silica, eluting with 5% EtOAc/petroleum ether, to give 4.71 
as a colourless oil (1.85 g, 80%). 
 
FTIR (KBr, cm-1): 2932, 2858, 1701, 1462, 1254, 1146, 1069, 837, 775. 
1H NMR (500 MHz, CDCl3): δ 0.03 (s, 3H), 0.03 (s, 3H), 0.87 (s, 9H), 1.35-1.45 (m, 1H), 1.80-
1.90 (m, 2H), 1.96-2.11 (m, 4H), 2.16-2.22 (m, 1H), 2.30 (ddd, J = 2.7, 5.7, 11.6 Hz, 1H), 2.50 
(ddd, J = 1.5, 3.4, 13.3 Hz, 1H), 2.60 (m, 1H), 2.75 (ddd, J = 1.6, 6.0, 12.5 Hz, 1H), 2.86 (ddd, J 
= 3.0, 11.6, 13.4 Hz, 1H), 3.91 (d, J = 11.7 Hz, 1H), 4.19 (d, J = 11.7 Hz, 1H). 
13C NMR (75 MHz, CDCl3): δ -5.42, -5.37, 18.2, 23.4, 24.2, 25.8, 30.6, 32.3, 32.7, 41.8, 46.7, 
61.5, 133.9, 138.2, 216.1.  
HRMS (EI): calc. for C17H30O2Si: 294.2015; obs. 279.1749 (C16H27O2Si, M+-Me, calc. 
279.1780), 237.1306 (C13H21O2Si, M+-tBu, calc. 237.1311). 
 
 
7-((Methoxymethoxy)methyl)-tricyclo[4.3.1.16,7]undecan-2-one (4.77) and  
7-((Methoxymethoxy)methyl)-2-methylene-tricyclo[4.3.1.16,7]undecane  (4.78) 
O
MOMO
H
O
MOMO
H
CH2
MOMO
H
4.77 4.784.69  
Et2Zn (803 μL, 0.99 mmol) was added dropwise to a solution of 4.69 (74.1 mg, 0.33 mmol) in 
toluene (10 mL) at 0°C causing gas evolution. After 30 min CH2I2 was added dropwise and O2 
slowly bubbled through the solution for 2 h causing a milky white suspension to form. The 
solution was stirred for 12 h, quenched via the addition of saturated aqueous NH4Cl solution (50 
mL) and extracted with Et2O (20 mL x 3). The solvent was removed under reduced pressure and 
the residue purified by flash chromatography on silica, eluting with 10% EtOAc/petroleum ether, 
to give 4.77 as a viscous oil (29.1 mg, 37%) and 4.78 as a colourless oil (36.6 mg, 47%). 
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7-((Methoxymethoxy)methyl)-tricyclo[4.3.1.16,7]undecan-2-one (4.77)  
FTIR (KBr, cm-1): 3433, 2939, 1697, 1458, 1150, 1103, 1049, 918. 
1H NMR (500 MHz, CDCl3): δ 0.43 (d, J = 4.5 Hz, 1H), 0.59 (d, J = 4.6 Hz, 1H), 1.02-1.10 (m, 
1H), 1.27 (ddd, J = 0.9, 4.4, 15.0, 1H), 1.42 (td, J = 3.4, 14.3, 1H), 1.50 (tdd, J = 1.4, 4.2, 12.8, 
1H), 1.79-1.86 (m, 1H), 1.93-2.08 (m, 4H), 2.27 (dd, J = 2.3, 15.0 Hz, 1H), 2.48-2.54 (m, 2H), 
2.83 (dt, J = 2.3, 12.8 Hz, 1H), 3.27 (d, J = 9.9 Hz, 1H), 3.34 (s, 3H), 3.50 (d, J = 9.9 Hz, 1H), 
4.60 (dd, J = 6.5, 15.2 Hz, 2H). 
13C NMR (75 MHz, CDCl3): δ 23.6, 24.1, 24.8, 25.5, 27.4, 32.3, 35.2, 42.6, 43.5, 53.6, 55.0, 
71.2, 96.2, 218.0. 
HRMS (EI): calc. for C14H22O3: 238.1569; obs. 223.1339 (C13H19O3, M+ - Me, calc. 223.1334). 
 
7-((Methoxymethoxy)methyl)-2-methylene-tricyclo[4.3.1.16,7]undecane  (4.78) 
FTIR (KBr, cm-1): 2939, 2878, 1466, 1373, 1211, 1150, 1088, 1049, 988, 918. 
1H NMR (500 MHz, CDCl3): δ 0.28 (d, J = 4.5 Hz, 1H), 0.32 (d, J = 4.5 Hz, 1H), 0.97 (dd, J = 
6.1, 15.2 Hz, 1H), 1.04 (dt, J = 4.8, 14.4 Hz, 1H), 1.23 (m, 1H) 1.57-1.64 (m, 1H), 1.65-1.84 (m, 
4H), 1.87 (dd, J = 7.5, 14.3 Hz, 1H), 2.00 (dd, J = 1.0, 15.1 Hz, 1H), 2.04 (ddd, J = 2.0, 4.9, 14.2 
Hz, 1H), 2.23 (ttd, J = 1.6, 6.0, 11.1 Hz, 1H), 2.32 (t, J = 13.5 Hz, 1H), 3.36 (s, 3H), 3.47 (d, J = 
10.1 Hz, 1H), 3.55 (d, J = 10.1 Hz, 1H), 4.64 (q, J = 6.6 Hz, 1H), 5.05 (s, 1H), 5.14 (s, 1H). 
13C NMR (75 MHz, CDCl3): δ 20.1, 20.2, 22.2, 24.7, 24.9, 27.1, 28.6, 29.6, 30.6, 37.7, 55.1, 
71.7, 93.7, 96.5, 114.2. 
HRMS (EI): calc. for C15H24O2: 236.1776; obs. 236.1406. 
 
 
7-(tert-Butyldimethylsilyloxymethyl)-tricyclo[4.3.1.16,7]undecan-2-one (4.89) 
O
TBSO
H
O
TBSO
H
4.71 4.89  
Activated zinc powder (1.86 g, 28.4 mmol, 20 equiv) and CuCl (56 mg, 0.57 mmol, 2 mol % 
based on Zn) were placed in a reflux set-up and evacuated for 30 min. Et2O (50 mL) and a single 
crystal of iodine were added and the solution subjected to ultrasound irradiation, causing reflux, 
for 30 min. Sonication was continued as olefin 4.71 (418 mg, 1.42 mmol) was added in one 
portion, followed by the dropwise addition of CH2I2 (1.14 mL, 14.2 mmol, 10 equiv in 5 mL of 
Et2O) over 8 h. Upon completion (ca. 24 h of sonication) the organic layer was separated from 
the solid via decantation. The solid residues were placed on a Celite pad and exhaustively 
Chapter Six – Experimental Details 269 
 
extracted with Et2O, EtOAc and CH2Cl2. The combined organic solvents was removed under 
reduced pressure and the residue purified by flash chromatography on silica, eluting with 5% 
EtOAc/petroleum ether, to give 4.89 as a colourless oil (141.4 mg, 32%). 
 
FTIR (KBr, cm-1): 2858, 2361, 2341, 1697, 1466, 1254, 1072, 837, 775, 667. 
1H NMR (500 MHz, CDCl3): δ 0.03 (s, 3H), 0.04 (s, 3H), 0.29 (d, J = 4.5 Hz, 1H), 0.45 (d, J = 
4.5 Hz, 1H), 0.89 (s, 9H), 1.05 (m, 1H), 1.25 (dd, J = 5.0, 15.0 Hz, 2H), 1.47 (td, J = 4.0, 14.0 
Hz, 1H), 1.69 (m, 1H), 1.79 (m, 1H), 1.90-2.07 (m, 4H), 2.26 (dd, J = 2.0, 15.0 Hz, 1H), 2.50 (m, 
1H), 2.59 (dd, J = 7.5, 12.0 Hz, 1H), 2.80 (dt, J = 2.5, 13.0 Hz, 1H), 3.44 (d, J = 10.5 Hz, 1H), 
3.61 (d, J = 10.5 Hz, 1H). 
13C NMR (75 MHz, CDCl3): δ -5.6, -5.5, 18.2, 24.2, 24.5, 24.9, 25.6, 25.87, 25.92, 26.6, 32.6, 
34.8, 42.7, 43.8, 66.6, 218.1. 
HRMS (EI): calc. for C18H32O2Si: 308.2172; obs. 251.1472 (C14H23O2Si, M+ - tBu, calc: 
251.1467). 
 
 
7-(Hydroxymethyl)bicyclo[4.3.1]dec-6-en-2-one (4.73) 
O
TBSO
H
O
HO
H
4.734.71  
TBAF (1.5 mL of a 1 M solution in THF, 1.5 mmol) was added to 4.71 (405 mg, 1.37 mmol) in 
THF (25 mL) at 0°C resulting in a peach colouration. The solution was stirred for 12 h at room 
temperature. The reaction mixture was quenched via addition to a solution of saturated aqueous 
NaHCO3 solution and water (1:1, 100 mL) and extracted with CH2Cl2 (20 mL x 3). The solvent 
was removed under reduced pressure and the residue purified by flash chromatography on silica, 
eluting with 40% EtOAc/petroleum ether, to give 4.73 as a colourless oil (197 mg, 80%). 
 
FTIR (KBr, cm-1): 3412, 2939, 2870, 1695, 1443, 1142, 1034, 1011. 
1H NMR (500 MHz, CDCl3): δ 1.37-1.46 (m, 1H), 1.79-1.86 (m, 1H), 1.88-1.96 (m, 1H), 2.02-
2.13 (m, 4H), 2.23 (dd, J = 8.2, 14.7 Hz, 1H), 2.29 (ddd, J = 3.1, 5.2, 11.6 Hz, 1H), 2.54 (ddd, J 
= 1.6, 3.6, 13.3 Hz, 1H), 2.61-2.64 (m, 1H), 2.76 (dd, J = 6.1, 11.8 Hz, 1H), 2.91 (ddd, J = 3.0, 
11.1, 21.8 Hz, 1H), 3.96 (d, J = 11.7 Hz, 1H), 4.10 (d, J = 11.7 Hz, 1H). 
13C NMR (75 MHz, CDCl3): δ 23.2, 23.8, 31.2, 32.2, 32.8, 41.7, 46.6, 60.9, 133.6, 139.9, 216.7.  
HRMS (EI): calc for C11H16O2: 180.1150; obs. 162.1051 (C11H14O, M+-H2O, calc: 162.1045).
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7-Hydroxymethyl-tricyclo[4.3.1.16,7]undecan-2-one (4.92) and  
7-Methoxymethyl-tricyclo[4.3.1.16,7]undecan-2-one (4.93) 
O
HO
H
O
HO
H
O
MeO
H
4.92 4.934.73  
Et2Zn (1.519 mL of a 1.236 M solution in toluene, 1.88 mmol) was added dropwise to a solution 
of DME (195 μL, 1.88 mmol) in CH2Cl2 (40 mL) at -15°C (internal temperature) at such a rate 
that the temperature remained constant. After 5 min, CH2I2 (303 μL, 3.76 mmol) was added 
dropwise so that no exotherm occurred. After 15 min at -15°C, 4.73 (169.1 mg, 0.94 mmol) was 
added via cannula in one portion with 2 x 1 mL CH2Cl2 washes and stirred at -15°C for 10 min 
and then at room temperature for 4 h. The mixture was quenched via the addition of saturated 
aqueous NH4Cl solution (100 mL) and extracted with CH2Cl2 (20 mL x 3). The solvents were 
removed under reduced pressure and the residue purified by flash chromatography on silica, 
eluting with 40% EtOAc/petroleum ether, to give the methyl ether 4.93 as a colourless oil (25.4 
mg, 13%) and 4.92 as a colourless oil (133.2 mg, 73%). 
 
7-Hydroxymethyl-tricyclo[4.3.1.16,7]undecan-2-one (4.92)  
FTIR (KBr, cm-1): 3437, 2941, 1698, 1448, 1319, 1170, 959. 
1H NMR (500 MHz, CDCl3): δ 0.36 (d, J = 4.3 Hz, 1H), 0.54 (d, J = 4.3 Hz, 1H), 1.05 (ddd, J = 
7.2, 14.6, 17.1 Hz, 1H), 1.26 (dd, J = 4.5, 15.0 Hz, 2H), 1.42 (dd, J = 5.5, 15.5 Hz, 2H), 1.82-
1.92 (m, 2H), 2.02-2.09 (m, 3H), 2.29 (d, J = 14.9 Hz, 1H), 2.48 (dd, J = 7.0, 11.0 Hz, 1H), 2.86 
(t, J = 12.5 Hz, 1H), 3.33 (d, J = 11.0 Hz, 1H), 3.56 (d, J = 11.0 Hz, 1H). 
13C NMR (75 MHz, CDCl3): δ 23.9, 24.6, 24.8, 25.2, 25.8, 27.2, 32.3, 35.3, 42.5, 43.7, 65.5, 
218.5. 
HRMS (EI): calc C12H18O2: 194.1307; obs. 194.1312. 
 
7-Methoxymethyl-tricyclo[4.3.1.16,7]undecan-2-one (4.93) 
FTIR (KBr, cm-1): 2960, 2874, 1693, 1458, 1196, 1168, 1103, 918. 
1H NMR (500 MHz, CDCl3): δ 0.41 (d, J = 4.4 Hz, 1H), 0.59 (d, J = 4.5 Hz, 1H), 1.02 (m, 1H), 
1.25 (m, 2H), 1.44 (m, 1H), 1.83 (m, 1H), 1.89-2.06 (m, 4H), 2.26 (d, J = 15.0 Hz, 1H), 2.49 (m, 
2H), 2.83 (t, J = 12.8 Hz, 1H), 3.07 (d, J = 9.6 Hz, 1H), 3.30 (s, 3H), 3.37 (d, J = 9.6 Hz, 1H). 
13C NMR (75 MHz, CDCl3): δ 23.8, 24.0, 24.1, 24.9, 25.3, 27.6, 32.4, 35.3, 42.7, 42.6, 58.6, 
76.0, 218.0. 
HRMS (EI): calc for C13H20O2: 208.1463; obs. 208.1467. 
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S-Methyl-O-(2-oxobicyclo[4.3.1.16,7]undecan-7-yl)-methyl dithiocarbonate (4.99) 
O
HO
H
4.92
O
O
H
4.99
S
MeS
 
Alcohol 4.92 (27.6 mg, 0.154 mmol) in THF (1 mL) was added to a solution of NaH (18.5 mg of 
a 60% dispersion in oil, 0.46 mmol) in THF (5 mL) and stirred for 30 min. Imidazole (0.5 mg, 
0.007 mmol, 5 mol %) and carbon disulfide (55.8 μL, 0.93 mmol) were added and the solution 
refluxed for 1 h. The reaction was cooled to room temperature and methyl iodide (115.5 μL, 1.85 
mmol) added in one portion. The solution was refluxed for 1 h. The mixture was cooled, 
quenched via the addition to saturated aqueous NH4Cl solution (50 mL) and extracted with 
CH2Cl2 (10 mL x 3). The solvents were removed under reduced pressure and the residue purified 
by flash chromatography on silica, eluting with 10% EtOAc/petroleum ether, to give 4.99 as a 
yellow oil (29.7 mg, 74%). 
 
FTIR (KBr, cm-1): 2939, 2870, 1697, 1643, 1458, 1319, 1221, 1065, 918, 872. 
1H NMR (500 MHz, CDCl3): δ 0.50 (d, J = 4.8 Hz, 1H), 0.69 (d, J = 4.8 Hz, 1H), 1.11-1.18 (m, 
1H), 1.30 (dd, J = 4.3, 15.0 Hz, 1H), 1.38-1.45 (m, 1H), 1.83-1.90 (m, 1H), 1.90-2.00 (m, 2H), 
2.05-2.15 (m, 2H), 2.35 (d, J = 15.2 Hz, 1H), 2.47-2.53 (m, 2H), 2.55 (s, 3H), 2.90 (dt, J = 2.5, 
12.8 Hz, 1H), 4.38 (d, J = 11.4 Hz, 1H), 4.56 (d, J = 11.4 Hz, 1H). 
13C NMR (75 MHz, CDCl3): δ 19.0, 22.8, 24.2, 25.0, 25.3, 25.9, 27.9, 32.5, 35.3, 42.7, 43.4, 
78.6, 216.4, 217.4. 
HRMS (EI): calc for C14H20O2S20: 284.09047; obs. 284.0911 
 
 
6-Methyl-7-methylenebicyclo[4.3.1]decan-2-one (4.102) and 
8-Methylenebicyclo[4.4.1]undecan-2-one (4.104) 
O
O
H
4.99
S
MeS
O
H
O
H
4.102 4.104  
The xanthate ester 4.99 (11.6 mg, 0.04 mmol), Bu3SnH (41 μL, 1.5 mmol) and AIBN (0.8 mg, 
0.004 mmol) were dissolved in benzene (25 mL) and degassed with a flow of argon for 5 min 
before being heated to reflux for 2 h. The solution was cooled to room temperature and the 
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solvent removed under reduced pressure. The crude material contained a mixture of 4.104 [δH 
4.66 (d, J = 2.2 Hz, 1H), 4.76 (s, 1H)] and 4.102 [δH 4.62 (qn, J = 1.85 Hz, 2H)] in a ratio of 5:1 
based on 1H NMR integration values. The residue was purified by flash chromatography on 
silica, eluting with 5% EtOAc/petroleum ether to give 4.104 (8 mg, 74%), contaminated with a 
small amount of tin residues. 
 
FTIR (KBr, cm-1): 2932, 2862, 1705, 1458, 1265, 1072, 1026, 802. 
1H NMR (500 MHz, CDCl3): δ 1.21-1.27 (m, 1H), 1.61-1.75 (m, 5H), 1.99 (dd, J = 7.0, 15.3 Hz, 
1H), 2.13-2.22 (m, 3H), 2.26-2.38 (m, 4H), 2.65-2.73 (m, 2H), 4.66 (d, J = 2.4 Hz, 1H), 4.76 (d, 
J = 1.2 Hz, 1H). 
13C NMR (75 MHz, CDCl3): δ 20.9, 29.4, 32.3, 34.8, 35.0, 35.5, 37.0, 42.7, 48.5, 111.4, 148.6, 
214.9. 
HRMS (EI): calc for C12H18O: 178.1358; obs. 178.1360 
 
 
6-Methyl-7-methylenebicyclo[4.3.1]decan-2-ol (4.105) and  
(±)-(2S)-8-Methylenebicyclo[4.4.1]undecan-2-ol (4.106) and 
(±)-(2R)-8-Methylenebicyclo[4.4.1]undecan-2-ol (4.107) 
O
O
H
4.99
S
MeS
OH
H
OH
H
4.105 4.106
OH
H
4.107  
The xanthate ester 4.99 (89.8 mg, 0.126 mmol), Bu3SnH (255 μL, 0.378 mmol) and AIBN (15.5 
mg, 0.04 mmol) were dissolved in toluene (10 mL) and heated to reflux for 30 min. The solution 
was then cooled to -78°C and DIBAL-H (3.6 mL of 0.35 M solution in hexanes, 0.50 mmol) 
added dropwise. The mixture was stirred for 30 min at -78°C and then for 90 min at 0°C before 
quenching with the addition of saturated aqueous Na/K-tartrate solution (30 mL). The solution 
was vigorously stirred for 1h and then extracted with EtOAc (25 mL x 3). The solvents were 
removed under reduced pressure and the residue purified by flash chromatography on silica, 
eluting with 10% EtOAc/petroleum ether to give the two alcohol diastereoisomers of 4.106 (36 
mg, 63%) and 4.107 (7.5 mg, 13%) as yellow oils. The desired bicyclo[4.3.1]decane 4.105 eluted 
subsequently, but was unable to be separated from co-eluting contaminants. 
 
Chapter Six – Experimental Details 273 
 
(±)-(2S)-8-Methylenebicyclo[4.4.1]undecan-2-ol (4.106)  
FTIR (KBr, cm-1): 3341, 2870, 1643 (w), 1450, 1358, 1296, 1026, 887. 
1H NMR (500 MHz, CDCl3): δ 1.27-1.36 (m, 1H), 1.43-1.80 (m, 8H), 1.97-2.10 (m, 3H), 2.15-
2.33 (m, 4H), 3.82 (dt, J = 2.8, 5.9 Hz, 1H), 4.62 (dd, J = 1.2, 2.5 Hz, 1H), 4.74 (d, J = 2.2 Hz, 
1H). 
13C NMR (75 MHz, CDCl3): δ 20.8, 29.9, 31.6, 33.1, 34.7, 34.8, 36.0, 43.2, 43.8, 73.0, 112.1, 
150.2.  
HRMS (EI): calc for C12H20O: 180.1514; obs. 180.1512. 
 
(±)-(2R)-8-Methylenebicyclo[4.4.1]undecan-2-ol (4.107) 
FTIR (KBr, cm-1): 3356, 2324, 2862, 1643 (w), 1458, 1026, 887. 
1H NMR (500 MHz, CDCl3): δ 1.17-1.34 (m, 3H), 1.47-1.67 (m, 3H), 1.80 (ddd, J = 8.2, 15.5, 
22.9 Hz, 1H), 1.85-1.92 (m, 1H), 1.94-2.05 (m, 2H), 2.22 (m, 2H), 2.21-2.29 (m, 1H), 2.39 (dd, J 
= 7.4, 13.4 Hz, 1H), 3.72 (td, J = 4.8, 10.1 Hz, 1H), 4.60 (s, 1H), 4.76 (d, J = 2.6 Hz, 1H). 
13C NMR (75 MHz, CDCl3): δ 21.6, 25.9, 30.96, 31.01, 33.9, 34.1, 35.2, 41.9, 45.9, 77.7, 112.5, 
150.8. 
HRMS (EI): calc for C12H20O: 180.1514; obs. 180.1507. 
 
6-Methyl-7-methylenebicyclo[4.3.1]decan-2-ol (4.105)  
Characteristic data: 1H NMR (500 MHz, CDCl3): δ 4.60 (s, 1H), 4.75 (s, 1H). 
 
 
(±)-(2S)-8-Methylenebicyclo[4.4.1]undecan-2-yl 3,5-dinitrobenzoate (4.108)  
O
H
4.108
O
NO2
NO2
OH
H
4.106  
3,5-Dinitrobenzoyl chloride (69.1 mg, 0.3 mmol) in 2 mL of CH2Cl2 was added via cannula to a 
solution of the alcohol 4.106 (36 mg, 0.2 mmol), Et3N (104 μL, 0.75 mmol) and DMAP (5 mg, 
0.04 mmol) in CH2Cl2 (5 mL) at 0°C. The addition resulted in the formation of a deep red 
solution which was stirred at room temperature for 16 h. The solution was quenched via the 
addition of saturated aqueous NH4Cl solution (20 mL) and extracted with EtOAc (10 mL x 3). 
The solvents were removed under reduced pressure and the residue purified by flash 
chromatography on silica, eluting with 10% EtOAc/petroleum ether to give 4.108 as a yellow 
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solid (31 mg, 54%). The solid was crystallized from an Et2O:pentane solution to give yellow 
needles, which were subjected to X-ray diffraction to obtain the crystallographic structure 
depicted in Figure 4.21. [P-1, Z = 2, R = 3.4%]. 
 
mp: 108-109°C. 
FTIR (KBr, cm-1): 3101, 2928, 2874, 2361, 2341, 1724, 1628, 1547, 1462, 1346, 1281, 1173, 
1076, 961, 910, 729. 
1H NMR (500 MHz, CDCl3): δ 1.31 (t, J = 12.5 Hz, 1H), 1.42 (q, J = 12.7 Hz, 1H), 1.54(q, J = 
12.8 Hz, 1H), 1.69-1.78 (m, 2H), 1.82 (q, J = 12.9 Hz, 1H), 1.94 (t, J = 8.3 Hz, 1 H), 1.97-2.16 
(m, 4H), 2.27 (m, 2H), 2.43 (dd, J = 7.5, 13.2 Hz, 1H), 2.51 (m, 1H), 4.66 (s, 1H), 4.82 (s, 1H), 
5.18 (dt, J = 4.8, 11.5 Hz, 1H), 9.09 (s, 2H), 9.20 (s, 1H). 
13C NMR (75 MHz, CDCl3): δ 21.3, 26.8, 30.6, 30.8, 31.5, 33.7, 33.8, 39.1, 45.7, 82.5, 113.1, 
122.1, 129.2, 134.6, 148.5, 150.1, 161.6. 
HRMS (EI): an accurate mass could not be obtained. A single ion with a m/z of 195, (C7H3N2O5) 
derived from cleavage of the 3,5-dinitrobenzoyl ester bond was observed. 
 
 
7-(tert-Butyldimethylsilyloxymethyl)-12,12’-dichlorotricyclo[4.3.1.16,7]undecan-2-one 
(4.143) 
O
TBSO
O
TBSO
Cl
Cl
4.71 4.143  
50% Aqueous NaOH solution (10 mL) was added to a solution of the olefin 4.71 (200 mg, 0.68 
mmol) and tetraethylammonium chloride (12 mg, 0.068 mmol) in CHCl3 (20 mL) at 0°C and 
stirred vigorously for 12 h at room temperature forming a white emulsion. The reaction was 
quenched via dilution with water (50 mL) and extracted with CH2Cl2 (20 mL x 3). The solvents 
were removed under reduced pressure and the residue purified by flash chromatography on 
silica, eluting with 5% EtOAc/petroleum ether to give 4.143 as a colourless oil (215 mg, 84%). 
 
FTIR (KBr, cm-1): 2955, 2930, 2858, 1701, 1472, 1464, 1256, 1097, 854, 837, 777. 
1H NMR (500 MHz, CDCl3): δ 0.93 (s, 3H), 0.95 (s, 3H), 1.78 (s, 9H), 2.39-2.52 (m, 2H), 2.69-
2.98 (m, 8H), 3.11 (d, J = 15.1 Hz, 1H), 3.39-3.46 (m, 2H), 3.74 (t, J = 21.7 Hz, 1H), 4.54 (m, 
1H). 
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13C NMR (75 MHz, CDCl3): δ -5.7,-5.6, 18.1, 20.0., 22.7, 23.9, 25.7, 28.0, 31.6, 34.1, 34.2, 
42.0, 42.1, 63.7, 75.9, 215.6.  
HRMS (EI): calc. for C18H3035Cl2O2Si: 376.1392, obs. 319.0688 (C14H2135Cl2O2Si, M+ - tBu, 
calc: 319.0688), 340.1610 (C18H2935Cl1O2Si, M+ - HCl, calc. 340.1625). 
 
 
12,12’-Dichloro-7-hydroxymethyl-tricyclo[4.3.1.16,7]undecan-2-one (4.144) 
O
TBSO
Cl
Cl
O
HO
Cl
Cl
4.143 4.144  
TBAF (0.64 mL of a 1.0 M solution in THF, 0.64 mmol) was added to a solution of 4.143 (200 
mg, 0.53 mmol) in THF (20 mL) at 0°C and stirred at room temperature 12 h. The reaction was 
quenched via the addition of H2O (100 mL) and extracted with EtOAc (20 mL x 3). The solvents 
were removed under reduced pressure and the residue purified by flash chromatography on 
silica, eluting with 40% EtOAc/petroleum ether to give 4.144 as a colourless oil which readily 
solidified to an amorphous mass upon standing (131 mg, 94%). The solid was recrystallised from 
Et2O:hexane to yield large crystalline plates which were subjected to X-ray diffraction to obtain 
the crystallographic structure depicted in Figure 4.30, [P-1, Z = 2, R = 2.6%]. 
 
mp: 106-108°C. 
FTIR (KBr, cm-1): 3422, 2955, 2870, 1695, 1456, 1034, 851. 
1H NMR (500 MHz, CDCl3): δ 1.32-1.40 (m, 1H), 1.58-1.64 (m, 1H), 1.72-1.79 (m, 1H), 1.91 
(ddd, J = 1.6, 4.4, 15.2 Hz, 1H), 1.95-2.13 (m, 5H), 2.25 (d, J = 14.5 Hz, 1H), 2.45-2.49 (m, 1H), 
2.53-2.58 (m, 1H), 2.91 (dt, J = 2.4, 12.8 Hz, 1H), 3.66 (q, J = 11.6 Hz, 1H). 
13C NMR (75 MHz, CDCl3): δ 19.1, 22.2, 24.7, 28.4, 31.9, 34.9, 35.2, 41.9, 42.2, 63.6, 76.0, 
216.0. 
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S-Methyl-O-(12,12’dichloro-2-oxobicyclo[4.3.1.16,7]undecan-7-yl)-methyl dithiocarbonate 
(4.145) 
O
O
Cl
Cl
MeS
S
O
HO
Cl
Cl
4.144 4.145  
The dichloro-xanthate ester was prepared via a method analogous to that used for the preparation 
of cyclopropyl-xanthate ester 4.99. Using these conditions 4.144 (37.5 mg, 0.143 mmol) was 
converted to the xanthate ester 4.145 (32 mg, 64%), which was isolated as a yellow oil following 
flash chromatography on silica, eluting with 10% EtOAc/petroleum ether. 
 
FTIR (KBr, cm-1): 2934, 1701, 1460, 1448, 1290, 1070, 955, 854, 733. 
1H NMR (500 MHz, CDCl3): δ 1.37-1.47 (m, 1H), 1.71 (td, J = 8.7, 16.0 Hz, 1H), 1.76-1.81 (m, 
1H), 1.91-1.98 (m, 2H), 2.01-2.12 (m, 4H), 2.33 (d, J = 15.2 Hz, 1H), 2.48-2.53 (m, 1H), 2.56-
2.60 (m, 1H), 2.57 (s, 3H), 2.94 (dt, J = 2.4, 13.1 Hz, 1H), 4.52 (d, J = 11.4 Hz, 1H), 4.61 (d, J = 
11.4 Hz, 1H). 
13C NMR (75 MHz, CDCl3): δ 19.0, 20.0, 22.2, 24.8, 28.4, 32.1, 32.2, 35.6, 42.9, 74.9, 75.0, 
214.9, 215.6. 
HRMS (EI): calc. for C14H1835Cl2O2S2: 352.0125; obs. 244.0416 (C12H14Cl2O, M+ - 
MeSC(S)OH, calc. 244.0422). 
 
 
7-Bromomethy-12,12’-dichloro-tricyclo[4.3.1.16,7]undecan-2-one (4.146) 
O
HO
Cl
Cl
O
Br
Cl
Cl
4.144 4.146  
Bromine (122 mg, 0.77 mmol) in CH2Cl2 (1 mL) was added dropwise to a solution of 
triphenylphosphine (210 mg, 0.8 mmol) in CH2Cl2 (5 mL) at 0°C resulting in immediate 
decolouration. The solution was stirred at 0°C for 30 min before 4.144 (100 mg, 0.382 mmol) 
was added via cannula in 1 mL of CH2Cl2 (10 mL x 4). The reaction mixture was stirred for 12 h 
at room temperature and then quenched with the addition of a saturated aqueous solution of 
NaHCO3 (20 mL) and extracted with CH2Cl2. The solvent was removed under reduced pressure 
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and the residue purified by flash chromatography on silica, eluting with 5% EtOAc/petroleum 
ether, to give 4.146 as a colourless oil (89 mg, 72%). 
 
FTIR (KBr, cm-1): 2951, 2866, 2361, 2341, 1701, 1655, 1458, 1231, 1180, 1061, 1026, 903, 
849, 733, 617. 
1H NMR (500 MHz, CDCl3): δ 1.31-1.41 (m, 1H), 1.69-1.75 (m, 2H), 1.94 (ddd, J = 1.1, 4.3, 
15.2 Hz, 1H), 1.97-2.10 (m, 5H), 2.30 (dd, J = 1.7, 15.1 Hz, 1H), 2.43-4.48 (m, 1H), 2.58-2.60 
(m, 1H), 2.92 (dt, J = 2.5, 13.1 Hz, 1H), 3.37 (d, J = 10.2 Hz, 1H), 3.50 (d, J = 10.2 Hz, 1H). 
13C NMR (75 MHz, CDCl3): δ 21.2, 22.4, 25.2, 29.0, 32.3, 33.9, 37.3, 37.9, 41.8, 42.4, 76.6, 
215.0. 
HRMS (EI): calc. for C12H1579Br35Cl2O: 323.9683; obs. 288.9995 (M+ - Cl, C12H1579Br35ClO, 
calc: 288.9995), 245.0494 (M+ - Br, C12H1535Cl2O, calc: 245.0500). 
 
7,7-dichloro-8-methylenebicyclo[4.4.1]undecan-2-one (4.148) 
O
Br
Cl
Cl
O
Cl
Cl
4.1484.146
O
ClCl
4.147  
Bromo adduct 4.146 (62 mg, 0.19 mmol) was added to a solution of activated Zn dust (125 mg, 
10 equiv) and two drops of glacial acetic acid in EtOH (25 mL) and heated to reflux for 6 h. The 
solution was cooled and passed through a Celite® plug, eluting with EtOAc to remove solid 
materials. The combined organic solvent was removed under reduced pressure and the residue 
purified by flash chromatography on silica, eluting with 5% EtOAc/petroleum ether to give 
4.148 as a colourless oil (39 mg, 83%). 
 
FTIR (KBr, cm-1): 2937, 2866, 1685, 1448, 1346, 1136, 1094, 912, 733, 648. 
1H NMR (500 MHz, CDCl3): δ 1.72-1.85 (m, 2H), 1.98-2.04 (m, 1H), 2.05-2.11 (m, 1H), 2.17-
2.24 (m, 1H), 2.26-2.31 (m, 1H), 2.35-2.39 (m, 1H), 2.41-2.47 (m, 2H), 2.54-2.59 (m, 2H), 2.74-
2.84 (m, 2H), 3.03 (td, J =  3.8, 12.2 Hz, 1H), 5.23 (t, J = 1.3 Hz, 1H), 5.26 (s, 1H).  
13C NMR (75 MHz, CDCl3): δ 26.5, 29.2, 29.6, 30.0, 32.7, 35.5, 36.1, 42.1, 42.3, 45.3, 117.8, 
147.7, 213.8. 
HRMS (EI): calc. for C12H1635Cl2O: 246.0578; obs. 210.0810 (M+ - HCl, C12H1535ClO, calc: 
210.08114). 
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6.5 X-Ray Crystallographic Data 
 
Table 6.1 lists the crystallographic data and X-ray experimental details for the three crystal 
structures described in this thesis. Complete crystallographic data and structure refinement tables 
including atomic coordinates, anisotropic displacement parameters and hydrogen atom 
coordinates are available from the Chemistry Department of the University of Canterbury.  
 
All measurements were made with a Seimens P4 four circle diffractometer, using a Siemens 
SMART 1K CCD area detector and irradiating the sample with graphite monochromated MoKα 
(λ 0.71073 Ǻ) radiation. The crystals were mounted 5.5 cm from the detector. The data was 
collected by the SMART program49 and data reduction was performed using SAINT.50 Intensities 
were corrected for Lorentz and polarization effects and for adsorption using SADABS.51 The 
structures were solved by direct and vector methods and refined using the SHELXTL52 program. 
All non-hydrogen atoms were refined with anisotropic displacement parameters. Hydrogen 
atoms were placed at calculated ideal positions and refined using a riding model. 
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Table 6.1 Crystal data and X-ray experimental details for 3.83, 4.108 and 4.144. 
Compound 3.84 4.108 4.144 
Empirical Formula  C20H24N2O7 C19H22N2O6 C12H16Cl2O2 
Formula Weight  404.41 374.39 263.15 
Temperature (K) 90(2) 273(2) 273(2) 
Crystal system  Monoclinic Triclinic Triclinic 
Space group  P21/c P-1 P-1 
Unit cell dimensions: a (Å) 13.7761(9) 7.6788(5) 6.5166(3) 
Unit cell dimensions: b (Å) 6.5610(3) 11.7696(8) 7.8814(4) 
Unit cell dimensions: c (Å) 21.5742(4) 11.8737(8) 12.3504(7) 
Unit cell dimensions: α (°) 90.00 112.9560(10) 80.6830(10) 
Unit cell dimensions: β (°) 91.6100(10) 105.8940(10) 89.5060(10) 
Unit cell dimensions: γ (°) 90.00 100.8480(10) 66.1070(10) 
Volume (Å3) 1949.2(2) 896.06(10) 571.51(5) 
Z 4 2 2 
Density (calculated) Mg/m3 1.378 1.388 1.529 
Adsorption coefficient (mm-1) 0.105 0.104 0.549 
F (000) 856 396 276 
Crystal size 0.59x0.41x0.12 0.47x0.25x0.09 0.80x0.37x0.10 
Theta range for data collection (°) 1.89 to 26.39 1.99 to 26.43 1.67 to 28.85 
Reflections collected 16453 11619 5906 
Independent reflections [R(int)] 3955 3632 2639 
Data / restraints / parameters  3955 / 0 / 263 3632 / 0 / 244 2639 / 0 / 146 
Goodness-of-fit on F^2  1.034 1.031 0.942 
R [I > 2σ(I)] 0.0364 0.0336 0.0245 
Rw [I > 2σ(I)] 0.0480 0.0387 0.0256 
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